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SUMMARY 
 
CACNA1C codes for the alpha-1 subunit of Cav1.2 L-type voltage gated calcium 
channels (LVGCCs).  Variation in CACNA1C has been reliably implicated in psychiatric 
illness, including schizophrenia and bipolar disorder. Analyses have indicated a 
convergence of genetic risk for schizophrenia on abnormalities in the synapse and in 
behaviours including associative learning.  LVGCCs play a role in synaptic plasticity and 
learning, partly through regulation of gene transcription.  Their role in specific aspects of 
associative learning that are relevant for symptoms of psychiatric illness is yet to be fully 
elucidated. 
A hippocampal-dependent fear conditioning paradigm was used to determine the role of 
Cacna1c and LVGCCs in specific aspects of associative learning in rats.  Studies 
measured the activity-regulated expression of Cacna1c and the effect of inhibition of 
LVGCCs.  A genetic Cacna1c knockdown rat model was used to investigate the effects 
of reduced expression on behaviour and the expression of brain derived neurotrophic 
factor (BDNF).  This model was additionally tested on reward-based reversal-learning.  
Analyses were translated to humans, to assess whether disease relevant variation in 
CACNA1C was associated with similar deficits in reversal learning and expression.  
Inhibition of LVGCCs affected the consolidation, extinction and latent inhibition of 
contextual fear memory, whereas reduced expression of Cacan1c had a selective effect 
on latent inhibition.  There were no effects on the acquisition of reward associations, but 
reversal learning was impaired.  Similar deficits in reversal learning were associated with 
disease relevant variation in CACNA1C in humans.  Reduced CACNA1C expression 
was found to be associated with changes in the expression of BDNF in both rats and 
humans.   
Results indicate a role for Cacna1c and LVGCCs in the appropriate formation and 
update of aversive and reward associations.  Impairments in these processes can 
underlie specific symptoms of disease including emotion dysregulation and delusions.  
The cross-species effects on BDNF require further investigation.  
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1 INTRODUCTION 
 The association of CACNA1C and L-type voltage gated calcium 
channels (LVGCCs) with psychiatric disorders 
The dysfunction of calcium channels, and calcium signalling more broadly, is robustly 
identified as playing a key role in the pathophysiology of multiple psychiatric illnesses 
including schizophrenia and bipolar disorder (Casamassima et al., 2010; Imbrici et 
al., 2013; Berger and Bartsch, 2014; Heyes et al., 2015).   
Schizophrenia affects approximately 1 % of the general population (Sullivan et al., 
2003).  It is a severe, debilitating disorder characterised by a broad spectrum of 
positive, negative and cognitive symptoms.  Positive symptoms include delusions, 
hallucinations and thought disorder and are considered to be the key symptoms of 
psychosis (Andreasen et al., 1990).  Current treatments for schizophrenia primarily 
focus on the alleviation of these positive symptoms through the use of anti-
psychotics, which primarily target the regulation of the dopamine system (Nordström 
et al., 1993; Gurevich et al., 1997).  Negative symptoms tend to include dysregulation 
of emotion, flat affect and apathy and cognitive symptoms are evident by impairments 
in memory, executive function and attention (Andreasen, 1982; Andreasen et al., 
1995). Onset of symptoms usually occurs in adolescence / early adulthood, though 
cognitive deficits can be observed in pre-psychotic high risk individuals (Lencz et al., 
2006; Simon et al., 2007).   
Twin studies and adoption studies have found that schizophrenia is highly heritable 
with estimates of heritability ranging from 65 - 80 % (Cardno and Gottesman, 2000; 
Sullivan et al., 2003).  Similarly, high levels of heritability (approximately 85 %) have 
been reported for bipolar disorder (McGuffin et al 2003).  Although symptom 
presentation differs, there is a significant overlap of genetic risk between the two 
disorders (International Schizophrenia Consortium et al., 2009; Lichtenstein et al., 
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2009; Moskvina et al., 2009).  Bipolar disorder is a mood disorder characterised by 
episodes of mania and depression with additional cognitive dysfunction.  Mania is 
often accompanied by impulsivity, high risk behaviours and psychosis, (Bourne et al., 
2013; Østergaard et al., 2013).   
The strong genetic component of these and other related psychiatric disorders, has 
led to studies which aim to identify specific genetic variation which may underlie their 
etiology.  Determining the function of the genes identified can contribute to the 
understanding of the neurobiological mechanisms which may be underlying illness.   
These disorders are highly complex, with interactions between multiple genetic and 
environmental factors (Sullivan et al., 2003).  They are not associated with a single 
gene mutation, instead being highly polygenic, with multiple genetic variants making 
potentially small contributions to overall vulnerability to disease (International 
Schizophrenia Consortium et al., 2009).   The advances in large scale genetic 
analyses over the last ten years, have led to the identification of over 100 genetic risk 
loci for schizophrenia (Ripke et al., 2014).  Multiple methods have robustly identified 
risk associated variation in specific channel subunits of voltage gated calcium 
channels, as well as indicating a convergence of risk on calcium signalling more 
broadly. 
 Genome-wide association studies (GWAS) 
GWAS rely on large sample sizes to detect variation within the whole genome that is 
associated with specific disorders or phenotypes.  They are primarily utilised for 
identifying common variation with potentially small effect sizes (odds ratios of < 1.2). 
This is particularly useful when investigating complex polygenic disorders, such as 
bipolar or schizophrenia (Hirschhorn and Daly, 2005).  One of the first and most 
robust findings of an association between LVGCCs and psychiatric illness, was 
between common variation in the CACNA1C gene and bipolar disorder. The single 
nucleotide polymorphism (SNP) rs1006737 was found to be significantly associated 
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with risk for bipolar disorder in a combined analysis of two GWAS (Wellcome Trust 
Case Control Consortium and STEP-UCL data), with the A allele conferring increased 
risk compared to the G allele (Sklar et al., 2008).  This association was confirmed in 
a later study which included a new data set, increasing the sample size to 4,387 
cases and 6,209 controls (Ferreira et al., 2008).  The identified variant lies within a 
non-coding region, in intron 3 of the CACNA1C gene and is thought to be associated 
with altered gene expression (Gershon et al., 2014; Roussos et al., 2014; Yoshimizu 
et al., 2014), though results are inconclusive.  
The investigation of association between rs1006737 and schizophrenia was 
subsequently conducted; given the mounting evidence supporting the overlap 
between genetic underpinnings of disorders involving psychotic phenotypes 
(Craddock et al., 2009).  It was found that the same common variant was associated 
with increased risk for schizophrenia with the same effect size (Nyegaard et al., 
2010). 
Since the original association was identified between rs1006737 and both bipolar and 
schizophrenia, multiple studies have confirmed this in different population samples 
(e.g. Green et al., 2009; Lee et al., 2013; Ripke et al., 2013; He et al., 2014; Porcelli 
et al., 2015).  The latest Psychiatric Genetics Consortium GWAS identifying 108 
significant loci, found SNPs in multiple calcium channel subunits associated with 
increased risk of schizophrenia (Ripke et al., 2014).  Including the replication of the 
association with CACNA1C, they found an association with variants in CACNB2 and 
CACNA1I.  The variation in CACNA1C was found to be strongest at rs2007044, which 
is also located in intron 3 of the gene. 
Further studies have also identified other risk SNPs that are not in linkage 
disequilibrium (LD) with rs1006737, within the same intronic region of CACNA1C.  
Linkage disequilibrium refers to the non-random association between alleles at 
different loci (Reich et al., 2001).  The identification of risk SNPs not in LD, indicates 
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that there may be independent signals within intron 3 of CACNA1C that confer risk 
for bipolar disorder and schizophrenia. For example, the risk SNP rs4765905 was 
found to be associated with schizophrenia in a new cohort including patients 
attending a clozapine clinic (CLOZUK)(Hamshere et al., 2013).  The identified risk 
variation in intron 3 has been postulated to affect interactions with the CACNA1C 
promoter region and therefore alter its expression (Roussos et al., 2014). 
Cross disorder association with rs1006737 and other risk SNPs suggests that 
common variation in CACNA1C is associated with symptom clusters that are shared 
between disorders, rather than a specific diagnosis.  Variants in CACNA1C and 
CACNB2 have been found to have shared effects across 5 disorders; attention deficit 
hyperactivity disorder (ADHD), autism spectrum disorder, bipolar disorder, major 
depressive disorder and schizophrenia (Smoller et al., 2013); though largest effects 
were observed for bipolar and schizophrenia.  This highlights the value of 
understanding the functional relevance of common variation to specific symptoms, 
rather than within rigid diagnostic boundaries. 
 Rare deleterious mutations 
In addition to common variation in individual calcium channel subunits, an enrichment 
in rare (less than 1 in 10,000 people) deleterious mutations has been found within 
voltage gated calcium channels associated with schizophrenia. Purcell et al., (2014) 
conducted a large scale exome sequencing study to investigate the polygenic burden 
of rare mutations in schizophrenia.  They found that patients had a higher rate of rare 
disruptive mutations compared to controls, with a significant enrichment in a calcium 
ion channel gene-set.  This enrichment was driven primarily by the pore-forming 
alpha-1 subunits and the alpha-2-delta auxiliary subunits of VGCCs.  The alpha-1 
subunits of LVGCCs were found to carry the most mutations in patients, with two 
deleterious mutations identified in the CACNA1C gene.  These are found to be 
protein-truncating and hypothesised to lead to loss of protein function.  Due to the 
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rarity of these variants, carriers are likely to have one functional copy of CACNA1C, 
indicating reduced rather than a loss of CACNA1C expression. 
Rare mutations have also been identified in other calcium channel subunits in relation 
to autism spectrum disorder (For review see Schmunk and Gargus, 2013).  
CACNA2D3 has been implicated through the identification of deleterious de novo 
mutations in a large exome sequencing study (Rubeis et al., 2014), as well as studies 
of copy number variants (Girirajan et al., 2013).  Copy number variants refer to 
sections of the genome which may be duplicated or deleted and the number of copies 
varies between individuals. CACNA2D3 codes for an alpha-2-delta auxiliary subunit 
of VGCCs and regulates their abundance at the synapse (Hoppa et al., 2012).  In the 
same exome sequencing study conducted by Rubeis et al., (2014) five mutations 
were identified in CACNA1D, coding for the Cav1.3 channel subtype of LVGCCs.  A 
summary of calcium channel associated risk for psychiatric illness is presented in 
Table 1.1. 
 Timothy syndrome 
Single gene psychiatric disorders are fairly rare; however, mutations in the CACNA1C 
gene have been found to cause Timothy Syndrome.  This is an autosomal dominant 
developmental disorder characterised by heart abnormalities, specifically long QT 
syndrome, which can cause arrhythmias and sudden death.  Individuals with the 
disorder also suffer from webbing of the fingers and toes and approximately half of 
those diagnosed have severe facial dysmorphologies.  It has been found that people 
who suffer with this disorder also present with symptoms of autism and autistic-like 
spectrum traits (Splawski et al., 2004).  Children appear to have reduced socialisation 
skills as well as a developmental delay in language and speech, with evidence of 
learning disability and seizures. 
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There are different types of Timothy Syndrome, all known to be caused by gain of 
function mutations in CACNA1C (Splawski et al., 2004; Barrett and Tsien, 2008).  
Type 1, also known as the classic type, is caused by mutations in exon 8 of the gene, 
leading to prolonged depolarisation of the associated Cav1.2 channel and excessive 
calcium to enter the cell.  Type 2, known as the atypical type, causes a more severe 
form of long QT syndrome and is caused by mutations in exon 8A.  A novel mutation 
was later identified in exon 38, causing type 3 (Gillis et al., 2011).  A rare case study 
in a patient with Timothy Syndrome that survived to adulthood, reported the 
development of bipolar disorder (Gershon et al., 2014).  In the same study, it was 
found that the previously identified risk allele at rs1006737 was associated with 
decreased expression of CACNA1C.  It was concluded that both increases and 
decreases in calcium influx in excitable cells may be related to bipolar disorder.    
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Table 1.1 Summary of evidence indicating variation in LVGCCs associated with psychiatric 
illness 
 
 Convergence on calcium signalling pathways 
Further analysis across GWAS, in conjunction with gene expression data, supports 
the involvement of calcium signalling in schizophrenia and other psychiatric 
disorders.  Hertzberg et al., (2015) integrated data from a large-scale genome wide 
expression dataset on post-mortem brain samples with GWAS data, to identify 
biological pathways and processes that may be implicated in schizophrenia.  They 
reported significant enrichment in pathways which included ion channels and 
specifically calcium channel activity.   
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Other genes and biological processes have been identified in genetic analyses, which 
may not directly include LVGCCs, but do implicate calcium signalling dysregulation 
in psychiatric illness.  There has been growing evidence of convergence of identified 
risk on the function of the synapse and its involvement in plasticity (For review see 
Hall et al., 2015).  An exome sequencing study found that small de novo mutations in 
patients with schizophrenia were enriched in glutamatergic post synaptic proteins and 
those that are involved in the strengthening of synapses and plasticity (Fromer et al., 
2014).  Synaptic plasticity is known to require calcium influx through N-methyl-D-
aspartate receptors (NMDAR) and VGCCs, resulting in the induction of new gene 
expression (West et al., 2001; Moosmang et al., 2005).     
Two of the genes known to be regulated by calcium influx are activity regulated 
cytoskeletal-associated protein (ARC) and brain derived neurotrophic factor (BDNF) 
(Zheng et al., 2009, 2011).  Pathway enrichment analyses have identified a role for 
neurotrophin signalling in schizophrenia (Chang et al., 2015), and the ARC complex 
was found to be associated in the de novo exome sequencing study mentioned above 
(Fromer et al., 2014).  The post-synaptic density gene set identified in this study also 
included CAPN5, a gene for a calcium activated protease, which evidence has 
suggested can be activated by VGCCs in dendrites (Kanamori et al., 2013).  Studies 
have also identified an association between both autism and schizophrenia and 
deletions in NRXN1, which encodes a synaptic adhesion protein (e.g. Kirov et al., 
2009; Rujescu et al., 2009).  This gene has been found to be important for the 
organisation of VGCCs in the synapse and their coupling to pre-synaptic machinery 
that is required for neurotransmitter release (Missler et al., 2003). 
Variation in CACNA1C and dysfunction of LVGCCs more broadly, clearly has a 
robust association with risk for schizophrenia and related disorders.  The involvement 
of calcium signalling in convergent areas of risk, highlights the need to investigate its 
role in specific biological processes implicated in psychiatric disorders and 
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interactions with wider networks of genes.  The convergence on synaptic plasticity 
more specifically, further indicates the significance of investigating the role for 
CACNA1C and LVGCCs in behaviourally relevant phenotypes of learning and 
memory.  
 L-type voltage gated calcium channels (LVGCCs) 
Voltage gated calcium channels mediate calcium influx into the cell in response to 
membrane depolarisation, which then regulates intracellular processes including: 
hormone secretion, pacemaker activity, neurotransmitter release and calcium-
dependent gene transcription (Striessnig and Koschak, 2008).  They function to 
transform an electrical signal into a molecular signal, which then communicates at 
the postsynaptic site with the nucleus through activation of specific secondary 
messengers and de novo proteins (Berridge et al., 2003).   
LVGCCs are part of a wider family of VGCCs which include T-, P/Q-, N- and R-type 
channels, separately named to correspond to the type of calcium current they elicit 
(Randall and Tsien, 1995).  These are sub-divided into three classes based on 
sequence homology; referred to as Cav1 (L-type), Cav2 (P/Q, N and R type) and Cav3 
(T-type).  The different types have distinct physiological properties and functions.  
Cav3 VGCCs are low voltage activated (LVA) channels and primarily function as 
pace-making and rebound bursting in neurons (Perez-Reyes, 2003). They have low 
unitary conductance (8 – 12 pS in 110 mM barium) and are rapidly inactivated over 
20 – 50 ms.  They do not appear to associate with any of the auxiliary subunits 
described below, functioning as monomers (Catterall et al., 2005).  In contrast, Cav2 
channels are high voltage activated (HVA) and are located at pre-synaptic nerve 
terminals. They have a unitary conductance of approximately 13 pS (in 110 mM 
barium) and show time dependent inactivation (50 – 110 ms) and voltage dependent 
inactivation.  They have been identified to have a role in transmitter release and 
neuronal excitability and have been found to interact with β and α2δ and possibly with 
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γ subunits (Simms and Zamponi, 2014).  A summary of the different subfamilies of 
VGCCs is presented in Table 1.2; for a full description of nomenclature and properties 
of Cav2 and Cav3 channels, see Catterall et al., (2005) and Catterall, (2015).   
 Structure and subunit composition  
LVGCCs can be made up of multiple subunits which define voltage sensitivity, 
pharmacological sensitivity and trafficking of the channel.  Each channel can be 
composed of up to 4 subunits to include: α1, β, α2δ and γ subunits (Figure 1.1), which 
regulate trafficking and gating properties.   
Alpha-1 (α1) subunits 
The α1 subunit forms the physical channel pore through which calcium ions enter the 
cell.  It defines the voltage sensitivity and pharmacological properties of the channel 
(Catterall et al., 2005).  It is structurally comprised of four transmembrane domains (I 
– IV) separated by cytoplasmic linkers, which each consists of six membrane 
spanning helices (S1 – S6) (Simms and Zamponi, 2014).  Each domain contains a 
voltage sensor and folds to form a quarter of the channel pore.  In mammals there 
are four genes coding for different α1 subunits of LVGCCs.  These are, CACNA1S, 
CACNA1C, CACNA1D and CACNA1F, corresponding to the L-type channels, 
Cav1.1, Cav1.2, Cav1.3 and Cav1.4 respectively.  There is greater than 70% amino 
acid sequence homology between LVGCC α1 subunits, though less than 40% 
homology with other types of VGCCs (Catterall et al., 2005).  The greatest sequence 
variation occurs in the cytoplasmic linkers and N and C termini, which are known to 
be important for protein-protein interactions and second messenger regulation (Dai 
et al., 2009).  All genes undergo extensive alternative splicing, with over 40 known 
human transcripts of the CACNA1C gene (Tang et al., 2004a).  There are three 
known and at least four predicted CACNA1C transcripts in the rat (Ensembl genome 
browser; www.ensembl.org). 
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Auxiliary subunits 
There are three additional auxiliary subunits that may interact with the α1 pore forming 
subunit; beta (β), alpha-2-delta (α2δ) and gamma (γ) (Figure 1.1).  β subunits bind to 
the intracellular loop between domains I and II of α1 subunits (Pragnell et al., 1994) 
and function as chaperones by trafficking the α1 to the cell membrane (Berrou et al., 
2002, 2005). They regulate the gating properties of the channels and are important 
for channel modulation by protein kinases and G-proteins (Buraei and Yang, 2010).  
They have further been described as a membrane-associated guanylate kinase 
(MAGUK)-like intracellular scaffold protein, providing binding domains for additional 
intracellular signalling proteins (Catterall, 2015).  For a detailed review of the β 
subunit of VGCCs see Dolphin, (2003) and Buraei and Yang, (2010).    
α2δ subunits are coded by a single mRNA and are post-translationally cleaved, 
remaining linked by a disulphide bond.  The δ part anchors the α2 protein to the 
membrane via a glycophosphatidylinositol anchor and together they regulate the 
activation and inactivation kinetics of the channel (Klugbauer et al., 1999).  Their main 
function is to increase calcium currents by promoting the trafficking of α1 subunits to 
the cell membrane and improved synaptic targeting (Canti et al., 2003; Hoppa et al., 
2012).  For a detailed review of α2δ see Dolphin, (2012, 2013). 
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Figure 1.1 Example subunit composition of LVGCCs.  Alpha-1 (α1) subunits forms the channel 
pore and define voltage sensitivity and pharmacology of the channel.  The auxiliary beta (β) 
and alpha-2-delta (α2δ) subunits are involved in the trafficking of the α1 subunits to the cell 
membrane and modulate the biophysical properties of the channel.  Gamma (γ) subunits are 
also sometimes associated with LVGCCs though have diverse functions.  
 
Less is known about the association of γ subunits with VGCCs than the other auxiliary 
subunits and appears to have only been confirmed in skeletal muscle calcium 
channels (Kuniyasu et al., 1992; Andronache et al., 2007).  Seven γ subunits have 
been found to be expressed in the brain (Klugbauer et al., 2000).  These neuronal 
expressed subunits have been found to regulate post synaptic glutamate receptors 
and are alternatively referred to as transmembrane AMPA receptor modulators 
(TARPs)(Nicoll et al., 2006).  Although there is evidence of co-expression with 
VGCCs and potential effects on inactivation state (Andronache et al., 2007), 
functional association in the brain is not conclusive in vivo.  For a review of the γ 
subunits see Black, (2003).  
 Physiological and pharmacological properties 
LVGCCs generally require strong depolarisation for activation, are long-lasting and 
produce slow inward calcium currents (Ertel et al., 2000). They have been found to 
exhibit calcium-dependent inactivation, with little voltage-dependent inactivation, and 
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have relatively large single channel conductance (20 – 27 pS in 110 mM barium); 
though there is variation within sub-types of Cav1 channels (Lipscombe, 2004).   
Cav1.2 channels are found to be activated by high voltages (> -35mV) and have slow 
inactivation, though subtle differences have been observed for different splice 
variants (Tang et al., 2004a).  In contrast, it has been shown that Cav1.3 channels 
may be activated at subthreshold depolarisations (around – 55 mV) and may exhibit 
faster kinetics than the Cav1.2 L-type channel, having a role for pacemaking in the 
sinoatrial node (Zhang et al., 2002).  Furthermore, it has been suggested that Cav1.3 
channels may also contribute to R-type currents in neurons.  These have been found 
to be involved in presynaptic transmitter release and synaptic plasticity in 
hippocampal pyramidal neurons (Yasuda et al., 2003).    
The physiology of these channels has primarily been defined by utilising the selective 
affinity of LVGCCs to organic compounds that block calcium influx.  This selectivity 
has been useful in determining the functional role for L-type currents in specific 
molecular processes and behaviours (Simms and Zamponi, 2014).  The pore forming 
α1 subunits of LVGCCs are specifically sensitive to a number of different organic 
agonists including dihydropyridines, benzothiazepines and phenylalkylamines, which 
are primarily used in the treatment of cardiac and hypertension conditions (Randall 
and Tsien, 1995; Triggle, 2006).  These compounds have been found to be highly 
selective for the inhibition of calcium influx through LVGCCs, with a preference for 
the inactivated channel state (Welling et al., 1993), though phenylalkylamines have 
been found to affect T-type VGCCs, sodium and potassium channels at higher doses 
(Freeze et al., 2006). 
Along with the physiological differences observed between Cav1.2 and Cav1.3 
channels, there is evidence of varied affinity of these organic inhibitors to channel 
sub-type; though there are currently no inhibitors that can reliably distinguish between 
LVGCCs. Cav1.2 channels have been found to show greater sensitivity to inhibition 
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by the dihydropyridines isradipine and nimodipine compared to Cav1.3 (Koschak et 
al., 2001; Xu and Lipscombe, 2001).  More recent studies have identified distinct 
properties and protein interactors between Cav1.2 and Cav1.3 channels which may 
be potentially useful in the future development of sub-type selective inhibitors 
(Zuccotti et al., 2011).      
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Table 1.2 Voltage gated calcium channel sub-types and distinguishing properties. 
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 Expression profile of LVGCCs 
Of the four LVGCCs, Cav1.1 and Cav1.4 are mainly restricted to skeletal muscle and 
retina respectively and are coded by CACNA1S and CACNA1F.  For the purpose of 
the current work, the focus will subsequently be on the neuronal expression LVGCCs, 
Cav1.2, and Cav1.3, coded by CACNA1C and CACNA1D.  
CACNA1C is located on chromosome 12p13 in humans and 4q42 in rats. CACNA1D 
is located on chromosome 3p21 and 16p16 in humans and rats respectively (NCBI, 
www.ncbi.nlm.nih.gov). Broadly, they are both expressed in cardiac and smooth 
muscle, endocrine cells and neurons (Catterall et al., 2005).  These genes are often 
co-expressed in many areas of the CNS, in many instances in the same cell 
(Striessnig et al., 2006), but they also have distinct regional as well as sub-cellular 
expression profiles.  CACNA1D and Cav1.3 channels are found to be additionally 
expressed in sensory cells, including photoreceptors and inner hair cells.   
Cav1.2 channels have been found to account for over 80% of all LVGCCs expressed 
in the brain, with Cav1.3 accounting for the remaining percentage (Clark et al., 2003; 
Sinnegger-Brauns et al., 2004; Sinnegger-Brauns and Huber, 2009).  Both sub-types 
are found across regions of the brain, with differential expression observed in the 
amygdala, cortex, cerebellum, caudate putamen, hippocampus, nucleus accumbens 
and substantia nigra; though there is conflicting evidence over their relative 
abundance across species (Hell et al., 1993; Sinnegger-Brauns and Huber, 2009; 
Marschallinger et al., 2015).  In mice, it was observed that Cav1.2 channels were 
more abundant than Cav1.3 in all regions of the brain, however, in rats there appeared 
to be similar levels of expression in some brain regions (Sinnegger-Brauns and 
Huber, 2009).   
Within the hippocampus, expression of Cav1.2 is abundant in the dentate gyrus and 
CA3 regions throughout, with lower levels of expression observed in the pyramidal 
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cell bodies in the CA1 (Hell et al., 1993).  Cav1.3 expression was found to be restricted 
to cell bodies and proximal dendrites, but with similar levels of expression observed 
across all sub-regions of the hippocampus (Hell et al., 1993).              
The expression profiles of Cav1.2 and Cav1.3 have also been found to be regulated 
during development in the rat hippocampus.  Kramer et al., (2012), found that steady-
state expression levels of Cav1.2 was greatest during the early stage of the neonatal 
period, peaking at day 6 and decreasing by day 12.  In contrast, Cav1.3 showed a 
gradual increase, reaching adult expression levels at approximately day 15.  
Expression was observed throughout the CA1 region of the hippocampus, as has 
been reported previously in mouse brain (Schlick et al., 2012).  A subsequent study 
found a similar developmental profile of Cav1.2 in the CA3 region of the hippocampus 
in rats (Morton et al., 2013).  The observed peak in Cav1.2 has been postulated to be 
involved in the maturation of the GABAergic circuitry, with a role in the shift from 
excitatory to inhibitory chloride currents observed in this period in the hippocampus 
(Ganguly et al., 2001; Kramer et al., 2012). 
A more detailed investigation of sub-cellular expression profiles of LVGCCs has been 
conducted in the hippocampus (Tippens et al., 2008) and specifically in the CA1 
region in vivo, using immunogold-labelling techniques and electron-microscopy 
(Leitch et al., 2009).  Cav1.2 channels were found to be located in the soma and 
throughout dendritic processes, predominately found in post-synaptic regions, to 
include the post-synaptic density and extra synaptic sites.  Although there was some 
evidence of pre-synaptic expression, it was extremely low relative to post synaptic 
expression observed.  Expression was found to be significantly higher at the cell 
membrane compared to within the cytoplasm, especially in the smallest dendritic 
processes and spines.  Localisation at more distal dendrites and within synaptic 
regions in spines indicates an appropriate positioning for the initiation of synapse to 
nucleus signalling (Leitch et al., 2009).                  
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The concentrated expression of LVGCCs at cellular regions for initiating signalling 
cascades that may be important for gene expression and synaptic plasticity, further 
highlights the importance of fully understanding their role in related processes.  
Furthermore, the partially distinct expression profiles of Cav1.2 and Cav1.3 indicates 
the likelihood of separable functions, potentially through interactions with signalling 
molecules and localised regulators (Leitch et al., 2009).   
 Calcium signalling pathways and gene transcription 
Calcium influx through LVGCCs is known to initiate downstream signalling cascades 
that regulate gene transcription and synaptic plasticity (Murphy et al., 1991; Striessnig 
et al., 2006; Calin-Jageman and Lee, 2008).  Although blockade of LVGCCs appears 
to have a relatively minor effect on the increase in cytoplasmic calcium following 
induced synaptic activity, there appears to be a disproportionate effect on the 
transcription of activity-dependent and immediate early genes (IEGs) (Murphy et al., 
1991; Dolmetsch et al., 2001; West et al., 2001).  This highlights the importance of 
these channels in the initiation of plasticity related IEG expression.         
Calcium influx through both Cav1.2 and Cav1.3 channels creates localised increases 
in intracellular calcium in close proximity to key signalling molecules.  This allows 
rapid and efficient signalling to the nucleus, compared to other routes of calcium entry 
into the cell, for example Cav2 channels, which rely on a broader pooled increase in 
calcium to communicate across greater intracellular distances (Wheeler et al., 2006).     
The calcium binding protein calmodulin (CaM) has been found to be bound to the C-
terminal of Cav1.2 and Cav1.3 channels (Peterson et al., 1999), mediating both 
calcium dependent inactivation of the channel and activation of calcium/calmodulin 
dependent kinases (CaMK) and the Ras/mitogen-activated protein kinase (MAPK) 
pathway (West et al., 2001; Barbado et al., 2009).  The MAPK pathway conveys the 
calcium signal from the mouth of the channel pore to the nucleus and initiates the 
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phosphorylation of cyclic adenosine monophosphate (cAMP) response element 
binding protein (CREB) at Ser133.  This allows the recruitment of CREB binding protein 
(CBP) and the initiation of gene transcription (Fields et al., 1997; Dolmetsch et al., 
2001; Wiegert and Bading, 2011).  Although phosphorylation of CREB can be initiated 
by calcium influx through other entry routes into the cell, including NMDA receptors 
(West et al., 2001), the sustained phosphorylation necessary for long term gene 
transcription is specifically induced by influx through LVGCCs (Dolmetsch et al., 
2001).      
The activation of these signalling cascades can differ due to different binding domains 
in the C-termini and intracellular loops of the α1 subunits, which influences 
interactions with specific signalling molecules.  For example, CaMKII interacts directly 
with the C-termini of Cav1.2 channels, however the interaction between Cav1.3 and 
CaMKII requires the protein densin (Hudmon et al., 2005).  It is worth noting that 
CaMKII can also phosphorylate CREB at Ser142 which has been found to be inhibitory 
(Sun et al., 1994).  Additionally, there has been found to be a C-terminus fragment of 
CACNA1C (Calcium channel associated transcription, CCAT), which can 
independently translocate to the nucleus and signal gene transcription (Gomez-
Ospina et al., 2006).  This suggests a potentially unique signalling ability of Cav1.2 
channels to the nucleus.  Conditional deletion of Cav1.2 channels in the cerebral 
cortex and hippocampus has also implied a specific role for these channels in the 
activation of the MAPK pathway in the hippocampus (Striessnig et al., 2014).   
The gene transcription initiated by the phosphorylation of CREB includes brain 
derived neurotrophic factor (BDNF) (Tao et al., 1998, 2002). BDNF is a small 
neurotrophic factor which binds to tyrosine kinase TrkB receptors as well as p75 
receptors (Binder and Scharfman, 2004).  It is known to be important for neuronal 
survival and synaptic plasticity (Bramham and Messaoudi, 2005; Sakata et al., 2009; 
Waterhouse and Xu, 2009; Leal et al., 2014), and acts as a neurotransmitter at the 
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post synaptic membrane (Kafitz et al., 1999).   Although the transcription of BDNF 
can be regulated by different routes of calcium influx into the cell, it has been found 
to be preferentially regulated by influx specifically through LVGCCs (Ghosh et al., 
1994; West et al., 2001).  The BDNF gene consists of several 5’ non-coding exons 
(from I-VIII) and one 3’ coding exon (IX).  It contains nine distinct transcriptional 
initiation sites, as well as alternative splice donor sites, resulting in at least 22 
predicted isoforms (Aid et al., 2007).  Due to the presence of only one coding exon, 
all isoforms are translated into the same functional protein, albeit undergo distinct 
regulation by interactors with the different promotors regions (Tabuchi et al., 2000; 
Zheng et al., 2011).  They are additionally found to have different temporal and spatial 
expression profiles (Pattabiraman et al., 2005; Chiaruttini et al., 2008; Baj et al., 
2011).  Multiple different variants may therefore be necessary to provide fine-tuned 
regulation of BDNF and allow it to function within multiple different cellular processes, 
depending on its route of activation. For example, acute versus transient increases 
in BDNF has been associated with different activation of TrkB receptors and distinct 
morphological changes in dendritic spines (Ji et al., 2010).       
The route of calcium entry into the cell has been found to be important for transcript 
specific regulation of BDNF, specifically activity dependent isoforms BDNFI and 
BDNFIV (Zheng et al., 2012).  In primary cultured cortical neurons, it was found that 
BDNFI was specifically activated by LVGCCs rather than NMDA receptors and that 
BDNFIV was differentially activated by both (Tabuchi et al., 2000).   Calcium influx 
through LVGCCs has been found to regulate the transcription of specific promoters 
through the activation of a calcium-responsive transcription factor (CaRF), known to 
contain consensus phosphorylation sites for CaMKII and MAP kinase (Tao et al., 
2002).  Subsequent studies in primary cultures identified a combined regulation of 
BDNFIV transcription through calcium response elements (CaRE), CaRE1 and 
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CaRE3 by calcium influx through NMDAR and LVGCCs, with a unique activation of 
CaRF by LVGCCs (Zheng et al., 2011).    
BDNF plays a role in many cellular functions including synaptic plasticity and long 
term memory (Pang et al., 2004; Bekinschtein et al., 2008; Lu et al., 2008).  The 
specific and finely regulated expression of BDNF by calcium influx through LVGCCs, 
would suggest that LVGCCs have a role in a specific subset of these functions.      
 LVGCCs role in synaptic plasticity and learning 
Synaptic plasticity is utilised as the primary model for investigation the molecular 
basis of learning and memory.  Long-term potentiation (LTP) is a form of synaptic 
plasticity that leads to the increased efficiency of synaptic transmission, evident 
following pathway stimulation at certain frequencies (Bliss and Collingridge, 1993). 
Although there has not been conclusive evidence that LTP is the formation of 
memory, similar synchronised firing patterns is observed in the hippocampus during 
learning (Otto et al., 1991).  As has already been alluded to, LVGCCs have a reliably 
implicated role in synaptic plasticity and learning and memory (Weisskopf et al., 1999; 
Moosmang et al., 2005; Striessnig et al., 2006; Seoane et al., 2009; Berger and 
Bartsch, 2014; Degoulet et al., 2015).  Parallel to expression and signalling pathways, 
there is evidence of overlapping and distinct roles for Cav1.2 and Cav1.3 in these 
processes.     
Freir and Herron, (2003), found that intra-peritoneal injection of LVGCC inhibitors 
verapamil or diltiazem reduced the induction of LTP in vivo in the CA1 region of the 
rat hippocampus.  The results suggested a combined role for LVGCCs and NMDA 
receptor with low levels of LTP still observed when LVGCCs were inhibited.  A 
separate study in rat brain slices, found that LTP in thalamic input synapses to the 
amygdala specifically depended on LVGCCs (Weisskopf et al., 1999).   Utilisation of 
channel specific genetic knockdown models has identified a specific role for Cav1.2 
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channels in hippocampal L-LTP (Moosmang et al., 2005; Striessnig et al., 2006).  
Moosmang et al., (2005) found that conditional genetic deletion of Cav1.2 channels 
resulted in the loss of NMDA-independent Schaffer collateral/CA1 L-LTP.  In contrast, 
disruption of Cav1.3 in mice has been found to have no effect on LTP in the CA1 
(Clark et al., 2003).   
Pharmacological block of LVGCCs has been found to facilitate working memory and 
spatial reference acquisition (Quartermain et al., 2001), and to reduce age-related 
decline of hippocampal-dependent learning in rodents and non-human primates 
(Sandin et al., 1990; Batuecas et al., 1998).  The study in rodents utilised chronic 
dietary administration of the LVGCC antagonist nimodipine. Effects were linked with 
a small increase in synaptosomal calcium binding protein, specifically in the cerebral 
cortex, though no changes were observed in the hippocampus (Batuecas et al., 
1998).  In contrast, systemic and local perirhinal cortex infusion of different classes 
of LVGCC inhibitor, was found to impair the long-term acquisition of recognition 
memory, without affecting short term memory (STM)(Seoane et al., 2009).  High 
doses of the inhibitor verapamil have also  been found to impair retrieval during a 
passive avoidance task (Lashgari et al., 2006).  These differential effects of inhibition 
highlight the potential for region specific roles of LVGCCs, as well as important 
considerations of differences in administration and timing of inhibition, when making 
conclusions about functionality.    
The role for LVGCCs has been most extensively investigated in associative learning 
(Cain et al., 2002; Barad et al., 2004; McKinney and Murphy, 2006; Busquet et al., 
2008; Mckinney et al., 2008; Davis and Bauer, 2012).  Given the relevance to the 
current work and the potentially more complex aspects of learning involved in these 
processes, this will be discussed in the separate section below.     
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 Associative learning 
The formation of associations in everyday life is vital in informing subsequent 
behaviour.  Prior associations allow predictions to be made about future experience 
and can provide an indication of when new learning may be required, when 
predictions are violated and associations need to be updated (McLaren and 
Mackintosh, 2000; Dickinson, 2012) .  Approach and avoidance behaviour is primarily 
influenced by associations from prior experience; whether a particular behaviour 
received a reward or led to an aversive response will tend to determine the frequency 
of that behaviour in the future (Valins and Ray, 1967).  Deficits in associative learning 
have been described as being a key feature of schizophrenia as early as 1911, when 
Bleuler emphasised the loosening of associations in relation to Dementia Praecox 
(Bleuler, 1950; Peralta and Cuesta, 2011).      
The investigation of associative learning has evolved from Pavlov’s classical 
conditioning paradigms (Pavlov and Anrep, 2012). Associative learning involves the 
formation of an association between an unconditioned stimulus (US) and a 
conditioned stimulus (CS), such that subsequent exposure to the CS in the absence 
of the US elicits a conditioned response (CR).  The US may be rewarding or aversive 
in nature, eliciting an innate reactive response, such as salivation, freezing behaviour 
or avoidance.     
Pavlovian fear conditioning is a single trial learning paradigm, involving the pairing of 
either an auditory cue or a context (CS) with an aversive stimulus (US); most often a 
footshock or burst of white noise.  These paradigms are incredibly useful for studying 
the mechanisms of associative fear learning, due to learning being rapid, long-lasting 
and producing stereotypical, measurable behavioural outcomes in animals (LeDoux, 
2003). The most common form of aversive associative learning studied in animals is 
cued/contextual fear conditioning, which is known to rely on regions including the 
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amygdala and hippocampus (Phillips and LeDoux, 1992; Daumas et al., 2005; 
Alvarez et al., 2008; Quirk and Mueller, 2008).     
There are different stages of fear conditioning paradigms that can be, at least in part, 
separated into distinct psychological processes; acquisition of associations, their 
long-term consolidation and the recall/expression of associations during subsequent 
exposure to the CS.  Additional manipulations of associative learning can be 
investigated by utilising paradigms that invoke extinction or latent inhibition. 
The acquisition of CS-US associations is initiated by the presentation of the CS, in a 
way that it could feasibly predict the US.  The likelihood or strength of an association 
formed can be influenced by multiple factors, including timing and relevance of the 
CS presentation to the US occurrence (Rescorla, 1988; Gallistel and Gibbon, 2000).  
Re-exposure to the CS is used to test the recall and expression of the associations, 
with fear response in the absence of the US indicating successful association 
formation.  In the case of aversive conditioning in rodents, this is usually measured 
by context avoidance or freezing behaviour.  Short-term acquisition is usually tested 
within the first four hours following training, with the consolidation of learning 
occurring over 24-48 hr period (Walker et al., 2003; Clopath, 2012).     
The novelty of the CS is another important factor that can influence association 
formation and can be manipulated through latent inhibition. Pre-exposure to a CS 
before its co-occurrence with a US reduces the predictive value of the CS and 
therefore reduces the likelihood of it forming an association (Lubow, 1973).  Latent 
inhibition is thought to involve the active inhibition of CS - US associations due to 
interfering information from prior experience through a CS – no US association 
(Escobar et al., 2002). 
Similar to latent inhibition, extinction involves repeated or prolonged exposure of the 
CS in the absence of the US, though occurring after the initial association (Figure 
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1.2). This is postulated to lead to the formation of a competing CS-no US association, 
that reduces the response to the CS, rather than a degradation of the original 
association (Bouton, 2004; Bouton et al., 2006; Herry et al., 2010; Trent et al., 2015).  
Like the formation of the original CS-US association, there is evidence to suggest 
separable processes of acquisition and consolidation of extinction, supported to 
involve a neural circuit to include the amygdala, hippocampus and medial PFC 
(Corcoran and Quirk, 2007). 
   
 
Figure 1.2 Standard paradigm for contextual fear conditioning in rodents.  The novel context 
(CS) is associated the footshock (US), such that the CS then elicits fear related behaviour 
(freezing) in the absence of the US.  Extinction of the association can be promoted by 
prolonged exposure to the conditioned context and the association between the CS and the 
US can be inhibited by prolonged pre-exposure to the to be conditioned context.  
 
Reward based associative learning requires longer training paradigms than aversive 
conditioning and has been found to engage different neural circuits and mechanisms 
(Schultz et al., 1997). The activation of the ‘reward circuit’ is required, with a central 
role for the ventral striatum (nucleus accumbens in animals) and inputs from the PFC, 
amygdala and the midbrain (Haber, 2011).  Although it is not as easy to distinguish 
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between potentially separate learning processes at a single trial or session level, it is 
possible to compare processes at different training phases.  Similar to aversive 
conditioning, it is also possible to investigate the inhibition and update of reward 
based associations.      
Pavlov’s traditional reward association paradigm (Pavlov and Anrep, 2012) has been 
adapted to include reward associations with more complex and multiple stimuli.  For 
example, studies of reversal learning require the learned discrimination between two 
stimuli for reward and the subsequent reversal of associations.  They have been used 
to investigate the acquisition of reward associations, their inhibition when 
contingencies change, the ability to respond to a previously unrewarded stimuli and 
the extinction of associations when there is no longer an association with reward (e.g. 
Brigman et al., 2008; Ghahremani et al., 2010; Bussey et al., 2012).   
These different behavioural paradigms have allowed the investigation of potentially 
distinct underlying molecular mechanisms for aspects of aversive and reward-based 
associative learning.  Previous studies have identified roles for certain genes in 
distinct aspects of these tasks and have indicated selective deficits in psychiatric 
illness (Waltz and Gold, 2007b; Brigman et al., 2008; Jensen et al., 2008; Kirtley and 
Thomas, 2010).   
 Previous research into role of LVGCCs in associative learning 
Previous studies have primarily used systemic injection of LVGCC inhibitors to 
investigate their role in specific aspects of cued fear conditioning.  This approach has 
reported no effects of inhibition on the acquisition or consolidation of cued fear 
learning, however they impair extinction (Cain et al., 2002, 2005; Busquet et al., 2008) 
and an indication of impaired latent inhibition (Barad et al., 2004). Region specific 
investigation has utilised local inhibition of LVGCCs via intracerebral injection.  Local 
infusion of LVGCC inhibitors into the basolateral amygdala has been found to impair 
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both consolidation and extinction of cued fear learning (Bauer et al., 2002; Davis and 
Bauer, 2012), though there appears to be different roles for Cav1.2 and Cav1.3 
channels, with Cav1.3 implicated in consolidation (McKinney and Murphy, 2006; 
Busquet et al., 2008).   
Studies of the role of LVGCCs in reward associations have focussed more specifically 
on addiction, which can be interpreted as a form of maladaptive reward learning 
(Everitt and Robbins, 2005; Isokawa, 2012).  Cav1.3 channels have been found to be 
necessary for the development of addiction to cocaine and amphetamine, whereas 
Cav1.2 are implicated in its maintenance (Kuzmin et al., 1992; Licata et al., 2000).  
Research has indicated a role for LVGCCs in reward responsiveness, with an 
attenuation of consumption of rewarding liquids observed with block of LVGCCs 
(Calcagnetti and Schechter, 1992).  Additionally, an association between risk 
variation in CACNA1C and reward responsiveness has been observed in healthy 
individuals (Lancaster et al., 2014). Functional investigations of these channels in 
normal processes involved in reward learning and its adaptation are lacking.  
 Associative learning deficits in psychiatric illness 
There is growing evidence of a convergence of genetic risk for schizophrenia 
associated with synaptic function and synaptic plasticity, known to underlie long term 
memory formation (Harrison and Weinberger, 2005; Hall et al., 2015).  It has also 
been hypothesised that the convergence of genetic risk on synaptic plasticity, as well 
as the mesolimbic dopamine system, may be understood by an associative learning 
theory (Hall et al., 2009).  More recent analyses of copy number variants has 
indicated an enrichment in duplications and deletions in gene sets associated with 
abnormal associative learning, abnormal contextual conditioning and other related 
learning behaviour (Pocklington et al., 2015).   
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Evidence has shown that patients with schizophrenia exhibit deficits in specific 
aspects of associative learning across different tasks (Lubow et al., 1987; Escobar et 
al., 2002; Waltz and Gold, 2007b; Jensen et al., 2008; Holt et al., 2009, 2012).  
Patients appear to be able to acquire aversive associations equally as well as healthy 
controls, presenting with specific deficits in extinction.  Holt et al., (2009) used 
measures of skin conductance response (SCR) to investigate Pavlovian fear 
conditioning in patients compared to healthy controls.  They found that patients were 
able to successfully acquire and extinguish a conditioned fear response, however, 
when tested 24 hrs later, patients showed an excessive fear response by elevated 
SCR to the CS.  This indicates a failure in patients to consolidate this extinction.  In 
a subsequent study they found that these abnormalities were associated with 
differences in neural activation of the vmPFC and limbic areas, including the 
hippocampus and amygdala (Holt et al., 2012).   
Studies have additionally observed deficits in latent inhibition at different stages of 
illness, indicative of processing of irrelevant stimuli (Baruch et al., 1988; Jones et al., 
1992).   Results from subsequent studies are mixed, with differences in latent 
inhibition appearing to be dependent on medication status and stage of illness 
(Swerdlow et al., 1996; Rascle et al., 2001; Vaitl et al., 2002).   
Patients have additionally been found to have abnormal activation of the reward 
system in conjunction with deficits in associative learning behaviour.  Abnormally 
strong activations of the ventral striatum were observed in patients, associated with 
inappropriate learning to neutral stimuli, suggesting deficits in appropriate association 
of motivational salience (Jensen et al., 2008).  Specific deficits in discrimination 
learning and reversal learning have also been observed in first episode psychosis 
patients and patients with schizophrenia (Waltz and Gold, 2007b; Murray et al., 
2008a), with errors in reversal learning additionally found to correlate with negative 
symptom severity (Murray et al., 2008a).  These deficits have been more explicitly 
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linked with abnormal mesolimbic dopamine activity, through functional magnetic 
resonance imaging (fMRI) indicating physiological differences in the mid-brain, 
striatum and limbic system in relation to reward prediction error (Murray et al., 2008b).              
It has been suggested that patients with schizophrenia do not necessarily have 
deficits in forming associations, but instead have a problem with retrieving, using and 
updating associative information (Escobar et al., 2002). Impairments in associative 
learning have been found to be shared across schizophrenia and bipolar disorder 
(Murray et al., 2008a; Brambilla et al., 2011) and deficits in latent inhibition have also 
been observed in “psychotic prone” healthy individuals (Baruch et al., 1988). 
Associative learning deficits are only one aspect of cognition that has been found to 
be impaired in schizophrenia and related psychiatric illnesses (Galderisi et al., 2009; 
Dere et al., 2010).  Cognitive deficits are key features of multiple psychiatric 
disorders, with impairments seen in multiple domains (Millan et al., 2012).  The impact 
of these impairments can be equally, if not more, debilitating than positive or negative 
symptoms in everyday life (Rupp and Keith, 1993).  Cognitive symptoms are found 
to be apparent long before onset of psychosis and the severity of impairments has 
been linked to outcome in patients with schizophrenia (Green et al., 2004; Galderisi 
et al., 2009).   
Current treatments for schizophrenia do not specifically address cognitive 
impairments.  Some efficacy has been observed with atypical antipsychotic drugs, 
including clozapine, olanzapine and risperidone, in the improvement of verbal 
learning and fluency, though they had no effect on visual learning and memory or 
attention (Meltzer and McGurk, 1999).  It is evident that there is a need for new 
treatments which are specifically designed to alleviate cognitive symptoms of 
psychiatric illness.  The recent progress in genetics has identified multiple genes and 
pathways which may contribute to cognitive dysfunction (Ripke et al., 2014).  
Furthermore, there has been significant advances in the measurement of specific 
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aspects of cognition as well as the development of translational behavioural assays 
(Bussey et al., 2012).  In order to potentially identify valid novel treatment targets, it 
is necessary to further understand the molecular mechanisms which may link genetic 
risk for psychiatric illness with specific cognitive symptoms.     
The current work aims to contribute to our understanding of the link between both 
LVGCCs and the psychiatric risk gene CACNA1C and specific aspects of associative 
learning.  Calcium channels and CACNA1C specifically, have been reliably 
associated with risk for psychiatric illness.  LVGCCs channels have a role in synaptic 
plasticity and regulate gene transcription.  Previous studies have further suggested a 
role in distinct aspects of associative learning in select brain regions.  Associative 
learning deficits are evident in patients with schizophrenia and other related 
psychiatric disorders.  The role of LVGCCs in hippocampal-dependent fear 
conditioning and reward-based reversal learning, is yet to be fully understood.    
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 Outline of experiments  
The experiments detailed in this thesis utilise contextual fear conditioning and 
reversal learning paradigms to investigate the role of Cacna1c and LVGCCs more 
broadly in aspects of associative learning.     
Chapter 3 presents the basal expression profile of Cacna1c in the rat brain and 
activity regulated expression changes during contextual fear conditioning.  This 
paradigm is the simplest form of implicit associative fear memory, with rapid single-
trial learning allowing the investigation of separable learning processes.  Chapter 4 
discusses the use of the selective LVGCC inhibitor diltiazem, to investigate the effect 
of inhibiting calcium influx through these channels on distinct aspects of contextual 
fear learning; consolidation, recall, extinction and latent inhibition.     
To separate the potential roles for Cav1.2 and Cav1.3 channels and explore Cacna1c 
more specifically, we re-derived a chronic heterozygous knockout Cacna1c rat model.  
Chapter 5 details the basic molecular and behavioural characterisation of this model.  
Expression levels of Cacna1c and Cacna1d were measured to determine the validity 
of the model and investigate potential compensation effects.  BDNF expression was 
additionally measured to determine whether there were effects of reduced Cacna1c 
on a relevant downstream signalling gene. Basic behavioural tests were conducted, 
including tests of locomotor activity, anxiety, startle response and pre-pulse inhibition.      
This rat model was then used to determine the effects of reduced expression of 
Cacna1c on specific aspects of contextual fear conditioning, intended to complement 
the findings with inhibition of LVGCCs.  The findings from these experiments are 
detailed in chapter 6.  In chapter 7, the same rat model was then used to investigate 
the role of Cacna1c in reward based reversal learning, using a translational touch-
screen paradigm.   
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In the final experimental chapter (chapter 8), analyses are translated to humans, to 
specifically investigate associations with risk variation in Cacna1c.  The association 
between rs1006737/rs2007044 and expression of Cacna1c and different BDNF 
transcripts, was investigated utilising an online expression database (BRAINEAC).  
Behavioural and genetic data from a separate cohort of people that underwent a 
reversal learning task was analysed to determine whether there was an allelic 
association between risk variants in Cacna1c and reversal learning behaviour.   
The overall findings of these experiments are discussed in relation to separable roles 
for LVGCCs in inhibitory learning and the convergence of effects on the synapse.  
The connection of these findings to current theories of schizophrenia and how these 
effects could manifest in symptoms of psychiatric illness is explored.   
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2 METHODS AND MATERIALS  
 Animals 
 Wild-type animals  
Adult male Lister Hooded rats (250-275 g, Charles Rivers, Margate, UK) were housed 
in pairs on a 12:12 reverse light dark cycle (lights off at 10am), with ad libitum access 
to food and water unless where indicated.  Experiments were conducted during the 
dark period.  All animals were given a minimum of five days from arrival before being 
used in any experiments. Experiments were conducted under licence PPL 30/3135 
and PIL IB00ACC93.  At the end point of each experiment, all animals were sacrificed 
by schedule one, using a rising concentration of CO₂ in a home cage culling chamber 
(Clinipath Equipment Limited, Hull, UK). 
 Transgenic heterozygous Cacna1c knock-out animals 
2.1.2.1 Generation of founders 
Cacna1c heterozygous knock-out animals were obtained from cryo-preserved 
embryos (TGRA6930, Sage Research Labs, Pennsylvania, USA) on a Sprague 
Dawley background.  Zinc Finger Nuclease (ZFN) technology was used to create the 
original line.  This method utilises a site-specific endonuclease to bind and cleave 
DNA, causing a double stranded break at the targeted region (Figure 2.1 Genome 
editing using ZFN technology: Zinc finger binding domains guide the cleavage 
domain to specific sites in the genome.  On forming a dimer the nuclease causes 
double stranded breaks in the DNA.  Repair mechanisms can then lead to mutations 
and/or deletions in the genome.  DNA repair can then occur through non-homologous 
end-joining, leading to mutations and/or deletions in the gene sequence (Bibikova et 
al., 2003).  ZFNs consist of two domains, a binding domain and a cleavage domain.  
The binding domain can be constructed of various combinations of zinc fingers to 
form arrays that recognise specific sequences in the genome.  The cleavage domain 
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must form a dimer to act as a nuclease, therefore requiring a pair of ZFNs.  These 
properties improve the affinity and specificity of the genome editing that occurs (Pabo 
et al., 2001).   A pair of 5-finger ZFNs, recognising a total of 30 base pairs were used 
to target a specific region of Cacna1c.  The selected successful founders used for 
breeding had a 4bp deletion (location 460649bp-460652bp in genomic sequence) in 
exon 6, resulting in a frame shift and an early stop codon.  
Cacna1c ZFN Target site: GTCCTGAACTCCATCatcaagGCCATGGTGCCCCTG 
 
 
Figure 2.1 Genome editing using ZFN technology: Zinc finger binding domains guide the 
cleavage domain to specific sites in the genome.  On forming a dimer the nuclease causes 
double stranded breaks in the DNA.  Repair mechanisms can then lead to mutations and/or 
deletions in the genome.   
Successful genetic manipulation of founders was confirmed by PCR and sequenced 
by Sage.  A PCR reaction was created with 1 µl of DNA in a solution of 1 µM Forward 
primer (5’-GCTGCTGAGCCTTTTATTGG-3’), 1 µM Reverse Primer (5’-
CCTCCTGGATAGCTGCTGAC-3’), 1 x JumpStartᵀᴹ Taq ReadyMixᵀᴹ (Sigma-
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Aldrich, St Louis, USA) and 14 µl ddH₂O.  The PCR reaction was run at 95˚C for 5 
mins, followed by 35 cycles of 95˚C for 30 secs, 60˚C for 30 secs and 68˚C for 40 
secs. The reaction was then held at 68˚C for 5 mins.  Amplified products were treated 
with Exo-SAP (Affymetrix, Santa Clara, USA) to dephosphorylate any residual 
primers and dNTPs as well as degrade any single stranded molecules, then sent 
directly for sequencing.  Sequencing data confirmed the site of the deletion in all 
founders (examples shown in Figure 2.2) 
 
Figure 2.2 Example sequencing data from 2 separate Cacna1c+/- founders, displayed using 
Sequence Scanner Software 2 (Applied Biosystems).  Site of 4 bp deletion is highlighted in 
yellow.   
Homozygous knock-out of Cacna1c is embryonically lethal (Seisenberger et al., 
2000); therefore breeding resulted in a Mendelian distribution of WT and HET pups, 
with litters of between 4 and 16.   Selected heterozygous founders were shipped to 
Charles River (Margate, UK) and bred up for experimental colonies, with both 
heterozygous females and heterozygous males used for breeding.  Cohorts of 
between 30 and 40 animals were transported to Cardiff University in litters at a 
minimum age of 12 weeks.  
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2.1.2.2 Housing 
Animals were housed with littermates in groups of 1-4 dependent on weight in large 
rat cages (38 cm (W) x 56 cm (L) x 22 cm (H). Individual housing conditions are 
described separately for each experiment, including lighting and any water 
deprivation protocols.   
2.1.2.3 Genotyping  
2.1.2.3.1 DNA extraction 
Ear punches taken from all weaned animals used experimentally were sent from 
Charles River for genotyping.  A small section of tail tissue was taken from all 
experimental animals post-mortem to confirm genotyping results. Genomic DNA was 
extracted using Qiagen DNeasy Blood & Tissue kits (Qiagen, Manchester, UK) as 
per the standard protocol.   
Approximately 0.6 cm of tail tissue or 1 single ear-punch was lysed overnight in 180 
µl buffer ATL and 20 µl proteinase K at 56˚c.  200 µl of both buffer AL and 96-100% 
ethanol were added before putting through a spin column at 8000rpm for 1 min.  
Buffers AW1 and AW2 were added to the spin column one at a time, with a final spin 
of 14,000 rpm for 3 mins to dry the membrane.  200 µl of buffer AE was pipetted 
directly onto the membrane and incubated at room temperature for 1 min.  DNA was 
eluted by centrifuging at 8000 rpm for 1 min and stored at -20˚c until required for 
PCR. The concentration of DNA and its purity was measured using a NanoDrop 
spectrophotometer (Thermo Fisher Scientific, Delaware, USA).  A 260/280 nm ratio 
of 1.8 or greater was deemed acceptable for DNA purity as per manufacturer’s 
recommendation.  Extraction resulted in yields of between 20 and 40 µg of DNA from 
0.6 cm of tail tissue.             
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2.1.2.3.2 Polymerase Chain Reaction (PCR)  
Two separate forward primers (24 bp) were designed to distinguish between WT and 
HET animals.  The first primer targeted a region upstream of the 4bp deletion (Chr 4: 
216724640 – 216724663) so that it would bind to DNA from all animals tested.  The 
second HET specific forward primer spanned the deleted region and therefore would 
only bind if the 4 bp were absent (Chr 4: 216724462 – 216724485).  The same 
reverse primer (22 bp) was used in both reactions (Chr 4: 216724019 – 216724040) 
(Table 2.1.  Two simplex reactions were run for each sample to detect WT and HET 
bands separately. Master mixes were made up with a total of 24 µl per reaction.  1-2 
µl (0.1 - 0.4 µg of DNA) was added from each sample to 17.25 µl distilled H₂O, 2.5 µl 
10 x PCR Buffer, 1 µl of dNTPs, 0.25 µl HotStarTaq DNA polymerase (Qiagen, 
Manchester, UK) and 1 µl of each primer.   
Samples were run on a BioRad Thermal Cycler (T100ᵀᴹ BioRad, Herts, UK).  
Conditions were 95˚C for 10 mins, followed by 40 cycles of 95˚C for 40 secs, 62˚C 
for 40 secs and 72˚C for 60 secs, with a fixed cycle of 72˚C for 5 mins.  Samples were 
then cooled to 8˚C.  
Table 2.1 Primer sequences for genotyping of Cacna1c HET and WT animals 
FOR1 5’ – AGCCTTTTATTGGGATGTGTCTCC – 3’ 
FOR2 (mutant specific) 5’ – TCCTGAACTCCATCAGGCCA – 3’ 
REV 5’ – CTGATGAACGGTGGGTGCTTAC – 3’  
 
2.1.2.3.3 PCR genotype analysis 
A 1.5% agarose gel was made with 0.5 x TBE buffer and 3 µl ethidium bromide.  30 
µl of the resulting PCR solution was loaded onto the gel and run at 100 mv for 30 
mins.  Gels were visualised on a BioRad Gel Doc XR imager (BioRad, Herts, UK) 
and bands were visually compared to distinguish WT and HET animals.  The 
expected WT band was 645bp and the HET 463bp (Figure 2.3).  
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Figure 2.3 Example of genotyping results for Cacna1c WT and HET animals.  The first 10 
lanes show 5 WT samples with only the WT band (645bp) present.  The last 10 lanes show 
HET samples, with bands at 645bp and 463bp clearly visible 
 Surgical procedures and infusions 
All surgery was conducted on a stereotaxic frame (Bilaney, model 963, including Ultra 
Precise Micro Manipulator model 961, Kent, UK) to ensure accurate targeting of the 
dorsal hippocampus.  Double guide cannula (Bilaney, Kent, UK) with projections 
extending 3 mm below pedestal were fitted onto the frame.  All tools and materials 
that would come in contact with the animal were autoclaved prior to surgery.  Rats 
were anaesthetised with 5% Isoflurane with an oxygen flow rate of 0.8 l/min and their 
heads were shaved to maintain a clear surgery site and clean wound.  Before 
attachment of the rats to the frame, gas flow rates were set; 0.8 l/min oxygen, 0.4 
nitrogen and Isoflurane at 3.5%.  These levels were constantly monitored throughout 
surgery to ensure that they did not change, though anaesthetic levels were adjusted 
depending on the individual rat’s weight and response at different points of the 
procedure.  
46 
 
Rats were attached to the frame using 18˚ tip ear bars and placed in a sterilisation 
bag on bubble wrap to keep them warm.  The site of incision was cleaned with a 
Clinell alcohol disinfectant wipe and a single incision was made from approximately 
4 mm anterior to bregma straight back to between 
the ears.  Four curved Hemostats (InterFocus, 
Cambridge, UK) were used to maximise the area for 
cannula placement and the wound cleaned with 
sterile swabs so bregma was clearly visible.  Co-
ordinates were then taken with the cannula 
positioned above the skull so that the left hand guide 
was directly above bregma.  The cannula was then 
moved + 0.19 cm in the coronal plane and - 0.35 cm 
in the sagittal plane to be accurately aimed bilaterally 
at the dorsal hippocampus (see Figure 2.4).  Using 
a stereotaxic drill holder (Bilaney, Kent, UK) with drill bit (Bilaney, Kent, UK) two holes 
were drilled in the skull in line with the trajectory of the guide cannula prongs, just 
deep enough to penetrate the skull.  Once the holes for the cannula were confirmed 
to be accurate, four screw holes were made using a Starrett pin vice (RS 
Components, Corby, UK); two holes in-line with bregma and two slightly anterior to 
lambda, as wide as possible to ensure the maximum spread of force on the cannula 
and therefore greater security.  Using a quickwedge screwdriver (RS Components, 
Corby, UK), the four screws (1/16, Bilaney, Kent, UK) were screwed into place and 
then the cannula was lowered into the holes until flush against the skull.  At this point, 
due to the reduced pressure on the skull, anaesthetic was typically lowered to 2.5% 
for the remainder of the surgery. 
To secure the cannula to the skull Kemdent Simplex Rapid Powder and Fluid 
(Associated Dental Products Ltd, Swindon, UK) were used to create an 
Figure 2.4 Placement of the guide 
cannula to target the dorsal 
hippocampus.  Positioned +0.19 
cm coronally and -0.35 cm 
sagittally from bregma 
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autopolymerising acrylic resin.   Using a metal spatula applicator (Fine Science Tools, 
Heidelberg, Germany) a thin solution was added around the base of the guide 
cannula to seal it to the skull.  A matrix of more viscous resin was then built up 
gradually to secure the cannula and spread to the four screws.  Each layer was left 
to dry between applications.  During this time analgesic was administered 
subcutaneously to each animal (Metacam 2 mg/kg) to alleviate post-surgery 
discomfort. Once the matrix was dry, the guide cannula was carefully detached from 
the frame holder and a dummy cannula (Bilaney, Kent, UK) was inserted, extending 
1 mm beyond the guide cannula. 
The resin was left for a further 5 min to ensure that it was sufficiently dry and then the 
wound was sutured up using Mersilk sutures (Henry Schein, Cardiff, UK). Two 
stitches were made in front of the cannula and two behind to secure the wound, with 
additional stitches as necessary.  The tails of the first rat in each cage were marked 
with the experimental number for later identification and then rats were removed from 
the frame and placed in an incubation chamber at 37˚C for approximately 30 min.  
Animals remained in the chamber until they were fully recovered from the anaesthetic 
and able to stably support their own weight, at which time they were returned to their 
home cage.  All rats were left for a minimum of 6 days before any further experimental 
procedures.   
 Infusions 
Infusions were done using a Standard Infusion Only Harvard Pump 11 Plus Dual 
system (Harvard Apparatus, Cambridge, UK) and Hamilton 800 Series 5 µl glass 
syringes (Harvard Apparatus, Cambridge, UK).  Infusion needles were attached to 
the syringes using fine bore polythene tubing (Portex, Kent, UK - inner diameter 0.38 
mm, outer diameter 1.09 mm).  The syringes and tubing were filled with sterile water 
and then a 2 µl air bubble was introduced to separate the infusion solution.  Infusions 
were always conducted at a rate of 0.5 µl/min with a total of 1 µl delivered bilaterally.  
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It was ensured that any excess solution was removed from the tubing after the 
infusion and the injector and tube were rinsed in ethanol between animals to avoid 
any cross-contamination.  
A minimum of six days following surgery, all animals received a practice infusion of 
sterile PBS to clear out the cannula and allow them to become familiar with the 
procedure.  Animals were always infused one cage at a time and taken to the 
procedure room in the same transport boxes (odd numbered animals always in box 
A, even in box B).  Rats were placed on the experimenter’s lap and allowed to freely 
explore for the duration of the infusion.  Dummy cannula were removed and the 
infusion needles inserted until fully flush with the guide cannula, resulting in a 1 mm 
protrusion into the hippocampus.  The needles remained in place for 2 min after the 
end of the infusion to ensure maximal delivery of the solution.  The injector was then 
removed and the dummy cannula replaced.     
Animals received the experimental infusion 40 mins prior to the condition of interest 
and were returned to their home cages until required for testing.  All infusions were 
counterbalanced so that home cage, conditioning chamber and any order effects 
were controlled.  Post mortem histology was performed to ensure correct placement 
of the cannula.    
 Solutions 
Diltiazem Hydrochloride (Sigma, Dorset, UK) was dissolved to stock concentration 
(100 nmol) in DEPC water.  0.1 M sterile PBS (pH 7.2) was filtered through a 0.22 
µm Millipore syringe and used to dilute the stock solution of Diltiazem for a working 
solution (10 nmol) and as the control.  Solutions were separated into 10µl aliquots 
and stored at -20˚c until use. 
BDNF antisense was designed to target all BDNF transcripts, binding to exon IX.  
Synthetic phosphorothioate-modified antisense and missense control 
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oligonucleotides were created by Sigma (Dorset, UK), with the first 5’ and last 3’ 
bonds modified only.  Sequences are listed in Table 2.2.  Blast 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to ensure missense did not bind to 
any other non-target mRNAs.    
Table 2.2 BDNF antisense (aso) and missense sequences used 
 Sequence 5’ – 3’ 
BDNFaso tCTTCCCCTTTTAATGgT 
Missense Control aTACTTTCTGTTCTTGcC 
 
   
 Behaviour 
 Contextual Fear Conditioning  
2.3.1.1 Apparatus 
All sessions were undertaken in two standard modular test chambers for rats, interior 
measuring 30.5 cm (L) x 24.1 cm (W) x 21.0 cm (H), with aluminium side walls and 
clear polycarbonate rear and door (Med Associates Inc., Vermont, USA).  Chambers 
had a grid floor consisting of 19 equally spaced bars positioned 1.6 cm above the 
floor, through which a 0.5 mA shock was delivered.  This was controlled by a stand-
alone aversive stimulator/scrambler (Med Associates Inc., Vermont, USA).  Boxes 
were placed inside sound attenuating chambers 55.9 cm (L) x 55.9 cm (W) x 35.6 cm 
(H) (Med Associates Inc., Vermont, USA).  The programmes for each session were 
controlled through Med-PC version IV research control and data acquisition system 
(Med Associates Inc., Vermont, USA).  Behaviour was digitally recorded from 
cameras (JSP Electronics Ltd, China) positioned centrally above the chambers and 
viewed using Numeroscope software (Viewpoint, France) for offline analysis.  
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Animals were taken from home cages to the testing room in large transport boxes.  
The same box was used for each session.         
2.3.1.2 Conditioning 
Animals were placed in conditioning chambers for 2 mins before receiving a 0.5 mA 
scrambled foot-shock (US) for 2 secs.  They remained in the chambers for 1 min after 
the shock before returning to home cages in the same transport boxes.  Conditioning 
took place in the morning, a minimum of 30 mins after the start of the dark period in 
the holding room.    
2.3.1.3 Recall 
Three hrs, 24 hrs and/or 7 days later rats were returned to the same conditioning 
chamber (CS) for a 2 min recall session in the absence of the US. The recall session 
3 hrs after CFC measured short-term memory and the 24 hr and 7 day sessions 
assessed long-term CFM.  
2.3.1.4 Extinction 
Twenty-four hrs following CFC rats were returned to the conditioning context for a 10 
min session in the absence of the US to elicit extinction of the acquired memory.  
Consolidation of this extinction was then tested through subsequent recall sessions, 
as above.    
2.3.1.5 Latent inhibition 
Twenty-four hrs prior to conditioning rats were exposed to the conditioning context 
for 4 hrs. Animals were returned to their home cages overnight and received CFC the 
next day as described above (Conditioning) excepting time of day was aligned to 
offset of the 4 hr LI period.  The 4 hr pre-exposure to the CS leads to reduced freezing 
following CFC (Lubow, 1973).      
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2.3.1.6 Control groups 
Two control groups were used.  Naïve animals were taken directly from home cages 
and a second Novelty group were exposed to the context in the absence of any US 
for 2 mins before being returned to home cages.  Animals in the Novelty group were 
exposed to the context at the same time of day as conditioned animals and were 
sacrificed 2, 4 or 24 hrs following context exposure to correspond to the time point of 
interest.  Naïve animals were sacrificed at the same time as cage-mates.  
2.3.1.7 Analysis 
Freezing behaviour, defined as complete immobility for 1 sec except for respiration, 
was scored every 10 secs blind to condition from offline digital recordings (as 
previously reported; Barnes and Thomas, 2008; Trent et al., 2015).  The number of 
instances of freezing was recorded for each session that the animal undertook, as 
well as for separate pre and post US periods.  The percentage freezing was 
calculated for each animal in each session and then averaged within experimental 
and control groups.  Scores were checked for reliability by a minimum of two scorers.   
Repeated measures ANOVAs were conducted for each cohort of animals, with all 
sessions included for analysis, with session as within-subjects factor.  Mauchly’s test 
of sphericity was used and if significant a Greenhouse-Geisser correction was 
applied.  Post-hoc analyses between specific conditions of interest were conducted 
if repeated measures results were significant (P < 0.05).       
 Reversal Learning 
2.3.2.1 Apparatus 
Animals were run in sets of 4 using Bussey-Saksida rat touch screen chambers 
(Figure 2.5, A, Campden Instruments, 80604, Leics, UK) with accompanying Animal 
Behaviour Environment Test (ABET) II software (Whisker Client) (Campden 
Instruments, 89505).  Chambers had a square environment area of 368 cm² with a 
52 
 
unique trapezoidal wall shape to focus the animal’s attention on the screens.  Walls 
were 345 mm high and chambers had a grid perforated floor (10 mm square with 14 
mm pitch).  The touchscreen was limited to two square openings (8 cm x 8 cm) by an 
acrylic mask secured in-front of the screen.    
Liquid reward (10% sucrose solution) was delivered to the reward magazine via a 
peristalsis pump through clear tubing (0.8 mm x 1.6 mm).       
 
Figure 2.5 Bussey Saksida Touchscreen chamber set-up.  A) the testing environment inside 
the outer chamber.  B) The inside of the testing environment with the screen displaying two 
example stimuli.  Images taken from http://www.limef.com/Downloads/bussey-chambers.pdf 
 
2.3.2.2 Water restriction 
Animals were placed on water restriction with a minimum of 2 hrs access to water per 
day (administered in experimental chambers and/or home cages).  Water was 
removed for a maximum of 22 hrs in any 24 hr period and animals were weighed daily 
for the first week to ensure none dropped below 85% of natural body weight.  
Subsequently animals were weighed once a week during any water restricted 
periods.  Animals underwent 5 days of water restriction before training to familiarise 
them with the procedure.  During training, access to water was given immediately 
following each session.  Water restriction was used in favour of food restriction 
following evidence to suggest that this produces a better response in rodents, 
specifically in terms of more stable body-weight fluctuations and exploratory 
behaviour (Tucci et al., 2006).      
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2.3.2.3 Habituation 
Naïve animals were placed into Bussey chambers for a 30 min session.  At the 
beginning of each session a brief (1000 ms) tone was played and the food tray light 
turned on.  The magazine tray was primed with an initial liquid reward of 10% sucrose 
solution (6000 ms) made up fresh every 7 days.  Rats were required to enter and 
leave the reward tray for the programme to continue and the light to turn off.  There 
was a 5 sec delay before the start of each subsequent trial.  The light was turned on 
coinciding with a tone and a further smaller reward of approximately 20-25 µl 
delivered.  If the rat was still in the reward tray at the end of the 5 sec delay, then 
there was an additional 1 sec delay.  This repeated until the end of the 30 min session 
or until 100 trials was reached.  To move on to the next stage of training, animals 
must have completed 100 trials within the 30 min session for 2 consecutive days 
(Table 2.3).   
Table 2.3 Criterion that were reached for each experimental condition before animals moved 
on to the next stage of training 
Experimental 
Condition 
Criterion 
Habituation 100 trials completed in 30 mins for 2 consecutive days 
Must-Touch training 100 trials with > 20 blank touches in 30 mins for 2 
consecutive days 
Visual Discrimination > 80% correct for 2 consecutive days 
Reversal > 80% correct for 2 consecutive days 
Extinction 5 sessions 
 
2.3.2.4 Must-Touch training 
Stimuli of various black and white shapes were displayed randomly one at a time on 
either the left or right side of the screen (Figure 2.5 B).  The other side was left blank.  
The position of the stimuli was chosen pseudo-randomly in that an image would not 
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be displayed on the same side more than 3 times consecutively.  The rat was required 
to nose poke the stimuli to receive the liquid reward.  Touching the screen elicited a 
tone, accompanied by the food tray light and a 500 ms delivery of liquid reward.  
There was a 5 sec delay following the rat entering the food tray and a new stimuli 
being presented.  Touching the blank screen gave no response. To progress to the 
next training phase, animals needed to complete 100 trials within 30 mins, with fewer 
blank screen touches on 2 consecutive days.      
2.3.2.5 Visual discrimination 
The food tray was primed with liquid reward and the light turned on.  The programme 
was initialised by the rat exiting the food tray.  Novel stimuli were presented 
simultaneously on both sides of the screen (Figure 2.6).  As before, the position of 
the stimuli was pseudo randomised.  The rat was required to touch the correct stimuli 
(S+) to elicit the tone/light and the reward.  Collecting the reward led to the usual 5 
sec delay before the next trial.  If the incorrect stimuli (S-) was touched then the trial 
was terminated and the food tray light turned on for a 10 sec time-out period, with no 
reward.  The animal had to then enter and exit the food tray to initiate the next trial. 
The correct stimuli type was counterbalanced between animals.  Animals were 
required to make at least 80% correct responses on two consecutive days. 
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Figure 2.6 Flow diagram of experimental paradigm for visual discrimination and reversal 
conditions.  Stimuli shown are those used in the experiment.  Correct stimulus was 
counterbalanced across animals. 
2.3.2.6 Reversal of visual discrimination 
Once criterion was reached for visual discrimination the contingencies were reversed, 
with the previously incorrect stimuli now being rewarded.  Training continued until the 
same criterion (80% correct for 2 consecutive days) was reached.  Following this, 
animals underwent 5 sessions where no reward was given for correct responses 
(extinction trials). 
2.3.2.7 Analysis 
Trial numbers and number of correct/incorrect responses, as well as latencies, tray 
entries and beam breaks were recorded for each session.  
The number of trials and sessions to reach criterion were totalled for each animal and 
averaged across WT and HET groups for all experimental conditions.  One-way 
ANOVAs were conducted for each comparison when assumptions of normality and 
equal variance were met (Shapiro Wilks and Levene’s tests respectively).  In cases 
where variances were not equal, an independent student’s t-test was conducted and 
the appropriate t-statistic used.  
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Below chance errors, defined as the number of errors made when an animal was 
performing significantly below chance (< 45%), were totalled for each animal and 
averaged across WT and HET groups for reversal sessions.  This was used as a 
measure of perseverative behaviour following reversal.  Above chance errors (errors 
made when animals were performing above chance, > 55%) were also calculated for 
each animal for both visual discrimination and reversal to assess ability to acquire 
initial learning as well as reversed contingencies.  One-way ANOVAs were conducted 
between groups to assess for differences.  
Similar comparisons were made between latencies for reward collection, correct and 
black touches; with the average time (ms) calculated for each stage of the experiment 
for both WT and HET animals.     
 Locomotor activity  
Rats were assessed for basal levels of locomotor activity.   
2.3.3.1 Apparatus and paradigm 
Animals were placed into novel empty home-cage equivalent cages 36 cm x 47 cm, 
fitted with 2 continuous laser beams for 2 hrs on 3 consecutive days.  A 
photobeam/rotometer activity system (Paul Fray Ltd, Cambridge) was used to record 
the number of beam breaks, as well as double beam breaks in quick succession to 
constitute a ‘run’ measure from one end of the box to the other.  
2.3.3.2 Analysis 
Total beam breaks and total runs were calculated for each animal for the 3 separate 
testing days.  The average was calculated for all WT and all HET animals and 
repeated measures ANOVA was conducted across the 3 sessions.  Post-hoc 
analyses were conducted where significant overall differences were observed, to 
determine which session/s may be disparate.   
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Beams breaks and runs were also totalled within 30 min bins for each of the 3 
sessions, to assess habituation to the novel context within session (indicated by 
reducing activity (Xavier et al., 1991)).  Repeated measures ANOVA was conducted 
across the four 30 min bins to determine the effect of time in the box and compared 
between genotype.   
 Startle Response 
2.3.4.1 Apparatus and paradigm 
Animals underwent a 30 min startle response session in a SR-Labᵀᴹ Startle 
Response System (San Diego Instruments, CA).  They were placed in acrylic tubular 
chambers 20 cm long with an internal diameter of 8.9 cm. These are designed to 
reduce stress by restraint by allowing animals to turn while remaining over the sensor 
and ensuring reliable response readings.  Chambers were positioned on top of the 
accelerometer sensor inside a Prime Isolation Cabinet, 40.6 cm (W) x 38.1 cm (D) x 
58.4 cm (H).     
Each session consisted of 91 trials and background noise was set at 70 dB. Test 
pulses were administered at 120 dB during the first half of the session and 105 dB in 
the second.  Interleaved pre-pulse trials were administered of 4 dB, 8 dB and 16 dB 
to assess attenuation of the startle response for each sound level.  
2.3.4.2 Analysis 
Average response for each animal was calculated for the first 3 pulses and final 10 
pulses of 120 dB and 105 dB alone to assess startle and any habituation in response. 
The mean differences in startle following each of 4 dB, 8 dB and 16 dB pre-pulses 
were calculated as a measure of pre-pulse inhibition for both 120 dB and 105 dB 
stimuli.  One-Way ANOVAs were conducted to compare the mean values for each 
measure between WT and HET animals.   
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 Open Field Exploration Test 
An Open Field Exploration Test was used to assess basic activity levels and provide 
an initial screen for anxiety-related behaviours (Prut and Belzung, 2003).   
2.3.5.1 Apparatus and paradigm 
A black wooden arena was used, 1 m² with 50 cm high walls in a room with dimmed 
lighting (70 lux).  A camera positioned centrally above the arena recorded a single 
track for each animal, processed using EthoVision XT software (Noldus, VA). A 
centre ‘zone’ was defined as the central 70 cm² of the arena to determine the amount 
of time spent at the perimeter and in the open area. 
Animals were transported in their home cages to an adjacent holding room a 
minimum of 20 mins prior to testing.  Each animal was taken to the testing room and 
placed into the arena in the corner closest to the door.  Recording was started 
immediately and sessions lasted 10 mins.  Animals were removed from the arena 
and returned to home cages.  The arena was cleaned with 70% Sani-Cloth 
disposable disinfection wipes between each run (PDI, Flints, UK).   
2.3.5.2 Analysis 
Total distance, velocity (mean and max) and time spent in centre were extracted for 
each animal.  Averages were calculated within WT and HET animals and one-way 
ANOVAs were conducted for each measure to compare genotypes.   
 Statistical approach 
All statistical analyses were conducted using standard null hypothesis testing. Due to 
this choice of analysis, it is not possible to conclude absence of effects in some 
experiments which have small group sizes and may suffer from low power.  For 
experiments where this may be the case and trends (or close to) were observed, 
caution is noted for concluding absence or specificity of effects.   
59 
 
 Standard Lab Protocols 
 DEPC Treatment 
For every litre of solution requiring treatment, 1 ml of diethylpyrocarbonate solution 
(DEPC, Sigma-Aldrich, Dorset, UK) was added.  The solution was shaken vigorously 
and left for a minimum of 1 hr in a fume hood.  Solutions were autoclaved and left to 
cool to RT before use.   
 Slide preparation 
Poly-L-lysine (25 mg, Sigma-Aldrich, Dorset, UK) was dissolved in DEPC treated 
water and stored in 1 ml aliquots until use.  Each 1 ml aliquot was diluted in 50 ml 
DEPC treated water for a working solution.  Twin frost microscope slides (VWR 
International, Leics, UK) were dipped in Poly-L-lysine, air dried and stored at 4˚C until 
needed.      
 Sectioning and fixing of brain slices for histology and in situ hybridisation 
Whole brains were taken from animals immediately post-mortem, fresh frozen on dry-
ice and stored at -80˚C. Coronal brain sections of 14 µm were slices at -20˚C using 
a cryostat (Leica Microsystems CM1860UV).  Slices were mounted on poly-L-lysine 
coated glass microscope slides and air-dried.  Each slide had 1 slice from 5 or 6 
brains, counterbalanced across experimental conditions.  This allowed a series of 
slides to be produced that represented all animals in an experiment. Slides from each 
experiment were processed in parallel to ensure internal technical control.    
Dried mounted slides were placed into glass slide racks and fixed using fresh 4% 
paraformaldehyde (PFA) solution.  PFA (P6148, Sigma-Aldrich, Dorset, UK) was 
diluted in 1 x phosphate buffered saline (PBS, pH 7.2), stirred and heated at 60˚C 
until fully dissolved.  The resulting solution was cooled to 4˚C and kept on ice while 
slides were fixed for 5 mins. Slides were then placed in 1 x PBS for 1 min and then 
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in 70% ethanol (EtOH) for 5 mins.  All racks were stored in 95% EtOH at 4˚C until 
required. 
 Histology 
A 1% thionin stock solution was made up using 1 g thionin acetate salt (Sigma, 
Dorset, UK).  This was added to a buffer solution of 1 M sodium acetate solution and 
1 M acetic acid solution (adjusted to pH 4.3) for a working solution of 0.1%.  Slides 
were briefly rehydrated in double distilled water (ddH₂0) before immersion in 0.1% 
thionin stain for 10 mins.  A brief wash in ddH₂0 and 70% EtOH were followed by 
differentiation in 70% EtOH + 2% 1 M acetic acid for as long as necessary 
(approximately 2 mins to remove excess thionin).  Sections were serially dehydrated 
in 95% and 100% EtOH for 1 min and left overnight in Histo-Clear (Agar-Scientific, 
Essex, UK) to de-lipidate the tissue.  Clear glass coverslips (Agar Scientific, Essex, 
UK) were secured onto the slides using DePeX mounting medium (VWR, Leics, UK). 
Excess mounting solution was removed with a razor blade and slides were cleaned 
with EtOH before viewing under a standard light microscope (Leica). 
 In situ hybridisation 
The semi-quantitative in situ hybridisation (ISH) protocol using radiolabelled 
oligonucleotide (45mers) probes was similar to that previously described by Wisden 
& Morris (1994).   
2.4.5.1 Oligonucleotide probe design 
Oligonucleotide probes (45mers) were designed using the FASTA gene sequences 
from NCBI (http://www.ncbi.nlm.nih.gov/) for both human and rat genes of interest.  
Probes were designed to be 45 base-pairs long, have an AT:CG ratio close to 50% 
with a maximum of 3 bases difference and to have a maximum of 3 consecutive 
matching bases.  Probes were identified that were homologous between rats and 
human and showed a maximum of 80% homology with other genes of interest.  All 
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designed probes were tested for homology elsewhere in the genome by using BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and Blat (http://genome.ucsc.edu/cgi-
bin/hgBlat?command=start) (Table 2.4). The Blat function of the UCSC website was 
also used in conjunction with Ensembl (http://www.ensembl.org/index.html) to ensure 
probes designed to detect all variants of a gene (pan probes) were inclusive of all 
known transcripts.   
Probes were synthesised by Sigma-Aldrich (Dorset, UK) and diluted to 1 µg/µl in 
phosphate buffer (PB, pH 7) on arrival.  Aliquots of working solutions at 5 ng/µl diluted 
in sterile water were made up of each probe for ease of use and to minimise repetitive 
thawing or contamination.    
Table 2.4 Oligonucleotide probe sequences for ISH including accession n˚ of targeted genes 
and the complementary nucleotide span to which the probes bind 
Gene 
Accession 
n˚ 
Nucleotide 
span 
Probe sequence 
Cacna1
c 
NM_012517
.2 
3940 - 
3896 
3’ - 
TCGAAGTAGGTGGAGTTGACCACGTACCACAC
TTTGTACTGGTGC -5’ 
BDNFI
X 
All BDNF 
transcripts 
 
3’ – 
CGAACCTTCTGGTCCTCATCCAGCAGCTCTTC
GATCACGTGCTCA – 5’ 
  
2.4.5.2 Radiolabelling of probes 
Probes were labelled using deoxyadenosine 5’- (α-thio) triphosphate [35S] (dATP) 
(Perkin Elmer, MA, USA) which has a half-life of 87 days.   
Each oligonucleotide probe (2 µl) was added to 4.5 µl deionized water, 2.5 µl terminal 
deoxynucleotidyl transferase buffer (Promega, WI, USA), 1.5 µl terminal 
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deoxynucleotidyl transferase (Promega, WI, USA) (kept at -20˚C) and 1.5 µl 35S - 
dATP.  The solution was incubated at 35˚C for 1 hr.  
After incubation, 38 µl of deionised water was added to the above solution. Qiaquick 
Nucleotide Removal Kits (Qiagen, Manchester, UK) were used for purification of the 
probes following the enzymatic reaction.  Protocol was conducted as manufacturer’s 
recommendation.  Ten volumes of buffer PNI were added to 1 volume of labelled 
probe and centrifuged for 1 min at 6000 rpm.  The spin columns were washed twice 
with 500 µl of buffer PE for 1 min at 6000 rpm and flow-through discarded.  Samples 
were spun for a further 1 min at 13,000 rpm to remove any residual EtOH.  DNA was 
eluted by applying 50 µl buffer EB directly to the spin column membrane, incubating 
at RT for 1 min and centrifuging at 13,000 rpm for 1 min.     
Once complete 2 µl of the solution was added to 2 ml of scintillation fluid (Perkin 
Elmer, MA, USA) and activity was measured using a Packard Tri-CARB 2100 TR 
liquid scintillation counter (Isocount laboratory services) before converting to activity 
per µl.  Labelling was deemed successful if values were between 200,000 and 
800,000 cpm.  
2.4.5.3 In situ Hybridisation 
Hybridisation buffer was made containing; 25 ml 100% deionised formamide, 10 ml 
20 x SSC (Saline - Sodium Citrate buffer, containing 3 M NaCl and 0.3 M sodium 
citrate, PH 7.0), 2.5 ml 0.5 M sodium phosphate (pH 7), 0.5 ml 0.1 M sodium 
pyrophosphate, 5 ml 50 x Denhardts solution, 2.5 ml 4 mg/ml acid-alkali hydrolysed 
salmon sperm DNA, 1 ml 5 mg/ml polyadenylic acid, 50 µl 120 mg/ml heparin and 5 
g Dextran sulphate (all purchased from Sigma-Aldrich, Dorset, UK).  The solution was 
shaken vigorously and stored overnight at 4˚C until fully dissolved.  It was made up 
to 50 ml with DEPC treated water and stored in foil at 4˚C until needed.    
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Three slides of brain sections per series per probe were selected for ISH, to provide 
2 slides to define Total hybridisation levels and 1 to define the Non-Specific (NS) 
hybridisation signal.  Radiolabelled probes were applied at a level of 200,000 cpm 
per slide.  A master mix for each probe was made up to include; radiolabelled probe, 
2 µl of Dithiothreitol (DTT, 1 M) and 100 µl HYB Buffer per slide.  This solution was 
applied to 2 Total slides per series (100 µl per slide).  Unlabelled probe was then 
added at a ratio of 8:1 labelled probe, and 100 µl applied to the remaining NS 
allocated slides. Parafilm (Sigma-Aldrich, Suffolk, UK) strips were used to spread and 
cover the solution across all brain sections on the slide and to form the necessary 
matrix for ISH to occur.  All slides were sealed in humidified plastic chambers and 
incubated at 42˚C overnight. 
Parafilm coverslips were removed in 1 x SSC at RT. Slides were then washed in 1 x 
SSC at 52˚c for 1 hr (2 x 30 min washes) before rinsing in 0.1 x SSC and dehydration 
in 70% and 95% ethanol (1 min each).   
2.4.5.4 Film development 
Slides were mounted in Amersham rapid development cassettes (Fisher Scientific, 
Loughborough, UK), with Carestream Biomax MR film (Anachem, Luton, UK) and a 
¹⁴C ladder (American Radiolabelled Chemicals, Saint Louis, USA) to allow 
quantification.  The length of exposure depended on the level of expression of the 
GOI and ranged from 2 to 17 days.  Autoradiograms were then developed in a dark 
room using an automatic developer (Photon Imaging Systems, Swindon, UK). 
2.4.5.5 Analysis 
Films were scanned using an Epson Perfection V330 flatbed Photo Scanner (Epson, 
Hertfordshire, UK) at high resolution to allow quantitative analysis of optical density. 
ImageJ 1.47v software (NIH, USA) was used to convert grey values of regions of 
interest (ROI) into pixel intensity values by creating a standard curve from the ¹⁴C 
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ladder with known levels of radioactivity.  A standard curve was created for each 
individual film to account for differences in development time.   
Five samples were taken from each ROI, from each hemisphere and from each brain 
slice in the series. This resulted in 20 Total activity values and 10 NS values for each 
ROI per animal.  The total of the NS values was subtracted from the Total activity to 
provide a Specific activity value.  These were averaged across all animals in each 
condition.  All values were normalised to the average of the control group in order to 
assess percentage change from baseline.   
Normalised Specific Value = Control (Total activity – NS activity)/ Condition (Total 
activity – NS activity) * 100 
Control values were also normalised to the average of the control group to determine 
within group variance.  
2.4.5.6 Statistics 
For learning regulated expression assays, one-way ANOVAs were conducted to 
determine the effect of condition on normalised density values.  Analysis was 
separated by region.  Where a significant effect was observed post-hoc Dunnett or 
Bonferroni analyses were conducted.  For basal expression comparison for WT and 
HET animals, student’s t-tests were used for each region.  
 ELISA immunoassays 
2.4.6.1 Protein extraction 
Approximately 100 µg of tissue was homogenised in 1 ml T-PER (Radio 
Immunoprecipitation Assay) buffer at RT using a hand borosilicate glass pestle and 
mortar (Fisher Scientific, Delaware, USA).  RIPA buffer was made up of 150 mM 
sodium chloride with 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium 
dodecyl sulphate and 50 mM Tris (pH 8) and protease inhibitor treated.  One 
cOmpleteᵀᴹ Mini EDTA – free Protease Inhibitor Cocktail tablet (Sigma-Aldrich, 
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Dorset, UK) was added per 10 ml of RIPA buffer.  The amount of homogenising was 
kept as consistent as possible between samples. Samples were centrifuged, 12000 
rpm for 20 mins at 4˚C.  The supernatant was carefully aspirated and stored at -20˚C 
until required (-80˚C for long-term storage). The pellet was discarded.  
2.4.6.2 Protein Assay 
A BCA assay (Pierce BCA Protein Assay kit, Thermo Scientific, UK) was used to 
quantify the amount of protein because it was a method compatible with tissue 
prepared in T-PER buffer (Desjardins et al., 2009). Seven standards were created 
with concentrations between 2-0.5 µg/ml using T-PER as a diluent and an additional 
blank (containing only RIPA).  Samples were diluted 10 x in T-PER buffer. Fifty µl 
was added to 1 ml reagent mix (1 part reagent B with 50 parts reagent A) and 
incubated at 37˚C for 30 mins.  These were quickly cooled to RT and transferred to 
BRAND UV cuvettes (Sigma, Dorset, UK). Absorbance was measured at 562 nm 
using a WPA Biowave II UV Spectrophotometer (Biochrom, Cambridge, UK).  A 
standard curve was created from the 7 standards and the equation of the line used 
to calculate the concentration of each sample.  The absorbance of the blank was 
subtracted from each value to account for absorbance of the diluent.      
2.4.6.3 Assay protocol 
BlueGene competitive immunoassays for CACNA1C and CACNA1D were purchased 
from American Research Products Inc. (Massachusetts, USA). Rat BDNF sandwich 
ELISA Kit was purchased from Thermo Scientific (Delaware, USA).  Protocols were 
conducted exactly to manufacturer’s recommendations.  
BDNF 
All reagents and samples were equilibrated to RT before use.  Seven standards were 
created for a dilution series ranging from 3000 pg/ml to 12.29 pg/ml and one blank to 
include only the assay diluents supplied.  Additional controls were used for T-PER 
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only to determine any effects of the extraction buffer on the reaction.  Samples were 
diluted 1:10 in extraction buffer to produce protein concentrations predicted to fall 
within the standard curve and kit detection range. 100 μl of standards, samples and 
T-PER control were added to wells; all reactions were run in duplicate.  The plate was 
covered and incubated overnight at 4 ⁰C with gentle shaking.  Wells were washed 4 
times with 1 x Wash buffer supplied (300 μl per well), with all liquid removed between 
washes.  The plate was inverted and blotted on clean paper towel to ensure complete 
removal following the fourth wash.  100 μl of biotinylated antibody was added to each 
well and incubated for 1 hour at RT.  This was discarded and the wells washed as 
above, before adding 100 μl of Streptavidin – HRP solution.  Plates were incubated 
for 45 mins followed by 4 more washes as previously.  Finally, 100 μl of TMB 
Substrate was added to each well and incubated for 30 mins at RT in the dark with 
gentle shaking, followed by 50 μl of Stop Solution.   
CACNA1C and CACNA1D 
All kit components were brought to RT before use.  Samples were diluted 1:2 in 
extraction buffer.  100 μl of standards, samples and T-PER control were added to 
wells with an additional 10 μl of supplied balance solution added to the samples and 
one set of control wells. 50 μl of HRP enzyme conjugate was added to each well, 
excluding the control wells, and the plate was covered and incubated at 37 ⁰C for 1 
hour.  The plate was washed manually 5 x with 1 x wash buffer, with all liquid 
aliquoted after each and blotted dry on clean paper towel following the final 
wash.  The plate was covered and incubated for 15 mins at 37 ⁰C with a substrate for 
HRP enzyme, with 50 μl of supplied substrate A and substrate B added to each 
well.  A stop solution was added (50 μl) and plates were evaluated within 5 mins.  
2.4.6.4 Analysis 
Plates were evaluated using a CLARIOstar microplate reader (BMG LABTECH Ltd, 
Bucks, UK) set at 450 nm and 550 nm.  For analysis, 550 nm values were extracted 
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from 450 nm values to account for any optical imperfections in the plate. A standard 
curve was produced from the standards, with the equation of the line used to calculate 
the concentration for each sample.  Values were multiplied by dilution ratio and 
normalised to sample protein concentration. 
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3 BASAL AND ACTIVITY-REGULATED EXPRESSION OF 
CACNA1C 
 Introduction 
Changes in levels of gene expression in relation to certain behaviours or cognitive 
processes, strongly implicate those genes in the molecular processes underlying 
them.  Long term potentiation and the synaptic plasticity underlying long-term 
memory formation require de novo gene transcription as well as protein synthesis 
(Impey et al., 1996; Hall et al., 2000; Nader et al., 2000).  Previous research in 
contextual fear conditioning has shown changes in the expression of specific genes 
during different aspects of associative learning; identifying separable molecular 
signatures of distinct memory processes to include consolidation, recall and 
extinction (Hall et al., 2000; Lee et al., 2004; Kirtley and Thomas, 2010; Mizuno et al., 
2012.  For review see Quirk and Mueller, 2008).   
Contextual fear conditioning (CFC) is a hippocampal dependent, single trial, 
associative learning task.  It relies on the implicit formation of an association between 
an aversive stimulus (footshock) and a novel context.  This results in a conditioned 
response (freezing behaviour) during subsequent exposures to the context in the 
absence of the footshock, indicative of contextual fear memory (CFM). Learning is 
rapid, requiring only a single association trial, and is robustly expressed when tested 
weeks later.  This memory can be manipulated by prolonged re-exposure to the 
context which reduces conditioned freezing behaviour through the extinction of CFM.  
The implicit nature of this task further limits the confounds of motivation, as the recall 
of associations and resulting behaviour is seemingly automatic, based on a natural 
response to fear of discomfort.  There is no need for pre-training or any additional 
manipulations to promote behaviour (e.g. hunger for food), which may differ 
dramatically between animal and across sessions.  This allows the investigation of 
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potentially separable mechanisms underlying consolidation, recall and the extinction 
of a CFM in the same animals in single sessions.       
Previous studies have focussed on regulated expression of immediate early genes 
Activity-Regulated Cytoskeletal-Associated Protein (Arc) and Zif268 and 
neurotrophic factor BDNF.  Arc has been found to be rapidly increased in the 
hippocampus following CFC, with expression changes evident from 15 mins 
(Czerniawski et al., 2011) and protein levels peaking at 6 hrs post training (Lee et al., 
2004), though increases are also associated with exploration of a novel context 
(Guzowski et al., 1999).  Re-exposure to a previously conditioned context for 3 mins 
has been found to lead to a similar increase in Arc expression in the CA1 and CA3 
regions of the hippocampus, measured 90 mins after recall (Mamiya et al., 2009).  In 
the same study mice that were re-exposed to the context for a 10 min extinction 
session did not exhibit increased Arc at the same time point, suggesting Arc is 
specifically required following recall of CFM.   
The transcription of Arc is known to be regulated by BDNF (Ying et al., 2002). Similar 
profiles of BDNF expression are observed following CFC, with increases observed in 
the CA1 region of the hippocampus from 30 mins, returning to baseline at 24 hrs (Hall 
et al., 2000; Lubin et al., 2008).  Furthermore, independent expression profiles have 
been found for different transcripts of BDNF suggesting more finely regulated 
transcription (Mizuno et al., 2012).  Following re-exposure to the context for a short 
recall session, BDNF expression is significantly elevated at 30 mins, though this 
increase is not evident following a prolonged extinction session (Kirtley and Thomas, 
2010).  It has been proposed that this increased expression of BDNF (and the 
associated increase in Arc) is acting to constrain extinction learning (Kirtley and 
Thomas, 2010; Trent et al., 2015) and that the lower levels observed following 
prolonged recall indicate a removal of that constraint. 
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In contrast, Zif268 has been found to be increased in the CA1 and CA3 regions of 
the hippocampus, 30 mins after exposure to a novel context alone; without an 
additional increase following experience of a footshock or the formation of an aversive 
association (Hall et al., 2000).  This suggests this gene may play a more vital role in 
the formation of context representations rather than CFM, emphasising the need for 
novelty controls in these single trial experiments.  Re-exposure to a trained context 
for 2 mins and 10 mins elicits a similar increase in expression 30 mins later in both 
conditions (Kirtley and Thomas, 2010). This suggests distinct roles for Zif268 and 
BDNF in the processes of recall and extinction; with Zif268 hypothesised to promote 
the persistence of CS-US associations, and BDNF more specifically providing a 
molecular switch between maintenance of CFM and its extinction (Kirtley and 
Thomas, 2010).         
These different profiles of expression indicate separable molecular processes 
underlying different aspects of learning.  Evidence supports a role for BDNF and Arc 
in the consolidation of CFM, with a potentially more complicated balance between 
Arc, BDNF and Zif268 in its recall and extinction.  It has also been observed that there 
may be a second phase of transcription (as well as protein synthesis) necessary for 
the consolidation of CFM (Igaz et al., 2002).  There is evidence of increases of 
transcripts of BDNF 24 hrs after CFC (Mizuno et al., 2012) and there has been a 
second peak in ARC protein observed at 24 hrs, though no change in Zif268 
(Lonergan et al., 2010).  This further highlights the importance of time-course 
expression profiles to distinguish the role of certain genes.    
The transcription of these genes is mediated by the phosphorylation of CREB which 
is induced by calcium influx into the cell following synaptic activation (Sheng et al., 
1991).  There are multiple routes for calcium to enter the cell, including glutamate 
receptors, N-methyl-D-aspartate receptors (NMDA-R), AMPA-R and mGluR, as well 
as LVGCCs.  Expression of subunits of NMDA-R and mGluR has been investigated 
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following LTP, though there is limited research into behaviourally induced expression 
changes of these channels in the hippocampus following CFC.  Thomas et al., (1996), 
found increased NR2B and mGluR1c expression, evident from 24 hrs after the 
induction of LTP in dentate gyrus granule cells.  These findings, in conjunction with 
evidence for two critical periods of mRNA transcription for consolidation, indicate the 
importance of investigating delayed expression to a minimum of 24 hrs in Cacna1c.      
Cacna1c codes for the alpha-1 subunit of Cav1.2 calcium channels.  These channels 
are known to be necessary for an NMDA-R independent memory formation 
(Moosmang et al., 2005) and calcium influx through these channels has been shown 
to mediate synaptic regulation of gene transcription (Murphy et al., 1991; Zheng et 
al., 2011).  BDNF has additionally been found to be preferentially regulated by 
calcium influx through LVGCCs compared to NMDA-R (Ghosh et al., 1994; West et 
al., 2001).  Although functionally implicated in certain types of learning and memory, 
there has been no investigation into potential effects of associative learning on 
expression levels of Cacna1c.  Changes in expression may indicate a role for this 
gene in specific aspects of learning and may provide a link to already established 
molecular signatures of learning in rapidly transcribed genes, including BDNF.        
The following experiments used in situ hybridisation techniques to quantify the 
baseline and relative expression of Cacna1c following specific aspects of associative 
learning in sub-regions of the hippocampus.  The basal expression profile of 
Cacna1c, as well as CACNA1C protein is initially presented.  MRNA was then 
assessed at different time points following CFC to establish an expression profile 
linked to consolidation of CFM; from 2 hrs to 24 hrs post conditioning.  Expression 
was also measured following exposure to a novel context and a latent inhibition 
paradigm to separate out expression changes specifically related to consolidation, 
rather than novelty or experience of an aversive stimuli.  Secondly, comparisons were 
conducted between expression following short and long recall sessions, the latter 
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designed to induce extinction of CFM. Experiments aimed to determine whether 
Cacna1c may have a specific role in distinct processes of associative learning.     
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 Methods 
 Animals 
Sixty-four male Lister Hooded rats (250 – 300 g) were housed as previously 
described on a reverse light-dark cycle with ad libitum access to food and water.  
Experiments were conducted in the dark period.  Animals were sacrificed in home 
cages using a rising concentration of COz at specific time points following each 
behaviour of interest.  
 Behavioural procedure 
3.2.2.1 Apparatus 
For full description of the apparatus and paradigm used, see General Methods 2.3.1.  
Contextual fear conditioning took place in a rat conditioning box with a metal grid floor 
(Standard modular test chamber for rat, Med Associated Inc., Vermont, USA).  Cages 
were cleaned with a 50% ethanol solution before and after each session, which also 
gave a mild background odour.  Animals were taken from their home cages to the 
procedure room in large transport boxes.  All animals in transport box A were placed 
in conditioning box A and animals in transport box B in conditioning box B.  Digital 
recording commenced prior to the animal being placed in the box to ensure full 
recording of the trial. 
3.2.2.2 Behaviour 
For contextual fear conditioning, animals were placed into the novel conditioning 
chamber for 2 mins prior to receiving a 0.5 mA scrambled footshock for 2 secs.  They 
remained in the chamber for an additional 1 min before being returned to their home 
cages.    A ‘Novelty’ group was exposed to the context for 2 mins without receiving a 
footshock and were returned to home cages.   Conditioned animals were sacrificed 
2, 4, 8 and 24 hrs later.  Naïve home cage litter mates were sacrificed at the same 
time.  ‘Novelty’ animals were sacrificed 4 hrs after exposure.  
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A separate group of animals was pre-exposed to the context for 8 hrs before receiving 
the footshock to induce a latent inhibition effect (Holland and Bouton, 1999) and 
control for the experience of the footshock in the absence of an association formed 
with the context.  A separate ‘Nov/LI’ group was used to control for the prolonged 
exposure to the context, spending 8 hrs in the box without a subsequent footshock 
before being returned to their home cage.  Both groups were sacrificed 4 hrs after 
return to their home cages.  N = 6 for all groups, except 2 and 8 hrs following CFC (n 
= 4).   
For the separate investigation of recall and extinction.  Eighteen animals underwent 
CFC as described.  Forty-eight hrs later 12 of the animals were returned to the 
conditioning context; 6 for 2 mins and 6 for 10 mins.  The 2 min exposure is designed 
to measure recall of the association without affecting CFM, whereas the prolonged 
re-exposure leads to extinction of CFM indicated by reduced freezing.  The additional 
6 animals were used as a ‘No recall’ control group and were sacrificed along with 
their cage mates 2 hrs after re-exposure to the context.   
3.2.2.3 Analysis 
Freezing behaviour, defined as complete immobility except for respiration for 1 sec, 
was manually scored blind to condition from digital recording. A visual decision on 
freezing was made every 10 seconds throughout each session, with number of 
instances divided by total number of bins to provide a % freezing for each animal (as 
done previously; Barnes and Thomas, 2008; Trent et al., 2015). Scores were checked 
for reliability by a minimum of 2 scorers.  Scores were taken for each rat during the 
first 2 mins of exposure to the context (Pre-US) to check basal levels of freezing 
behaviour which may indicate anxiety.  A second score was taken following the 
footshock (post-US) in animals that underwent conditioning, to measure acquisition 
of the association between shock and context and to ensure the latent inhibition 
manipulation produced the expected reduction in freezing behaviour.  In animals that 
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underwent a recall session, scoring was conducted as above to establish successful 
recall of CFM and to confirm reduced freezing during extinction training.  Scores were 
averaged within experimental group.  Paired samples student’s t-tests were 
conducted to determine whether freezing increased post-US compared to pre-US in 
groups designed to acquire CFM and also to determine decreased freezing in the 
prolonged extinction group (first 2 mins compared to the last 2 mins of the session). 
Repeated measures ANOVAs were used to compare freezing levels pre and post-
US between LI and CFC groups as well as maintenance of freezing levels in recall 
and extinction groups.  Levene’s tests for equality of variances were conducted for 
all variables.      
 In situ hybridisation 
3.2.3.1 Sectioning and hybridisation 
For detailed methods see General Methods 2.4.6.  Brains were removed immediately 
post-mortem, fresh frozen on dry-ice and stored at – 80°C. Coronal sections 14 µm 
thick were sliced from each brain through the hippocampus, mounted on poly-L-lysine 
coated microscope slides and air-dried at RT.  Series were created to include one 
slice from each experimental condition. Slides were fixed in 4 % PFA solution 
followed by a 1 min wash in 1 x PBS and dehydration in 70% EtOH.  All slides were 
stored at 4°C in 95% EtOH until required.  
For hybridisation, 3 slides were selected from each series to produce 2 “total” slides 
and 1 “non-specific” control.  A master mix was made to include hybridisation buffer, 
DTT and deoxyadenosine 5’- (α-thio) triphosphate [35S] (dATP) labelled 
oligonucleotide probe specific to Cacna1c. 100 µl of master mix was added to each 
“total” slide and covered with Parafilm.  Unlabelled probe was added to the master 
mix at a ratio of 8:1 before being added to the “non-specific” slides for each series.  
Slides were incubated overnight at 42°C.  Parafilm covers were removed in 1 x SSC 
at RT, followed by 2 x 30 min washes in 1 x SSC at 52°C.  Slides underwent a final 
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wash for 1 min in 0.1 x SSC at RT and were dehydrated in 70% and 95% EtOH and 
left to air dry.   All slides were mounted together in a rapid development cassette for 
7 days with Biomax MR film and a 14C ladder for quantification.  Autoradiograms were 
developed using an automatic developer.    
3.2.3.2 Analysis 
Films were analysed using ImageJ software (NIH).  Values were converted using a 
standard curve calculated from the 14C ladder.  Measurements were taken from each 
region of interest and average across the 2 “total” slides.  Values from each “non-
specific” slide were subtracted before values were averaged within each experimental 
condition and normalised to Naïve.  One-way ANOVAs were conducted to determine 
the effect of condition on normalised density values.  Post-hoc Bonferroni tests were 
conducted where ANOVAs were significant.  Tests of normality and equality of 
variances were conducted throughout and corrected where necessary.    
 ELISA immunoassays 
3.2.4.1 Assay protocol 
For detailed methods see General Methods 2.4.8.  Protein was extracted from PFC, 
cerebellum and DG/CA3 region of the hippocampus in 1 ml T-PER extraction buffer.  
Protein concentration was measured using a BCA assay.  A BlueGene competitive 
immunoassay for CACNA1C was used and protocols conducted exactly to 
manufacturer’s guidelines.  Wells were incubated with 100 µl of sample, a balance 
solution and HRP enzyme conjugate at 37°C for 1 hr.  After washing, wells were 
incubated with a substrate for HRP enzyme for 15 mins before a stop solution was 
added.  Plates were analysed immediately using a CLARIOstar microplate reader at 
450 nm.  
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3.2.4.2 Analysis 
A standard curve was produced from 6 standards and used to convert values to 
protein concentrations.  For presentation, concentrations were normalised to PFC.     
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 Results 
 Basal expression of Cacna1c 
ISH and ELISA immunoassays were conducted to determine the basal expression 
profile of Cacna1c.  Basal levels of expression were compared between the PFC, 
cerebellum and hippocampus (Figure 3.1).  Transcripts levels were highest in the 
dentate gyrus (DG) sub-region of the hippocampus, followed by the CA3 and the 
granule layer of the cerebellum.  Expression in the PFC was highest in the medial 
PFC.  Protein levels similarly were highest in the DG/CA3, with equal levels of 
CACNA1C observed in the PFC and cerebellum (Figure 3.2).    
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Figure 3.1 Basal expression of Cacna1c mRNA. a) Quantification of ISH density values, 
normalised to medial PFC.  Greatest expression observed in the dentate gyrus.  Bars 
represent mean density values.  Error bars are +/- SEM. n = 4 b) Representative ISH 
autoradiogram images of Cacna1c expression in the PFC, cerebellum and hippocampus.  
Total binding of probe is shown on the left hand side and non-specific binding on the right.  
Specific binding values were calculated by subtracting ‘non-specific’ from ‘total’.      
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Figure 3.2 Basal expression of CACNA1C protein.  Protein levels were highest in the DG/CA3 
region of the hippocampus and similar in the PFC and cerebellum.  Bars represent protein 
levels normalised to PFC.  Error bars are +/- SEM. n = 6. 
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 Expression of Cacna1c following consolidation of CFM 
The expression of Cacna1c was compared in animals at 2, 4, 8 and 24 hrs after CFC 
and naïve home-cage controls, to determine whether expression was related to the 
consolidation of CFM.  Expression was also compared in animals 2 hrs after exposure 
to the novel context for 2 mins (Novelty) or 8 hrs (Nov/LI), as well as a latent inhibition 
(LI) group that received CFC training following 8 hrs exposure to the context.  These 
additional groups allowed comparisons which controlled for exposure to a novel 
context (brief and prolonged) and the experience of a footshock in the absence of 
association formation.  
3.3.2.1 Conditioned animals exhibited the expected increase in freezing behaviour   
Freezing behaviour was scored for all animals that were exposed to the training 
context (Figure 3.3).   There were no differences in freezing behaviour across groups 
during the first 2 mins in the context (F(3,20) = 1.990, P = 0.148).  In those animals 
that received a footshock (CFC and LI groups), freezing behaviour was scored 2 mins 
before the foot shock (Pre-US) and during the 1 min afterwards (Post-US).  There 
was a significant interaction between test-phase and condition (F(1,10) = 34.757, P 
< 0.001, ƞp2 = .777). Animals in the CFC group exhibited significantly greater freezing 
following the footshock compared to those animals that experience prolonged pre-
exposure to the context (LI) (F(1,10) = 25.879, P < 0.001, ƞp2 = .721), indicating 
successful acquisition of CFM. 
3.3.2.2 Reduced expression of Cacna1c following exposure to a novel context  
There was a significant effect of control condition on the expression of Cacna1c 
(F(3,60) = 5.249, P = 0.003), with reduced expression observed in the Novelty group 
compared to naïve animals (P = 0.033, Dunnett’s 2-sided test) (Figure 3.4).  There 
was no effect of region (F(2,60) = 1.059, P = 0.353) and no evidence of an interaction 
(F(6,60) = 0.249, P = 0.958).  Significant changes in individual regions were observed 
in the CA1 (t(10) = 2.933, P = 0.015).    
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3.3.2.3 Increased expression of Cacna1c 24 hrs after CFC 
Expression of Cacna1c differed at specific time points following CFC when compared 
with Novelty controls (F(4,21) = 3.339, P = 0.029). Post-hoc Bonferroni tests revealed 
significantly increased expression at 24 hrs post conditioning compared to Novelty 
controls (P = 0.017).   Differences between Novelty and 24 hrs were found to be 
significant in the DG (F(4,21) = 3.434, P = 0.026) (Figure 3.4). There was no effect of 
CFC on expression in the CA1 or CA3 regions of the hippocampus independently 
(F(4,21) = 0.149, P = 0.961 and F(4,21) = 0.666, P = 0.622, respectively); though 
there was not a significant effect of region (F(2,42) = 0.384, P = 0.684) or a condition 
by region interaction (F(8,42) = 0.768, P = 0.633) to confirm region specific effects. 
There were no differences observed between expression 24 hrs following CFC and 
LI (F(1,30) = 0.647, P = 0.427). 
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Figure 3.3 Freezing behaviour by condition for Pre and Post US.  % Freezing behaviour was 
scored for each group that was exposed to the context for the first 2 mins.  Animals that 
experienced the footshock were scored for the 1 min following.  Freezing behaviour in the 
CFC group was significantly greater than in the LI group that underwent prolonged pre-
exposure to the context.  Bars represent average freezing behaviour for each group at each 
phase.  Error bars are SEM.  *** P < 0.001.  
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Figure 3.4 Expression of Cacna1c in CA1, CA3 and DG sub-regions of the hippocampus 
following different learning experiences. There was a significant reduction in expression 
following exposure to novel context compared to naïve animals (P = 0.003). Expression 
following CFC showed an increase at 24 hrs compared to Novelty (P = 0.029). Bars represent 
mean optical density normalised to Naïve control.  Error bars are +/- SEM. n = 6 for all groups 
except 2 and 8 hrs (n = 4). * P < 0.05 
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 Expression of Cacna1c following recall and extinction of CFM  
A separate cohort of animals all underwent CFC.  Comparisons were made between 
expression in animals that were re-exposed to the training context 48 hrs later for 
either a 2 min recall session or a prolonged 10 min extinction session and animals 
that were not re-exposed to the context. 
3.3.3.1 Prolonged exposure to the conditioned context results in reduced freezing behaviour 
All animals successfully acquired CFM, indicated by increased freezing following the 
footshock compared to the 2 mins before (t(17) = -16.898, P < 0.001, ƞp2 = .944). 
Following CFC animals re-exposed to the trained context exhibited high levels of 
freezing indicative of successful recall of CFM (Figure 3.5)  There were no differences 
observed between freezing behaviour during the 1 min following the footshock during 
CFC and the first 2 mins of recall (F(1,10) = 0.059, P = 0.813)  with no differences 
between recall or extinction groups (F(1,10) = 4.543, P = 0.059) and no evidence of 
an interaction (F(1,10) = 0.237, P = 0.637).   
The prolonged 10 min exposure to the context resulted in reduced levels of freezing 
indicative of the extinction of CFM.  Freezing levels were significantly reduced in the 
last 2 mins of the session compared to the first (t(5) = 9.690, P < 0.001).      
3.3.3.2 Reduced expression of Cacna1c following recall in the CA1 
Cacna1c expression differed following recall and extinction in the CA1 region of the 
hippocampus (Figure 3.6: F(2,15) = 4.628, P = 0.027).  Post-hoc Bonferroni tests 
revealed a significantly reduced expression in animals that underwent the short 2 min 
recall session compared to those that experienced the 10 min extinction session (P 
= 0.029). Neither group differed significantly from the ‘No Recall’ group.   
There were no differences in expression in the CA3 or DG region of the hippocampus 
between any of the 3 groups (F(2,15) = 0.358, P = 0.705 and (f(2,15) = 0.196, P = 
0.824, respectively). 
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Figure 3.5 Freezing behaviour in 'No recall', 'Recall' and 'Extinction' groups.  PreUS: 2 mins 
prior to footshock, PostUS: 1 min following footshock. First 2 mins and Last 2 mins refer to 
recall session.    Behaviour was scored in 2 min bins during the prolonged extinction phase to 
indicate within-session extinction.  There was a significant increase in freezing following US 
presentation in all groups (t(17) = -16.898, P =< 0.001) indicating acquisition of CFM and 
significantly reduced freezing following prolonged re-exposure (t(5) = 9.690, P < 0.001), 
indicative of its extinction. Data points represent the average % freezing for each group during 
each testing phase. Error bars are SEM. *** P < 0.001  
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Figure 3.6 Expression of Cacna1c 2 hrs following a 2 min recall session or a 10 min recall 
session, normalised to animals that underwent no recall.  There was a significant reduction in 
expression in CA1 region of the hippocampus following the 2 min recall session compared to 
the 10 min extinction session (* P < 0.05 Bonferroni corrected).   
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 Discussion 
The expression of Cacna1c was investigated following specific aspects of a 
hippocampal dependent contextual fear conditioning task.  Of the regions that were 
investigated, basal expression of Cacna1c was found to be highest in the DG region 
of the hippocampus, followed by the CA3 and the granule layer of the cerebellum.  
The lowest levels were observed in the CA1, molecular layer of the cerebellum and 
the medial PFC.  In situ hybridisation revealed decreased expression following 
exposure to a novel and a conditioned context, as well as increased expression 24 
hrs following CFC.   
 Delayed regulated expression of Cacna1c in the dentate gyrus following CFC 
There was an increase in expression of Cacna1c 24 hrs following CFC, compared to 
both novelty controls. Changes were significant in the dentate gyrus region of the 
hippocampus, with no effects observed at earlier time points investigated.  This 
indicates that the expression of Cacna1c is related to the consolidation of CFM. The 
expression profiles of IEGs, with much earlier increases, indicate that the increase 
observed is unlikely to drive the initial changes in their expression, though it may be 
a consequence or compensatory response.   
This increase in expression 24 hrs following CFC may indicate a role for Cav1.2 
channels in a structural alteration in the synapse as a result of plasticity.  Previous 
studies have found delayed upregulation of subunits of glutamate receptors in the 
dentate gyrus following the induction of LTP in hippocampus (Thomas et al., 1994, 
1996).  Thomas et al., (1996) found an increase in the NR2B subunit of NMDA 
receptors evident from 24 hrs, peaking at 48 hrs, along with increases in mGluR1c 
which only became evident at 96 hrs following induction of LTP.  It was proposed that 
these late-phase profiles of expression may relate to cascades of events that are 
required for the maintenance of LTP and that increased glutamate receptors maybe 
reflect a switch from silent synapses to functional ones.  Persistence of long-term 
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memory has also found to be related to delayed protein synthesis of BDNF at around 
12 hrs following CFC (Bekinschtein et al., 2007). The increase of expression in 
Cacna1c observed here may indicate a delayed role in consolidation and 
maintenance of CFM.  Alternatively, increased expression may be part of a structural 
consequence of synaptic plasticity induced by CFC as alluded to by Thomas et al, 
(1996).  With the changes observed being greatest in the dentate gyrus, it is possible 
that this increase in Cacna1c in relation to learning could be associated with 
neurogenesis; a process known to be required for contextual fear conditioning (Saxe 
et al., 2006).  
 Selective reduced expression of Cacna1c following novelty exposure and recall  
Results further indicated a reduction of Cacna1c following the exposure to both a 
novel context for 2 mins and a previously trained context during recall.  Different 
expression levels of Cacna1c were observed following recall and extinction of CFM.  
Research has established that the process of extinction requires active learning of a 
CS – no US association rather than the degradation of the previous memory (Myers 
and Davis, 2002).  In contrast, the process of recall involves short exposure to the 
previously trained context and has been postulated to involve molecular mechanisms 
which constrain extinction rather than an active re-consolidation of CFM (Trent et al., 
2015). The reduced expression of Cacna1c following recall could be part of this active 
constrain on extinction, or could potentially reduce the activation of downstream 
mechanisms involved in extinction; further experiments would be necessary to 
investigate this fully.   
These results indicate changes in the expression of Cacna1c that are related to the 
formation of CFM.  Although relative levels of expression of Cacna1c do not appear 
to drive the increases in downstream signalling genes observed for specific aspects 
of learning in CFC, they may be relevant for persistence of CFM.    Observing 
changes in expression of a gene is one way to establish its role in a particular 
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psychological process.  However, the lack of early changes in expression does not 
confirm that this gene or related protein is not functionally related to the changes in 
IEG expression previously observed.  CACNA1C forms the alpha-1 subunit of Cav1.2 
channels and controls the voltage sensitivity of the channel pore.  Calcium influx 
through these channels is known to regulate immediate early genes implicated in 
these processes and has been specifically found to regulate the transcription of 
BDNF (Ghosh et al., 1994; Zheng et al., 2012).  Finely regulated calcium influx 
through these channels may therefore play a role in a subset of these processes, 
without an accompanying initial change in expression levels.   
 Limitations and future directions 
It is worth noting that expression was only investigated in the hippocampus for this 
study and that changes may exist in different areas of the brain.  The expression of 
Arc has previously been found to be upregulated in the amygdala and the 
hippocampus following short re-exposure to a trained context, whereas upregulation 
was observed in the amygdala and medial PFC following extinction (Mamiya et al., 
2009).  It is also possible that there may be transcript specific regulation, as has been 
observed in BDNF (Lubin et al., 2008).  However, with multiple unconfirmed predicted 
transcripts coded by the Cacan1c gene (with over 40 coded by the human gene), this 
is difficult to discern at present. 
This experiment was designed to establish whether changes in expression of 
Cacna1c were associated with consolidation, recall and extinction, potentially relating 
to those observed with IEGs.  The time points selected therefore reflected the critical 
periods in which previous evidence has implicated expression changes in these 
processes. The observation of increased expression at 24 hrs following CFC in the 
DG would require additional timed comparison groups for novelty and latent inhibition 
to conclude that this is related specifically to a mechanism involved in the formation 
or persistence of CFM.  It would also be pertinent to extend the time points out further 
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to establish when expression may return to baseline, as well as explore a complete 
time-course following recall.   
Given the minimal changes in Cacna1c expression observed and previous findings 
regarding the role for calcium influx through LVGCCs in learning (Davis and Bauer, 
2012), it would be logical to investigate whether there are separable roles for calcium 
influx through LVGCCs in the hippocampus in specific aspects of CFM processing.  
 Conclusion 
Increases in the expression of Cacna1c following CFC suggest a role for the 
expression of this gene in the consolidation of CFM. Although expression changes 
do not seem to reflect changes observed in IEGs, the delayed increase may reflect a 
role for the expression of Cacna1c in the persistence of associative learning. These 
results further indicate a reduction in expression of Cacna1c following exposure to a 
context in the absence of new fear learning. It is likely that any distinction in the role 
of Cacna1c earlier in these aspects of learning will be revealed by investigating the 
functional regulation of calcium influx through LVGCCs. 
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4 INHIBITION OF L-TYPE VOLTAGE GATED CHANNELS 
WITH DILTIAZEM: EFFECTS ON ASSOCIATIVE 
LEARNING 
 Introduction 
Calcium influx through L-type voltage gated calcium channels (LVGCCs) is known to 
be necessary for certain forms of NMDA receptor independent LTP and learning 
(Moosmang et al., 2005).  Selective pharmacological inhibitors of these channels 
have been developed, which block or enhance this calcium flow into the cell, while 
leaving other routes unaffected.  This provides the opportunity to investigate the effect 
of acute functional inhibition of LVGCCs on specific aspects of behaviour.  
 L-type calcium channel inhibitors 
There are 3 main classes of LVGGC inhibitors currently available for clinical use; 
phenylalkylamines, dihydropyridines and benzothiazepines.  These bind to three 
separate receptor sites on the alpha 1 subunit of the L-type calcium channels, which 
are allosterically linked (Hockerman et al., 1997).  They are highly selective for L-type 
channels over other types of VGCC, however there is evidence of binding to other 
sodium and potassium channels at higher doses.  Both Cav1.2 and Cav1.3 channels 
are affected by these inhibitors and due to their high homology there is currently no 
selective inhibitor for Cav1.2 channels.      
Experimental investigation implicates the IIIS5, IIIS6 and IVS6 transmembrane 
segments of the α1 subunit in binding all three classes of these drugs.  Individual 
amino acids have been identified which are necessary for high affinity binding of each 
type.  Mutation of these specific amino acids leads to a reduction in inhibitor affinity 
to the level of that observed with other classes of calcium channels. The binding 
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regions for each drug class are in close proximity, with potential overlap in necessary 
residues.   Because of this close proximity, it is suggested that phenylalkylamines 
and dihydropyridines bind to different faces of the IIIS6 and IVS6 transmembrane 
segments.  L-type calcium channel affinity to all of the classes of drug are state and 
membrane potential dependent, with greater affinity to inactivated and open state 
channels. 
Phenylalkylamines:  
These inhibitors are thought to access calcium channels from the intracellular side, 
though evidence is mixed and may depend on cell-type.  They inhibit L-type calcium 
currents by blocking channels directly through obstructing the transmembrane pore.         
The binding site for phenylalkylamines is allosterically linked to that for 
benzothiazepines and dihydropyridines, in that it’s binding will inhibit the binding of 
the other two.   Although L-type calcium channels are most sensitive to 
phenylalkylamines, other calcium channels as well as some sodium and potassium 
channels have been found to be blocked by the drug verapamil at higher 
concentrations (Freeze et al., 2006) and affinity is influenced by channel state.  It has 
a half-life of 2.8-7.4 hours and is soluble in water (70 mg/ml) 
Dihydropyridines:  
Dihydropyridines are calcium channel modulators that may act as channel agonists 
or antagonists depending on drug structure, membrane potential and the frequency 
of stimulation.  Nifedipine and Nimodipine are dihydropyridine calcium channel 
blockers that target primarily L-type calcium channels. Unlike Verapamil they do not 
directly block the transmembrane pore, but bind to a site at which agonists increase 
calcium channel activity and antagonists decrease it.  Nifedipine is highly insoluble in 
water and so for experimental purposes is usually dissolved in high concentrations of 
dimethyl sulfoxide (DMSO), which has been suggested to cause degeneration in the 
developing brain (Hanslick et al., 2009).  It has a short half-life of 2 hours.     
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4.1.1.1 Benzothiazepines:  
Research suggests that benzothiazepines are intermediate between 
dihydropyridines and phenylalkylamines in terms of blocking properties. Diltiazem is 
one of the main benzothiazepines used commercially.  It is found to produce more 
tonic block than Verapamil but less than Nifedipine and more frequency dependent 
block than Nifedipine but less than Verapamil (Herzig et al., 1992).  Although selective 
for L-type calcium channels, it will block other calcium channel types at much higher 
doses.  Inhibition occurs via binding to an extracellular domain.  It has a half-life of 
between 3 and 5 hours and is soluble in water (50mg/ml), making it more desirable 
for infusion into the brain compared to classes requiring alternative solvents.  
 Previous findings 
All three classes of inhibitors have previously been used to study the role of LVGCCs 
in associative learning, primarily in mice.  Both systemic administration and local 
infusion of the drugs have been investigated to determine effects on specific aspects 
of learning, however results are mixed and conclusions are incomplete.  
4.1.2.1 Acquisition 
In the context of fear conditioning, acquisition involves learning an association of a 
conditioned stimulus (CS) such as a tone or context with an aversive unconditioned 
stimulus (US) such as a mild foot shock.  This aversive learned association is robust 
and rapidly acquired.  Inhibition of L-type calcium channels has been found to not 
affect the acquisition or expression of fear conditioning.  Cain et al., (2002), used 
systemic injection of two dihydropyridine LVGCC inhibitors (Nifedipine and 
Nimodipine) to test the role of LVGCCs in acquisition, expression and extinction of 
conditioned fear in mice.    They found that acquisition was not affected by inhibition 
with 40mg/kg doses of Nifedipine at either 20 minutes or 50 minutes prior to 
conditioning.  This suggests that neither the sensitivity to the foot shock or the 
processing of the US is impaired by inhibition of LVGCCs when inhibitors are 
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administered systemically.  Local infusion of inhibitors into the amygdala similarly 
report no effects on the acquisition of CFM (e.g. Bauer et al., 2002). 
4.1.2.2 Consolidation 
Cain et al., (2002) further tested consolidation of the acquired memory with a two-
minute drug-free recall test 24 hrs following conditioning.  Systemic administration of 
Nifedipine 20 or 50 mins prior to training was found to have no effect on consolidation, 
however Nimodipine (15 mg/kg) was found to be state-dependent. Mice injected with 
a second dose of Nimodipine prior to the recall session showed comparable freezing 
levels to mice treated with vehicle prior to training, suggesting that the drug may 
provide an internal context or ‘state’ to which fear is conditioned.  Suzuki et al., (2008) 
report similar results, finding that systemic injection of Nimodipine (8-32 mg/kg) 
immediately following, rather than prior to fear conditioning, also does not appear to 
affect recall in mice 24 hours later. 
However, investigations into the consolidation of fear memory appear to show mixed 
results regarding the effects of LVGCC inhibition.  Bauer et al., (2002) examined the 
effects of bi-lateral infusion of different doses of Verapamil into the lateral amygdala 
on auditory fear conditioning.  In line with previous findings, there was no effect of 
infusion on post-shock freezing behaviour.  However, 24 hrs later, rats infused with 
Verapamil showed a dose-dependent impairment in long-term memory for the tone 
CS.  Only the two highest doses showed a significant effect on freezing behaviour.  
This impairment was not evident at 1, 3 or 6 hrs post conditioning, suggesting that 
inhibition of LVGCCs in the amygdala affects the consolidation of fear association but 
not its acquisition. 
The contradictory results regarding long-term impairment of consolidation with 
pharmacological inhibitors may be due to the different drugs and doses used, 
administration method and time delay between infusion and conditioning.  Localised 
injection in the lateral amygdala may have targeted more specific cell types to induce 
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the impairment observed at 24 hrs with Verapamil.  However, the role of LVGCCs in 
consolidation of fear conditioning may also depend on the specific isoform of the L-
type channel which may be expressed in different ratios in different tissue types.      
4.1.2.3 Recall 
The recall of conditioned fear memory has been found to involve dissociable 
molecular processes from consolidation (Lee et al., 2004).  There does not appear to 
be any strong effects of LVGCC inhibition on the recall of conditioned fear memory.  
However, there are limited studies that have investigated in isolation the effects of 
inhibitor infusion directly before the primary recall session in the absence of any prior 
injections.  Cain et al., (2002) conducted additional experiments to determine whether 
the effects of Nimodipine observed on consolidation were state-dependent.  The 
systemic infusion prior to the recall session following drug free conditioning did not 
affect freezing behaviour, suggesting that the inhibition of LVGCCs does not affect 
the expression of conditioned fear memory during a subsequent recall session.  
Similar to consolidation, it is possible that more precise local infusions may produce 
different results.   
4.1.2.4 Extinction 
Extinction is a form of inhibitory learning (Bouton, 2004; Herry et al., 2010), in which 
conditioned responding to a stimulus is reduced in the absence of the reinforcer.  
Prolonged exposure to the CS in the absence of the US leads to new learning which 
inhibits the previously acquired association.  The inhibition of previous learning rather 
than the degradation of memory is supported by findings that the original memory 
can be recovered spontaneously, through intended reminders or through pathology 
(Quirk and Mueller, 2008).  There are seemingly considered to be two stages to 
extinction; training and recall. 
Multiple studies have found an effect of LVGCC inhibition on extinction, though 
results are not entirely consistent.  Cain et al., (2002) found that systemic infusion of 
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Nifedipine or Nimodipine prior to an extinction session led to a perseverance of 
freezing behaviour during training compared to vehicle infused mice, which showed 
a time dependent decline.  They found the same results for both cued and context 
fear conditioning. In contrast to these results, Davis and Bauer, (2012) found no effect 
of local BLA infusions of Verapamil or Nifedipine on extinction training of cued fear 
conditioning.  They found similar levels of freezing in rats infused with inhibitor and 
those infused with vehicle 15 minutes prior to the extinction training session.  
However, when tested 24 hours later it was found that animals infused with inhibitor 
prior to training showed an impaired retrieval of extinction learning, with greater levels 
of freezing observed.  This suggests a distinct role for LVGCCs in extinction learning, 
however the precise role they play at different stages and in different regions of the 
brain is yet to be elucidated.    
4.1.2.5 Latent Inhibition  
Latent inhibition (LI) describes the conditions in which there is reduced association 
formed between the CS and US when there has been pre-exposure to the CS, 
compared to when the CS is novel.  It takes longer for familiar stimuli to acquire 
meaning as a CS compared to novel stimuli, with the idea that a CS-No US 
association has been formed (Lubow, 1973).  There are very few studies that have 
investigated the role of LVGCCs in LI, however impairments have been observed 
following systemic injection of two independent inhibitors (nifedipine and diltiazem).   
Barad et al., (2004)  injected mice before a CS pre-exposure session 1 day before 
fear conditioning and compared freezing behaviour recall 1 day later. Mice were 
injected systemically with either vehicle or Nifedipine (40mg/kg).  Half the mice 
underwent the pre-exposure session one day before conditioning.  Nifedipine was 
found to block LI completely, with no significant difference observed between mice 
pre-exposed to the context and those that were not.  Further investigation determined 
that the effect was not due to state-dependent learning and that similar effects were 
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observed with diltiazem at the same concentration.  The LI effect that was observed 
was not as extreme as previous observations, which may have been due to the one-
day delay between pre-exposure and conditioning. 
These previous findings suggest a specific role for LVGCCs in associative learning.  
However, there are conflicting and incomplete conclusions from the existing literature.  
Different studies have used very different experimental designs, different drugs and 
different methods of administration.  Importantly the systemic administration of certain 
drugs has since been noted to cause an aversive response confounding the 
conclusions that can be made.  For example, Mckinney et al., (2008) found that 
systemic injection of Nifedipine impairs locomotor activity as well as induces an 
aversive state which may itself act as a CS during fear conditioning.      
To date, local infusion of LVGCC inhibitors has primarily focussed on the amygdala 
in relation to fear conditioning.  It is well established that the hippocampus plays a 
vital role in contextual fear conditioning and associative learning (Eichenbaum, 2004; 
Matus-Amat et al., 2004).  Furthermore, hippocampal function is robustly found to be 
altered in patients with schizophrenia and carriers of risk variants for the disorder as 
discussed previously (Heckers, 2001; Erk et al., 2014).  Considering the identification 
of calcium channels and calcium signalling in risk for schizophrenia, it is pertinent to 
determine their role in regions relevant to the disorder.   
 Experimental aims 
For the following experiments we use contextual fear conditioning as a model of 
hippocampal dependent associative learning.  The experiments in this chapter aim to 
determine the effects of local inhibition of L-type voltage gated calcium channels in 
the hippocampus on specific aspects of associative learning, namely; acquisition, 
consolidation, recall, extinction and latent inhibition.  Diltiazem was infused bilaterally 
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into the rat hippocampus prior to different context exposures and freezing behaviour 
was assessed as an index of association formation.   
Diltiazem was chosen as the inhibitor for these experiments due to its intermediate 
properties of tonic block and frequency dependency.  Although at the time of the 
experiments there was no available Cav1.2 selective drug, it is highly selective for 
LVGCCs over other types of voltage gated calcium channels expressed in the brain. 
It is highly soluble in water, allowing for PBS to be used as a diluent without the need 
for DMSO, making it more suitable for local infusion into the brain with lower toxicity.  
It has a biological half-life of 3.5-4 hours which is ideal for the intended acute 
inhibition, but still long enough to be appropriate for longer behavioural sessions.      
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 Experiment 1 – Effect of intrahippocampal diltiazem on acquisition 
and short-term recall 
The aim of this experiment was to assess the effect of local inhibition of calcium influx 
through LVGCCs on the acquisition and short term recall of contextual fear memory 
(CFM). Diltiazem or PBS was infused bilaterally into the hippocampus prior to 
conditioning and freezing behaviour was compared as a measure of learned 
association between the context and aversive stimuli.  Behaviour was assessed in 
the context prior to any exposure to the footshock (US) to determine any baseline 
differences following the infusion.  Scores were then taken immediately following the 
US in the same session and in the 2 min recall session 3 hrs later to assess CFM.     
 Method and Materials 
4.3.1.1 Subjects 
12 Adult male Lister Hooded rats (250-275 g, Charles Rivers, Margate, UK) were 
housed in pairs as previously described.  All animals were given a minimum of five 
days from arrival to settle before being used in any experiments.  At the end point of 
each experiment, animals were sacrificed using a rising concentration of CO₂ in a 
home cage culling chamber (Clinipath Equipment Limited, Hull, UK) and brains were 
removed and fresh frozen on dry-ice.  One animal in the control group for this 
experiment showed no evidence of any conditioning following training and so was 
excluded from analysis, resulting in 6 animals in the diltiazem group and 5 in the PBS 
treated group.  
4.3.1.2 Surgery 
All surgery was conducted under anaesthetic (2.5-5% Isoflurane) on a stereotaxic 
frame (Bilaney, Kent UK) to ensure accurate targeting of the dorsal hippocampus 
(see General Methods).  Double guide cannulae were inserted and secured to the 
skull targeted at + 0.19 cm from bregma in the coronal plane and – 0.35 cm in the 
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sagittal plane.  Dummy cannulae were inserted to protect the guide from blockage or 
infection prior to and following infusions. 
Rats were tail marked and left to recover in an incubation chamber at 37˚C for 30 
mins.   There was a minimum 6-day interval between surgery and behavioural 
procedures.  Post-hoc histological analyses were conducted to establish correct 
placement of cannula (Figure 4.1; See General Methods 2.4.4 for full description).  
 
Figure 4.1 Histological analysis for cannula placement for infusions for Acquisition and STM 
experiment. a) Example thionin stained brain slice indicating guide cannula placement. b) 
Location of point of guide cannula for all animals.  Crosses indicate focal point of infusion, red 
cross indicates animal excluded from analysis due to behaviour. 
4.3.1.3 Infusions 
All animals received a practice infusion of sterile PBS (pH 7.2) to clear out the cannula 
and allow them to become familiar with the procedure.  Animals were always infused 
one cage at a time and taken to the procedure room in the same transport boxes (odd 
numbered animals always in box A, even in box B).  Rats were placed on the 
experimenter’s lap and allowed to freely explore for the duration of the infusion.  
Dummy cannulae were removed and the infusion needles inserted until fully flush 
with the guide cannula, resulting in a 1 mm protrusion into the hippocampus.  The 
needles remained in place for 2 min after the end of the infusion to ensure maximal 
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delivery of the solution.  The injector was then removed and the dummy cannula 
replaced.     
Animals received the experimental infusion 40 mins prior to the condition of interest 
and were returned to their home cages until required for testing.  Animals received 
infusions of either PBS (pH 7.2) or diltiazem (10 nmol) at a rate of 0.5 µl/min, with a 
total of 1 µl delivered bilaterally.  All infusions were counterbalanced so that home 
cage, conditioning chamber and any order effects were controlled.  Post mortem 
histology was performed (see General Methods) to ensure correct placement of the 
cannula.    
4.3.1.4 Behavioural apparatus 
For full description of the apparatus and paradigm used, see General Methods 
2.3.1.  Contextual fear conditioning was conducted as previously in a rat conditioning 
box with a metal grid floor.  Animals were transported from home cages to the testing 
room in large transport boxes, with the same box used for each session.  Digital 
recordings were taken for the full duration of each session. 
Contextual Fear Conditioning  
Animals were placed in conditioning chambers for 2 mins before receiving a 0.5 mA 
foot-shock for 2 secs.  They remained in the chambers for 1 min after the shock before 
returning to home cages.  To assess acquisition and short term recall of contextual 
fear memory, rats were returned to the conditioning chambers 3 hrs following training 
and then 24 hrs and 7 days later for a long term recall session. Rats were placed in 
the same context as training but in the absence of any US for 2 mins and then 
returned to home cages. 
4.3.1.5 Analysis 
Freezing behaviour was scored as previously described and checked for reliability by 
additional scorers.  Scores were taken for each rat before the administration of the 
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footshock (Pre-US) to check basal levels of freezing behaviour which may indicate 
anxiety.  A second score was taken following the footshock (post-US) to measure 
acquisition of the association between shock and context and scores were taken from 
each subsequent recall test to assess the consolidation of this association.   
Freezing levels were compared between diltiazem and PBS treated animals using 
repeated measure ANOVA, unless otherwise stated.  Greenhouse Geisser 
corrections were applied where Mauchly’s test of sphericity was significant.  Post-hoc 
one-way ANOVAs were conducted for individual test sessions based on a-priori 
hypotheses where appropriate.   
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 Results 
4.3.2.1 Intrahippocampal diltiazem has no effect on the acquisition or short-term recall of 
contextual fear memory 
Diltiazem (10 nmol, 1 µl, 0.5 µl/min) or PBS was infused 40 mins prior to CFC (Figure 
4.2).  Repeated measures ANOVA showed a significant effect of session on freezing 
behaviour (session: F(2,18) = 151.633, P<.001, ƞp2 = .94).  Increased freezing was 
evident post-US (M = 54.54%, SEM = 3.25%) and during the short-term recall session 
3 hours later (M = 68.94%, SEM = 4.22%) compared to pre-US (0%, t(10) = 16.785, 
P<.001; t(10) = 16.344, P<.001 respectively), indicative of successful acquisition and 
recall of CFM.      
There was no effect of diltiazem on freezing behaviour (group: F(1,9) = 1.05, P = 
.332, ƞp2 = .10) or an interaction between session and group (session x group: F(2,18) 
= .801, P = .464, ƞp2 = .08).  When tested 3 hours following conditioning, diltiazem 
treated animals showed the same levels of freezing (M = 68.06%, SEM = 6.00%) 
compared to PBS treated animals (M = 70.00%, SEM = 6.58%).  This suggests that 
there was no effect of infusion of diltiazem on initial context exploration, processing 
of the US, or acquisition and short-term recall of CFM.         
4.3.2.2 Intrahippocampal diltiazem affects the recall of CFM at 24 hours and 7 days 
following conditioning 
Animals were returned to the training context for further recall sessions at 24 hours 
and 7 days to assess the effects of diltiazem on consolidation. Repeated measures 
ANOVA across the two recall sessions showed no effect of session (session: F(1,9) 
= 1.947, P = .196, ƞp2 = .18) or an interaction between group and session (session x 
group: F(1,9) = 3.017, P = .116, ƞp2 = .25), suggesting freezing behaviour was 
maintained across the recall sessions.    
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There was a significant effect of diltiazem on freezing levels across recall sessions 
(group: F(1,9) = 8.376, P = .018, ƞp2 = .48), with reduced freezing observed in 
diltiazem treated animals. Follow up independent sample t-tests, with equal variances 
not assumed, revealed a significant difference between freezing in diltiazem (M = 
9.72%, SEM = 2.56) and PBS treated animals (M = 46.67%, SEM = 19.81) at 7 days 
following conditioning (t(4.717) = 4.126, P = .010, d = 2.59).  This suggests a specific 
effect of diltiazem infusion prior to training on the consolidation of CFM.    
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Figure 4.2 Intrahippocampal diltiazem has no effect on the acquisition of short term recall of 
CFM.  Tests of consolidation at 24 hours and 7 days later indicate a significant effect of 
diltiazem on freezing behaviour during recall (F(1,9) = 8.376, P = .018) with no evidence of an 
interaction (F(1,9) = 3.017, P = .116).  Data points represent average % freezing for each 
group.  Error bars are SEM. 
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 Experiment 2 – Effect of intrahippocampal diltiazem on 
consolidation 
This experiment aimed to further assess the effect of diltiazem on consolidation of 
CFM without the confounding experience of a short term recall session.  Re-exposure 
to the context 3 hrs following conditioning and recall of the association has been 
posited to lead to reactivation of the acquired CFM and induction of a labile state 
(Nader, 2003).  This further experience of the context may therefore lead to new 
learning about its association with the US and influence future consolidation (Lee et 
al., 2004).   
As experiment 1, diltiazem was infused bilaterally into the hippocampus prior to 
conditioning and freezing behaviour was assessed 24 hrs and 7 days later in the 
absence of any short-term recall test.    
 Methods and materials 
4.4.1.1 Subjects 
Twelve adult male Lister Hooded rats, housed as above.  All animals underwent the 
full experiment and were included in analysis.  
4.4.1.2 Surgery 
As experiment 1.  Histological analyses were conducted to confirm cannula 
placements (Figure 4.3)  
4.4.1.3 Infusions 
As experiment 1.  Infusions of diltiazem or PBS were administered 40 mins prior to 
the conditioning session. 
4.4.1.4 Contextual Fear Conditioning 
Animals were conditioned as in experiment 1 and underwent 2 recall sessions at 24 
hrs and 7 days following conditioning.   
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Figure 4.3 Histological analysis for cannula placement of infusions for Consolidation 
experiment. a) Example thionin stained brain slice indicating guide cannula placement. b) 
Location of point of guide cannula for all animals.  Crosses indicate focal point of infusion. 
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 Results 
4.4.2.1 Hippocampal infusion of diltiazem impairs the consolidation of contextual fear 
memory 
Animals were infused with diltiazem or PBS 40 mins prior to CFC.  Repeated 
measures ANOVA across all sessions showed a significant effect of session (session: 
F(3,30) = 28.262, P < 0.001, ƞp2 = .74), in line with findings in experiment 1.  There 
was a significant effect of diltiazem on freezing behaviour (Group: F(1,10) = 10.465, 
P = .009, ƞp2 = .87) and evidence of an interaction (session x group: F(3, 30) = 12.112, 
P < .001, ƞp2 = .55). 
Post-hoc analyses across pre and post-US sessions showed that freezing behaviour 
was increased following CFC (session: F(1,10) = 53.309, P < .001, ƞp2 = .84), 
indicative of acquisition of CFM, with no effect of diltiazem (group: F(1,10) = .013, P 
= .910, ƞp2 = .001) or evidence of an interaction (group x session: F(1,10) = .129, P = 
.727, ƞp2 = .013), as shown in experiment 1.   
However, repeated measures ANOVA across recall sessions showed significantly 
reduced freezing behaviour in diltiazem treated animals (M = 10.42%, SEM = 6.20%) 
compared to PBS treated animals (M = 51.39%, SEM = 6.20%) across both sessions 
(F(1,10) = 21.838, P = .001, ƞp2 = .69) with little or no evidence of a learned 
association (Figure 4.4).  This concurs with findings in experiment 1, though further 
post-hoc analyses show reduced freezing evident at both 24 hours and 7 days later 
(One-way ANOVA: F(1,10) = 25.415, P = .001, ƞp2 = .72; F(1,10) = 14.257, P = .004, 
ƞp2 = .59 respectively).  In line with experiment 1, this suggests inhibition of LVGCCs 
during training selectively impairs the consolidation of CFM.    
In addition there was a significant effect of recall session on freezing behaviour 
observed (session: F(1,10) = 9.494, P = .012, ƞp2 = .49) with reduced freezing at 7 
days compared to 24 hours following CFC.  This was in conjunction with an interaction 
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between group and session (F(1,10) = 6.798, P = .026, ƞp2 = .41), with reduced 
freezing only evident in PBS treated animals. This suggests there may be between 
session extinction of CFM in PBS treated animals, as previously reported.   
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Figure 4.4 Intrahippocampal infusion of L-type VGCC inhibitor diltiazem impairs consolidation 
of contextual fear memory. There was reduced freezing in diltiazem treated animals at recall 
24 hours and 7 days later (Session x Group, F(1,10)=6.798, P = 0.026).  Data points represent 
average % freezing for each group at each testing phase.  Error bars are SEM. 
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 Experiment 3 - Effect of intrahippocampal diltiazem on recall 
Previous studies have shown that the recall of associative memory involves 
separable molecular processes from those activated by consolidation (Lee et al., 
2004).  With such strong effects of diltiazem observed on consolidation, this 
experiment aimed to investigate the effects of inhibiting LVGCCs on the recall of 
CFM.   
Animals underwent CFC drug free.  The following day they received infusions of 
diltiazem or PBS 40 mins prior to a 2 min recall session.  Freezing was assessed 
during this session and in 2 subsequent recall sessions 24 hrs and 7 days later to 
determine the immediate effect of inhibition and any future recall attempts.  
 Methods and Materials 
4.5.1.1 Subjects 
14 animals were housed in pairs as previously described. 
4.5.1.2 Surgery 
As experiment 1.  Histological analyses were conducted to confirm cannula 
placement (Figure 4.5). 
4.5.1.3 Infusions 
Infusions occurred 40 mins prior to the first recall session 24 hrs following drug free 
training.  Solutions were administered as experiment 1.  
4.5.1.4 Behaviour 
Animals were conditioned drug free with a 3 min CFC session as experiment 1.  A 2 
min recall session occurred 24 hrs later, with diltiazem or PBS infused 40 mins before 
exposure to the context.  There were two subsequent drug free recall sessions 24 
hrs and 7 days later.   
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Figure 4.5 Histological analysis for cannula placement for Recall experiments a) Example 
thionin stained brain slice indicating guide cannula placement. b) Location of point of guide 
cannula for all animals.  Crosses indicate focal point of infusion. 
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 Results 
4.5.2.1 Intrahippocampal infusions of diltiazem prior to retrieval has no effect on the recall 
of CFM 
Diltiazem or PBS was infused 40 mins prior to a 2 min recall session 24 hrs following 
drug free CFC.  Animals showed the expected conditioned freezing behaviour prior 
to infusions (pre-US vs post-US, Figure 4.6), with increased freezing observed post-
US (session: F(1,12) = 180.390, P < .001, ƞp2 = .94).  There was no difference 
between animals that subsequently received infusions of diltiazem or PBS (group: 
F(1,12) = 2.362, P = .15, ƞp2 = .16) and no evidence of an interaction (F(1,12) = .878, 
P = .367, ƞp2 = .07).  
There was no effect of diltiazem on freezing behaviour across recall sessions; 40 
mins following the infusion, nor at 24 hours and 7 days later when tested drug free 
(group: F(1,12) = .320, P = .582, ƞp2 = .03).  As experiments 1 and 2, there was 
evidence of between session extinction of CFM, with reduced freezing observed 
across subsequent recall sessions (session: F(2,24)  = 5.032, P = .015, ƞp2 = .30), 
though there was no indication of an interaction between group and session (session 
x group: F(2,24) = 1.305, P = .290, ƞp2 = .10). This suggests there is no effect of 
inhibition of LVGCCs prior to retrieval on the recall of CFM.    
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Figure 4.6 Intrahippocampal infusion of diltiazem prior to recall has no effect on freezing 
behaviour or on recall 24hours and 7 days later (F(1,12) = 0.32, P = 0.582).  Data points 
represent average % freezing.  Error bars are SEM.  
  
116 
 
 Experiment 4 – Effect of intrahippocampal diltiazem on extinction 
learning 
Prolonged exposure to a previously conditioned context in the absence of the US 
results in a reduction in learned freezing behaviour, termed extinction (Bouton, 1993).  
Evidence suggests that this extinction occurs due to new learning of a CS-No US 
association which competes with and inhibits previous conditioning (Myers and Davis, 
2002).   
This experiment aimed to investigate whether the infusion of diltiazem into the 
hippocampus prior to an extinction session interfered with extinction training (i.e. the 
reduction of freezing seen within session) and/or the consolidation of extinction when 
tested 24 hrs and 7 days later. 
 Methods and Materials 
4.6.1.1 Subjects 
16 animals were housed as previously described.  One animal was excluded from 
analysis following post-hoc histological analysis of cannulae placement, suggesting 
incorrect infusion location (Figure 4.7). This resulted in 8 animals in the diltiazem 
group and 7 in the PBS control group for final analysis.  
4.6.1.2 Surgery 
As experiment 1.  Histological analyses were conducted to confirm cannula 
placement (Figure 4.7) 
4.6.1.3 Infusions 
Diltiazem or PBS was infused prior to a 10 min recall session 24 hrs following drug 
free CFC.  Solutions were prepared and administered as experiment 1.   
117 
 
4.6.1.4 Behaviour 
Animals underwent 3 min CFC as experiments 1-3.  24 hrs later animals were re-
exposed to the training context for 10 mins to induce extinction of the learned 
association.  Freezing behaviour was scored every 10 secs throughout the entire 
extinction session.  Behaviour was then assessed 24 hrs and 7 days later during 2 
min US free recall sessions, as experiments 1-3.   
 
 
Figure 4.7 Histological analysis for cannula placement for Extinction experiments a) Example 
thionin stained brain slice indicating guide cannula placement. b) Location of point of guide 
cannula for all animals.  Crosses indicate focal point of infusion. The red cross indicates the 
site of infusion for the 1 animal excluded from analyses. 
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 Results 
All animals acquired the learned association drug free on testing day one (repeated 
measures ANOVA: F(1,13) = 109.975, P < .001, ƞp2 = .89), with no difference between 
animals which subsequently received infusions of diltiazem or PBS (F(1,13) = .095, 
P = .763, ƞp2 = .01), or any evidence of an interaction (F(1,13) = .085, P = .775, ƞp2 = 
.01).   
4.6.2.1 Intrahippocampal diltiazem has no effect on the acquisition of extinction learning 
All animals showed the expected reduction in freezing behaviour within the 10 min 
extinction session (Figure 4.8: F(1,13) = 18.635, P = .001, ƞp2 = .59), indicating 
successful extinction acquisition.  There was no effect of diltiazem on freezing 
behaviour during the extinction session (F(1,13) = 2.415, P = .144, ƞp2 = .16) and no 
evidence of an interaction (F(1,13) = 2.099, P = .171, ƞp2 = .14).   
4.6.2.2 Intrahippocampal diltiazem specifically affects the consolidation of extinction 
learning 
To assess the consolidation of extinction animals were returned to the context 24 hrs 
and 7 days following training.  There was a significant effect of diltiazem on freezing 
behaviour, with treated animals showing greater freezing 24 hrs and 7 days later 
(Figure 4.8: F(1,13) = 8.92, P = 0.011, ƞp2 = .41).  There was no evidence of changes 
in freezing behaviour between the two recall sessions (F(1,13) = .012, P = .916, ƞp2 
= .001) nor an interaction with group (F(1,13) = 2.630, P = .129, ƞp2 = .17).  This 
implicates a specific effect of diltiazem on the consolidation of extinction learning. 
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Figure 4.8 Intrahippocampal infusion of L-type VGCC inhibitor diltiazem impairs extinction 
consolidation but not training.  There was no effect of diltiazem on within session extinction 
(F(1,13) = 2.415, P = 0.144), however freezing was greater in diltiazem treated animals when 
tested 24 hours and 7 days post extinction training (F(1,13) = 8.92, P = 0.011).  Data point 
represent average % freezing.  Error bars are SEM.    
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 Experiment 5 – Effect of intrahippocampal diltiazem on latent 
inhibition 
Similar to extinction learning, pre-exposure to a context prior to conditioning can 
interfere with the formation of association with an US.  This process is called latent 
inhibition (LI) and refers to the fact that it is harder for familiar stimuli to gain predictive 
status as a CS than novel stimuli (Kiernan and Westbrook, 1993).   
Following the observed deficits in extinction consolidation, this experiment aimed to 
investigate the effects of infusion of diltiazem prior to a 4 hr LI session, 24 hrs before 
CFC.  Animals experiencing prolonged exposure to the context prior to training, would 
be expected to show reduced conditioned freezing behaviour compared to those 
conditioned to a novel context, as in experiments 1-4.  
 Methods and Materials 
4.7.1.1 Subjects 
12 animals were housed as experiments 1-4. 
4.7.1.2 Surgery 
As experiment 1.  Histological analyses were conducted to confirm cannula 
placements (Figure 4.9). 
4.7.1.3 Infusions 
Diltiazem or PBS was administered 40 mins prior to a 4 hr LI session.  Solutions and 
procedure were as experiments 1-4. 
4.7.1.4 Behaviour 
Animals underwent a 4 hr pre-exposure LI session in the training context 24 hrs 
before drug free CFC.  There were two subsequent 2 min recall sessions 24 hrs and 
7 days later, as experiments 1-4.  Freezing was scored fully for the first 2 mins and 
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last 2 mins of the LI session and behaviour was observed during the session to assure 
no confounding experiences. 
 
Figure 4.9 Histological analysis for cannula placement for Latent Inhibition experiments a) 
Example thionin stained brain slice indicating guide cannula placement. b) Location of point 
of guide cannula for all animals.  Crosses indicate focal point of infusion. 
 
 Results 
4.7.2.1 Intrahippocampal diltiazem impairs latent inhibition of CFM 
Across the full experiment, repeated measures ANOVA with Greenhouse-Geisser 
correction, revealed a significant effect of session on freezing behaviour (F(2.313, 
23.127) = 22.732, P < .001, ƞp2 = .69), an effect of diltiazem (F(1,10) = 11.113, P = 
.008, ƞp2 = .53) and evidence of an interaction (F(2.213, 23.127) = 5.381, P = .009, 
ƞp2 = .35).  This indicates an effect of diltiazem infusion on behaviours related to latent 
inhibition of CFM.  As experiments 1 - 4, there was no effect of infusion on initial 
exploratory behaviour of the context (Independent samples t-test, equal variances 
not assumed: t(5) = -1.000, P = .363), or on behaviour during the LI session, 
suggesting no adverse behavioural side-effects of diltiazem infusion.   
During CFC 24 hrs following the LI session, there was a significant effect of 
conditioning on freezing behaviour (Figure 4.10: F(1,10) = 7.692, P = .020, ƞp2 = .44), 
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however there was also a trend towards an interaction between group and session 
(F(1,10) = 4.923, P = .051, ƞp2 = .33), suggesting that the conditioning may have had 
different effects on diltiazem and PBS treated animals.  There was no main effect of 
diltiazem on freezing behaviour (F(1,10) = 2.609, P = .137, ƞp2 = .21).      
Animals were returned to the context 24 hrs and 7 days later to assess whether CFM 
had been consolidated.  There was significantly greater freezing in the diltiazem 
infused (M = 55.56%, SEM = 7.35%) compared to PBS infused (M = 19.44%, SEM = 
7.35%) animals (Figure 4.10: F(1,10) = 12.071 , P = 006, ƞp2 = .55).  Diltiazem treated 
animals formed a CFM despite prolonged pre-exposure to the context, whereas PBS 
treated animals showed the expected effects of latent inhibition, with reduced levels 
of freezing. This suggests that inhibition of LVGCCs impairs latent inhibition of CFM.   
As previous experiments there was evidence of between session extinction with 
reduced freezing observed during the second recall (F(1,10) = 9.412, P = .012, ƞp2 = 
.49), though no evidence of an interaction (F(1,10) = 1.324, P = .277, ƞp2 = .117). 
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Figure 4.10 Infusion of diltiazem impairs the latent inhibition of CFM.  Diltiazem treated 
animals showed increased freezing following LI compared to PBS treated animals (F(1,10) = 
11.113, P = 0.008).  Data points represent average % freezing for each group.  Error bars are 
SEM   
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 Experiment 6 – Effect of intrahippocampal BDNF antisense on 
latent inhibition 
As previously discussed, calcium influx through LVGCCs has been found to regulate 
transcription of BDNF.  Studies have robustly identified a role for BDNF activity in the 
consolidation and extinction of contextual fear memory. Infusion of BDNF antisense 
into the hippocampus led to an impairment in CFM formation (Lee et al., 2004) and 
heterozygous knockout mice have shown similarly impaired consolidation, rescued 
by recombinant BDNF infused into the hippocampus (Liu et al., 2004).  Elevated 
BDNF levels have further been found to constrain extinction learning (Kirtley and 
Thomas, 2010).  Given the implication of this downstream mechanism from LVGCC 
in consolidation and extinction, it is pertinent to investigate whether this extends to 
latent inhibition. 
The following experiment aimed to determine whether knockdown of BDNF, using 
antisense infused into the hippocampus, produced a similar deficit in latent inhibition 
as observed with diltiazem.  Results would contribute to our understanding of 
potential downstream or convergent mechanisms which may be affected by acute 
block of LVGCCs.  
 Methods and materials 
4.8.1.1 Subjects 
12 adult male Lister Hooded rats (250 – 275 g) were housed as experiment 1.  One 
animal was excluded from analysis due to post-hoc histology, leaving 6 animals in 
the control group and 5 in the experimental group (Figure 4.11).   
4.8.1.2 Surgery 
As experiment 1.  Histological analyses were conducted to confirm cannula 
placements location (Figure 4.11).  
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Figure 4.11 Histological analysis for cannula placement for Recall experiments a) Example 
thionin stained brain slice indicating guide cannula placement. b) Location of point of guide 
cannula for all animals.  Crosses indicate focal point of infusion.  The red cross indicates the 
infusion location of the animal that was subsequently excluded from analyses.  
4.8.1.3 Infusions 
BDNF antisense and missense were synthesised from Sigma, as PAGE-purified 
phosphorothioate end-capped 18-mer sequences.  They were re-suspended in sterile 
PBS (PH 7.4) to a concentration of 1 nmol/µl.  Sequences (See Table 4.1) were 
BLAST searched in NCBI database to ensure no off-target effects were predicted.  
Control missense sequences were made up of the same 18 nucleotides as the 
antisense and were similarly subjected to BLAST searches to ensure no match to 
any nucleotide in the rat.      
 
Table 4.1 Sequences for BDNF antisense and missense 
BDNFaso 5’ - TCT TCC CCT TTT AAT GGT - 3’ 
BDNFmso 5’ - ATA CTT TCT GTT CTT GCC – 3’ 
 
BDNF antisense or missense was infused locally into the hippocampus as 
experiments 1-5, albeit with longer infusion time (1 µl per hemisphere at a rate of 
0.125 µl/min) and at 90 mins prior to experiment.  As before, cannula remained in 
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place for an additional 2 minutes to ensure full delivery of the solutions.  Animals were 
returned to home cages until required for testing.  
4.8.1.4 Behaviour 
All animals underwent the same LI behavioural paradigm as experiment 5, with a 4 
hr pre-exposure session on day one in the absence of any US and CFC 24 hrs later.  
Recall was assessed at 24 hrs and 7 days as previously.  Analysis was conducted 
as experiments 1 – 5.   
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 Results 
BDNFaso infused locally into the hippocampus significantly impaired the latent 
inhibition of CFM (Figure 4.12). Repeated measured ANOVA with a Greenhouse-
Geiser correction showed an effect of session on freezing behaviour (F(1.763, 
15.866) = 37.816, P < .0001, , ƞp2 = .808), an effect of genotype (F(1,9) = 13.600, P 
= .005, , ƞp2 = .602) and a significant interaction (F(1.763, 15.866) = 4.941, P = 0.025, 
, ƞp2 = .354).   
Post-hoc ANOVAs reveal a significant greater levels of freezing in animals infused 
with BDNFaso compared to missense in both long term recall sessions (LTM1: F(1,9) 
= 32.479, P < .0001; LTM2: F(1,9) = 28.512, P = .039).  There was no difference in 
freezing behaviour during the first 2 mins of LI, pre-US or post-US.  This suggests 
there was no confounding effects of infusion on freezing behaviour prior to CFC.    
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Figure 4.12 Infusion of BDNFaso impairs the latent inhibition of CFM compared to infusion of 
a missense control F(1.763,15.866) = 37.816, P < 0.0001. Data points represent average % 
freezing for each group.  Error bars are SEM.   
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 Summary 
Local infusion of diltiazem into the hippocampus impairs the consolidation of CFM.  It 
further impairs the consolidation of extinction learning and latent inhibition, while 
having no effect on the acquisition or recall of CFM.  Inhibition of BDNF with local 
infusion of antisense into the hippocampus, results in a similar impairment in latent 
inhibition as that observed with diltiazem.   
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 Discussion 
Diltiazem is an L-type specific calcium channel inhibitor that acutely blocks the influx 
of calcium into the cell through these channels.  By timing infusion of this drug prior 
to specific behavioural testing sessions it is possible to discern the role of these 
channels in different aspects of associative learning.  Diltiazem was infused bilaterally 
into the hippocampus to assess regional specific effects on behaviour.  Results 
suggest a specific role for hippocampal LVGCCs in the consolidation of CFM as well 
as inhibitory learning processes; the consolidation of extinction and latent inhibition.  
Additional investigation into the effect of inhibition of BDNF suggests a putative 
convergent downstream mechanism which may link calcium influx through LVGCCs 
with behaviour.  
 LVGCCs in the hippocampus are necessary for the consolidation of CFM 
Inhibition of LVGCCs prior to CFC selectively impairs the consolidation of CFM while 
leaving acquisition and short term recall intact.  One can thus infer that calcium influx 
through these channels in the hippocampus is necessary for long-term consolidation.  
Importantly there was no aversive response to the drug that may have affected 
behaviour, with no evidence of anxiety related behaviour on exposure to the context.  
The necessity of calcium influx through these channels for consolidation concurs with 
previous findings with infusion into the basolateral amygdala (Bauer et al., 2002), 
suggesting a conserved role for LVGCCs across different brain regions.  It also further 
confirms that the hippocampus, in addition to the amygdala, is an essential part of 
the network involved in  successful consolidation of contextual associative learning 
(Phillips and LeDoux, 1992; Kim et al., 1993; Frohardt et al., 2000).   
Previous studies have focussed primarily on cued fear conditioning rather than 
contextual conditioning in relation to LVGCCs.  As the hippocampus is required for 
the processing of contextual information (Holland and Bouton, 1999), it may be that 
the localised role of LVGCCs observed in these experiments is specific to the 
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consolidation of more complex contextual associations.  Evidence supports the 
requirement of the hippocampus for contextual fear conditioning, whereas the 
amygdala is found to be necessary for both contextual and cued fear associations 
(Phillips and LeDoux, 1992).  Our results demonstrate that it is LVGCCs within the 
hippocampus that are a necessary part of its function in consolidation.        
The results observed are not in line with systemic infusion of inhibitors which have 
found no effect on consolidation for either cued or contextual fear conditioning (e.g. 
Cain et al., 2005).  It is possible that systemic infusion may have had peripheral 
effects due to the expression of these channels in the heart (Treinys and Jurevicius, 
2008), or that this method of drug delivery led to inadequate/inaccurate dosing in the 
brain regions that are specifically involved in fear memory.  Furthermore systemic 
infusion has been found to produce aversive effects, resulting in conditioning 
occurring to the drug itself in addition to the intended CS (Moosmang et al., 2005), 
which may in part explain the preserved freezing observed.    
It is not possible to conclude whether calcium influx through LVGCCs is sufficient for 
the consolidation of CFM, but these experiments do imply that it is necessary.  
Previous studies have shown that NMDA receptor activity is also necessary for the 
acquisition and consolidation of CFM (Fanselow and Kim, 1994; Dalton et al., 2012; 
Davis and Bauer, 2012), suggesting that it might be the combined signalling through 
these channels that creates the appropriate message for successful consolidation, 
whether of initial learning or extinction.  
 Inhibition of LVGCCs impairs inhibitory learning processes of extinction and 
latent inhibition 
The current results suggest calcium influx through LVGCCs is necessary for the 
consolidation of extinction, as well as the latent inhibition of CFM.  Similar to 
acquisition of CFM there was no effect of inhibition on extinction training, however 
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recovery of conditioned freezing was evident 24 hours and 7 days later.  This extends 
the role of LVGCCs beyond the consolidation of an aversive CS-US association, to 
include CS-no US associations.  
The results support the notion that extinction is an active process that requires 
additional learning regarding a previously conditioned stimuli, rather than a 
degradation of the original memory (Quirk, 2002; Bouton, 2004).  Inhibition did not 
affect the recall of CFM, but showed a selective impairment on the processing of a 
prolonged exposure to the context.  This could indicate the activation of separate 
processes following continued exposure, or as has been suggested previously, a 
threshold effect of a single process that leads to competing inhibitory associations of 
CS-No US that becomes stronger with longer exposure (Trent et al., 2015).  
Importantly, the process of extinction is not simply the formation of a separate new 
association, with the effect of inhibition simply being generalised to consolidation.  
Wang et al., (2012), found that infusion of LVGCC inhibitors into the dorsal 
hippocampus impaired initial learning of CFC, but had no effect on the consolidation 
of a second CFC trial.  The effect observed on extinction consolidation therefore 
suggests a separate process that is relevant for the processing of relevant competing 
information regarding previously salient stimuli.   
These findings are in agreement with those observed previously in the amygdala 
(Davis and Bauer, 2012). Similar to consolidation, this suggests a conserved role for 
LVGCCs in extinction learning across brain regions.  In contrast, systemic infusions 
of inhibitors prior to training were found to result in perseverance of freezing within 
the extinction session.  As previously discussed, this may be due to peripheral effects 
of the drug or to a global inhibition masking relevant network effects. To address the 
concern of drug effects during training, Suzuki et al., (2008) administered the inhibitor 
immediately after extinction.  They found that systemic infusion resulted in recovery 
of freezing behaviour when tested 24 hrs later in agreement with the current findings.  
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They further investigated the combined effects of LVGCC inhibition and anisomycin 
on recall and subsequent expression of CFM.  They found that blockage of protein 
synthesis with anisomycin immediately before or after a short recall session resulted 
in a deficit in conditioned freezing 24 hrs later.  However, this deficit was completely 
rescued by inhibition of LVGCCs.  They conclude that this implicates LVGCCs in the 
destabilisation of reactivated memory, however this can also be interpreted in-line 
with present findings as the facilitation of inhibitory extinction learning.     
The effect of inhibition observed on LI effects is in agreement with that found 
previously.  Barad et al., (2004) found the LI effect was completely abolished with 
systemic infusion of LVGCC inhibitor, with freezing behaviour being indistinguishable 
from animals conditioned to a novel context.  This is the first experiment to investigate 
the local infusion of inhibitor in the hippocampus on the latent inhibition of CFM, as 
well as to determine its lasting effects on subsequent behaviour.  Findings suggest 
that the processes involved may be similar to that of consolidation and extinction, 
extending the role of LVGCCs to the formation of potentially relevant contextual 
representations of novel stimuli.   
 Downstream signalling effects and gene transcription 
An important distinction to make is that there were no effects of diltiazem on 
behaviour when the drug was present; rather differences were observed during 
subsequent drug free sessions.  This highlights the notion that calcium influx through 
LVGCCs in this instance is required for longer term processing rather than immediate 
response, likely requiring de novo gene transcription.  It is well documented that 
calcium influx through these channels activates specific downstream signalling 
processes and facilitates gene transcription (see Barbado et al., 2009).  For example, 
calcineurin regulates gene transcription through nuclear translocation of the NF-ATc 
family of transcription factors; a process dependent upon calcium influx through 
LVGCCs (Graef et al., 1999).  Furthermore, there is growing evidence of selective 
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regulation of isoforms of Brain Derived Neurotrophic Factor (BDNF) by LVGCC 
specific calcium influx (Tabuchi et al., 2000; Zheng et al., 2011), which is known to 
play a significant role in synaptic plasticity and learning (Cunha et al., 2010).  The 
delayed effect on behaviour we observe is therefore likely due to the disruption of 
these downstream mechanisms at the time of learning and subsequent absence of 
necessary gene transcription, the consequence of which only becomes apparent 
hours or days later. 
This effect on downstream mechanisms is supported by the current results showing 
deficits of latent inhibition following inhibition of BDNF.  Similar impairments following 
inhibition of LVGCCs and BDNF suggest that they are part of the same molecular 
mechanism involved in this process.  Given the evidence supporting the regulation of 
BDNF by calcium influx through LVGCCS and previous findings with consolidation 
(Lee et al., 2004; Liu et al., 2004), it is viable that BDNF is a key component which is 
disrupted by inhibition of LVGCCs.     
 Distinguishing between L-type channel sub-types 
Although diltiazem is specific to L-type channels at the dose used, inhibition does 
affect both types of L-type channel expressed in the brain; Cav1.2 and Cav1.3.  The 
more robustly identified risk gene CACNA1C codes for the alpha-1 sub-unit of Cav1.2 
channels, however at present it is impossible to discern the role of these specific 
channels with pharmacological methods.  Previous studies combining genetic and 
pharmacological approaches have suggested that Cav1.3 channels may be involved 
specifically in the consolidation of CFM whereas Cav1.2 may be necessary for 
extinction (Moosmang et al., 2005).  Separable roles of NMDA receptors (GluN2A 
and GluN2B) have been found in relation to consolidation and extinction of a 
conditioned fear response (Dalton et al., 2012).  Inhibition of GluN2A was found to 
selectively affect consolidation, whereas inhibition of GluN2B was found to affect 
extinction. 
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As with NMDA receptors, it could be the case that different sub-types are relevant for 
the initial formation of CS-US conditioning and others for subsequent relevant CS-No 
US associations.  In the absence of sub-unit specific inhibitors, genetic manipulations 
may be able to more successfully separate their function in relation to specific 
behaviours.    
 Conclusions 
These experiments demonstrate a selective role for calcium influx through LVGCCs 
in specific aspects of associative learning; consolidation, extinction and latent 
inhibition.  Inhibition of LVGCCs resulted in both deficits in conditioned behaviour as 
well as its recovery or erroneous perseverance.  This makes it highly unlikely that 
diltiazem may be having an effect due to simple damage of the system. It instead 
indicates a role for LVGCCs in the formation of both new and competing associative 
memories, as well as potentially relevant contextual representations, which are then 
used to inform subsequent behaviour. 
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5 BASIC CHARACTERISATION OF CACNA1C 
HETEROZYGOUS KNOCK-OUT RATS 
 Introduction 
Previous experiments using diltiazem have revealed a role for LVGCCs in specific 
aspects of associative learning.  However, as discussed, these experiments are 
unable to distinguish between the sub-types of LVGCC, Cav1.2 and Cav1.3.  To 
address the specific role of Cacna1c and Cav1.2 channels in these processes we 
utilised a global heterozygous Cacna1c knock-out rat model (Sage Research Labs – 
See Methods 2.1.2).  
The investigation of effects of reduced expression of a gene complements 
pharmacological studies in allowing assumptions to be made about the necessity of 
the gene product in specific processes.  Above and beyond this, it also provides a 
method for understanding how this gene may be relevant in psychiatric illness and 
how alterations in its expression may manifest functionally in specific symptoms.  
Common variation in the CACNA1C gene associated with risk for schizophrenia and 
bipolar disorder, has been linked to decreased expression in certain regions of the 
brain, including the cerebellum (Roussos et al., 2014; Eckart et al., 2016)(see 
Chapter 8 for more detailed discussion in humans).  Furthermore, exome sequencing 
has reported an enrichment in rare deleterious mutations in calcium channel subunits, 
to include CACNA1C, in people with schizophrenia (Purcell et al., 2014b), supporting 
the investigation of a reduced expression model.   
Conditional Cacna1c knock-outs and region specific knock-outs have been extremely 
valuable for understanding the roles of Cav1.2. However, these models do not 
necessarily reflect relevant disease state.  Genetic risk is present throughout the life-
course and will likely affect central and peripheral systems across development. 
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Chronic haploinsufficiency may therefore be a better model when considering 
relevance to psychiatric illness.  There are no instances of people with complete 
deletion of the CACNA1C gene and homozygous knockout in rodents is 
embryonically lethal (due to its vital role in cardiac function, Goonasekera et al., 
2012); therefore, investigating the subtle effects of expression manipulation, rather 
than gene absence is more relevant when considering symptoms of disease.  It is 
worth noting that overexpression of Cav1.2 in mice has been found to cause a slowly 
progressing hypertrophy and eventual heart failure (Muth et al., 2001).  This 
complicates the investigation of a global over expression model of Cacna1c for 
investigation of more complex long term behaviour.  
A newly characterised haplo-insufficient rat model was chosen for study. Rats allow 
the modelling of more complex behaviours and cognitive processes that better reflect 
neuropsychological testing in humans with relevance to disease (Iannaccone and 
Jacob, 2009).  Their physiology is also closer to humans than that of mice and their 
systems should respond in a more similar way to any pharmacological manipulations 
that may be used at a later date. Larger brain sizes also make certain techniques 
more practical in rats.  It further provides greater continuity with regard to previous 
experiments with LVGCC inhibition and expression profiling.   
It was important to establish the validity of this novel rat model in relation to Cacna1c 
expression and to conduct some basic characterisation of behaviour; including 
locomotor activity, anxiety behaviour and startle response, which potentially could 
impact on later learning paradigms.   This is particularly pertinent to fear conditioning, 
as freezing behaviour is used as the measure of associative memory formation and 
expression.  Changes in activity levels could confound both conditioned and 
unconditioned fear associated behaviours.    In addition, it has been found that anxiety 
can affect both the acquisition and extinction of fear memories in people (Lissek et 
al., 2005).   
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Genetic knockout models of Cacna1c have, to date, all been in mice.  Global 
heterozygous models have shown minimal differences in baseline behaviour 
measures.   Dao et al., (2010) found no differences between WT and HET mice on 
motor coordination using an accelerating rotarod task, as well as no differences in 
pain sensitivity or muscle strength, measured by a hot plate and hanging wire test 
respectively.  Similarly, there have been no differences reported in activity during an 
open field or home-cage locomotor paradigms in male mice with either global 
haploinsufficiency or forebrain specific knockout of Cacna1c (Dao et al., 2010; Lee et 
al., 2012).  However, there has been subtle indication of reduced locomotor activity 
in female HET mice compared to WT (Dao et al., 2010).      
Conflicting results regarding anxiety have been reported. Lee et al., (2012) found that 
both global haploinsufficiency of Cacna1c and forebrain specific knockdown led to 
decreased time spent in the open arm of an elevated plus maze (EPM), an indication 
of increased anxiety.  However, they found no differences in behaviour in an open 
field exploration task (OF) or during a light-dark conflict test (LDC) in mice with a 
global knock-down of Cacna1c.  Conversely, Dao et al., (2010) found no effects of 
globally reduced Cacna1c on any of the above tasks in male mice and additionally 
no effects on physiological response to stress/anxiety.  However, female HET mice 
showed mildly increased anxiety.  Overall, studies suggest that forebrain specific 
knockout of Cacna1c rather than global haploinsufficiency may lead to anxiety-like 
behaviour. 
There has been minimal investigation of the effects of reduced Cacna1c on startle 
response.  Dao et al., (2010) reported no effects of genotype on acoustic startle 
response in male mice at pulse intensities from 80 – 120 dB, though they did observe 
an attenuated response at 120 dB in female mice.  The acoustic startle task is also 
utilised to assess pre-pulse inhibition (PPI), though this does not appear to have been 
investigated in Cacna1c knockout models at present. Deficits in pre-pulse inhibition 
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are well-established in schizophrenia and this measure is a reliable quantitative 
phenotype for potential sensorimotor gating deficits in rodents (Swerdlow et al., 2000, 
2008).   
Compensation from increases in Cacna1d expression have been investigated across 
previous models.  There does not appear to be evidence to support increased 
Cacna1d expression in the brain of HET mice, either with global haploinsufficiency 
(Dao et al., 2010) or with region specific knockout (Langwieser et al., 2010).  
Increases of Cacna1d expression have been found in the heart, though this does not 
appear to be sufficient to fully compensate Cacna1c gene function (Rosati et al., 
2011).  One study did identify a compensation effect, observing increases of calcium 
permeable AMPA receptors (cp-AMPAR) in the lateral amygdala of conditional CNS 
knockout mice and LVGCC independent LTP (Langwieser et al., 2010).  This has 
been suggested to be part of a mechanistic adaptation to LVGCC inactivity, through 
the alternative use of cp-AMPAR, as has been observed in hippocampal neurons in 
vitro (Thiagarajan et al., 2005).  However, this effect is unlikely to be a significant 
mechanism in heterozygous knockout models due to the continued presence of 
functioning LVGCCs. The upregulation of other calcium channels in 
haploinsufficiency models has not been reported.  
These experiments aimed to establish the validity of the Cacna1c heterozygous rat 
model and characterise basal expression levels.  The expression of Cacna1c and 
Cacna1d was explored to determine successful reduction of the target gene and 
assess potential compensation.  Basal expression of BDNF was also measured to 
investigate potential effects on known downstream mechanisms. Basic 
characterisation of activity and anxiety levels were conducted to ensure no 
confounding effects on later learning paradigms.  Animals were tested for activity 
levels and habituation during repeated exposure to a novel home cage environment.  
An additional measure of activity was obtained from an open field exploration task 
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and anxiety was assessed based on time spent in the centre of the open field arena.  
Animals underwent an acoustic startle response test to determine startle reactivity 
and to measure pre-pulse inhibition. 
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 Experiment 1 - Gene expression in Cacna1c HET animals 
For the full description of the design and production of the genetic mutation in 
Cacna1c and development of the model see General Methods, 2.1.2.  Before any 
behavioural experiments were conducted on these animals it was vital to establish 
the validity of the model.  Protein and mRNA levels were measured to determine 
successful reduction of expression of Cacna1c in different regions of the brain.  
Cacna1d expression was measured to determine whether there were any 
compensatory increases in the other LVGCC expressed in the brain. Levels of 
LVGCC regulated and learning associated gene BDNF were also measured as a 
potential indicator of a downstream effect of altered LVGCC function (as previously 
discussed, General Introduction).    
 Methods and materials 
5.2.1.1 Subjects 
Thirty-eight adult male Sprague Dawley animals were obtained from Charles River 
and housed in groups of 1 – 4 on a reverse light-dark cycle (lights on at 10am) as 
previously described.  Animals were given 7 days to settle before sacrifice in home 
cages with a rising concentration of CO2 (Clinipath Equipment Limited, Hull, UK).  
Whole brains were taken from 10 of the animals (5 WT and 5 HET) and fresh frozen 
immediately post-mortem for in situ hybridisation analysis.  Microdissections were 
manually taken from the remaining animals and fresh frozen on dry-ice, to include 
PFC, cerebellum, CA1 and DG/CA3.  These were used for extractions of mRNA and 
protein for RT-qPCR and ELISA assays.  
5.2.1.2 Transcript quantification by in situ hybridisation (ISH) 
For detailed methods see General Methods 2.4.6.  14µm coronal slices of the PFC, 
cerebellum and hippocampus were taken from the ten whole brain samples and 
mounted on poly-L-lysine coated slides (VWR International, Leics, UK).  Two series 
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of five brains per slide were created with WT and HET brains represented in both 
series.  Slides were fixed with 4% PFA, dehyrdrated and stored in 95% ethanol until 
use.  The 45 bp oligonucleotide probes for Cacna1c and BDNFIX (see Chapter 3) 
were radiolabelled using deoxyadenosine 5’- (α-thio) triphosphate [35S] (dATP) 
(Perkin Elmer, MA, USA). Three slides from each series per brain region were 
hybridised separately to each labelled probe, two “Total” slides and one “Non-
specific”.  Hybridisation was performed overnight at 42 °C, followed by two 30 min 
washes in 1 x SSC at 52 °C.  Slides underwent additional washes in 0.1 x SSC, 70% 
and 95% EtOH for 1 min each and left to air dry before apposing to Carestream 
Biomax MR film (Anachem, Luton, UK). Sections were exposed for 1 week before 
being developed using an automatic developer (Photon Imaging Systems, Swindon, 
UK).  
Analysis was conducted using imageJ software as described previously, with optical 
density values quantified using a 14C ladder.  Ten measurements (five bilateral) were 
made for each region of interest from each brain slice.  Specifically, CA1, CA3 and 
DG regions of the hippocampus, the granule layer of the cerebellum and the medial 
PFC.  Regional values were averaged within animal for the two “Total” slides as a 
technical repeat and the “Non-specific” average was subtracted to give a “Specific” 
value for each animal. Values were normalised to mean WT by region and averaged 
within genotype.  Student’s t-tests were conducted for each region to compare 
expression between WT and HET. Bonferroni corrections were applied where there 
were no prior hypotheses.  Dunnet’s tests were used when comparing to control 
group.   
5.2.1.3 Protein quantification by ELISA assay 
5.2.1.3.1 Protein extraction 
For detailed protocol, see General Methods, 2.4.7. Approximately 100 µg of tissue 
was homogenised in 1 ml T-PER (Tissue Protein Extraction Reagent, Thermo 
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Scientific, UK) with protease inhibitors.  Samples were centrifuged at 10,000 x g for 
5 mins and the supernatant taken for analysis.  Protein concentration was measured 
using a BCA assay (Pierce BCA Protein Assay Kit, Thermo Scientific, UK).       
5.2.1.3.2 Immunoassays 
BlueGene ELISA kits (American Research Products Ltd, MA, USA) were used to 
quantify protein of the two calcium channels genes using the competitive enzyme 
technique. Experiments were conducted as per manufacturer’s protocols.  Samples 
were diluted 1:2 in extraction buffer and added to wells, along with a balance solution 
and enzyme conjugate and incubated for 1 hour at 37°C. Six standards were run 
alongside to provide a standard curve for quantification as well as a blank control.   
A sandwich ELISA (Thermo Scientific, UK) was used to quantify BDNF protein levels.  
Samples were diluted 1:10 in extraction buffer before adding to wells along with 7 
standards and a blank control.  The plate was incubated overnight at 4°C, before 
washing 4 x and adding biotinylated antibody.   
Wells for all plates were incubated with a substrate for HRP enzyme, followed by a 
stop solution. Plates were measured within 5 mins at 450 nm in a microplate reader.  
A standard curve was plotted from the standards to calculate protein concentration 
of each sample from intensity readings. Student’s t-tests were conducted to compare 
expression between WT and HET animals for each region. Values were normalised 
to WT for graphical representation.   
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 Results 
5.2.2.1 Reduction of CACNA1C expression in HET animals compared to WT across brain 
regions 
The expression of Cacna1c was assessed by ISH. HET animals showed an average 
48% reduction of Cacna1c mRNA in the hippocampus, 37% reduction in the 
cerebellum and 17% in the PFC (Figure 5.1).  Reduced Cacna1c mRNA levels were 
observed in HET animals in the CA1 and CA3 sub-regions of the hippocampus and 
the cerebellum (t(8) = 2.306, P = 0.05; t(8) = 4.945, P = 0.001; and t(6.003) = 3.117, 
P = 0.021 respectively).  mRNA expression levels in the DG and PFC of HET animals 
were found not to be normally distributed, therefore log10 transformations were 
conducted.  There was significantly reduced expression of Cacna1c in HET animals 
in the DG sub-region of the hippocampus and a strong trend towards a reduction in 
the PFC (t(8) = 4.101, P = 0.003 and t(8) = 2.290, P = 0.051 respectively). 
Protein levels were measured using an ELISA assay for PFC, cerebellum and 
DG/CA3 regions of the hippocampus (Figure 5.2).  There was a significant reduction 
of CACNA1C expression in the cerebellum (t(10) = 2.751, P = 0.020).  Expression in 
the PFC was not normally distributed and a log10 transformation did not result in 
normality, therefore a non-parametric Mann-Whitney-U test was conducted.  
Significantly reduced expression was observed in HET animals compared to WT (U 
= 5.00, P = 0.041).  Expression in the DG/CA3 did not significantly differ between WT 
and HET animals (t(10) = 1.136, P = 0.283).    
There were no differences observed between WT and HET animals in the level of 
CACNA1D protein measured from the same protein extractions as above (Figure 5.3) 
(PFC: t(10) = -1.674, P = 0.125; cerebellum: t(10) = 1.064, P = 0.312; DG/CA3: t(10) 
= 0.226, P = 0.826).     
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Figure 5.1 CACNA1C mRNA expression in PFC, cerebellum and hippocampus.  HET animals 
show reduced expression across brain regions (17 – 48%).  Bars represent mean value 
normalised to WT for each genotype, error bars are SEM. * P < 0.05, + P <0.06. 
Representative ISH for WT, HET and non-specific binding (N.S.) for; a) PFC; b) Cerebellum; 
c) Hippocampus CA1, CA3 and DG regions labelled. 
  
146 
 
 
Figure 5.2 CACNA1C protein expression in PFC, cerebellum and DG/CA3 region of the 
hippocampus.  Significantly reduced expression in the PFC and cerebellum.  Bars represent 
mean fold change normalised to WT, error bars are SEM.  * P < 0.05. 
 
 
Figure 5.3 CACNA1D protein expression in PFC, cerebellum and DG.CA3 region of the 
hippocampus.  No significant differences between WT and HET animals in any region.  Bars 
represent mean fold change normalised to WT, error bars are SEM.    
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5.2.2.2 Reduced BDNFIX expression in HET animals  
Repeated measures ANOVA found a region by genotype interaction effect on the 
expression of total BDNF (BDNFIX) (F(4,32) = 2.672, P = 0.050). HET animals were 
found to have a 22% reduction in total BDNF (BDNFIX) mRNA levels in the PFC (t(8) 
= 2.316, P = 0.049), though this did not survive correction for multiple comparisons  
(Figure 5.4). There was a trend towards increased BDNF expression in HET animals 
in the DG region of the hippocampus (t(8) = -2.177, P = 0.061), but no evidence to 
support differences in expression in the CA1 or CA3 sub-regions (t(8) = -1.418, P = 
0.194; t(8) = -0.558, P = 0.592).  No differences in expression were observed in the 
cerebellum (t(8) = -0.885, P = 0.402).   
There were no changes in BDNF protein levels between WT and HET animals (Figure 
5.5). The ELISA assay showed similar levels of BDNF expression in the DG/CA3 
region of the hippocampus, cerebellum and PFC (t(10) = 0.011, P = 0.991; t(10) = 
0.104, P = 0.919; t(10) = 0.521, P = 0.614 respectively).    
  
148 
 
 
Figure 5.4 BDNFIX mRNA expression levels compared between WT and HET animals in 
PFC, cerebellum and hippocampus. There was a region by genotype interaction effect with 
results showing a 22% reduction in PFC in HET animals and a trend towards increased 
expression in the hippocampus.  There was no evidence of changes in cerebellum, CA1 or 
CA3 regions. Bars represent mean expression normalised to WT and error bars are SEM. * 
P < 0.05. + P < 0.1 a) Representative ISH of PFC, b) cerebellum and c) hippocampus, for WT 
and HET animals and a non-specific (N.S) control. 
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Figure 5.5 BDNF protein expression in WT and HET animals in PFC, cerebellum and DG/CA3 
region of the hippocampus.  No differences observed between WT and HET. Bars represent 
mean concentration of BDNF for each genotype in each region of interest (pg/ml), error bars 
are SEM. 
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 Experiment 2 - Basic behavioural characterisation of HET and WT 
animals 
The following experiments assessed the basal activity and anxiety levels in WT and 
HET animals.  Exposure to a novel home-cage environment was used to assess 
locomotor activity and an open field exploration was conducted as a further measure 
of activity in a mildly aversive context and an indication of any anxiety-related 
behaviour.  Startle response was further compared between WT and HET animals 
using an auditory startle response paradigm.  The same paradigm was used to 
conduct analyses of pre-pulse inhibition, as a measure of sensorimotor gating, a 
common phenotype assessed in relation to schizophrenia. 
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 Methods 
5.3.1.1 Animals 
Thirty-two Sprague Dawley rats, 16 WT and 16 HET litter mates, were housed in 
groups of 2-4 with ad libitum access to food and water.  All animals were weighed 
before any experiments occurred and handled for 5 days to habituate.  Weights 
ranged from 267 g to 486 g. There was no difference in weight between genotype 
(t(30) = 1.086, P = 0.286).    
5.3.1.2 Locomotor activity 
Behaviour 
Activity levels were tested in empty home-cage equivalent contexts for 2 hrs on 3 
consecutive days (See General Methods).  Animals were taken in groups of 8 to the 
testing room in home-cages and transferred to individual testing boxes.  The number 
of beam breaks and the number of runs (2 consecutive independent beam breaks, 
indicative of rapid movement from one end of the cage to the other) were counted for 
each animal, split into four 30 min bins.  
Analysis 
Shapiro-Wilks tests revealed that data were not normally distributed.  All variables 
underwent a square root transformation before analysis to attain a normal distribution; 
a log transformation was unsuitable with the high incidence of ‘0’ values later in the 
sessions.  Total beam breaks and runs were compared between WT and HET 
animals using independent samples student’s t-tests, as measures of locomotor 
activity.  Levene’s tests for equality of variances were conducted and corrections 
used where stated.  Differences within the sessions and across the 3 testing days 
were compared within animals and between genotype using repeated measures 
ANOVA, as a measure of habituation to a novel context.  As behaviour was consistent 
across the 3 testing days, data was averaged across the 3 days for each animal for 
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within session analyses.  Between session analyses were conducted on total beam 
breaks and runs.  Greenhouse-Geisser corrections were applied where unequal 
variances were observed.  One WT animal was excluded due to concerns that the 
apparatus recording may have temporarily malfunctioned with data being more than 
3 standard deviations away from the mean.   
5.3.1.3 Open Field Exploration 
Behaviour 
Animals were placed into an arena (1 m2) for 10 mins (See General Methods).  A 
central zone was defined as the centre 70 cm x 70 cm square.  Distance and speed 
travelled were recorded for each animal as an additional measure of activity. Duration 
of time spent in the central zone and in the perimeter of the arena were recorded, 
with greater time spent in the central zone indicating reduced anxiety. 
Analysis 
Student’s t-tests were used to compare distance, speed and time in the central zone 
between WT and HET animals.  Shapiro Wilk’s test found a non-normal distribution 
for time spent in the central zone, therefore a log10 transformation was conducted 
prior to a student’s t-test.  Levene’s test for equality of variances found no significant 
results for any variable.     
5.3.1.4 Startle response and pre-pulse inhibition 
Behaviour 
Animals underwent a 30 min startle response session in a SR-LabTM Startle 
Response System, consisting of 91 trials.  Background noise level was set to 70 dB 
and test pulses were administered at 120 dB and 105 dB.  Pre-pulse trials were 
interleaved throughout the session at 4 dB, 8 dB and 16 dB to determine levels of 
pre-pulse inhibition. At the end of the session there were 6 additional pulses of 
increasing intensity; 70 dB, 80 dB, 90 dB, 100 dB, 110 dB and 120 dB to measure 
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increasing startle response. An accelerometer sensor measured the amount of 
movement of each animal in response to each test pulse.   
Analysis 
Repeated measures ANOVA was used to analyse the effect of increased pulse 
intensity and genotype on startle response; as well as to determine the effect of 
increased pre-pulse intensity.  Student’s t-tests were used to compare overall startle 
response for 120 dB pulses alone and 105 dB pulses between WT and HET animals.  
One HET animal was excluded from analyses due to values being greater than 2 
standard deviations away from the mean. Levene’s tests for equality of variance were 
conducted and Greenhouse-Geisser corrections were applied where necessary.  
Shapiro-Wilk’s tests for normality found no significant effects.    
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 Results 
 Reduced expression of Cacna1c does not affect activity levels or habituation 
to a novel environment 
There was no difference in the total number of beam breaks or runs made between 
WT and HET animals across the full 3 days of testing (t(29) = -1.666, P = 0.107 and 
t(29) = -1.526, P = 0.138 respectively) (Figure 5.6).  
 
Figure 5.6 Total number of "Breaks" and "Runs" for WT and HET animals across the 3 
consecutive test days.  No differences were observed between WT and HET animals, P > 
0.05.  Bars represent mean value for each genotype, transformed by square-root, error bars 
are SEM. Y-axis is the square root of counts. 
All animals showed normal habituation to context exposure within session, with fewer 
beam breaks and runs being made in the last half hour of the sessions compared to 
the first.  The number of beam breaks and runs were compared between WT and 
HET split into four 30 min bins across the 2-hour sessions (Figure 5.7). Repeated 
measures ANOVA showed a significant effect of time within session on number of 
beam breaks (F(2.069, 59.990)Ɛ = 0.690 = 184.494, P < 0.001, ƞp2 = 0.864).  There was 
no evidence of an interaction, though a trend towards an effect of genotype (F(2.069, 
59.990)Ɛ = 0.690 = 0.173, P = 0.849 and F(1,29) = 3.407, P = 0.075 respectively).   
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Similarly, there was a significant effect of time within session on number of runs 
(F(1.942, 56.332)Ɛ = 0.647 = 187.085, P < 0.001, ƞp2 = 0.866).  There was no evidence 
of an interaction but a trend towards an effect of genotype (F(1.942, 56.332)Ɛ = 0.647 = 
0.427, P = 0.649 and F(1,29) = 3.620, P = 0.067 respectively).  Post hoc analyses 
revealed that both trends towards genotype effects were driven by differences in the 
third 30-minute bin (Breaks: P = 0.047, Runs: P = 0.026), with no effects observed in 
the first hour or last 30 minutes of the task.    
All animals showed between session habituation with fewer breaks and runs 
observed on testing day 3 compared to day 1.  Repeated measures ANOVA reported 
a significant effect of day on beam breaks and runs (F(2,58) = 5.465, P = 0.007, ƞp2 
= 0.159 and F(2,58) = 5.695, P = 0.006, ƞp2 = 0.164 respectively).  There was no 
evidence of an interaction between day and genotype for either beam breaks or runs 
(F(2,58) = 0.169, P = 0.845 and F(2,58) = 0.543, P = 0.584 respectively).  Beam 
breaks across the 3 days did not differ by genotype, though a trend was reported for 
runs (F(1,29) = 2.893, P = 0.100 and F(1,29) = 3.354, P = 0.077 respectively). Post-
hoc analysis of separate days indicated that this was driven by a trend on day 2 
towards reduced runs in HET animals (F(1,29) = 3.013, P = 0.093), with no effects 
on day 1 or day 3 (P = 0.212 and P = 0.510 respectively).  
Power analysis of these comparisons indicate that sample sizes were adequate (at a 
level of 0.8) to detect large effect sizes (< 0.6).  Previous studies have reported large 
effects of genotype on similar tasks (e.g. Miyakawa et al., 2003), however given the 
trends observed, it is possible that small effects of genotype on locomotor activity 
may have been neglected.  Results should therefore be interpreted with caution in 
relation to the absence of effects and will be taken into account for future experiments 
where this may influence interpretations.  
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Figure 5.7 Locomotor activity split by test day. a) Number of beam breaks for WT and HET 
animals during three consecutive days of 2-hour exposure to a novel home-cage style 
environment. Numbers 1-4 represent individual 30 min bins within the 2-hour recording period.  
No differences observed between genotype, P > 0.05. b) As graph a. for “runs”, recorded as 
two different consecutive beam breaks indicating movement from one end of the cage to 
another. Data points represent mean number of breaks or runs for each genotype 
(transformed by square-root), error bars are SEM. 
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 Reduced expression of Cacna1c does not affect activity or anxiety levels in an 
Open Field Exploration task.   
 There was no difference in activity levels between WT and HET animals, with similar 
distance travelled and similar mean and max velocities during the task (t(30) = -0.294, 
P = 0.771; t(30) = -0.293, P = 0.771; and t(30) = -0.064, P = 0.950 respectively) Figure 
5.8).  
 
Figure 5.8 Open Field Activity Levels. a) No difference between WT and HET animals in the 
distance travelled during the task, P = 0.771. b) No difference in the mean or max velocity 
travelled between WT and HET animals, P = 0.771 and P = 0.950 respectively.  Bars represent 
mean values for each genotype, errors bars are SEM. 
 
There was no difference in anxiety levels between WT and HET animals (Figure 5.9), 
indicated by a similar amount of time spent in the central zone during the 10 min 
exploration (t(30) = 1.567, P = 0.128).  
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Figure 5.9 Duration spent in central zone of arena for WT and HET animals.  No differences 
observed between genotype. Data presented has undergone a log10 transformation.  Bars 
represent means for each genotype and error bars are SEM. 
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 Reduced expression of Cacna1c does not affect startle response or pre-pulse 
inhibition 
Animals were compared on auditory startle response and effects of pre-pulse 
inhibition (Figure 5.10). There was no effect of genotype on startle to 120 dB or 105 
dB test pulses compared to 70 dB background noise (t(29) = 1.070, P = 0.293 and 
t(29) = -0.240, P = 0.813 respectively).  Increasing test pulses in increments of 10 
dB, from 70 dB to 120 dB, resulted in the expected increase in startle response 
(F(1.444, 41.872) Ɛ = 0.298  = 145.237, P < 0.001, ƞp2 = 0.834), with no effect of genotype 
observed or an interaction (F(1,29) = 0.987, P = 0.329 and F(1.444, 41.872) Ɛ = 0.298  = 
0.696, P = 0.460). 
Pre pulses of 4 dB, 8 dB and 16 dB were interleaved between trials to measure pre-
pulse inhibition of startle response to test pulses.  There was a significant effect of 
pre-pulse intensity on percentage inhibition of startle to 120 dB pulses (F(1.292, 
37.469) Ɛ = 0.646  = 50.581, P < 0.001, ƞp2 = 0.636), though no differences observed 
between genotypes or evidence of an interaction (F(1,29) = 1.462, P = 0.236 and 
F(1.292, 37.469) Ɛ = 0.646  = 0.041, P = 0.895 respectively).   
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Figure 5.10 Startle response compared between WT and HET animals. a) Average response 
amplitude to 120 dB and 105 dB pulse alone trials. b) Effect of increasing startle response 
between 70 dB and 120 dB.  c) Percentage inhibition of response to 120 dB test pulses for 4 
dB, 8 dB and 16 dB pre-pulses.  No differences were observed between WT and HET animals 
(P> 0.05).  Bars and data points correspond to average amplitude of response for each 
genotype.  Error bars are +/- SEM.   
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 Discussion 
 Reduced expression of Cacna1c in heterozygous rats with no evidence of 
compensation by Cacna1d 
The model used for all subsequent experiments shows a significant reduction of 
Cacna1c transcript in the cerebellum and the hippocampus and a trend towards 
reduced expression in the PFC.  Protein levels of CACNA1C were significantly 
reduced in the cerebellum and PFC, though reductions did not reach significance in 
the DG/CA3 region of the hippocampus.  There is no evidence of compensation in 
the expression of the highly homologous gene Cacna1d, which codes for the other 
LVGCC that is expressed in the CNS.  This suggests that differences in behaviour 
observed between WT and HET animals can be attributed to the selective reduction 
of Cacna1c.   
 Reduction in Cacna1c is associated with alterations of BDNF mRNA expression 
with no effects on protein 
HET animals showed reduced expression of total BDNFIX transcript in the mPFC 
and a trend towards an increase in expression in the DG region of the hippocampus.  
Whether the effects are truly specific to sub-regions of the hippocampus requires 
further investigation.  Reduced BDNF has been observed in post-mortem PFC tissue 
of patients with schizophrenia (Weickert et al., 2003) and dysregulated expression of 
BDNF and its associated TrkB receptor has been reported in post-mortem patient 
hippocampus (Takahashi et al., 2000). Furthermore, processes known to require 
BDNF, including hippocampal neurogenesis (Lee et al., 2002), are found to be 
disrupted in mental illness (Schoenfeld and Cameron, 2015).   
Previous findings have indicated a reduction in BDNFIX expression in the forebrain 
of Cacna1c knockout mice (Lee et al., 2016), though region specificity was not 
investigated.  It was found that reduced Cacna1c in these mice was associated with 
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increased cell death of young hippocampal neurons, with no effects on proliferation.  
In contrast to these findings in mice, we observe only a small decrease in BDNF 
mRNA in the PFC, with no effects on protein.  This may be due to the difference in 
model used, with a forebrain specific knockout in Cacna1c expression having larger 
downstream consequences.   Although basal differences in expression of BDNF in 
the hippocampus were not significant, it would be pertinent to investigate expression 
in this region following tasks which are known to involve BDNF dependent 
mechanisms including learning and neurogenesis.  
As discussed (in the introduction) calcium influx through LVGCCs preferentially 
regulates CREB-dependent transcription of BDNF through the rapid activation of 
signalling cascades in response to stimulation (West et al., 2001).  The reduced 
expression of Cacna1c, in the absence of changes in Cacna1d, could therefore lead 
to decreased calcium influx through these channels, affecting the transcription of 
BDNF as observed in the PFC.  Calcium influx through LVGCCs is thought to 
preferentially activate transcription of BDNFIV which is an activity-dependent 
transcript.  Mutant mice with a selective disruption of this transcript have been found 
to show only a modest decrease in basal levels of BDNFIX, whereas significantly 
reduced activity-induced BDNF was seen compared to WT (Sakata et al., 2009).  The 
indications of subtle differences in basal expression observed here may therefore 
become more pronounced following procedures known to induce synaptic plasticity 
and transcription of activity-dependent BDNF. 
Future experiments should investigate activity dependent expression of BDNF 
protein and BDNFIV transcript in these animals, as well as potentially determining 
sub-cellular localisation. This will be discussed in more detail in the General 
Discussion.   
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 No effects of reduced expression of CACNA1C on activity levels, anxiety or 
startle response 
The current results primarily concur with previous studies that have found no effect 
of reduced CACNA1C on locomotor activity (Dao et al., 2010; Lee et al., 2012).  There 
were no effects of genotype in a mildly aversive open field, though there were trends 
towards effects following prolonged exposure to a home-cage like environment.  This 
suggests that activity levels are not likely to confound later experiments involving 
short exposure to a novel or aversive context. However, it is important to take into 
account that there may be small effects on locomotion that may not have been 
detected and which may have a greater influence on tasks involving prolonged 
exposure.  There was also no effect of genotype on habituation following repeated 
exposures to a novel environment, indicated by reduced activity.  The expected 
decrease in ambulation within and across sessions, indicates that animals are able 
to form and recall a representation of the context (Terry, 1979).        
There were no differences observed between WT and HET animals in measures of 
anxiety related behaviour.  Global heterozygous knockout mice models have similarly 
been found to display comparable levels of anxiety with WTs across multiple tasks, 
including Open Field, and Light-Dark avoidance, though evidence is conflicted 
regarding the Elevated Plus Maze task (Dao et al., 2010). Forebrain specific knockout 
of Cacna1c has been associated with increased anxiety related behaviours across 
all three of these anxiety tasks. This is thought to be due to the more extreme 
reduction in regional expression induced by a conditional knockout (Lee et al., 2012).   
It is worth noting that the open field task is only one measure of anxiety-related 
behaviour and is thought to potentially only represent one dimension of anxiety 
(Ramos, 2008).   It is therefore possible that HET animals may differ on other anxiety-
related tasks.  For a more detailed assessment of anxiety in these animals it would 
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be pertinent to conduct multiple tests of anxiety related behaviour to include the 
Elevated Plus Maze.  
WT and HET animals did not differ in reactivity during the acoustic startle response 
test and there was no evidence of any deficits in pre-pulse inhibition in HET animals.  
This is in line with the previous study in Cacna1c knockout mice, which found no 
effects of genotype in startle response in males (Dao et al., 2010).  There does not 
appear to be any previously published investigation of the effects of reduced Cacna1c 
on PPI in rodents.  Studies of PPI in humans have reported no deficits associated 
with the risk allele for schizophrenia in CACNA1C (Roussos et al., 2011).  Reduced 
expression of Cacna1c may not have effects on sensorimotor gating or this task may 
not be sensitive enough to reveal differences which may exist in these animals.  
 Limitations of a genetic knockdown model 
A chronic global knockdown model does have limitations including potential 
compensation effects and rearing environment.  In accord with previous studies, there 
was no evidence of compensation by the other closely related Cacna1d gene. One 
previous study did observe compensation through an increase in calcium permeable 
AMPA receptors, though this has only been reported in forebrain specific knockout 
mice (Langwieser et al., 2010).  Regardless of compensation effects, any behavioural 
differences observed in these animals would indicate a necessary function for 
Cacna1c, or at least one that cannot be fully compensated for by other mechanisms.  
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 Conclusions 
The novel heterozygous rat model displays a reduction in Cacna1c expression across 
different regions of the brain, including the mPFC, cerebellum and hippocampus, with 
no evidence of compensation in the expression of other brain specific LVGCC 
varaints.  Reduced Cacna1c was associated with reduced expression of basal BDNF 
mRNA specifically in the PFC, indicative of effects on relevant downstream 
mechanisms.  There is no evidence of abnormalities in locomotor activity or anxiety 
levels in the model, reducing potential confounds on subsequent investigations of 
associative learning and memory. 
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6 THE EFFECT OF GENETIC KNOCK-DOWN OF CACNA1C 
ON AVERSIVE CONDITIONING 
 Introduction 
Pharmacological inhibition has identified a role for LVGCCs in specific aspects of 
contextual fear conditioning, conserved across different brain regions.  However, at 
present, pharmacological methods cannot distinguish between Cav1.2 and Cav1.3 
channels (coded for by CACNA1C and CACNA1D genes respectively).  Genetic 
knock-down of the individual genes can be utilised to understand the relative 
contribution and potentially separable roles these channels may play in aversive 
conditioning. 
As discussed previously, intronic variation in CACNA1C has been associated with 
risk for psychiatric illness and dysregulated expression of the gene (Quinn et al., 
2010; Gershon et al., 2014; Yoshimizu et al., 2014).  Investigating the effect of 
reduced expression of Cacna1c on specific aspects of learning known to be disrupted 
in schizophrenia, may help to understand the molecular mechanisms which link 
genetic risk with relevant symptoms.  
To date, the majority of studies have utilised mice for investigation of the effects of 
haploinsufficiency of Cacna1c.  Evidence supports the role of Cav1.2 in NMDAR-
independent L-LTP and spatial learning (Moosmang et al., 2005), however there are 
a limited number of studies that have investigated the effect of reduced expression 
on associative learning.  Previous findings suggest there may be a limited role for 
Cav1.2 channels in the consolidation and extinction of CFM, however results are 
inconclusive and based on region specific knockouts (White et al., 2008; Langwieser 
et al., 2010).  At present, there do not appear to be any studies that have investigated 
effects on latent inhibition.       
167 
 
Moosmang et al., (2005) found that inactivation of the Cacna1c gene, primarily in the 
hippocampus and neocortex of mice, led to deficits in protein synthesis dependent, 
NMDAR-independent LTP in the CA1 region of the hippocampus. In conjunction with 
this, they found deficits in spatial learning and an impairment in CREB activation.  
They conclude that this demonstrates a necessary role for Cav1.2 channels in certain 
types of hippocampal-dependent synaptic plasticity and spatial learning.  This is 
supported by findings in mice with a forebrain specific conditional deletion of Cacna1c 
in excitatory neurons (White et al., 2008).  There was no difference between knockout 
and wild-type animals during acquisition of spatial learning, however when tested 30 
days later knockout mice demonstrated a deficit in recall, indicative of an effect on 
the consolidation of remote spatial learning.   
In these same mice Mckinney et al., (2008) investigated the effects on CFC.  Mice 
were conditioned over two days in the same context to an un-cued footshock.  There 
were no differences observed between genotypes for the acquisition or consolidation 
of CFM, with both groups showing the expected increase in freezing following 
training.  This corresponds to additional studies, suggesting that the consolidation of 
CFM may instead rely on Cav1.3 channels (McKinney and Murphy, 2006; Berger and 
Bartsch, 2014).   
There was also no effect of Cacna1c knockdown on the extinction of CFM in these 
mice.  Both WT and knockout animals showed the expected reduction in freezing 
during prolonged re-exposure to the context and maintained reduced levels when 
assessed during a recall session 24 hrs later.  It was therefore concluded that Cav1.2 
channels do not have a necessary role in extinction, or account for the effect 
observed with inhibition of LVGCCs more generally.  In contradiction to this, Busquet 
et al., (2008) found that in mice genetically modified to possess dihydropyridine 
insensitive Cav1.2 channels, the effect of systemic infusion of Nifedipine (an LVGCC 
inhibitor) on extinction was completely abolished.  However, further investigation 
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suggested that the role of Cav1.2 channels was mediated by a peripheral mechanism 
rather than a central one, with no effects observed with intracerebroventricular 
administration of Nifedipine.  This may be explained by the observation that 
Nifedipine has been found to produce aversive effects when injected peripherally (as 
previously discussed) which may lead to conditioning to the drug alone. The effects 
may therefore be abolished in animals with dihydropyridine insensitive Cav1.2 
channels because these aversive effects are not experienced.  Cav1.3 knockout mice 
have also been found to show no deficits in the acquisition or consolidation of 
extinction learning (McKinney and Murphy, 2006; Busquet et al., 2008).  Together, 
these results are unable to explain the contribution of specific L-type channels to the 
effect observed with LVGCC inhibitors locally infused into the brain. 
One factor that may influence the differences observed is the effect of chronic 
haploinsufficiency compared to acute inhibition.  Langwieser et al., (2010) also found 
that chronic CNS specific deletion of Cacna1c had no effect on the consolidation of 
CFM compared to acute inhibition of LVGCC, even though they confirmed that the 
effect of inhibition was specifically driven by Cav1.2 channels.  On further 
investigation, they found that chronic knockout of Cacna1c led to compensatory 
changes in the amygdala.  They observed a homeostatic switch in plasticity from an 
LVGCC-dependent mechanism to one which utilises post-synaptic calcium-
permeable AMPA receptors (cp-AMPAR).  There was a significant increase in the 
expression of GluA1 in knockout animals, suggesting a compensatory mechanism in 
response to a lack of Cav1.2 channels.  This could explain some of the discrepancy 
in previous results, both between genetic models and also in relation to acute 
pharmacological inhibition.  However, they only investigated the effects in the 
amygdala and in relation to the consolidation of CFM.  Whether this mechanism is 
able to compensate fully for the potential function of Cav1.2 channels in extinction 
and other inhibitory learning processes is yet to be elucidated.       
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Other fear learning related behaviours have been found to be affected by localised 
deletion of Cacna1c.  Jeon et al., (2010) found that deletion of Cacna1c in the anterior 
cingulate cortex (ACC) of mice led to an impairment in observational fear learning.  
Mice that observed other mice receiving repetitive foot-shocks developed freezing 
behaviour even though they did not experience the aversive stimuli themselves.  This 
effect was impaired in knockout mice, with reduced freezing behaviour observed, 
suggesting that Cav1.2 channels in the ACC are necessary for observational social 
fear.  Interestingly these mice did not show any deficits in classical fear conditioning, 
further highlighting the potential significance of regional specificity in knockdown 
models.     
Although forebrain specific and conditional knockout models are incredibly useful for 
understanding region specific roles of these genes and to establish direct causality, 
they are not necessarily representative of the disease state to which CACNA1C has 
been associated.  As previously discussed, the risk SNP identified as being 
associated with schizophrenia and bipolar, is associated with significantly reduced 
expression of CACNA1C in the cerebellum (Gershon et al., 2014). Furthermore, rare 
deleterious variants in calcium channel subunits have been found to be associated 
with risk for schizophrenia (Purcell et al., 2014b).  It is therefore pertinent to use 
models which reflect this when investigating disease relevant behaviour, which not 
all previous models have.  The effect of a chronic global haploinsufficiency of 
Cacna1c on contextual fear conditioning has yet to be investigated, and as of yet, no 
studies have investigated any of these behaviours in rats.  Considering the 
association of CACNA1C with schizophrenia, it would also be highly relevant to 
investigate the effect of reduced expression on latent inhibition due to deficits 
observed in patients, in addition to those aspects of associative learning addressed 
previously.  
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Previous results aiming to determine the separable role of Cav1.2 and Cav1.3 
channels in CFC are conflicting and rely on the comparison of multiple models across 
multiple methodologies.  To help elucidate the relative contribution of Cav1.2 
channels to the effect observed with acute LVGCC inhibitors and to understand the 
role of Cacna1c more fully, it is necessary to investigate these behaviours across one 
disease relevant model.   
 Experimental aims 
The aim of the following experiments was to determine the effect of chronic global 
haploinsufficiency of Cacna1c in Sprague Dawley rats on specific aspects of 
associative learning: acquisition, consolidation, extinction and latent inhibition.  As 
previously, CFC was used as a model of hippocampal dependent associative 
learning.  Heterozygous knock-out rats were compared to wild-type litter mates for 
each behavioural paradigm.  This is the first study to assess the effect of genetic 
knockdown of Cacna1c on associative learning in rats and specifically the first study 
to assess the effect of any form of reduced expression on latent inhibition.    
Experiment 1 – Effect of Cacna1c knockdown on the acquisition and consolidation of 
CFM 
Experiment 2 – Effect of knockdown on the extinction of CFM and the consolidation 
of extinction 
Experiment 3 – Effect of knockdown on the latent inhibition of CFC 
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 Experiment 1 – Effects of reduced expression on the acquisition 
and consolidation of CFM 
This experiment aimed to determine whether reduced expression of Cacna1c 
affected the acquisition, short term recall and/or the consolidation of CFM.   
 Methods and materials 
6.3.1.1 Animals 
14 animals (8 WT and 6 HET) were housed as previously described.  All animals 
were given a minimum of five days from arrival to settle before being used in any 
experiments.  Animals were sacrificed at the end of the experiment using a rising 
concentration of CO₂.  Brains were removed and fresh frozen on dry-ice and tail 
biopsies were taken for post-mortem confirmation of genotypes.    
6.3.1.2 Behaviour  
Animals underwent the standard CFC paradigm as described previously.  They 
received conditioning in the morning, followed by recall sessions at 3 hrs, 24 hrs and 
7 days.  Shock intensity was maintained from previous experiments at 0.5 mA 
following confirmation of conditioning in Sprague Dawley control animals at this level.  
6.3.1.3 Analysis 
Freezing was scored blind to genotype for each session from digital recordings.  
Genotypes were confirmed post-mortem and freezing behaviour was compared 
between WT and HET animals using repeated measures ANOVA, unless otherwise 
stated.  Greenhouse Geisser corrections were applied where Mauchly’s test of 
sphericity was significant.  Post-hoc one-way ANOVAs were conducted for individual 
test sessions based on a-priori hypotheses where appropriate.   
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 Results 
6.3.2.1 Reduced expression of Cacna1c does not affect the acquisition or consolidation of 
CFM 
All animals showed the expected increase in freezing following exposure to the US, 
with increased freezing observed immediately following shock and at 3 hrs, 24 hrs 
and 7 days later (Test: F(4,48) = 29.624, P < 0.001, ƞp2 = .71).  There was no 
difference in behaviour between genotypes (Genotype: F(1,12) = .385, P = .546, ƞp2 
=.03) and no evidence of an interaction between genotype and test session (Test x 
Genotype: F(4, 48) = .533, P = .712, ƞp2 =.04).  This indicates that a reduction in 
Cacna1c does not affect the acquisition or consolidation of CFM (Figure 6.1). 
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Figure 6.1 Cacna1c haploinsufficiency does not affect the acquisition, short term recall or 
consolidation of CFM (F(1,12) = 0.385, P = 0.546) (STM1: 3 hour recall; LTM1: 24 hour recall; 
LTM2: 7 day recall).  Data points represent average % freezing for each genotype.  Error bars 
are SEM. 
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 Experiment 2 – Effects of reduced expression on the extinction of 
CFM 
As Cacna1c HET knockout animals were able to successfully consolidate contextual 
fear associations, it allowed further investigation of post retrieval processes and other 
aspects of inhibitory learning. This experiment aimed to establish whether 
haploinsufficiency of Cacna1c affects the acquisition and/or consolidation of 
extinction.  Animals underwent CFC as in experiment 1 and were then re-exposed to 
the training context for a prolonged recall session, designed to induce extinction of 
CFM.  Acquisition of extinction was assessed by freezing levels within this session 
and the consolidation of extinction was determined by the freezing during recall 
sessions 24 hrs and 7 days later.  Successful extinction was determined by reduced 
freezing within the 10 min session and maintained low levels of freezing during recall.    
 Methods and materials 
6.4.1.1 Animals 
32 male Sprague Dawley rats (16 HET and 16 WT) were housed as previously 
described with littermates in cages of 2 - 4.   
6.4.1.2 Behaviour 
All animals underwent CFC as previously described.  24 hrs later they were returned 
to the conditioning chambers for a 10 min extinction training session in the absence 
of the US.  They were re-exposed to the same context for two 2 min recall sessions 
24 hrs and 7 days following extinction to assess the consolidation of extinction.   
6.4.1.3 Analysis 
Analysis was conducted as experiment 1.  During the 10 min extinction session, 
freezing behaviour was scored as previously, averaged across 2 min bins.  Freezing 
behaviour is presented for the first 2 mins and last 2 only, though profiles throughout 
the 10 mins were checked for consistency.    
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 Results 
6.4.2.1 Reduced expression of Cacna1c does not affect the acquisition or the consolidation 
of extinction learning 
There was no difference in freezing behaviour between Cacna1c +/- knockout and 
WT animals (Figure 6.2).  Repeated measures ANOVA with a Greenhouse-Geisser 
correction showed a significant effect of test on freezing behaviour (F(3.113, 93.386) 
= 14.809, P < .0001) with no indication of an effect of genotype (F(1,30) = .850, P = 
.364, ƞp2 .028) or an interaction (F(3.113, 93.386) = .604, P = .620, ƞp2 .02).   
As previously, all animals acquired the initial CFM (F(1,30) = 107.143, P < .001, ƞp2 
= .781) with no evidence of a difference between genotype (F(1,30) = .042, P = .839, 
ƞp2 = .001) or an interaction (F(1,30) = .00, P = 1.00).  The 10 min extinction trial 
successfully reduced freezing within session for both groups (F(1,30) = 7.479, P = 
.010, ƞp2 .20).   
Results suggest that there is no effect of reduced expression of Cacna1c on freezing 
behaviour during an extinction training session or during recall of extinction when 
tested 24 hrs and 7 days later.  
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Figure 6.2 Reduced Cacna1c expression does not affect the acquisition of consolidation of 
extinction learning (F(1,30) = .850, P = .364). FIRST: Freezing during first 2 mins of the 10 
min extinction session; LAST: Last 2 minutes of the 10 min extinction session.  Data points 
represent average % freezing for each genotype.  Error bars are SEM.  
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 Experiment 3 – Effects of reduced expression on latent inhibition 
This experiment aimed to investigate the effects of reduced Cacna1c on the latent 
inhibition of CFM.  This involved prolonged exposure to the context for 4 hrs prior to 
CFC, so that the context was no longer novel at training.  Familiarity with the CS 
reduces the association formed with the US, as discussed previously (See Chapter 
4.), indicated by a blunted freezing response following training.  Animals underwent 
a 4 hr LI session 24 hrs before CFC, then underwent training and recall sessions as 
experiment 1.   
 Methods and materials 
6.5.1.1 Animals 
17 animals (7 WT and 10 HET) were housed as previously described with littermates 
in cages of 3 or 4.  One WT and one HET animal were excluded from analysis due 
to an incorrect shock intensity being used for CFC, leaving 6 WT and 9 HET animals 
for comparison.    
6.5.1.2 Behaviour 
Animals were exposed to the training context for 4 hrs on the morning of day one.  
CFC was conducted 24 hrs later to coincide with the offset time of LI.  Recall sessions 
at 24 hrs and 7 days later were conducted as experiment 1.   
6.5.1.3 Analysis 
Behaviour was scored for the first 2 mins of the LI session to establish baseline 
freezing.  The full LI digital recording was inspected to ensure no abnormal behaviour 
or faults which may confound the experience.  Statistical comparisons were as 
experiment 1.  
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 Results 
6.5.2.1 Genetic knockdown of Cacna1c affects the latent inhibition of CFM 
Cacna1c HET animals showed increased freezing compared to WT animals following 
CFC, indicating a reduced latent inhibition effect (Figure 6.3).   
HET and WT animal freezing behaviour was compared across the whole of the task.  
Repeated measures ANOVA with a Greenhouse-Geisser correction showed a 
significant effect of test session on freezing behaviour (F(2.496, 32.453) = 58.781, P 
< 0.001, ƞp2 = .819), an effect of genotype (F(1,13) = 35.080, P < .001, ƞp2 =  .730) 
and an interaction (F(2.496, 32.453) = 14.927, P < .001, ƞp2  = .534).   
Cacna1c knockout animals showed significantly greater freezing levels post US (two 
tailed, independent samples t-test: t(13) = -2.289, P = .039).  They also showed 
higher freezing levels during recall sessions at 24 hrs (M = 87.96%, SEM = 5.22%) 
and 7 days (M = 76.85%, SEM = 8.54%) following CFC compared to WT animals (M 
= 34.72%, SEM = 9.48%; M = 19.44%, SEM = 7.66% respectively; t(13) = -5.337, P 
< .001 and t(13) = -4.692, P < .001).  There was no freezing behaviour observed in 
either group during the first 2 minutes of LI and no effect of genotype on freezing 
behaviour pre-US (t(13) = -1.183, P = .258), confirming these animals did not show 
abnormal behaviour prior to CFC, with differences isolated to sessions following 
training.  
Results demonstrate a deficit in the latent inhibition of CFM in Cacna1c HET animals, 
with increased freezing behaviour indicating the formation of an association despite 
pre-exposure to the CS.   
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Figure 6.3 Cacna1c HET knockout animals show a deficit in the latent inhibition of CFM 
(F(2.496, 32.453) = 58.781, P < 0.001).  Pre: 2 mins prior to footshock; Post: 1 min following 
footshock; Recall: 24 hrs following CFC; LTM1: 7 days later.  Data points represent average 
% freezing.  Error bars are SEM. 
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 Summary 
Global chronic knockdown of Cacna1c in Sprague Dawley rats has no effect on the 
acquisition, consolidation or extinction of CFM.  However, Cacna1c knockdown 
animals show a significant deficit in the latent inhibition of CFM; demonstrating the 
inappropriate formation of an association between an US and a familiar CS, which is 
maintained at 7 days.   
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 Discussion 
This is the first study investigating the effect of chronic global haploinsufficiency of 
Cacna1c in rats on specific aspects of contextual fear conditioning.     While there 
was no evidence of a general learning impairment, there was a specific deficit 
observed in the latent inhibition of CFM, a behaviour found to be altered in people 
with schizophrenia (Escobar et al., 2002). 
 Reduced expression of Cav1.2 channels does not affect the formation of 
hippocampal dependent associative memory  
In agreement with previous studies, there was no evidence of a deficit in the 
acquisition or consolidation of CFM in Cacna1c knockout rats.  Similar to findings 
across knockout mouse models, changes in expression of Cacna1c do not lead to a 
general learning impairment of associative memory.  Although in these experiments 
animals only had approximately a 50% reduction of CACNA1C, other previous 
studies have shown similar lack of effects with complete brain specific knockout 
(Mckinney et al., 2008; Langwieser et al., 2010).  It is therefore viable that CACNA1C 
expression may not be necessary for the consolidation of hippocampal dependent 
CFM.   
Previous studies have identified a more critical role for Cav1.3 channels in 
consolidation.  McKinney and Murphy, (2006) investigated the effect of a knockout of 
Cacna1d on CFC.  They found that knockout mice were specifically impaired on the 
consolidation of CFM, which they concluded was due to a deficit in the formation of 
associations rather than an inability to encode the context.  These findings in 
conjunction with those presented above, suggest that the impairment in consolidation 
of CFM observed with acute LVGCC inhibition is primarily driven by the block of 
calcium influx through Cav1.3 channels.  Furthermore, Cav1.2 channels are neither 
necessary nor sufficient for the acquisition and consolidation of CFM.   
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Although cognitive impairments are a key symptom in people with schizophrenia, a 
general impairment in learning is not commonly observed in patients (Rushe et al., 
1999).  It is therefore more likely that risk genes that have been identified, to include 
Cacna1c, will have subtler effects on cognition.       
 Cav1.2 channels are not necessary for the acquisition or consolidation of 
extinction of CFM 
There was no evidence of a difference between Cacna1c knockout and wild-type rats 
in extinction learning following CFC.  This concurs with previous findings with 
conditional knockouts in mice that found no effect of brain specific reduced 
expression on extinction learning or consolidation (Mckinney et al., 2008).  However, 
separable effects on extinction and latent inhibition disagree with previous findings 
that suggest they may involve the same molecular mechanisms (Barad et al., 2004).  
Although both may involve calcium influx through LVGCCs, there are clearly 
mechanisms yet to be discerned that distinguish between inhibition following pre-
exposure and re-exposure following training.    
Previous evidence also suggests that the knockdown of Cav1.3 channels does not 
affect extinction (McKinney and Murphy, 2006).  This is at odds with the 
pharmacological findings which demonstrate an effect on the consolidation of 
extinction learning.  Mckinney et al., (2008) investigated the effects of Nifedipine to 
see if they could replicate the findings of Cain et al., (2005).  They administered the 
LVGCC inhibitor systemically and found similar effects on extinction, however they 
attributed this to an effect of the drug on locomotor activity.  This conclusion does not 
explain the consistent findings of an effect of LVGCC inhibitors infused locally into 
the brain, or the findings observed with different classes of inhibitor.  It is possible 
that the consolidation of extinction relies on calcium influx through both Cav1.2 and 
Cav1.3 channels, the complete inhibition of which is only achieved by a 
pharmacological blockade and not through partial genetic knockdown of either 
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channel.  Alternatively, as suggested by Busquet et al., (2008) there may be a 
peripherally mediated mechanism, or potentially off-target central effects of the 
inhibitors which are not yet fully understood.   
The current findings in conjunction with previous studies cannot yet fully explain the 
effect of LVGCC inhibitors on extinction learning.  It is possible that calcium influx 
through Cav1.2 channels play a role in extinction, however there may be 
compensation mechanisms that are not yet fully characterised.    
 Reduced expression of Cacna1c leads to the formation of inappropriate 
aversive associations with familiar stimuli 
Cacna1c knockout rats had a profound impairment in the latent inhibition of CFM.  
This implies a vital role for Cav1.2 channels for inhibiting the formation of associations 
between a CS and an aversive US, based on prior information.  As there was no 
observed deficit in the acquisition of CFM or the subsequent acquisition of extinction, 
it can be assumed that Cacna1c knock out rats are capable of acquiring both CS-US 
and CS-no US associations under some circumstances.  There may be a requirement 
of prior salience to form new CS-no US associations (as in the case of extinction), or 
it may be an inability to transfer prior learned irrelevance contingencies to current 
experience.  Inappropriate associations are then formed based on a response to the 
contingencies of their current environment rather than previous information.  
The process of latent inhibition has been suggested to be impaired in schizophrenia, 
though results are conflicting. Escobar et al., (2002) proposed that people with 
schizophrenia have an inability to compare and express stored representations.  This 
is in line with Cohen and Serven-Schreiber’s cognitive model which suggests that 
patients can successfully process contextual information but have difficulties in 
maintaining and using it to inhibit subsequent inappropriate responses (Cohen et al., 
1992).  The data presented here fits with these models, as well as with the observed 
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impairment in people with schizophrenia in the processing of neural signals of 
prediction error (Gradin et al., 2011).  Deficits in LI have been observed in patients 
(Gray et al., 1995a; Escobar et al., 2002) as well as a more general formation of 
abnormal associations (Jensen et al., 2008).  However, there has been found to be 
a difference in impairment between acute and chronic episodes, with impairment 
being seen only in those patients suffering acute psychotic episodes (Gray et al., 
1995b).  Different observations have been theorised to possibly relate to medication 
status of participants (Lubow et al., 1987) indicating a likely interaction of these 
processes with the dopamine system.     
Previous studies have found that the administration of amphetamine, an indirect 
dopamine agonist, leads to impairments in latent inhibition in both rats (Weiner et al., 
1984, 1988; Young et al., 1993) and humans (Gray et al., 1992; Salgado et al., 2000).  
This has led to latent inhibition being seen as a viable behaviour to model positive 
symptoms of psychosis, due to the disruption of the dopamine system in patients and 
the effective use of dopamine antagonists in treatment.  Interestingly amphetamine 
administration has been found to have an effect on the function and expression of 
Cav1.2 channels (Andres et al., 2015a; Cameron et al., 2015).  Acute administration 
of methamphetamine in human cells in vitro has been found to block calcium influx 
through LVGCCs, whereas longer exposure leads to a specific upregulation of 
CACNA1C  (Andres et al., 2015b).  A more direct link between dopamine and 
LVGCCs has been postulated in primary mid-brain mouse neurons, with endogenous 
dopamine through D2R receptors found to suppress the activation of LVGCCs and 
the generation of synchronous oscillations (Yasumoto et al., 2004).  Whether there is 
a direct mechanism which links the similar behavioural effects on latent inhibition of 
reduced expression of Cacna1c and dopamine agonists is yet to be fully elucidated; 
though it is possible that converging effects are mediated through BDNF.    
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Previous results (Chapter 3) suggest a similar effect of reduced BDNF on latent 
inhibition and studies have found that BDNF controls and maintains the expression 
of the dopamine D3 receptors (Guillin et al., 2001; Sokoloff et al., 2002).  Furthermore, 
BDNF has been implicated in methamphetamine-induced release of dopamine and 
its link to psychosis (Narita et al., 2003; Manning et al., 2015). Future studies should 
explicitly investigate a link between LVGCC, BDNF and dopamine in latent inhibition, 
as well as the possibility to rescue behavioural deficits with the manipulation of 
dopamine and/or BDNF in Cacna1c knockout animals.   
 Limitations and future directions 
It is possible that compensatory mechanisms may have developed in these animals 
that are able to fulfil some of the functionality of Cacna1c and the role that Cav1.2 
channels may play in a ‘normal’ brain.  It has previously been shown that conditional 
CNS knockout of Cacna1c can lead to an increase in calcium-permeable AMPAR, 
though this was only investigated in the amygdala (Langwieser et al., 2010).  
Although it is possible that compensation mechanisms have evolved in response to 
reduced Cacna1c that may be able to fulfil a role in extinction, it is evident that normal 
expression levels of Cacna1c are necessary for the latent inhibition of CFM.  Future 
studies would need to investigate this more fully; to determine if there is a 
compensation by cp-AMPAR and whether this is sufficient for the acquisition and 
consolidation of extinction, as well as initial learning as previously observed 
(Langwieser et al., 2010).  It is also possible, that any compensation that may have 
occurred may not be as stable as the natural mechanisms involving Cav1.2 channels. 
Further investigation into any potential environmental interactions, including stress, 
could help interrogate their ability to fully compensate for the function of CACNA1C.   
It is not yet known whether the deficits observed here are specific to aversive 
associations or whether they may additionally affect reward based association 
formation.  The same brain regions (primarily the ventral striatum) have been found 
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to be activated in response to prediction error regardless of valence in healthy 
controls (Jensen et al., 2007).  With the added accordant impairments in LI seen with 
the manipulation of the dopamine system, it would be pertinent to translate this work 
into reward learning.  Future studies will aim to investigate whether deficits in 
Cacna1c knockout animals generalise to inhibition of reward learning or if they are 
specific to aversive associations.     
 Conclusions 
Chronic global haploinsufficiency of Cacna1c in rats causes a profound specific deficit 
in latent inhibition of CFM.  This is the first study to investigate this aspect of 
associative learning in a reduced expression model of Cacna1c and suggests a 
necessary role for Cav1.2 channels.  Latent inhibition has been found to be impaired 
in people with schizophrenia and has been further linked with dysregulation of the 
dopamine system.  It is possible that dysfunction of signalling through Cav1.2 
channels may play a role in the etiology of these related symptoms, with a potential 
convergence and/or interaction with BDNF and dopamine, requiring further 
investigation. 
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7 EFFECT OF GENETIC KNOCKDOWN OF CACNA1C ON 
REVERSAL LEARNING 
 Introduction 
Reversal learning involves the inhibition of a previous learnt association between a 
stimuli and reward and the acquisition of a new opposite contingency or rule.  It is a 
necessary form of behavioural flexibility which allows new experience to influence 
subsequent behaviour (Floresco et al., 2009).  Deficits in this form of learning can 
lead to maladaptive, perseverative behaviour that is not supported by, or beneficial 
in, the current environment.  Impairments in this task have been reliably observed in 
patients with schizophrenia and bipolar disorder (Elliott et al., 1995; Waltz and Gold, 
2007a; McKirdy et al., 2009; Adleman et al., 2011).  Experimental studies have shown 
that reversal learning can be dissociated, to an extent, into specific phases which 
require separable functional mechanisms and neural circuitry.  These include initial 
acquisition of contingencies, reversal and inhibition of prior contingencies and the 
increased control of behaviour to respond to previously unrewarded stimuli.  These 
highly dissociable components of behaviour and neurobiology can be useful in 
relating a particular pattern of effects in a single cohort of animals, to discrete 
psychologies and brain functions.  Importantly homologous cortical-striatal networks 
have been found to be involved in these processes in both rats and humans (Balleine 
and O’Doherty, 2010) and the development of a touchscreen based paradigm for 
rodents makes reversal learning a highly translatable function (Bussey et al., 2012).  
The molecular mechanisms underlying the separate phases of reversal, and the 
potential role of risk genes for schizophrenia in these processes, is yet to be fully 
understood.  
Neural circuitry to include the frontal cortex (specifically ventral medial prefrontal 
cortex (vmPFC) and orbitofrontal cortex (OFC)), medial temporal lobe and dorsal 
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medial striatum (DLS), have been reliably found to play an important role in reversal 
learning tasks, through lesion studies (Clarke et al., 2008; Castañé et al., 2010; 
Graybeal et al., 2011) and human imaging (Cools et al., 2002; Ghahremani et al., 
2010).  The DLS and dopamine signalling more broadly is also known to be 
necessary for reversal learning through inhibitor studies (e.g. Lee et al., 2007). 
Evidence has further identified a role of the amygdala in the updating and change of 
reward associations, however results are conflicting (e.g. Izquierdo and Murray, 
2007; Clarke et al., 2008; Rudebeck and Murray, 2008). It is postulated that it may 
play a specific role in the use of positive reinforcement for the adaptation of 
subsequent behaviour (Rudebeck and Murray, 2008). 
Dysfunction in these key brain regions and dopamine signalling are known to be 
prevalent in neuropsychiatric disorders, including schizophrenia, bipolar and autism 
(e.g. Drevets et al., 1997; Goldberg et al., 1999; Culbreth et al., 2015).  It has been 
suggested that reversal learning assays can be exploited to provide greater specificity 
in identifying PFC dysfunction (Clark et al., 2004) in patients with schizophrenia, with 
behavioural deficits only evident during specific phases of the task.         
Acquisition of visual discrimination 
In a typical reward based reversal task using visual cues, performance is initially at 
chance level with approximately equal responses to each of two visual stimuli.  As 
the association with reward is learned, the rewarded stimulus is selected more often 
and performance increases (Figure 7.1).  As discrimination is incrementally acquired, 
responses become quicker and eventually behaviour becomes over-trained to the 
point of being habitual (Reading et al., 1991).   
Genetic knockout studies have identified a role for N-methyl-D-aspartate receptor 
(NMDAR) NR2A subunit in the acquisition and maintenance of stable associations 
between stimuli and reward (Brigman et al., 2008).  Despite the implication of the 
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dopamine system and NMDAR function, patients with schizophrenia have been found 
to successfully acquire discrimination at this phase (Elliott et al., 1995; Waltz and 
Gold, 2007a; Leeson et al., 2009).  However, some studies have observed subtle 
deficits in patients in first-episode psychosis (Murray et al., 2008a) as well as stable 
outpatients (Reddy et al., 2016).   
Inhibition of previous contingencies (Early reversal) 
Once a pre-determined criterion is reached for discrimination, contingencies are 
reversed and the previously unrewarded stimulus now predicts reward.  Performance 
is reduced to below chance level as responses are initially still made to the previously 
rewarded stimuli (Figure 7.1).  Previous studies have referred to this as “Early” 
reversal (Graybeal et al., 2011; Bussey et al., 2012).  Errors made at this stage are 
termed perseverative errors, referring to the inappropriate continuation of behaviour 
driven by prior associations (Bussey et al., 2012).  Correct response to the newly 
reversed association requires the inhibition of the prior contingency and the 
comparison of new information with stored representations (Floresco et al., 2009). 
Animals must be able to employ cognitive control networks to inhibit the habitual 
responding acquired during the “Visual discrimination” phase of the task.  This is 
typically manifested by increased response latencies and uncertainty in reward 
collection, as behaviour shifts from habitual to goal-directed (Balleine and O’Doherty, 
2010).  Goal directed behaviour is postulated to be more flexible, relying on the 
associations formed between action and outcome, compared to the habitual 
response system which relies on stimuli and response associations (Keramati et al., 
2011).  
 
190 
 
 
Figure 7.1 Progression of performance throughout the Reversal Learning task identifying 
relatively distinct phases of behaviour.  Evidence suggests separable psychological and 
neural mechanisms are involved in the acquisition, inhibition and maintenance of competing 
contingencies. 
The dopamine system has been more specifically implicated in this early stage of 
reversal with inhibitor studies, with dopamine neuron signalling from the midbrain to 
the striatum known to involved in the balance between habitual and goal-directed 
decision making (Keramati et al., 2011). It has been reported that the D2/D3 receptor 
antagonist raclopride specifically affected reversal learning in monkeys, with a greater 
number of errors made in treated animals compared to controls; with no effects on 
subsequent learning or the retention of the initial discrimination (Lee et al., 2007).  
Similar effects were observed with the D2 agonist bromocriptine in healthy humans 
(Mehta et al., 2001).  D1-receptor agonism has been found to impair early reversal in 
mice (Izquierdo et al., 2006).  Intraperitoneal injection of SKF81297 prior to each 
reversal session resulted in fewer correct responses in the first sessions of reversal 
but differences were absent by the third session with no effect on the time taken to 
reach reversal criteria.  These findings support the role of the dopaminergic midbrain 
in the reversal but not acquisition of contingencies. 
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This early phase of reversal has been found to be significantly impaired in people 
with schizophrenia and bipolar disorder (Elliott et al., 1995; Crider, 1997; Waltz and 
Gold, 2007a; McKirdy et al., 2009; Adleman et al., 2011; Reddy et al., 2016).  Elliott 
et al., (1995) found that patients were unimpaired on the initial acquisition of 
associations between stimuli and reward. However, when contingencies were 
reversed, patients took much longer to adjust their behaviour, demonstrating a 
perseverance of prior associations.  There is no evidence that these impairments are 
related to medication status (Schlagenhauf et al., 2014), appearing relatively stable 
over time and there has been no association found with intelligence (Reddy et al., 
2016).  Imaging studies have further found that performance on this task in patients 
is correlated with activation of regions of the cognitive control network known to be 
necessary for this phase of the task (Schlagenhauf et al., 2014; Culbreth et al., 2015).  
Animal models of relevance to schizophrenia have also been found to have specific 
deficits in “Early” reversal.  Impairments have been observed in Phencyclidine (an 
NMDA-receptor antagonist) treated animals, with reduced performance levels 
following reversal (McLean et al., 2009).  These were found to be significantly 
improved with IP injection of D1-like receptor antagonist SKF- 38393.  An 
investigation of behavioural effects of homozygous knockout of schizophrenia risk 
gene Dlg2 in mice has similarly reported increased perseveration in the early stages 
of reversal, extending to later reversal when a more demanding task was employed 
(Nithianantharajah et al., 2013).  
Acquisition of new contingencies (Late reversal) 
In comparison to the earlier stages of reversal in which inhibition of prior behaviour is 
required, later sessions necessitate the learning and maintenance of a new response 
contingency (Bussey et al., 2012).  Performance increases incrementally, as in the 
“Visual discrimination” phase, until criteria is reached.   
192 
 
Studies have found that abnormalities at this stage can be dissociated from those in 
“Early” reversal, with more errors being made during late sessions, without increased 
perseverative errors (Chudasama and Robbins, 2003; Brigman et al., 2008).  
Inactivation of the dorsal medial striatum has been found to specifically impair rats’ 
ability to maintain a new choice response pattern (Ragozzino, 2007).  Lesions of the 
infralimbic PFC were also reported to result in impaired reversal learning, but in the 
absence of increased perseverative errors (Chudasama and Robbins, 2003).  
Animals were observed to make more learning related errors, indicative of problems 
in acquiring the new contingency rather than inhibiting the old. 
Conversely, facilitations of “Late” reversal have been reported in relation to 
abnormalities of vmPFC function (Graybeal et al., 2011; Bryce and Howland, 2015). 
Graybeal et al. (2011) found that excitotoxic vmPFC lesions following acquisition 
resulted in fewer errors specifically during late reversal, with fewer sessions required 
to reach criteria.  They suggest that this facilitation may be due to the vmPFC 
providing a brake on learning and that dysfunction of this region leads to deficits in 
this inhibition; promoting learning in subcortical regions.  Interestingly they were able 
to rescue this facilitation with local infusions of BDNF into the vmPFC, suggesting this 
effect is mediated by stress effects on the regulation of BDNF in this region (Duman, 
2004; Gourley et al., 2009).  Conflicting evidence is likely due to the different timings 
of vmPFC lesion.   
Human imaging studies during this late phase have identified altered activation in 
brain regions of patients required for cognitive control; finding a correlation with 
activation and behaviour consistent with deficits in forming adequate correct 
response representations (Culbreth et al., 2015).  It is evident that normal reversal 
learning requires the coherent communication between multiple brain regions, with 
separable mechanisms more/less vital at different stages.  Abnormalities during 
specific phases may indicate impairments in distinct underlying circuitry and 
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mechanisms.  Determining whether individual risk genes for schizophrenia have a 
role in specific stages of reversal learning would help to elucidate the functional link 
between risk and the symptoms observed in patients.   
CACNA1C and Cav1.2 channels more broadly have been found to be important for 
behaviours that are mediated by the mesolimbic dopamine system, specifically in 
relation to depression related behaviours and stimulant sensitisation (Bhat et al., 
2012; Berger and Bartsch, 2014; Kabir et al., 2016).  These channels have also been 
implicated in the processing of reward (Wessa et al., 2010; Bhat et al., 2012; 
Lancaster et al., 2014) .  People with the risk associated variant in CACNA1C were 
found to have blunted reward responsiveness, without an observed effect on 
discriminability (Lancaster et al., 2014).  Evidence has also suggested a direct role 
for Cav1.2 channels in the presynaptic regulation of mesolimbic dopamine signalling 
(Terrillion, 2015), as well as a role in mediating the inhibitory or excitatory 
consequences of D1 receptor activation (Hernandez-Lopez et al., 1997).  Despite the 
extensive evidence of the relevance of CACNA1C for regions implicated in reversal 
learning and the impairments observed in patients with schizophrenia, to date no 
study has investigated the specific role of CACNA1C in this task.  
Using a translational touchscreen reversal learning paradigm based on the one 
developed by Bussey et al, the current study aimed to establish the effects of reduced 
expression of Cacna1c on behaviour.  Given the impairments in patients and 
previously observed effects on inhibitory aversive learning, it is pertinent to determine 
whether effects translate to the inhibition of reward associations within a dopamine 
dependent paradigm. It is hypothesised that a reduced expression of Cacna1c would 
result in impairments in “Early” reversal; when there is the requirement to elicit an 
inhibition of behavioural response to prior contingencies.   
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 Methods and materials 
 Animals 
26 male Sprague Dawley Cacna1c heterozygous knockout rats were used, aged 
between 89 and 111 days.  All animals were given at least 2 weeks from arrival before 
any training procedures started.  Animals were housed with littermates in groups of 
1-4 depending on their size before transport from Charles River.  Animals were 
placed on water restriction on testing days to maximise motivation for reward.  Water 
restriction was conducted in accordance with Home Office regulations.  One rat was 
euthanised due to the development of an aggressive tumour during the visual 
discrimination phase, therefore analyses were conducted on the 25 remaining 
animals.   
 Equipment 
Animals were run in sets of 4 using Bussey-Saksida rat touch screen chambers 
(Campden Instruments, 80604, Leics) with accompanying Animal Behaviour 
Environment Test (ABET) II software (Campden Instruments, 89505).  Touch screen 
chambers were used over operant boxes to allow a more direct translation to human 
paradigms (as tested in CANTAB).  All sessions were completed in the afternoon.  
 Reversal learning paradigm 
Animals were habituated to the apparatus and the delivery of reward prior to stimuli 
presentation.  Liquid reward (10% sucrose solution) was used throughout the 
experiment.  The order of sessions and criteria for each session are listed in Table 
7.1. For a full description of conditions and trials see General Methods 2.3.2. 
Habituation and Must-Touch training were categorised as pre-training conditions, to 
familiarise rats with the apparatus and the required nose-poke of the touch screen to 
receive reward in the magazine.  In brief, during habituation a light was turned on 
coinciding with a tone and delivery of reward.  Animals were required to enter the 
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food tray to collect the reward and then exit to elicit the start of the next trial, with a 
5s inter-trial interval (ITI).  Once criteria were reached (Table 7.1) animals moved on 
to Must-Touch training, where they were required to nose-poke a stimulus (consisting 
of randomised white shapes on a black background) in favour of a blank screen to 
receive reward.  Animals progressed to Visual Discrimination once criteria 
performance was reached. Visual Discrimination and Reversal involved the 
distinction between two stimuli to receive reward (Figure 7.2).    
Table 7.1 Order of experimental conditions for Reversal Learning paradigm and criteria for 
each session. 
Experimental 
Condition 
Criterion 
Habituation 100 trials completed in 30 mins for 2 consecutive days 
Must-Touch training 100 trials with < 20 blank touches in 30 mins for 2 
consecutive days 
Visual Discrimination > 80% correct for 2 consecutive days 
Reversal > 80% correct for 2 consecutive days 
 
 
Figure 7.2 Schematic of trials used for Visual Discrimination and Reversal sessions for correct 
and incorrect responses.   
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 Analysis 
Chi-squared analysis of differences was used to establish whether there was a 
significant difference in completion rate between WT and HET animals across the 
whole task (defined as ability to successfully reach criteria in the Reversal stage) and 
for specific training phases. 
Number of sessions to reach criterion were recorded for each condition, to determine 
how quickly animals acquired the contingencies.  Animals were only included if they 
had reached criterion for that training phase.  Correct responses and number of errors 
for each session were recorded to establish performance across phases and 
perseveration.  Number of tray entries and beam breaks were used as a general 
measure of activity levels and interest in reward.  Student’s t-tests were used to 
compare mean values between WT and HET for each training phase.  One-tailed 
tests were applied where prior hypotheses indicated direction of effect. 
Latencies to respond to stimuli and latencies to collect reward were recorded to 
indicate speed of decision and association with reward.  Repeated measures ANOVA 
were conducted for latencies within each task phase to compare averages for the first 
and last session of each phase.  Due to low trial numbers in the first session following 
reversal, latencies were averaged across the first 3 sessions.  For consistency, this 
was also done for both “Visual discrimination” and “Late” reversal measurements.   
Where unequal variances were observed using Levene’s test, Greenhouse Geisser 
corrections were applied.  Normality of variables was assessed using Shapiro-Wilk’s 
tests.  Where significant statistics were observed a log10 transformation was 
conducted to produce a normal distribution.  Non-normal distributions were only 
observed for response latencies (where stated).  One outlier (defined as ± 2 standard 
deviations from the mean) was excluded from error rate analysis.    
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 Results 
The final experiment consisted of 120 sessions with 12 animals completing the full 
reversal paradigm.  All animals completed the Habituation phase of the paradigm, 
though 2 animals were unable to reach criteria for Must Touch phase.  21 animals 
reached criteria for Visual Discrimination though only 19 were able to return to chance 
level performance following reversal of contingencies.    
 Performance trajectory concurs with previous studies in Sprague Dawley rats 
Performance followed the expected trajectory as seen in previous reversal learning 
studies (Figure 7.3).  Performance on first “Visual discrimination” session was 
approximately 50%, increasing to 80% criteria level through the training phase. 
Following reversal of contingencies, performance dropped to significantly below 
chance (16.85%, t(20) = -10.835, P < 0.001) with no differences between genotypes 
(t(19) = 1.471, P = 0.158).   
This cohort of Sprague Dawley rats took more sessions to reach criteria than previous 
experiments have described in the same strain (Bussey et al., 2008), with an average 
of 25 sessions required to reach initial discrimination criteria and 41 sessions to reach 
reversal, compared to < 15 reported by Bussey et al.   They had comparable trial 
numbers to reach criterion, just performing fewer trials during each session.  
Importantly for subsequent analyses there were no differences in beam breaks or 
tray entries between WT and HET rats during pre-training (t(44) = -.783, P = 0.446 
and t(37.943) = 0.338, P = 0.810 respectively), nor in the overall number of trials 
completed between WT and HET animals during “Visual Discrimination” (t(21) = -
1.162, P = 0.258) or “Reversal” (t(19) = -1.007, P = 0.327); suggesting a sub-strain 
effect rather than a phenotype relevant to reduced expression of Cacna1c.   
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Figure 7.3 Performance by genotype across reversal learning. VD: Visual Discrimination; Rev: 
Reversal; First: First session of training phase; 50%: Session in which performance returns to 
approximately 50% following reversal. Criteria: Last session of training phase when 
determined criteria are reached. Expected reduced performance following reversal, with no 
differences between genotype.  
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 No effects of genotype on Habituation or Must Touch training stages  
7.3.2.1 Habituation 
Both genotypes successfully habituated to the testing chamber and the reward 
protocol, with no differences in number of sessions or trials to reach criteria (t(21) = -
0.249, P = .806 and t(21) = -7.86, P = 0.441 respectively: Figure 7.4 a and b). 
Repeated measures ANOVA comparing first and last session reward collection 
latency by genotype revealed a significant effect of session (F(1,21) = 15.837, P = 
0.001, ηp2 = 0.430) indicating a decrease in latency (Figure 7.4 c), with no effect of 
genotype (F(1,21) = 1.350, P = 0.258) or evidence of an interaction (F(1,21) = 1.275, 
P = 0.272); demonstrating both groups habituated to reward delivery and collection.  
All animals reached criterion and progressed to “Must Touch” phase of the task.  
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Figure 7.4 a) Sessions and b) Trials to criteria for WT and HET animals for “Habituation”.  
There was no difference between genotype for either measure; P > 0.05. c) Average reward 
collection latency for first and last sessions with habituation.  Significant reduction in latency 
with no differences observed between genotype or an interaction; P > 0.05. (WT: n = 13, HET: 
n = 12) 
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7.3.2.2 Must Touch  
Both groups were able to learn to nose-poke a stimulus in favour of a blank screen 
to receive reward.  There was no difference between genotypes in number of 
sessions or trials to reach criteria ((t(18.206) = 1.323, P = 0.202 and t(21) = -0.092, 
P = 0.928 respectively)(Figure 7.5 a and b).  The expected reduction in correct touch 
latency and reward collection latency between first and last sessions was observed 
(F(1,21) = 26.265, P < 0.001, ηp2 =  0.556, and F(1,21) = 28.648, P < 0.001, ηp2 = 
0.577 respectively), with no difference by genotype (F(1,21) = 0.006, P = 0.939) and 
no evidence of an interaction (F(1,21) = 0.042, P = 0.839; F(1,21) = 0.015, P = 
0.905)(Figure 7.5 c and d).  Two animals did not reach criteria (1 WT and 1 HET) and 
so did not progress to “Visual discrimination”.    
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Figure 7.5 a) Session and b) Trial numbers to criteria for Must Touch condition by genotype.  
There was no difference between WT and HET animals, P > 0.05. b) Latency for animals to 
make a correct choice by nose-poking the touch-screen from the start of the trial and c) latency 
to collect reward for the first and last sessions of Must Touch by genotype.  Significant 
reduction in latencies between sessions; P < 0.001 with no effect of genotype, P > 0.05. (WT: 
n = 12, HET: n = 11)  
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 Fewer HET animals return to chance level performance following reversal 
Of the 13 WT animals, 12 reached criteria for “Visual discrimination” (92%) and 9 of 
11 HETs (82%).  There was no significant difference in the proportion of completion 
between genotypes (χ(1) = 2.390, P = 0.122).  A total of 12 out of 23 rats completed 
the full reversal task.  Eight of those that completed were WT and 4 were HET. Test 
for equality of proportions across the whole task did not show a difference between 
genotypes (χ(1) = 2.112, P = 0.146).  Further analyses were conducted to compare 
the proportion of WT and HET animals that were able to complete the “Early” reversal 
stage, indicating a successful inhibition of response to prior contingency.  There was 
a trend towards fewer HETs completing this stage, with all 12 WT animals 
successfully completing, compared to 7 out of the 9 HET animals (78%) (χ(1) = 2.947, 
P = 0.086, Cramer’s V = 0.375) (Figure 7.6).  These results should be interpreted with 
caution due to the low number of animals in each group and the low minimum 
expected count for a chi-squared test (<5).  Fisher’s exact test reported a p value of 
0.17.  
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Figure 7.6 Completion rates (% of animals of each genotype) for each experimental condition 
from Must Touch to Reversal Criterion.  Trend towards fewer HET animals compared to WT 
completing Early rev stage of 50% performance levels following reversal.  + P < 0.10.      
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 Indication of fewer sessions required for HET animals to reach criteria in “Late” 
reversal 
Sessions to reach criteria were compared between genotypes for “Visual 
discrimination”, “Reversal” and “Early” and “Late” phase reversal separately (Figure 
7.7).  There was no difference between genotype in the number of sessions to reach 
criteria for “Visual Discrimination” (t(19) = -0.833, P = 0.415), though a trend towards 
fewer sessions to criteria in “Reversal” in HET animals (t(10) = -1.977, P = 0.076).  
Analysis of the two stages of reversal (Early and Late) indicate that this trend is likely 
driven by fewer sessions in those HET animals that complete the task, specifically in 
the “Late” reversal once performance has returned to chance level (t(10) = -2.202, P 
= 0.052). 
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Figure 7.7 Number of sessions to reach criteria for "Visual Discrimination" (Vis Disc) and 
"Reversal" for WT and HET animals. Early reversal refers to the number of sessions 
completed before performance returned to chance level following reversal.  Late reversal 
refers to the number of sessions to reach criteria once at chance level. Error bars are ± SEM.  
Labels inside bars are the number of animals included in each analysis. No significant 
differences between genotypes, though trends observed in reversal driven by fewer sessions 
to criteria in HETs during Late reversal. + P < 0.08.  
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Due to the trends observed, further analyses were conducted to compare “Early” 
reversal when separated by animals that completed or failed to complete the task.  A 
two x two ANOVA with genotype and completion as the fixed variables found a 
significant effect of completion (F(1,15) = 4.561, P = 0.050, ηp2 =  0.233), as well as 
a significant interaction between completion and genotype (F(1,15) = 6.266, P = 
0.024 ηp2 =  0.295).  Post-hoc student’s t-tests show greater sessions to chance 
required in HET animals that do not complete the task (t(5) = 2.104, P = 0.045, one-
tailed), whereas there is no significant difference between those that complete (Figure 
7.8).  Greater numbers are required for this comparison to be sufficiently powered.  
 
 
Figure 7.8 Sessions in Early reversal split by genotype and by reversal completion status.  
Animals that completed the full reversal task took fewer sessions to reach 50% performance 
than those that failed (F(1,15) = 4.561, P = 0.05).  Significant interaction between genotype 
and completion (F(1,15) = 6.266, P = 0.024). Post-hoc student’s t-test show a significant 
effect of genotype between animals that do not complete the task. * P < 0.05 
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 HET animals make an increased number of errors during early reversal 
 The number of errors were compared between WT and HET animals during “Visual 
discrimination”, “Early” and “Late” reversal phases.  A repeated measures ANOVA 
was conducted across phases for those animals that completed the full task. There 
was no effect of genotype (F(1,9) = 0.554, P = 0.476) or phase (F(2,18) = 1.348, P = 
0.285) but there was a significant interaction (F(2,18) = 4.946, P = 0.019, ηp2 =  0.355).  
Further post-hoc analyses to include all animals which completed each stage found 
there was no difference between the numbers of errors made during visual 
discrimination (t(21) = -0.001, P = 1).  HET animals made significantly more errors 
compared to WT during “Early” reversal (t(17) = 2.176, P = 0.044, d’ = 1.03), however 
there was a trend towards fewer errors made in “Late” reversal (t(9) = -2.005, P = 
0.076) (Figure 7.9).   
 
Figure 7.9 Number or errors made by WT and HET animals during "Visual Discrimination", 
"Early" and "Late" reversal. Error bars represent SEM, labels within bars refer to the number 
of animals included in each analysis.  Significantly more errors were made by HET animals 
during “Early” reversal with a trend towards fewer in “Late” reversal.  One animal was excluded 
from “Late” reversal analysis due to value being 2 sd above the mean. * P < 0.05, + P < 0.10    
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 HET animals respond faster to stimuli following reversal with no differences in 
reward collection 
There are no differences between WT and HET animals in response latency during 
“Visual discrimination”, though animals responded faster to stimuli during the last 
sessions of the phase (Figure 7.10).  A significant effect of session was observed 
(F(1,19) = 7.322, P = 0.014, ηp2 =  0.278, log10 transformed to normal distribution), 
with no effect of genotype (F(1,19) = 1.134, P = 0.300) or an interaction (F(1,19) = 
2.487, P = 0.131).  
During “Early” reversal HET animals respond significantly faster to stimuli 
presentation compared to WT.  Repeated measures ANOVA showed no effect of 
session (F(1,16) = 2.240, P = 0.154), but a significant effect of genotype (F(1,16) = 
10.921, P = 0.004, ηp2 =  0.406, log10 transformed to normal distribution). There was 
no evidence of an interaction (F(1,16) = 0.273, P = 0.608).  
During the “Late” reversal stage a significant effect of session was observed (F(1,10) 
= 9.421, P = 0.012 ηp2 =  0.485, log10 transformed to normal distribution), with faster 
responding seen at the end of the reversal phase.  HET animals appeared to respond 
faster to stimuli, however this was not supported statistically. There was no difference 
between genotype (F(1,10) = 2.770, P = 0.127) or evidence or an interaction (F(1,10) 
= 0.375, P = 0.554).   
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Figure 7.10 Response latencies for WT and HET animals compared at start and end of "Visual 
discrimination", "Early" and "Late" reversal. Latencies are averaged across the first 3 and last 
3 sessions of each phase respectively. Error bars are SEM.  Data presented has undergone 
a log10 transformation due to non-normal distribution. Significant effect of session in “Visual 
discrimination” and “Late” reversal and significantly faster responding in HET animals during 
“Early” reversal, P < 0.05.   
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There were no differences between genotype for reward collection latency during 
“Visual discrimination”, “Early” or “Late” reversal.  Repeated measures ANOVA 
showed an effect of session in “Visual discrimination (F(1,19) = 4.458, P = 0.048, ηp2 
=  0.19, log10 transformed to normal distribution) indicating faster reward collection 
at the end of the phase, though no effect of genotype (F(1,19) = 0.044, P = 0.836) or 
an interaction (F(1,19) = 0.000, P = 0.991).  No effects were observed during “Early” 
reversal for session (F(1,16) = 0.171, P = 0.684) or genotype (F(1,16) = 0.492, P = 
0.493) and there was no significant interaction (F(1,16) = 1.225, P = 0.285).  Similarly 
no effects were observed during “Late” reversal for session (F(1,10) = 0.621, P = 
0.449), or genotype (F(1,10) = 0.384, P = 0.550) and no evidence of an interaction 
(F(1,10) = 1.767, P = 0.213) (Figure 7.11).    
 
Figure 7.11 Reward Collection Latencies compared between WT and HET for "Visual 
Discrimination", “Early” and “Late” reversal.  Reduced latency to collect reward was observed 
during “Visual Discrimination” only (P < 0.05).  Latencies are averaged across the first 3 and 
last 3 sessions of each phase respectively. Error bars are SEM.  Data presented has 
undergone a log10 transformation due to non-normal distribution.  There was no significant 
difference between genotypes. P > 0.05.  
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 Discussion 
Cacna1c heterozygous knockout rats were compared to wildtypes during a 
touchscreen reward based reversal learning task.  Results indicate that reduced 
expression of Cacna1c has no effect on the acquisition of visual discrimination, 
implying no effects on basic learning of reward associations, motivation or motor 
function (Mar et al., 2014).  Altered behaviour was observed in HET animals 
specifically during the reversal learning stage indicative of behavioural inflexibility. 
Reduced expression of Cacna1c affects inhibition of responding to prior 
contingencies 
There was a trend towards fewer HET than WT rats completing the early stage of 
reversal to return to chance level performance.  Further investigation of this trend, 
with greater numbers of animals is needed to determine its significance.  HET animals 
that did return to chance levels made significantly more perseverative errors during 
this phase of the task and were faster to respond to stimuli than WT.  This indicates 
that the normal expression of Cacna1c is not required for the acquisition of initial 
novel stimulus-reward associations.  Behaviour associated with reduced expression 
instead indicates a specific impairment of the comparison and update of new 
information with existing representations, with a deficit in the appropriate inhibition of 
response to prior contingencies.   
These current findings provide further support for separable mechanisms underlying 
the acquisition of reward associations and their adaptation or reversal (Cools et al., 
2002; Chudasama and Robbins, 2003; Ghahremani et al., 2010).  Specific 
impairment observed in “Early” reversal concurs with findings in genetic knockout of 
other disease relevant genes having a role in behavioural flexibility.  Homozygous 
knockout mice for Dlg2 show similar increases in perseverative errors during early 
stages of reversal (Nithianantharajah et al., 2013).  Importantly, similar impairments 
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are consistently evident in patients with schizophrenia (Waltz and Gold, 2007a; 
Floresco et al., 2009; McKirdy et al., 2009; Culbreth et al., 2015). Patients are found 
to make increased perseverative errors and complete fewer reversal sessions than 
healthy controls in probabilistic reversal learning paradigms. The coherence of 
findings may suggest a convergence of risk gene related dysfunction on mechanisms 
of cognitive flexibility.     
Decreased reaction times in HET animals during the reversal phase suggest lack of 
inhibition may be due to a propensity to continue to favour habitual responding 
instead of goal-directed decision processing, though it should be noted that current 
work did not carry out specific tests for goal-directed/habitual responding, such as 
differential sensitivity to reinforce devaluation.  Dual-process theories of decision 
making indicate a competition that occurs between habitual and goal-directed 
responses, to maximise reward and minimise threat (Rangel et al., 2008); with goal-
directed seemingly flexible but slow and habitual rapid but inflexible (Keramati et al., 
2011).  For decision making to be optimal, the appropriate inhibitory control must be 
exerted over the rapid habitual responses when outcomes change (Eagle et al., 2008; 
Izquierdo and Jentsch, 2012).  Habitual responding is known to, in part, rely on 
glutamatergic projections from the infralimbic cortex to the dorsolateral striatum, with 
phasic dopamine signalling from the midbrain to areas of the striatum being 
necessary for the formation of stimulus-response associations (Redgrave et al., 
2010). In comparison, action-outcome associations underlying goal directed 
behaviour rely heavily on the associative loop, comprising of the dorsomedial striatum 
and areas of the paralimbic cortex (Lanciego et al., 2012).  Separate manipulation of 
tonic and phasic dopamine signalling to the nucleus accumbens has been found to 
selectively impair initial discrimination and response switching, with a disconnection 
of the mPFC leading to perseverative behaviour (Grace et al., 2007). Furthermore, 
tonic activity of dopamine neurons has been found to directly influence the 
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competition that occurs between response strategies by modulating the perceived 
cost of goal-directed behaviour (Keramati et al., 2011).   
Both genotypes are able to acquire the initial discrimination, indicated by successfully 
reaching criteria and a significant reduction in response latencies.  However, HET 
animals continue to respond faster than WT in early reversal with increased 
perseverative errors.  This pattern of behaviour is consistent with the suggestion that 
habitual decision processes are functional in the mutants; whereas there is an 
impairment in switching from habitual to goal-directed responding to match the 
requirements of the changing contingencies.  This could be a result of a deficit in the 
cost/benefit comparison required to facilitate an appropriate inhibitory control of 
habitual responding and allow a switch to goal-directed behaviour.   
People who carry the variant in Cacna1c associated with increased risk of 
schizophrenia have been found to show blunted reward responsiveness (Lancaster 
et al., 2014) and patients with schizophrenia are known to have increased synthesis 
of dopamine (Breier et al., 1997).  It is possible that reduced expression of Cacna1c 
leads to impairments in reward value representation through effects on tonic 
dopamine, modulating the perceived benefit of goal-directed behaviour and a 
perseveration of habitual responding.   
The neural circuitry implicated in this task is also known to have a role in emotion 
regulation (Bechara et al., 2000; Davidson et al., 2000).  Emotion regulation is a 
prominent symptom across psychiatric illness and is specifically evident in 
schizophrenia and bipolar disorder.  It is conceivable that dysfunction in HETs in 
regions involved in this reversal task, could also manifest in dysregulation of emotion 
regulation and may partly underlie the shared genetic risk that CACNA1C has with 
these disorders.      
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Reduced Cacna1c may facilitate learning of new contingencies in a subgroup of 
animals 
It appears that there was a subgroup of behaviourally distinct HET animals that were 
able to complete the reversal learning task.  These animals demonstrated faster 
acquisition of the new contingency and reduced response latencies compared to WT.    
Previous studies have observed a similar pattern of behaviour with lesions of the 
vmPFC and also acute moderate stress following successful visual discrimination 
(Graybeal et al., 2011).  It was found that lesioned animals were faster to acquire the 
reversed contingency and made fewer errors in late reversal than sham controls.  
Similar effects were observed following a forced swim test, however response 
latencies were increased.  The facilitation produced in late reversal with acute stress 
was prevented with local infusion of BDNF into the vmPFC.  Although the pattern of 
responding in stressed animals may differ in some respect from that seen in lesioned 
or HET animals completing the task, this study highlights the potential role 
dysregulated BDNF may have in the facilitation of reversal observed.  Given previous 
findings with these animals and evidence of reduced BDNF expression in conditional 
Cacna1c knockout mice (Lee et al., 2016), it would be pertinent to investigate these 
effects more fully, as well as determine the effects of manipulation of BDNF at 
different stages of reversal.   
Studies into the effects of stress on learning have shown that under stress people 
and animals utilise a simpler habit based approach rather than goal directed 
behaviour (Schwabe and Wolf, 2009; Braun and Hauber, 2013).    Although there 
appears to be a facilitation in later stages of reversal in those HET animals that are 
able to complete the task, response latencies still indicate a propensity for habit 
based responding rather than goal directed decision making. This highlights the 
potential value of future studies which aim to establish the effect of added stress on 
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specific learning behaviours in these animals, as well as manipulations of task 
difficulty (as in Dlg2 mice, Nithianantharajah et al., 2013).    
It could be the case that certain animals have developed a compensatory mechanism 
that does not rely on the presence of Cacna1c at normal expression levels and are 
therefore able to perform the task.  It is only when comparing the subtle aspects of 
latency that the sub-optimal nature of this strategy may be revealed.  The current task 
was not designed, nor is it sufficiently powered, to be able to investigate differences 
within HET animals, however future studies would look to determine potential 
environmental interactors that may influence these behaviours.   
Limitations and future directions 
The low completion rates in HETs, although a phenotype in itself, makes it difficult to 
compare the subtler effects which may exist on inhibitory learning.  Statistical 
analyses of these low numbers have questionable validity, with the results from chi 
squared tests with minimum expected values of less than 5 requiring further 
confirmation. As the experiment was terminated before all animals reached criteria, 
it is not possible to conclude whether animals are unable to reverse responses or if 
they are simply slower to acquire.   It may be the case that the task procedure was 
not optimised for Sprague Dawley rats. Previous studies have found reduced activity 
in Sprague Dawley animals, though comparison between Sprague Dawley and Long 
Evans strains in the touchscreen tasks have previously found no difference (Bussey 
et al., 2008).  Sprague Dawley animals are reported to have reduced visual acuity 
which may have also made the discrimination between squares and grid more difficult 
(Prusky, Harker, Douglas and Whishaw 2002).  Animals in this task performed fewer 
trials in individual sessions than previously reported (Bussey et al., 2008).  This may 
explain the greater number of sessions required to reach the criteria, which were 
originally set at 100 trials.  Stimulus choice and criteria may therefore need adjusting 
in future experiments to achieve greater completion rates.  A larger cohort of animals 
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is necessary, with optimised conditions, to ensure sufficient numbers reach criteria 
for more powerful analyses across the full course of the task. A greater completion 
rate would also allow a more formal interrogation of habitual responding in mutant 
animals, through an additional phase of reward devaluation, though this may require 
investigation in a separate cohort.      
The seeming existence of sub-groups of HET animals with opposing behavioural 
phenotypes indicates additional variables interacting with genotype.  The method of 
breeding these animals meant that pups may have been reared by a Cacna1c 
heterozygous mother, which may have had an additional effect on the pre and/or 
postnatal environment.  This will be discussed in more detail in the General 
Discussion, however it is worth noting that the HET animals that showed facilitation 
in late reversal were all born to a WT mother.  Potential parenting effects and the 
influence of stress already discussed, highlight the need to consider environmental 
interactors when making conclusions about the effect of chronic genetic knockdown.   
Future studies will need to discern the effects of reduced Cacna1c on specific aspects 
of dopamine signalling directly, to include tonic and phasic signalling and region 
specific analyses.  Dopamine levels could be inferred by indirect measurement of 
tyrosine hydroxylase or quantified directly by dialysis tubes implanted stereotaxically 
into regions of interest.  Determining the regulation of BDNF within more specific 
regions of the brain, particularly the PFC, would also be valuable to inform potential 
normalisation of behaviour.   
 Conclusions 
The normal expression of Cacna1c is required for the appropriate behavioural 
adaptation to changing reward contingencies in a translational touchscreen reversal 
learning task.  Behaviour is consistent with an inability to appropriately inhibit rapid 
habitual responding to optimise decision making processes. This supports the role 
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for Cacna1c in cognitive processes known to be impaired in patients with 
schizophrenia, as well as those relying on dopamine signalling in cortical-striatal 
neural circuits.  Species homology of the neural circuitry involved in this task and the 
utilisation of the touchscreen paradigm enhances translation to humans. These 
findings contribute to our understanding of how the CACNA1C gene may confer risk 
for psychiatric illness, by identifying effects on specific learning related mechanisms 
and cognitive flexibility in a reduced expression model. 
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8 RISK ASSOCIATED VARIATION IN CACNA1C IN 
HUMANS: EFFECTS ON GENE EXPRESSION AND 
REVERSAL LEARNING BEHAVIOUR 
 Introduction 
As previously discussed, common variation in CACNA1C is robustly associated with 
risk for multiple psychiatric disorders (e.g. Ripke et al., 2014).  Like many other SNPs 
found to be associated with schizophrenia, the risk variants rs1006737 and 
rs2007044 are not located in an exonic region (Ripke et al., 2014) but instead reside 
in the large intron 3 of the gene.  There is no evidence that these common variants 
lead to any changes in the sequence of the protein and at present their exact 
functional effects are still under debate.  It is important to discern the effect of these 
variants on biological mechanisms, in order to better understand their contribution to 
the pathology of schizophrenia and other psychiatric illnesses and to help guide the 
development of novel treatment targets.    
Two key approaches have been utilised to further understand the functional 
relevance of risk variants and how they may confer susceptibility to disease. First, the 
potential for SNPs to act as expression quantitative trait loci (eQTL) has been 
explored. EQTLs are genomic loci at which variation is found to affect transcript 
expression. Those loci found to affect expression of genes in close proximity (+/- 1 
MB) are termed cis-eQTLs and effects on gene expression outside this region are 
termed trans-eQTLs.  Typically, cis-eQTLs have a more pronounced effect on 
expression and are thought to more likely indicate a direct functional effect of variation 
on that specific gene (McKenzie et al., 2014).  Trans-eQTLs may reflect an indirect 
relationship between variant and expression, though may provide an insight into 
overlapping biological mechanisms where multiple genes are affected.       
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Secondly, associations between risk variants and specific behaviours have been 
investigated to identify endophenotypes which may better link risk to known biological 
mechanisms (Flint and Munafò, 2007).  Studies have explored multiple levels of 
endophenotype, to include cognitive function across multiple domains, brain imaging 
of structure and connectivity, and functional imaging to assess effects on neural 
activation (e.g. Zhang et al., 2012; Paulus et al., 2013; Lancaster et al., 2015).    
It has been repeatedly found that GWAS risk loci are enriched for eQTLs  (Nicolae et 
al., 2010; Richards et al., 2012) as well as cis-regulatory elements (CREs). Roussos 
et al., (2014) found that schizophrenia related SNPs were enriched for certain 
functional annotation categories, to include enhancers and promoter regions.  A 
specific investigation of CACNA1C found that the risk allele at rs1006737 is 
associated with decreased gene expression (P = 1.88 x 10-5) in post-mortem brain 
tissue and hiPSC-derived neurons. Using chromosome confirmation capture 
Roussos et al., further identified a 1.4 kb enhancer region within the risk loci that 
physically interacts with a proximal gene promoter.  This is supported by recent 
findings which examined the expression of CACNA1C in the superior temporal gyrus 
(STG) of post-mortem human brain tissue; with decreased expression observed in 
risk allele carriers (Eckart et al., 2016).  They further investigated the potential of 
transcript specific changes in expression, finding similar effects in all three different 
types of transcscript studied. Reduced expression has also been observed in the 
cerebellum of people carrying the risk allele at rs1006737 (Gershon et al., 2014) 
across multiple transcripts, though no effect was observed in the parietal cortex.  
In contrast, Bigos et al., (2010), found that the risk allele predicted increased 
CACNA1C expression in the dorsolateral prefrontal cortex (dPFC) of post-mortem 
brain samples.  However, the samples ranged from gestational week 14 through to 
old age, as well as including samples of Caucasian and African American origin, 
which may have confounded results.  Yoshimizu et al., (2014), similarly found an 
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increased expression of CACNA1C associated with the risk allele in functional 
induced neurons (iNs), in conjunction with an enhanced L-type calcium current 
density.  Cell lines were derived from both healthy controls and a mixed population 
of patients (including schizophrenia, bipolar and major depressive disorder), which 
could contribute to differences observed.  
Conflicting evidence of effects of rs1006737 on expression of CACNA1C suggests 
there may be brain region specific and potentially transcript specific regulation.  The 
online database BRAINEAC (www.braineac.org) provides expression data from the 
UK Brain Expression Consortium (UKBEC), across different regions of the brain and 
with multiple probe sets detecting different transcripts.  Gene expression can be 
stratified by risk SNP, both those located within or near the gene and those located 
elsewhere in the genome.  This database provides a useful tool for investigating 
changes in expression associated with risk variants across multiple brain regions in 
the same individuals, which previous studies did not fully achieve.  Effects on relevant 
downstream gene expression can further be interrogated to identify potential 
downstream biological mechanisms which are altered by risk variation.   
With the existing evidence of altered CACNA1C expression in risk allele carriers, it 
becomes more informative to investigate the associated effects on other 
endophenotypes including measures of behaviour in an attempt to determine the 
functional effects of such genetic variation on brain systems.  Associations with 
rs1006737 have been quite extensively studied across domains of cognition, to 
include verbal fluency, attention and memory, though evidence is conflicting on the 
effect of variation.    
Previous studies suggest an effect of the risk allele on working memory in healthy 
controls and patients (Zhang et al., 2012).  Using tasks aimed to measure 
interference control and goal maintenance (a spatial N-back and a dot pattern 
expectancy task), it was found that healthy risk allele carriers made more errors 
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compared to non-risk allele carriers.  This was consistent with findings in people with 
schizophrenia; interestingly, in people with bipolar disorder, those who carried the 
risk allele were found to make fewer errors on the tasks.  Further deficits have been 
observed in logical memory in patients (Hori et al., 2012) and verbal working memory 
in healthy controls (Dietsche et al., 2014).  In contrast, Rolstad et al., (2016) found no 
effects of the risk allele in CACNA1C across multiple domains of cognition.  The 
neuropsychological test battery was administered to assess performance on: 
memory/learning, speed/attention, executive function, verbal functioning and 
visuospatial function (see Sparding et al., 2015 for full description of battery).  Rolstad 
et al., found no association of genotype in CACNA1C with performance in any 
cognitive domain. 
Aside from type I and type II errors, these conflicting results could be due to common 
variation having effects on more specific aspects of cognition rather than resulting in 
a broad deficit.  Cognitive test batteries are more often designed to assess these 
broader deficits. In addition, it is likely to be combined genetic risk load, rather than 
an individual risk SNP, that results in the more profound deficits observed in people 
with psychiatric illness.  This would also explain differences observed between patient 
subgroups.  Identifying the subtle deficits associated with common variation and 
looking for a potential convergence, would help to identify molecular mechanisms 
and pathways which may be affected.    
To date, no study has looked at whether genotype at the relevant CACNA1C risk 
SNPs is associated with behaviour on a reversal learning task.  This task allows the 
investigation of not only associative learning and reward response, but allows the 
interrogation of behaviour flexibility, a cognitive domain known to be affected in 
individuals with schizophrenia (as discussed previously, Chapter 7, e.g. Floresco et 
al., 2009).  Previous studies have found an effect of rs1006737 on brain activation 
during reversal learning with enhanced amygdala activity seen in response to reward 
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in risk allele carriers (Wessa et al., 2010).  However, there has been no investigation 
into the potential effects on specific aspects of reversal learning.  
 Aims 
Interrogation of the online human tissue expression database BRAINEAC 
(www.braineac.org), aimed to identify whether risk variants in CACNA1C (rs1006737 
and rs2007044), known to be associated with psychiatric illness, are associated with 
changes in expression of CACNA1C. In light of previous findings with Cacna1c 
heterozygous knockout models, analyses additionally aimed to establish whether 
there are any effects of the risk alleles on the expression of specific BDNF transcripts.          
Further analyses aimed to determine whether these same risk variants in CACNA1C 
are able to predict performance on a probabilistic reversal learning task.  Behavioural 
and genotype data at specific loci was extracted from existing data in a cohort of 
healthy controls (Lancaster et al., 2015).  The number of risk alleles carried at 
rs1006737 and rs200747 were investigated for association with total performance on 
the task and performance following reversal.  
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 Methods and materials 
 Analysing gene expression associated with risk SNPs using BRAINEAC  
The BRAINEAC online database (www.braineac.org) is the product of the UK Brain 
Expression Consortium (UKBEC) which provides data on the regulation and 
alternative splicing of genes expressed in the human brain.  The current database 
includes samples from 134 brains from individuals with no evidence of 
neurodegenerative disorders.  Up to 10 regions of interest were collected from control 
individuals by both the Medical Research Council Sudden Death Brain and Tissue 
Bank, and the Sun Health Research Institute, to include: cerebellum (CRBL), 
hippocampus (HIPP), substantia nigra (SNIG), frontal cortex (FCTX), temporal cortex 
(TCTX), occipital cortex (OCTX), medulla (MEDU), putamen (PUTM), thalamus 
(THAL) and intralobular white matter (WHMT).  Of the 134 samples 102 were male, 
with a mean age of 59 (16 – 102).  For full RNA extraction and genotyping methods 
used in producing this data, see www.braineac.org and for quality control parameters 
see Trabzuni et al., (2011).   
Using the online general user interface, the expression of CACNA1C and BDNF was 
stratified by rs1006737 and rs2007044 for each individual probe set available, across 
the 10 brain regions.  Where significant (P < 0.05) changes were observed, the probe 
set was cross-linked to the specific transcript/s which it identifies using Affymetrix – 
NetAffxTM Analysis Centre (www.affymetrix.com/analysis/index.affyx).  For BDNF this 
resulted in transcripts being separable by probes, allowing specific comparisons 
between them and for CACNA1C expression changes could be compared between 
sets of transcripts.  
 Acquisition of behavioural and genotype data for reversal learning analyses 
Novel analyses were conducted on behavioural and genetic data collected by 
Lancaster et al., (2015).   
225 
 
8.3.2.1 Probabilistic reversal learning behavioural task 
One hundred participants were recruited (aged 19 – 47) from staff and students at 
Cardiff University.  Ethical approval was given by the ethics committee of the School 
of Psychology and informed consent was obtained from each participant prior to the 
study.  Participants had no history of psychiatric illness (themselves or first degree 
relative) and did not report taking any psychotropic medication or illegal substances.  
A total of 84 participants (49 female) were used for analysis, after exclusion for quality 
control of genetic data and/or missing information.   
Participants were asked to make a choice between a blue and a green stimulus 
presented simultaneously (Figure 8.1).  A correct response was followed by a white 
‘smiley’ face and rewarded with a +1 p reward and an incorrect response was 
followed by a red ‘frowny’ face and a -1 p punishment.  Participants were told to 
maximise their ‘earnings’ throughout the task.  After 7 – 11 trials the contingencies 
were reversed and the previously rewarded stimuli was now punished.  There were 
12 reversal sessions in total (108 choice trials).  Each session consisted of 1 or 2 
‘probabilistic errors’ in which the correct response was punished to ensure sufficient 
difficulty in the task, as well as provide additional measures of behavioural flexibility.  
“Total Earnings” were calculated for each participant for the full task (in pence) based 
on the amount of rewards and punishments they received throughout.  Performance 
following the first contingency reversal was calculated as percentage correct for that 
session block – “Reversal Accuracy”.   
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Figure 8.1 Reversal learning paradigm. Participants were presented with a choice between 
blue or green squares.  Correct choices were rewarded with monetary winning and a white 
‘smiley’ face and incorrect responses with a red ‘frowny’ face and a monetary fine.  One or 
two probabilistic error trials were included within each session block in which the ‘correct’ 
response was punished.  There were 7 – 11 trials in each block before contingency reversal 
(Figure from Lancaster et al., 2016). 
8.3.2.2 DNA extraction and genotyping 
Samples of saliva were collected by Lancaster et al., from participants for genotyping 
using Oragene DNA (OG-500) kits (DNA Genotek Inc., Ottawa, Canada).  
Genotyping was conducted using a custom HumanCoreExome BeadChip Kit 
(Illumina, San Diego, USA) which included 570,038 variants.  Data was quality 
controlled in PLINK (whole genome data analysis toolset, (Purcell et al., 2007)).  
Participants were removed if data suggested non-European ancestry, ambiguity of 
sex, relation to other participants (through identity of descent) or incomplete 
genotyping <97%.  Genotypes were then imputed by estimating haplotypes using 
SHAPEIT and imputing genotypes from the reference set 1000 Genomes (December 
2013, release 1000 genomes haplotypes Phase 1 integrated variant set) using 
IMPUTE2 (Default parameters were used as detailed in Howie et al., 2009 & 
Delaneau et al., 2012). 
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For the purpose of the current analysis genotypes were extracted from the full SNP 
dataset for rs1006737 and rs200747 only.  
 Behavioural Analyses       
Performance was compared between risk allele and non-risk allele for rs1006737 and 
rs2007044 separately.  Total earnings (pence) and accuracy following reversal (%) 
were used as the dependent variables for analysis to provide measures of general 
performance on the task as well as behavioural flexibility.    
Student’s t-tests were conducted in IBM SPSS Statistics 20 to determine if there was 
an allelic association with performance; with the hypothesis that the risk allele would 
be associated with decreased performance.  Shapiro-Wilk and Levene’s statistics 
were used to test for normality and homogeneity of variance.   
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 Results  
 Risk associated variation in CACNA1C selectively reduces expression in the 
cerebellum 
The BRAINEAC human expression online database was interrogated to determine if 
schizophrenia risk variants in CACNA1C are associated with changes in expression.  
CACNA1C and BDNF were analysed from up to 10 brain regions across multiple 
transcripts.  Allele frequency at rs1006737 was A: 29.1% G: 70.9% and at rs2007044 
was G: 36.9% A: 63.1%, full genotype splits can be seen in Table 8.1. 
Table 8.1 Sample number for each genotype of rs1006737 and rs2007044.  Risk allele (A) 
frequency: 29.1% and (G) 36.9% respectively 
Rs1006737 Rs2007044 
Genotype N⁰ Genotype N⁰ 
AA  11 GG 17 
AG 56 GA 65 
GG 67 AA 52 
 
At a whole transcript level (using the winsorised mean across all probe-sets) there 
was a significant effect of genotype at both rs1006737 and rs2007044 on the 
expression of CACNA1C in the cerebellum (Figure 8.2: P = 8.5 x 10-7 and P = 6.1 x 
10-9 respectively).  There were 130 cerebellum samples included in the analysis. 
There was no effect of genotype on expression in any other brain region at this level 
(P = 0.16 – 0.87). 
Observations at individual probe-set level showed effects on expression in the 
cerebellum in 46 / 57 probe-sets (81%), though magnitude and significance levels 
varied.  Following previous work which showed different functionality of splice 
variants around exon 32 (Tang et al., 2004b), additional comparisons were made 
between probe sets that could distinguish between subsets of transcripts.  Probe set 
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3400895 and 3400898 distinguish between transcripts that contain or skip exon 32 
respectively.  Both sets showed significantly reduced expression of CACNA1C in the 
cerebellum in risk allele carriers, suggesting that effects are broad across different 
types of transcripts.   
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Figure 8.2 Box plots of expression changes in CACNA1C stratified by rs1006737 and 
rs2007044 across multiple brain regions.  Both risk SNPs are associated with reduced 
expression specifically in the cerebellum (outlined in red).  Figures adapted from 
www.braineac.org.   
231 
 
 Risk variants in CACNA1C are associated with region specific changes in BDNF 
The same risk variants were applied to stratify the expression levels of BDNF across 
different regions of the brain on the basis of CACNA1C genotype.  At the average 
transcript level (winsorised mean across probe sets) there is no effect of genotype at 
rs1006737 or rs2007044 on the expression of total BDNF in any brain region.   
The transcripts of BDNF are formed from the alternative splicing of unique 5’ exons 
(I – VIII) with a common protein coding 3’ exon IX.  Due to these structural features, 
the 17 known human transcripts can be separately targeted by different probe-sets 
to the individual 5’ exons, in addition to a global measure of BDNF mRNA with probes 
targeting the protein coding exon IX (Pruunsild et al., 2007). 
Probe sets that identified exon IX (affymetrix exprID: 336247 & 336244; detecting all 
transcripts of BDNF) show a significant association of BDNF expression in the 
substantia nigra dopaminergic regions, with genotype at rs1006737 and rs2007044 
(Figure 8.3).  Both CACNA1C risk alleles are associated with decreased expression 
of global levels of BDNF in this specific brain region (P = 0.011 and P = 0.002 
respectively), with no effects observed elsewhere.   
Further analyses were focussed on exons 1, 2, 4 and 6 as BDNFI, II, IV and VI 
transcripts are most highly expressed in neurons (Rousseaud et al., 2015). Probe 
sets specific to exon 1 (affymetrix exprID: 336274) revealed an association between 
BDNF expression and genotype at rs1006737 (P = 0.013).  The risk allele is 
associated with increased expression of BDNFI specifically in the hippocampus 
(Figure 8.4a).  Exon two specific probe-sets show a similar association between risk 
allele and BDNF expression in the hippocampus (affymetrix exprID: 336273; HIPP: 
P = 0.011), with an additional effect in the frontal cortex (FCTX: P = 0.007) with the 
risk allele at rs1006737 associated with decreased BDNFIIa, BDNFIIb and BDNFIIc 
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(Figure 8.4).  There was no indication of effects of genotype on BDNFIV or BDNFVI 
expression levels. 
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Figure 8.3 Expression levels of BDNF exon IX (affymetrix exprID: 336247; present in all 
transcripts) in substantia nigra (SNIG) stratified by genotype at rs1006737 and rs2007044.  
Risk allele is associated with decreased expression of BDNF in the substantia nigra.  Figure 
adapted from www.braineac.org. 
 
Figure 8.4 Expression levels of BDNF exon I and II stratified by rs1006737. a) BDNFI - 
affymetrix exprID 336274: Increased expression in the hippocampus in risk allele carriers, P 
= 0.013. b) BDNFIIabc – affymetrix exprID 336273: Increased expression in the hippocampus 
(P = 0.011) and decreased expression in the frontal cortex (P = 0.007) in risk allele carriers.  
Figure adapted from www.braineac.org.    
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 Association of individual risk SNPs with reversal learning performance 
Data was analysed from healthy participants who completed a probabilistic reversal 
learning task and provided saliva samples for genotyping.   The effect of genotype at 
the two identified risk variants in CACNA1C (rs1006737 and rs2007044) on “Total 
Earnings” and “Reversal Accuracy” was explored.  Reversal accuracy was 
specifically investigated to correspond to the stage of this task most commonly found 
to be impaired in patients with schizophrenia (Waltz and Gold, 2007a; McKirdy et al., 
2009), as well as to most closely correspond to the stage at which deficits were 
observed in Cacna1c heterozygous knockout rats.   
A total of 84 participants were used for analysis of rs1006737.  There were 37 people 
who were non-risk homozygous (GG), 32 heterozygous (GA) and 15 risk 
homozygous (AA), giving a minor allele frequency of 37%. The variant is within Hardy 
Weinberg Equilibrium (χ(1) = 1.664, P = 0.20) Genotypes were missing for two of the 
participants for rs2007044, therefore a total of 82 were used for analysis. For 
rs2007044 there were 27 people who were non-risk homozygous (AA), 39 
heterozygous (AG) and 16 risk homozygous (GG) carriers, resulting in a minor allele 
frequency of 43%.  Analysis was conducted to determine whether there was an allelic 
association with performance during the first reversal and across the whole of the 
task.   
Total earnings on the task ranged from -12p to 50p and performance on first reversal 
ranged from 9.09% to 100%.  
 Schizophrenia risk variants are associated with accuracy of reversal learning  
The risk allele in both rs1006737 and rs2007044 was associated with fewer correct 
responses during the first reversal session (Figure 8.5).  Average performance 
associated with the risk allele (A) at rs1006737 was 64.08% (SEM = 2.66) compared 
to 71.27% (SEM = 1.90) associated with the non-risk allele (G); and at rs2007044 
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average performance associated with the risk allele (G) was 64.66% (SEM = 2.41) 
compared to 71.69% (SEM = 2.04).  Student’s t-tests between revealed a significant 
effect of risk allele at rs1006737 and rs2007044 with “Reversal Accuracy” (t(166) = -
2.242, P = 0.026 and t(165) = -2.230, P = 0.027 respectively).  
There were no significant effects of risk allele at rs1006737 (t(166) = -1.562, P = 
0.120) or rs2007044 on “Total Earnings” (t(165) = -1.122, P = 0.264)(Figure 8.6).  
 
 
Figure 8.5 Comparison of reversal accuracy following first reversal for risk and non-risk alleles 
at rs1006737 and rs2007044.  Risk allele was associated with significantly reduced 
performance compared to non-risk allele carriers.  Bars represent average % correct.  Error 
bars are SEM. *  P < 0.05. 
236 
 
 
Figure 8.6 Comparison of "Total Earnings" across the whole task in risk allele and non-risk 
allele carriers in rs1006737 and rs2007044.  There were no significant differences between 
risk and non-risk groups, P > 0.05. Bars represent average total earnings for each allele.  Error 
bars are SEM.  
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 Discussion  
The results presented in this chapter demonstrate an effect of genotype at disease 
associated risk SNPs in CACNA1C on the expression of CACNA1C and transcripts 
of BDNF in healthy controls.  They further suggest an effect of risk allele on specific 
aspects of reversal learning that are associated with behavioural flexibility.  
 Risk variants are associated with decreased expression of CACNA1C and region 
specific regulation of BDNF 
Schizophrenia related risk alleles are associated with decreased expression of 
CACNA1C in the cerebellum of healthy controls and regulation of BDNF in the 
substantia nigra, hippocampus and frontal cortex.  Decreased expression of 
CACNA1C is in line with some previous findings (Gershon et al., 2013; Eckart et al., 
2016), though effects here were only observed in the cerebellum.  Functional 
implications of the risk associated SNP on the expression of CACNA1C highlight the 
importance of understanding the role of this gene in disease relevant behaviours.  
Previous studies have suggested a key role for the cerebellum in reversal learning.  
Patients with focal vascular lesions of the cerebellum were found to have specific 
deficits in reward based reversal learning (Thoma et al., 2008) and imaging studies 
have indicated activation of the cerebellum in response to unpredicted rewards and 
an association with prediction error (Ramnania et al., 2004).  These suggest that the 
mechanism associating reduced expression in the cerebellum with deficits in reversal 
learning is worth further investigation.  Region specificity of decreases and evidence 
of increases elsewhere (Bigos et al., 2010; Yoshimizu et al., 2014) suggests that it 
may be the dysregulation of this gene rather than a loss or gain of function that leads 
to impairments.  Therefore, it is important to understand effects on convergent 
downstream mechanisms and where/when they may be relevant.  The data 
presented only relates to basal resting conditions, therefore it is possible that the full 
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consequences of expression dysregulation may only be observed during evoked 
behaviour.  
These are the first analyses to identify expression changes in a relevant downstream 
gene associated with the risk SNP in CACNA1C.  Changes in expression of BDNF 
provide an indication of the pathways which may be affected by risk variation at this 
locus.  The most consistent finding across risk SNPs was the reduction of BDNFIX in 
the substantia nigra in risk allele carriers.  Alterations of activation in people with 
schizophrenia in the substantia nigra and ventral tegmental area have been observed 
in relation to reward processing (Murray et al., 2008b).  Additionally, structural 
changes in the substantia nigra have been identified in patients with schizophrenia, 
with reduced synaptic terminal size reported (Kolomeets and Uranova, 1999).  The 
substantia nigra is known to play a role in movement and reward processing, 
particularly through the dopaminergic input to the striatum (Schultz, 2000; Howe and 
Dombeck, 2016).  BDNF has been reported to be important for promoting the survival 
of dopaminergic neurons in this region (Hyman et al., 1991) and for regulating the 
normal expression of the D3 receptor (Guillin et al., 2001).  Reduced BDNF in the 
substantia nigra and behaviour known to recruit the same region, appear to be 
associated with an increased risk of schizophrenia.  This could provide a mechanistic 
link between common genetic risk and observed endophenotypes.   It further provides 
a viable link between common risk SNPs in CACNA1C and the well-supported 
“dopamine hypothesis” of schizophrenia. 
Transcript specific regulation of BDNF in distinct brain regions, implicates a more 
finely tuned effect of risk variation.  Different transcripts have different temporal and 
spatial properties in basal and activated conditions, with transcripts I and IV reported 
to be more activity dependent (Zheng et al., 2012). BDNFIX and BDNFIV specifically 
have been found to be increased in the hippocampus following associative learning 
paradigms (Hall et al., 2000; Rattiner et al., 2004; Zheng et al., 2012).  Furthermore, 
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selective inhibition of activity dependent BDNF in the CA1 region of the hippocampus 
has been previously found to impair performance on tasks requiring behavioural 
flexibility, while keeping other forms of learning intact (Sakata et al., 2013).  It is 
therefore plausible that changes in expression level of activity regulated transcripts 
in the hippocampus of risk allele carriers could have an effect on similar learning 
mechanisms in reversal learning.  Further investigation of activity regulated effects 
on expression and behaviour in reduced expression models of CACNA1C would help 
to understand these effects.   
These analyses do not provide a causative link between risk in CACNA1C and 
specific changes in BDNF expression associated with behavioural deficits.  They do, 
however, provide a putative mechanism through which a single risk SNP acting as a 
cis-eQTL, affects downstream gene expression of another gene, having multiple 
distinct effects on different regions of the brain. This, in combination with other risk 
variations, may be part of a core set of neurobiological features which affect distinct 
behaviours associated with schizophrenia.  
 Risk allele carriers show impaired reversal learning performance 
It was found that the risk allele at both variants was associated with fewer correct 
responses following the first reversal of contingency in a probabilistic reversal 
learning task.  This contrast measures participants’ behavioural flexibility. Results 
suggest that the risk variant may be affecting molecular mechanisms that are 
important for the comparison and update of existing information to inform subsequent 
behaviour.  Impairment in different forms of behavioural flexibility is reliably observed 
in patients with schizophrenia (Murray et al., 2008a; Floresco et al., 2009; McKirdy et 
al., 2009).  An fMRI study of patients found alterations in brain activation in regions 
linked to cognitive control in schizophrenia compared to controls (Culbreth et al., 
2015).  People with schizophrenia were found to achieve fewer reversals during a 
similar probabilistic reversal learning task, showing evidence of reduced behavioural 
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adaptation to incorrect responses.  The current results suggest cognitive control may 
be one feature of cognitive impairment to which risk variation in CACNA1C is 
contributing and may inform future investigation into molecular mechanisms 
underlying abnormalities observed in patients.    
A previous study found an association between rs1006737 and reward 
responsiveness, with risk allele carriers not acquiring a bias to an implicitly more 
commonly rewarded stimuli (Lancaster et al., 2014).  These effects suggest that 
differences in reward responsiveness could partially explain the results observed with 
the current analysis, rather than differences in reversal learning or behavioural 
flexibility per se.  However, as no effects were observed on performance across the 
full task, it can be assumed that participants in this study were able to acquire 
contingencies in this explicitly rewarded paradigm.  Rs1006737 has also been found 
to be associated with altered emotion responsiveness and recognition, processes 
known to require overlapping neural circuits with reversal learning (Bechara et al., 
2000).  It was reported that greater time was needed to recognise emotion in faces 
in healthy risk allele carriers (Nieratschker et al., 2015) and reduced activation has 
been observed in the ventrolateral PFC in bipolar risk allele carriers compared to 
relatives and controls (Jogia et al., 2011).   
The current results are in line with previous evidence suggesting genotype at 
rs1006737 is associated with deficits in learning and memory (Hori et al., 2012; Zhang 
et al., 2012; Dietsche et al., 2014); extending findings with verbal, logical and spatial 
learning to include reward based reversal.  In contrast, Rolstad et al., (2016) reported 
no effects of risk variants in CACNA1C or BDNF with cognition.  The current results 
concur with Rolstad et al., regarding performance across the whole task, with 
significant effects only seen when probing specific behaviours indicative of behaviour 
flexibility.  This highlights the need to explore specific aspects of behaviour in relation 
to common variation as well as broader deficits, to aid identification of 
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endophenotypes.  The pleiomorphic nature of schizophrenia, bipolar and other 
related psychiatric illnesses would support a subtler effect of common variation, 
potentially leading to a susceptibility rather than a clear deficit in cognition.       
Further analysis of the same participants in this study using fMRI imaging data, has 
revealed a significant negative association between schizophrenia risk profile scores 
and activation of fronto-striatal brain regions with choice behaviour on this reversal 
learning task (Lancaster et al., 2015).  Thus these common genetic variations may 
be associated with alterations in frontal-striatal networks that play a role in processing 
of reward contingencies and choice decision, but not to reward outcome.  The 
convergence of current findings with single risk SNPs and those seen with broader 
risk profile scores and patients, would support further investigation of the role of 
CACNA1C and associated downstream pathways. 
 Limitations and future directions 
Expression data are generated from post-mortem brain tissue and therefore cannot 
not convey test condition expression levels or changes which may be relevant for 
specific behaviours.  Considering the fact that BDNF has been identified as an activity 
regulated gene important for synaptic function (Lanahan and Worley, 1998), it could 
be the case that these differences become more profound following learning or that 
they extend to different transcripts. Further investigation in animal models would help 
to determine activity dependent regulation, which would be fundamental to 
understanding effects relevant for neuroplasticity and learning.    
It is worth noting that rs1006737 and rs2007044 are in high linkage disequilibrium 
(LD) with an r2 of 0.794.  Although not in complete LD, it is possible that they may be 
representing the same signal.  It is also not known whether either of the risk SNPs 
investigated are the functional variant or whether another risk SNP in LD may be 
causative of changes in expression and associated behavioural deficits.  Brief 
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analysis across other identified SNPs in CACNA1C related with psychiatric illness 
(Smoller et al., 2013) showed consistent effects on BDNF expression. Future 
analyses may look to establish any convergent effects of other risk variation on this 
pathway.      
 Conclusions 
Risk variation in CACNA1C has shared effects on the expression of CACNA1C and 
BDNF and performance in a reversal learning task.  The regulation of BDNF 
expression in specific brain regions, including the substantia nigra, may provide a 
molecular link between genetic risk for schizophrenia and phenotypes of behavioural 
flexibility that are known to rely on dopamine; as well as putatively link risk with well-
established dopamine dysregulation observed in patients.  Future studies need to 
establish whether there is a causal relationship, the effects of activity dependent 
regulation and investigate the potential for rescue of behavioural deficits in relevant 
animal models. 
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9    DISCUSSION 
L-type calcium channels and CACNA1C more specifically, have been reliably 
associated with risk for psychiatric illness.  Common variation in CACNA1C and other 
calcium channel subunits has been associated with increased risk for schizophrenia 
and bipolar disorder and there is an enrichment of rare deleterious mutations in L-
type calcium channel subunits (Purcell et al., 2014a; Ripke et al., 2014).  Calcium 
signalling is known to play a vital role in synaptic plasticity and learning and memory, 
and there appears to be a convergence of identified risk genes of schizophrenia on 
the synapse and associative learning (Harrison and Weinberger, 2005; Hall et al., 
2009, 2015; Pocklington et al., 2015). The specific role that LVGCCs and CACNA1C 
have in aspects of learning that are relevant for symptoms of psychiatric illness is yet 
to be fully elucidated.   
This thesis thus aimed to identify the role of LVGCCs and CACNA1C in specific 
aspects of associative learning.  In understanding the molecular mechanisms which 
may link genetic risk for schizophrenia and specific cognitive symptoms of illness, it 
is hoped that potential novel treatment targets may be identified.   
 Summary of findings 
 Selective role for LVGCCs and Cacna1c in specific aspects of associative and 
inhibitory learning 
Calcium influx through LVGCCS was found to have a specific role in the 
consolidation, extinction and latent inhibition of CFM.  Reduced Cacna1c expression 
using a newly characterised HET model impaired the latent inhibition of CFM and the 
inhibition of previously acquired reward associations in a reversal learning task.  This 
indicates a select role for LVGCCs in the appropriate formation and maintenance of 
CFM, with a distinct role for Cacna1c, and associated Cav1.2 channels, in inhibitory 
learning processes.   
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The investigation of expression of Cacna1c in a hippocampal-dependent CFC 
paradigm revealed activity-regulated gene expression related to specific 
experiences.  Following conditions in which associative learning is expected to occur, 
latent inhibition, consolidation and extinction, normal basal expression of Cacna1c 
was maintained in those regions associated with CFC.  In contrast, brief exposure to 
a novel or conditioned context, which does not support associative learning, was 
found to be associated with decreased expression of Cacna1c in the CA1 region of 
the hippocampus.  Activity-regulated expression of Cacna1c following specific 
associative learning events, implicates a role for this gene in the formation and 
maintenance of appropriate Pavlovian fear associations, though not in their 
recall/expression. 
The functional investigation of the role for calcium influx through LVGCCs was 
conducted using the same CFC paradigm.  Local inhibition of LVGCCs in the 
hippocampus via infusion of diltiazem was found to have a specific effect on the 
consolidation of CFM and the consolidation of extinction. These results concur with 
previous findings with local infusion in the basolateral amygdala (Davis and Bauer, 
2012), suggesting a conserved role for LVGCCs in the network of brain regions 
involved in CFC.  This was the first study to investigate the effect of local inhibition of 
LVGCCs on the latent inhibition of CFM.  Latent inhibition was found to be impaired 
following infusions of diltiazem, with strong associations formed to the context 
regardless of context pre-exposure. There were no effects of inhibiting calcium influx 
on the acquisition of CFM or on its recall. The lack of effects at recall corresponds to 
the decreased expression of Cacna1c observed in expression studies, supporting a 
limited role for calcium influx through these channels in related processes. Results 
suggest a specific role for LVGCCs in the hippocampus, in processes which utilise 
prediction error to signal learning and/or the appropriate update of existing 
representations.   
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Constitutively reduced expression of Cacna1c was found to have no effect on the 
acquisition or consolidation of reward or aversive associations.  Wild-type and 
knockout animals were able to successfully form associations between a novel 
context and a footshock during CFC and could learn to associate select visual stimuli 
with reward in a reversal learning task.  In contrast to hippocampal specific inhibition 
of LVGCCs, select deficits in these animals were only observed in relation to the 
latent inhibition of CFM.  This implies that the normal expression of Cacna1c is 
necessary for the inhibition of inappropriate aversive contextual association 
formation.  Whether this is driven by disrupted mechanisms in the hippocampus only, 
cannot be concluded from the current data.  However, the overlap with deficits 
observed with local inhibition of LVGCCs, would indicate at least a contributory role 
for Cav1.2 channels in the hippocampus.          
The different profile of deficits observed between local inhibition of LVGCCs and 
global genetic knockdown of Cacna1c during CFC, supports previous findings for 
distinct roles of Cav1.2 and Cav1.3 channels.  The different expression profiles (Hell 
et al., 1993; Leitch et al., 2009) and biophysical properties of Cav1.2 and Cav1.3 
channels (Catterall et al., 2005), suggest that subtypes have different functional roles.  
Previous investigations of knock-out mice have specified a role for Cav1.3 channels 
in the consolidation of CFM, with no effects on extinction (McKinney and Murphy, 
2006) and have suggested that Cav1.2 channels are not necessary for either 
consolidation or extinction (Mckinney et al., 2008).  The current results support this 
dissociation in the hippocampus, with consolidation more like to rely on calcium influx 
through Cav1.3 channels and a newly identified role for Cav1.2 in latent inhibition.  
The exact contribution of LVGCC subtypes to extinction is still yet to be fully 
determined.     
Effects of reduced expression on inhibitory learning in latent inhibition were found to 
translate to reward based reversal learning in the same rat model.  Reduced 
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expression of Cacna1c was found to lead to deficits in the inhibition of prior reward 
contingencies and behavioural flexibility.  Mutant animals showed difficulties in 
reversing responses to new contingencies, with greater perseverative errors 
observed in the early stage of reversal.  This suggests that normal expression of 
Cacna1c may be necessary for the comparison and update of new information with 
existing contingencies in an appetitive task, as was seen in aversive conditioning.  
Furthermore, results showed faster reaction times following reversal compared to 
wild-types, indicative of continued ‘over-trained’ responding, rather than appropriate 
activation of behavioural inhibition.     
Although results suggest effects of reduced expression on inhibitory learning across 
aversive and reward learning, there were no deficits observed in PPI of acoustic 
startle response.  This reflects the potential for distinct psychological functions and 
neural processes underlying latent inhibition and PPI.  Even though these two 
measures have been used previously as attentional models in relation to deficits in 
schizophrenia, previous studies have found separable effects of environmental 
manipulations.  Wilkinson et al. (1994), found that social isolation from rearing age in 
rats selectively disrupted PPI of the acoustic startle response, with no evidence of 
effects on latent inhibition.  It has been suggested that latent inhibition recruits 
associative processes, rather than the ‘sensory gating’ processes attributed to PPI.  
This further supports a selective role for Cacna1c in aspects of associative learning, 
rather than a broader role in attention-related processing.        
 Implicated downstream effects on BDNF and relation to the dopamine system   
Basal levels of BDNF were found to be decreased in the PFC in Cacna1c mutant 
rats.  Analysis of gene expression in humans, revealed similar dysregulation of BDNF 
associated with risk alleles in CACNA1C.  Additional experiments indicated an effect 
of intrahippocampal BDNF antisense on latent inhibition, as was observed with both 
LVGCC inhibition and with reduced expression of Cacna1c within this region.   
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Local infusion of BDNF antisense into the hippocampus, prior to extended pre-
exposure, resulted in abnormal CFC 24 hrs later, with an inappropriate association 
formed between the CS and the US.  This implicates BDNF expression in the same 
process which requires calcium influx through LVGCCs and the normal expression 
of Cacna1c; though this is not indicative of a direct functional relationship with the 
effects observed with diltiazem.  There is reliable evidence of activity-regulated 
expression of BDNF by calcium influx through LVGCCs (Tabuchi et al., 2000; Tao et 
al., 2002; Zheng et al., 2011, 2012), though this is the first evidence of their 
convergence on latent inhibition.   
Reduced expression of Cacna1c in rats was found to be associated with reduced 
expression of basal BDNF in the PFC and a trend towards an increase in expression 
in the dentate gyrus region of the hippocampus.  In humans, risk alleles in CACNA1C 
were associated with decreased expression in CACNA1C and a similar profile of 
expression changes in BDNF as observed in the rat, though with additional decreases 
observed in the substantia nigra.  In humans, there were changes in the expression 
of specific transcripts of BDNF. BDNFI was found to be increased in the 
hippocampus, whereas BDNFII was increased in the hippocampus and decreased in 
the PFC.  Total BDNF (BDNFIX) expression was found to be reduced in the 
substantia nigra in association with CACNA1C risk alleles. Although there was no 
change in basal protein expression of BDNF in rats, the change in BDNF mRNA 
observed suggests there may be transcript specific dysregulation of BDNF, related 
to a decrease in Cacna1c expression.  Further investigation is warranted to establish 
the effects of reduced Cacna1c expression on activity-regulated BDNF transcripts 
and protein expression.  
BDNF is highly expressed by dopaminergic neurons (Seroogy et al., 1994; Baquet et 
al., 2005).  It has been found to be a key regulator of the mesolimbic dopamine 
pathway, with activation of TrkB receptors promoting dopamine release in the nucleus 
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accumbens (Goggi et al., 2003). Evidence has found that BDNF released from 
dopamine neurons is responsible for normal expression of the dopamine D3 receptor 
in the nucleus accumbens (Guillin et al., 2001; Sokoloff et al., 2002).  Interestingly, 
dopamine D2/D3 receptors have been found to have a specific role in the reversal of 
reward associations in monkeys, with no effects on initial learning (Lee et al., 2007), 
as was observed in the Cacna1c knockout rats.  
The distinct deficits that were observed in Cacna1c knockout animals are in 
behaviours that are known to be dependent on dopamine signalling, specifically latent 
inhibition and reward learning (Young et al., 2005).  The mesolimbic dopamine 
pathway has a vital role in approach and avoidance behaviour.  Dopamine neurons 
in the ventral tegmental area (VTA) and their projections to the nucleus accumbens 
are necessary for animals to process emotionally salient stimuli and form 
associations to inform future behaviour (Wise, 2004; Schultz, 2006).  Although the 
current work did not directly measure the levels of dopamine in the brain of Cacna1c 
animals, behavioural deficits in these processes could indicate a downstream effect 
of reduced Cacna1c on dopamine signalling.    
The present data suggests that calcium channel manipulation may be having a 
downstream effect on dopamine pathways, with effects on similar behaviours.  
Furthermore, the effects on BDNF provide a direct molecular link between LVGCC 
and dopamine regulation, placing it within currently supported hypotheses of the 
etiology of schizophrenia.    
 Translation of findings to humans 
In addition to the effects on BDNF expression already discussed, similar impairments 
in reversal learning were observed in humans associated with risk alleles in 
CACNA1C. Risk alleles were found to be associated with decreased performance 
following the reversal of contingencies.  The same risk alleles were found to be 
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associated with decreased expression of CACNA1C in the cerebellum.  This 
demonstrates a translation of findings across species, identifying a disease relevant 
phenotype and further supports the use of rats with reduced expression of Cacna1c 
to investigate underlying molecular mechanisms.  
The use of the touchscreen reversal learning task in the rat studies allows greater 
translation between species, as similar tasks can be conducted in rodents and 
humans.  Importantly, touchscreen reversal learning is known to engage similar 
underlying neural networks in both rats and humans (Bussey et al., 2012).  Observing 
similar impairments associated with changes in CACNA1C expression, suggests that 
its role is conserved across species.  Importantly, the results in humans specifically 
provide an association with disease relevant variation.  The overlap of findings would 
indicate that it is likely an effect of the risk allele on CACNA1C expression that may 
be affecting the observed behaviours.   
Being able to translate animal findings to humans and specifically to disease relevant 
variations, is incredibly important for the ultimate goal of improving treatments.  
Understanding the role of Cacna1c in the rat in specific aspects of learning and 
memory, allows those behaviours to be specifically tested in humans.  The additional 
identification of molecular markers that are associated with dysfunction in both 
species, suggests that the mechanisms underlying impairments are conserved.  The 
dysregulation of BDNF associated with reduced CACNA1C expression in both rats 
and humans supports this conserved mechanism in relation to learning impairments.  
Further investigation in the rat model is necessary to fully understand these 
mechanisms, with the continued translation between rodent and human.  The 
identification of potential treatment targets in the rat would therefore more likely be 
relevant to the human disease state.   
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 Relation to symptoms of psychiatric illness 
Cognitive deficits are a key feature of multiple psychiatric illnesses (Millan et al., 
2012).  The deficits that these studies found to be associated with reduced Cacna1c 
expression are observed in patients with schizophrenia.  Deficits have been 
specifically reported in the reversal of reward discriminations (Crider, 1997; Waltz and 
Gold, 2007b; Reddy et al., 2016) and aspects of inhibitory associative learning 
(Swerdlow et al., 1996; Holt et al., 2009). The inability to ignore irrelevant stimuli, 
inhibit inappropriate behaviour or correctly compare and update representations, can 
be seen to manifest in other core symptoms of illness.  
Deficits in associative inhibitory learning can clearly be linked to the development of 
positive symptoms in schizophrenia and related psychiatric illnesses.  False beliefs 
and delusions are a key feature of psychosis and rely on the formation and 
persistence of beliefs, despite contrary evidence and experience (Coltheart, 2010).  
It has been theorised that these abnormal beliefs can arise from impairments in a 
prediction error signal (Fletcher and Frith, 2009), with evidence of disrupted 
processing seen in patients using fMRI (Corlett et al., 2007).  The deficits observed 
in latent inhibition indicate errors in the use of previous experience to predict current 
outcomes and the formation of inappropriate associations to irrelevant stimuli.  
Predictive value given to irrelevant stimuli can lead to multiple conflicting 
associations, which require an increasingly convoluted model and set of beliefs to 
make sense of.  This can lead to the resistant delusions that are evident in psychosis.  
Furthermore, beliefs and predictions about experiences influence how they are 
perceived.  Abnormalities in perception could further manifest in hallucinations and 
have reciprocal effects on beliefs.       
The appropriate adaptation and update of associations is vital for the regulation of 
emotional response and related approach or avoidance behaviour (Laviolette and 
Grace, 2006).  Emotion dysregulation is a key symptom observed in patients with 
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bipolar disorder, with both automatic and voluntary emotion regulation seemingly 
impaired (Phillips et al., 2008). Deficits in fear learning and the perseveration of 
reward associations, can lead to emotional valence being assigned and maintained 
to irrelevant stimuli.  This leads to emotion dysregulation and can lead to 
inappropriate reinforcement of behaviours.  Similar deficits in emotional associative 
learning can be seen to underlie addictive behaviour.  Appetitive associations can be 
formed with neutral/irrelevant environmental stimuli, which can trigger drug seeking 
behaviour.  Reduced behavioural flexibility can lead to perseverance of drug seeking, 
even in the absence of expected reward, leading to addiction (Laviolette and Grace, 
2006).   
The appropriate formation and regulation of fear associations is clearly also relevant 
for anxiety disorders, including post-traumatic stress disorder (PTSD).  The 
development of PTSD is not due to the experience of a traumatic event in itself, but 
due to a pathological memory of that event and associations which inappropriately 
trigger those memories (Rubin et al., 2008).  Inappropriate formation of threat 
associations can also be seen to underlie symptoms prevalent in generalised anxiety 
disorder.  Patients are found to have biased memory for aversive stimuli (Coles et al., 
2007).  Increased negative associations with irrelevant stimuli can easily lead to the 
characteristic feelings of being ‘on edge’ and a sense of dread, especially when 
experiences are not predictable.  Salience given to stimuli that would normally be 
perceived as irrelevant, could also lead to difficulties in concentration and attention.      
Given the overlap of genetic risk of CACNA1C with multiple disorders, it is 
unsurprising that the deficits observed in these studies could potentially manifest in 
a broad spectrum of symptoms which cross diagnostic boundaries.  CACNA1C is just 
one of many genes, across over 100 genetic loci, that has been associated with 
increased risk for schizophrenia (Ripke et al., 2014).  The role of this gene in 
associative learning indicates how changes in expression may contribute to 
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symptoms of disease.  The convergence of genetic risk on synaptic plasticity and 
calcium signalling more specifically, suggests that the combined polygenic burden 
could have a detrimental effect on these processes, contributing to symptom 
development.        
 Limitations 
 Behavioural paradigms 
The behavioural paradigms used in these studies are designed to assess different 
aspects of learning, though each method has limitations.  CFC is an inherently implicit 
task, which although great for discerning basic functional roles, may not be directly 
representative of the more cognitive decisions on behavioural control that may 
manifest in everyday life.  Single trial learning allows very precise manipulation and 
separation of underlying biological processes, which was necessary to discern the 
separable roles of LVGCCs.  However, it cannot be assumed these processes would 
completely translate to more complex situations, with multiple changing 
contingencies, more representative of learning in natural settings. 
The CFC experiments all compared behavioural effects between animals, rather than 
using a within-subjects design.  It is difficult to re-test associations in the same animal 
with different manipulations, without using multiple stimuli which may add increased 
variation and confound results.  It is therefore not possible to determine the strength 
of a latent inhibition effect in individual animals, rather only compare group effects 
using this method.  It has also been found that different strains of rat can respond 
differently during CFC (Graham et al., 2009), with Sprague Dawley rats found to 
freeze more in certain instances.  The current experiments are all comparing effects 
within strain and therefore this does not negate the differences observed, however it 
is worth considering for future experimental design.   
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Compared to CFC, behavioural measures during reversal learning primarily only 
become apparent when averaged across a large number of sessions.  This paradigm 
is very useful for determining effects on different psychological processes known to 
be engaged during certain stages of the paradigm, though it is less useful in 
separating out specific biological mechanisms.  It requires extended training periods 
and performance may have been influenced by additional variables, including 
hedonic/motivational factors (Mar et al., 2014).  There was no evidence of an overt 
difference in motivation, however, it is postulated that reward related behaviour can 
be separated into three psychological components; liking (hedonic), wanting 
(incentive salience) and learning (acquired predictive association to cues)(Berridge 
et al., 2009), which this paradigm is not specifically designed to delineate. The 
combined use of aversive, implicit and reward based instrumental learning go part 
way to addressing some of these limitations, with a convergence on inhibitory 
learning processes suggesting a shared phenotype.   
Although the touchscreen operant platform used in reversal allows greater translation 
between species, there are still necessary differences between tasks in rodents and 
humans; most evident in difficulty, instruction and motivation.  The human reversal 
paradigm had to employ probabilistic contingencies in order for the task to be difficult 
enough to produce any divergence in behaviour, whereas the paradigm used in the 
rats had a simple correct/incorrect reward dichotomy.  Human participants were also 
working for a monetary reward, whereas the rats were responding to a desire for 
liquid reward following water deprivation, likely resulting in different motivational 
drives.  The convergence of findings across species supports shared mechanisms, 
however differences in behaviour should be interpreted with caution.  
 Pharmacological and genetic manipulations 
Both pharmacological and genetic approaches to investigating gene function have 
limitations, however, by combining the two approaches they can complement one 
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another to address some of these issues.  Pharmacological inhibitors have different 
affinity to different channel subtypes and different activation states (Hockerman et al., 
1997).  It is therefore not possible to conclude the exact proportion of channels that 
are inhibited in vivo, during specific behavioural paradigms.  It is also possible that 
inhibitors can have off-target effects that may not be fully understood, with some 
LVGCC inhibitors being found to affect sodium, potassium and nicotinic acetylcholine 
receptors at high doses (Wheeler et al., 2006).  Acute, local pharmacological 
inhibition does allow the precise timing of inhibition that permits greater distinction 
between psychological processes.  Specific genetic knockdown of genes of interest 
is able to provide greater specificity over the cause of effect, however does have 
limitations relating to the separation of functional roles in related processes. It is not 
always possible to determine if impairments in two processes indicate a role for that 
gene in both, or that one may be a behavioural consequence of the other.  The 
combination of pharmacology and genetic approaches complement each other to 
partially address these limitations and makes convergent findings more reliable.    
The use of a chronic genetic knockdown model has additional limitations regarding a 
potential interaction with parent genotype in early life.  Some animals were bred to a 
wild-type mother with a mutant father and some to a mutant mother with a wild-type 
father.  It is possible that the pre-natal or post-natal environment provided by a mutant 
mother, could affect the development of the offspring, as well as interact with their 
genetic status.  It is well established that rearing behaviour and experience during 
development affects behaviour in later life (Würbel, 2001; Pryce and Feldon, 2003; 
Fone and Porkess, 2008; Lupien et al., 2009). The psychiatric illnesses to which 
CACAN1C has been associated are primarily developmental and therefore an effect 
on early life likely plays a vital role. The investigation of the effects of pre and post-
natal environment on adult behaviour was beyond the scope of this thesis, however 
future studies should look to investigate the potential interaction between genotype 
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of the pup, the mother and early environment.  Differences in maternal care have 
been found to affect the development of psychopathology (Champagne and Curley, 
2009).  Preliminary analyses comparing adult mutant and wild-type rats from different 
mothers has indicated a potential interaction affecting extinction behaviour and pre-
pulse inhibition, as well as a potential involvement in the differences observed in 
mutant animals in reversal learning.  There is no evidence of any imprinting of the 
Cacna1c gene in mice or humans that could have subsequently affected gene 
dosage in the mutant offspring (Falls et al., 1999) and results presented here 
regarding the expression of Cacna1c further negate a gene dosage effect.  Further 
investigation would be relevant to discern potential environmental and interaction 
effects that may be contributing to behavioural phenotypes.     
  “Modelling” schizophrenia 
It is worth emphasising that any animal model investigating the function of psychiatric 
risk associated genes is not a “model of psychiatric illness”.  Animal models rely on 
indexed behavioural measures to make inferences about symptoms which may be 
‘uniquely’ human. Single gene models cannot take into account the complex 
polygenic background in which specific risk variants occur, or the environmental 
factors which may contribute to symptom development.  They do allow the 
interrogation of the functional role of the gene that has been associated with risk for 
illness, contributing to our understanding of how alterations in function may manifest 
in specific symptoms.  Importantly, they also allow the investigation of related 
molecular processes that may be important for identifying novel treatment targets.  
Utilising translational approaches and aligning animal model findings with those 
observed with risk variation in humans, can help bridge the gap between gene 
function and disease mechanism.  
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 Future directions 
Given the convergence of findings on BDNF and previous implications of its 
regulation by calcium influx through LVGCCs (Tabuchi et al., 2000; West et al., 2001; 
Zheng et al., 2011), it would be pertinent to investigate activity-regulated expression 
of different BDNF transcripts in Cacna1c animals as well as protein.  The preferential 
regulation of BDNFI and BDNFIV by calcium influx through LVGCCs (Tabuchi et al., 
2000; Zheng et al., 2012) would suggest that these transcripts may be specifically 
reduced in the Cacna1c knockout model.  As these transcripts are known to be 
activity dependent (Aid et al., 2007), differences may only become apparent following 
activation.  Considering the specific role of Cacna1c observed in inhibitory learning 
processes, it would also be worth investigating the cleavage of BDNF and the relative 
ratio between proBDNF and its mature form in Cacna1c knockout animals.  The 
different forms of BDNF have been found to have opposing effects on synaptic 
plasticity in the hippocampus (Pang et al., 2004; Park and Poo, 2013) with mature 
BDNF activating the TrkB receptor and proBDNF activating p75 receptors and their 
different downstream effector mechanisms.  Activation of these receptors is thought 
to differentially promote LTP and LTD in the hippocampus (Woo et al., 2005).  Effects 
on the ratio of pro BDNF : mature BDNF in Cacna1c animals could provide a synaptic 
plasticity mechanism through which these channels are affecting inhibitory learning 
processes.  Previous studies have further observed differential methylation of the 
BDNF gene following different aspects of contextual fear conditioning (Lubin et al., 
2008; Mizuno et al., 2012).  It would therefore also be beneficial to determine whether 
there may be differential methylation of BDNF promoters in the Cacna1c knockout 
animals.  
Given the implication of a specific role for LVGCCs in the hippocampus in relation to 
learning, as well as activity regulated expression of Cacna1c in the dentate gyrus, it 
would be relevant to explore potential differences in neurogenesis in association with 
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reduced Cacna1c. A recent study reported enhanced cell death in young 
hippocampal neurons in forebrain specific Cav1.2 knockout mice (Lee et al., 2016).  
Effects on neurogenesis may provide a further mechanistic link between Cacna1c 
and deficits in hippocampal dependent inhibitory learning (Kempermann et al., 2015).  
As discussed, findings further indicate deficits in processes that are known to rely on 
dopamine signalling (Young et al., 2005), including specifically latent inhibition and 
reward reversal.  The role of dopamine in latent inhibition has been extensively 
studied in relation to schizophrenia (Gray et al., 1995a).  The administration of D-
amphetamine, an indirect dopamine agonist, abolishes the latent inhibition effect in 
rats (Weiner et al., 1984, 1988) and humans (Gray et al., 1992; Salgado et al., 2000).  
This affect has been found to be reversed by co-administration of antipsychotics, 
known to function as dopamine antagonists (Solomon et al., 1981; Warburton et al., 
1994).  Furthermore, association between a CS and US has been found to be 
associated with increased dopamine release in the nucleus accumbens, which is 
absent following pre-exposure and latent inhibition (Young et al., 1993, 2005).  It was 
therefore suggested that dopamine is important for controlling the salience of pre-
exposed stimuli and subsequent association formation.  The deficits observed with 
manipulation of LVGCCs are consistent with effects on this system in relation to latent 
inhibition. 
There is an established role for dopamine in reward learning, with dopamine neurons 
responding to reward presentation and being activated by cues predictive of reward 
(Mirenowicz and Schultz, 1996; Stuber et al., 2008).  Furthermore, it has been shown 
that dopamine responses correspond to prediction error, with increased levels to 
unexpected reward, rather than a general reward response (Waelti et al., 2001; Howe 
and Dombeck, 2016).  Alterations of dopamine have also been found to affect 
reversal learning behaviour (Izquierdo et al., 2006; Clarke et al., 2011; den Ouden et 
al., 2013; Costa et al., 2015), with specific effects observed during the reversal stage, 
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with increased perseverative behaviour, reflective of the current results in the 
Cacna1c knockout rats.  
It would be essential to measure dopamine levels in Cacna1c knockout rats, to 
determine whether reduced expression of Cacna1c has specific effects on dopamine 
levels and activity-dependent regulation.  This could initially be conducted by 
measuring the expression of tyrosine hydroxylase as a proxy measure, though 
quantification of dopamine using microdialysis would be optimal.  It would also be 
relevant to measure the functional link between calcium influx through LVGCCs, 
BDNF and dopamine in relation to latent inhibition.  
Observed reduced expression of BDNF in Cacna1c knockout animals suggests that 
it might be a promising downstream target for rescue of the specific deficits seen in 
learning.  A sphingosine-1 phosphate receptor modulator, Fingolimod, has been 
found to increase the levels of BDNF in the mouse brain (Deogracias et al., 2012).  
Preliminary experiments conducted have reproduced these findings in the Sprague 
Dawley rat brain, with acute intra-peritoneal injection of Fingolimod found to increase 
BDNF in both the hippocampus and PFC.  Future experiments aim to investigate the 
effect of administration of this drug on the deficits in latent inhibition, as well as other 
interventions known to modulate BDNF levels in the brain, such as environment 
enrichment and exercise (Sleiman et al., 2016).  
LVGCCs have been identified as promising therapeutic targets themselves, due to 
their selective pharmacological properties and are currently targeted with inhibitors 
for the treatment of angina and hypertension (Triggle, 2007).  There has been 
substantial investigation into the efficacy of LVGCC inhibitors for the treatment of 
symptoms of bipolar disorder (See Cipriani et al., 2016 for review). The results do not 
support a conclusive benefit for inhibitors in the treatment of mania and there appears 
to be significant side effects observed with manipulation of LVGCC function more 
broadly, including headaches, blood pressure and nausea (Caillard, 1985; 
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Silverstone and Birkett, 2000).  The upregulation of LVGCC expression has also been 
found to cause hypertrophy and eventual heart failure (Muth et al., 2001).   LVGCCs 
have high levels of peripheral expression which are likely driving a large proportion 
of side-effects observed and there are currently no brain isoform specific modulators 
of channel (Cipriani et al., 2016).  Targeting brain specific mechanisms which may be 
affected by abnormal LVGCC signalling, rather than LVGCCs themselves, could help 
bypass some of the issues of peripherally mediated side-effects.   
Preliminary data further suggests an interaction of parent genotype with subsequent 
adult genotype.  Therefore, future experiments should aim to investigate the effect of 
genetic knock-down of Cacna1c on rearing behaviour and potentially the prenatal 
environment of mothers.  This provides a direct investigation of the link between 
genetic and environmental effects of one gene associated with increased risk for 
schizophrenia.  It may also reveal further deficits in behaviours which may be 
predisposed by dysregulated Cacna1c expression, if not directly influenced, for 
example in PPI and extinction of CFM.  Cross-fostering experiments would also help 
to determine whether effects on the mother’s behaviour interact with genotype, as 
well as potentially identify an early intervention period.   
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 Conclusions 
L-type voltage gated calcium channels have a vital role in the consolidation and 
appropriate manipulation of contextual fear memory.  Cacna1c appears to have a 
selective role in aspects of inhibitory learning of both aversive and reward based 
associations, suggesting the inappropriate use of information to update 
representations and adapt behaviour.  Related behavioural deficits are found to be 
associated with disease relevant variation in human healthy controls.  Reduced 
expression of Cacna1c, in both rodents and humans, is associated with region 
specific changes in BDNF expression.         
Deficits observed are reflective of impaired psychologies which may underlie 
symptoms in patients with schizophrenia and other psychiatric illnesses.  The 
translation of research across species when considering inherently human disease, 
is vital in determining symptom relevant etiology.    The current findings contribute to 
our understanding of how genetic risk in CACNA1C may result in specific cognitive 
learning deficits.  Future studies should further explore transcript specific and learning 
regulated changes in BDNF expression in these models and investigate a causal link 
between CACNA1C, BDNF and dopamine, with the potential to rescue behavioural 
deficits by selective BDNF manipulation. 
  
261 
 
10  REFERENCES 
Adleman NE, Kayser R, Dickstein D, Blair RJR, Pine D, Leibenluft E (2011) Neural 
correlates of reversal learning in severe mood dysregulation and pediatric bipolar 
disorder. J Am Acad Child Adolesc Psychiatry 50:1173–1185. 
Aid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T (2007) Mouse and Rat BDNF 
Gene Structure and Expression Revisited. J Neurosci Res 85:525–535. 
Alvarez RP, Biggs A, Chen G, Pine DS, Grillon C (2008) Contextual fear conditioning 
in humans: cortical-hippocampal and amygdala contributions. J Neurosci 28:6211–
6219. 
Andreasen N (1982) Negative symptoms in schizophrenia: Definition and reliability. 
Arch Gen Psychiatry 39:784–788. 
Andreasen N, Arndt S, Alliger R, Miller D, Flaum M (1995) Symptoms of 
schizophrenia: Methods, meanings, and mechanisms. Arch Gen Psychiatry 52:341–
351. 
Andreasen N, Flaum M, Swayze V, Tyrrell G, Arndt S (1990) Positive and negative 
symptoms in schizophrenia: A critical reappraisal. Arch Gen Psychiatry 47:615–621. 
Andres M a., Cooke IM, Bellinger FP, Berry MJ, Zaporteza M, Rueli RH, Barayuga 
SM, Chang L (2015a) Methamphetamine acutely inhibits voltage-gated calcium 
channels but chronically upregulates L-type channels. J Neurochem:n/a-n/a. 
Andres M a., Cooke IM, Bellinger FP, Berry MJ, Zaporteza M, Rueli RH, Barayuga 
SM, Chang L (2015b) Methamphetamine acutely inhibits voltage-gated calcium 
channels but chronically upregulates L-type channels. J Neurochem 134:56–65. 
262 
 
Andronache Z, Ursu D, Lehnert S, Freichel M, Flockerzi V, Melzer W (2007) The 
auxiliary subunit gamma 1 of the skeletal muscle L-type Ca2+ channel is an 
endogenous Ca2+ antagonist. Proc Natl Acad Sci U S A 104:17885–17890. 
Baj G, Leone E, Chao M V., Tongiorgi E (2011) Spatial segregation of BDNF 
transcripts enables BDNF to differentially shape distinct dendritic compartments. 
Proc Natl Acad Sci 108:16813–16818. 
Balleine BW, O’Doherty JP (2010) Human and rodent homologies in action control: 
corticostriatal determinants of goal-directed and habitual action. 
Neuropsychopharmacology 35:48–69. 
Baquet ZC, Bickford PC, Jones KR (2005) Brain-Derived Neurotrophic Factor Is 
Required for the Establishment of the Proper Number of Dopaminergic Neurons in 
the Substantia Nigra Pars Compacta. J Neurosci  25:6251–6259. 
Barad M, Blouin AM, Cain CK (2004) Like extinction, latent inhibition of conditioned 
fear in mice is blocked by systemic inhibition of L-type voltage-gated calcium 
channels. Learn Mem 11:536–539. 
Barbado M, Fablet K, Ronjat M, De Waard M (2009) Gene regulation by voltage-
dependent calcium channels. Biochim Biophys Acta 1793:1096–1104. 
Barnes P, Thomas KL (2008) Proteolysis of proBDNF is a key regulator in the 
formation of memory. PLoS One 3. 
Barrett CF, Tsien RW (2008) The Timothy syndrome mutation differentially affects 
voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. 
Proc Natl Acad Sci U S A 105:2157–2162. 
Baruch I, Hemsley DR, Gray JA (1988) Latent inhibition and “psychotic proneness” 
in normal subjects. Pers Individ Dif 9:777–783. 
263 
 
Batuecas A, Pereira R, Centeno C, Pulido JA, Hernández M, Bollati A, Bogónez E, 
Satrústegui J (1998) Effects of chronic nimodipine on working memory of old rats in 
relation to defects in synaptosomal calcium homeostasis. Eur J Pharmacol 350:141–
150. 
Bauer EP, Schafe GE, LeDoux JE (2002) NMDA receptors and L-type voltage-gated 
calcium channels contribute to long-term potentiation and different components of 
fear memory formation in the lateral amygdala. J Neurosci 22:5239–5249. 
Bechara A, Damasio H, Damasio AR (2000) Emotion, decision making and the 
orbitofrontal cortex. Cereb Cortex 10:295–307. 
Bekinschtein P, Cammarota M, Igaz LM, Bevilaqua LRM, Izquierdo I, Medina JH 
(2007) Persistence of Long-Term Memory Storage Requires a Late Protein 
Synthesis- and BDNF- Dependent Phase in the Hippocampus. Neuron 53:261–277. 
Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo 
I, Medina JH (2008) BDNF is essential to promote persistence of long-term memory 
storage. Proc Natl Acad Sci U S A 105:2711–2716. 
Berger SM, Bartsch D (2014) The role of L-type voltage-gated calcium channels 
Cav1.2 and Cav1.3 in normal and pathological brain function. Cell Tissue Res 
357:463–476. 
Berridge KC, Robinson TE, Aldridge JW (2009) Dissecting components of reward: 
“liking”, “wanting”, and learning. Curr Opin Pharmacol 9:65–73. 
Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, 
homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517–529. 
Berrou L, Dodier Y, Raybaud A, Tousignant A, Dafi O, Pelletier JN, Parent L (2005) 
The C-terminal residues in the alpha-interacting domain (AID) helix anchor Cav?? 
subunit interaction and modulation of Cav2.3 channels. J Biol Chem 280:494–505. 
264 
 
Berrou L, Klein H, Bernatchez G, Parent L (2002) A specific tryptophan in the I-II 
linker is a key determinant of beta-subunit binding and modulation in Ca(V)2.3 
calcium channels. BiophysJ 83:1429–1442. 
Bhat S, Dao DT, Terrillion CE, Arad M, Smith RJ, Soldatov NM, Gould TD (2012) 
CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol 
99:1–14. 
Bibikova M, Beumer K, Trautman JK, Carroll D (2003) Enhancing gene targeting with 
designed zinc finger nucleases. Science 300:764. 
Bigos KL, Mattay VS, Callicott JH, Richard E, Vakkalanka R, Kolachana B, Thomas 
M, Lipska BK, Kleinman JE, Daniel R (2010) Genetic Variation in CACNA1C affects 
brain circuitries related to mental illness. Arch Gen Psychiatry 67:939–945. 
Binder DK, Scharfman HE (2004) Brain-derived neurotrophic factor. Growth Factors 
22:123–131. 
Black JL (2003) The Voltage-Gated Calcium Channel γ Subunits: A Review of the 
Literature. J Bioenerg Biomembr 35:649–660. 
Bleuler E (1950) Dementia Praecox or the Group of Schizophrenias (Zinkin JT, ed). 
New York: International University Press. 
Bliss T V, Collingridge GL (1993) A synaptic model of memory: long-term potentiation 
in the hippocampus. Nature 361:31–39. 
Bourne C et al. (2013) Neuropsychological testing of cognitive impairment in 
euthymic bipolar disorder: An individual patient data meta-analysis. Acta Psychiatr 
Scand 128:149–162. 
Bouton ME (1993) Context, time, and memory retrieval in the interference paradigms 
of Pavlovian learning. Psychol Bull 114:80–99. 
265 
 
Bouton ME (2004) Context and behavioral processes in extinction. Learn Mem 
11:485–494. 
Bouton ME, Westbrook RF, Corcoran KA, Maren S (2006) Contextual and Temporal 
Modulation of Extinction: Behavioral and Biological Mechanisms. Biol Psychiatry 
60:352–360. 
Brambilla P, Cerruti S, Bellani M, Perlini C, Ferro A, Marinelli V, Giusto D, Tomelleri 
L, Rambaldelli G, Tansella M, Diwadkar VA (2011) Shared impairment in associative 
learning in schizophrenia and bipolar disorder. Prog Neuro-Psychopharmacology Biol 
Psychiatry 35:1093–1099. 
Bramham CR, Messaoudi E (2005) BDNF function in adult synaptic plasticity: the 
synaptic consolidation hypothesis. Prog Neurobiol 76:99–125. 
Braun S, Hauber W (2013) Acute stressor effects on goal-directed action in rats. 
Learn Mem 20:700–709. 
Breier A, Su TP, Saunders R, Carson RE, Kolachana BS, de Bartolomeis A, 
Weinberger DR, Weisenfeld N, Malhotra AK, Eckelman WC, Pickar D (1997) 
Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine 
concentrations: evidence from a novel positron emission tomography method. Proc 
Natl Acad Sci U S A 94:2569–2574. 
Brigman JL, Feyder M, Saksida LM, Bussey TJ, Mishina M, Holmes A (2008) 
Impaired discrimination learning in mice lacking the NMDA receptor NR2A subunit. 
Learn Mem 15:50–54. 
Bryce CA, Howland JG (2015) Stress facilitates late reversal learning using a 
touchscreen-based visual discrimination procedure in male Long Evans rats. Behav 
Brain Res 278:21–28. 
266 
 
Buraei Z, Yang J (2010) The Beta Subunit of Voltage-Gated Calcium Channels. 
Physiol Rev 90:1461–1506. 
Busquet P, Hetzenauer A, Sinnegger-Brauns MJ, Striessnig J, Singewald N (2008) 
Role of L-type Ca2+ channel isoforms in the extinction of conditioned fear. Learn 
Mem 15:378–386. 
Bussey TJ, Holmes A, Lyon L, Mar AC, McAllister KAL, Nithianantharajah J, Oomen 
CA, Saksida LM (2012) New translational assays for preclinical modelling of cognition 
in schizophrenia: The touchscreen testing method for mice and rats. 
Neuropharmacology 62:1191–1203. 
Bussey TJ, Padain TL, Skillings E a, Winters BD, Morton  a J, Saksida LM (2008) 
The touchscreen cognitive testing method for rodents: how to get the best out of your 
rat. Learn Mem 15:516–523. 
Caillard V (1985) Treatment of Mania Using a Calcium Antagonist – Preliminary Trial. 
Neuropsychobiology 14:23–26. 
Cain CK, Blouin AM, Barad M (2002) L-type voltage-gated calcium channels are 
required for extinction, but not for acquisition or expression, of conditional fear in 
mice. J Neurosci 22:9113–9121. 
Cain CK, Godsil BP, Jami S, Barad M (2005) The L-type calcium channel blocker 
nifedipine impairs extinction, but not reduced contingency effects, in mice. Learn 
Mem 12:277–284. 
Calcagnetti DJ, Schechter MD (1992) Attenuation of drinking sweetened water 
following calcium channel blockade. Brain Res Bull 28:967–973. 
Calin-Jageman I, Lee A (2008) Ca(v)1 L-type Ca2+ channel signaling complexes in 
neurons. J Neurochem 105:573–583. 
267 
 
Cameron KN, Solis E, Ruchala I, De Felice LJ, Eltit JM (2015) Amphetamine activates 
calcium channels through dopamine transporter-mediated depolarization. Cell 
Calcium 58:457–466. 
Canti C, Davies A, Dolphin AC (2003) Calcium channel α2δ subunits - Structure, 
functions and target site for drugs. Curr Neuropharmacol 1:209–217. 
Cardno A, Gottesman I (2000) win studies of schizophrenia: from bow-and-arrow 
concordances to star wars Mx and functional genomics. Am J Med Genet 97:12–27. 
Casamassima F, Hay AC, Benedetti A, Lattanzi L, Cassano GB, Perlis RH (2010) L-
type calcium channels and psychiatric disorders: A brief review. Am J Med Genet B 
Neuropsychiatr Genet 153B:1373–1390. 
Castañé A, Theobald DEH, Robbins TW (2010) Selective lesions of the dorsomedial 
striatum impair serial spatial reversal learning in rats. Behav Brain Res 210:74–83. 
Catterall W a (2015) Voltage-Gated Calcium Channels. Perspect Biol. 
Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of 
Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-
gated calcium channels. Pharmacol Rev 57:411–425. 
Champagne F a, Curley JP (2009) Epigenetic mechanisms mediating the long-term 
effects of maternal care on development. Neurosci Biobehav Rev 33:593–600. 
Chang S, Fang K, Zhang K, Wang J (2015) Network-based analysis of schizophrenia 
genome-wide association data to detect the joint functional association signals. PLoS 
One 10:1–10. 
Chiaruttini C, Sonego M, Baj G, Simonato M, Tongiorgi E (2008) BDNF mRNA splice 
variants display activity-dependent targeting to distinct hippocampal laminae. Mol 
Cell Neurosci 37:11–19. 
268 
 
Chudasama Y, Robbins TW (2003) Dissociable contributions of the orbitofrontal and 
infralimbic cortex to pavlovian autoshaping and discrimination reversal learning: 
further evidence for the functional heterogeneity of the rodent frontal cortex. J 
Neurosci 23:8771–8780. 
Cipriani A, Saunders K, Attenburrow M-J, Stefaniak J, Panchal P, Stockton S, Lane 
TA, Tunbridge EM, Geddes JR, Harrison PJ (2016) A systematic review of calcium 
channel antagonists in bipolar disorder and some considerations for their future 
development. Mol Psychiatry 21:1–9. 
Clark L, Cools R, Robbins TW (2004) The neuropsychology of ventral prefrontal 
cortex: Decision-making and reversal learning. Brain Cogn 55:41–53. 
Clark NC, Nagano N, Kuenzi FM, Jarolimek W, Huber I, Walter D, Wietzorrek G, 
Boyce S, Kullmann DM, Striessnig J, Seabrook GR (2003) Neurological phenotype 
and synaptic function in mice lacking the Ca V1.3 ?? subunit of neuronal L-type 
voltage-dependent Ca 2+ channels. Neuroscience 120:435–442. 
Clarke HF, Hill GJ, Robbins TW, Roberts AC (2011) Dopamine, but not serotonin, 
regulates reversal learning in the marmoset caudate nucleus. J Neurosci 31:4290–
4297. 
Clarke HF, Robbins TW, Roberts AC (2008) Lesions of the medial striatum in 
monkeys produce perseverative impairments during reversal learning similar to those 
produced by lesions of the orbitofrontal cortex. J Neurosci 28:10972–10982. 
Clopath C (2012) Synaptic consolidation: An approach to long-term learning. Cogn 
Neurodyn 6:251–257. 
Cohen JD, Servan-schreiber D, Csernansky J, Horowitz L, King R, Kristoffersen T, 
Spiegel D, Targ E, Thei- S (1992) Context , Cortex , and Dopamine : A Connectionist 
Approach to Behavior and Biology in Schizophrenia. 99:45–77. 
269 
 
Coles ME, Turk CL, Heimberg RG (2007) Memory bias for threat in generalized 
anxiety disorder: the potential importance of stimulus relevance. Cogn Behav Ther 
36:65–73. 
Coltheart M (2010) The neuropsychology of delusions. Ann N Y Acad Sci 1191:16–
26. 
Cools R, Clark L, Owen AM, Robbins TW (2002) Defining the neural mechanisms of 
probabilistic reversal learning using event-related functional magnetic resonance 
imaging. J Neurosci 22:4563–4567. 
Corcoran K, Quirk G (2007) Recalling safety: cooperative functions of the 
ventromedial prefrontal cortex and the hippocampus in extinction. CNS Spectr. 
Corlett PR, Murray GK, Honey GD, Aitken MRF, Shanks DR, Robbins TW, Bullmore 
ET, Dickinson A, Fletcher PC (2007) Disrupted prediction-error signal in psychosis: 
Evidence for an associative account of delusions. Brain 130:2387–2400. 
Costa VD, Tran VL, Turchi J, Averbeck BB (2015) Reversal Learning and Dopamine: 
A Bayesian Perspective. J Neurosci 35:2407–2416. 
Craddock N, O’Donovan MC, Owen MJ (2009) Psychosis genetics: Modeling the 
relationship between schizophrenia, bipolar disorder and mixed (or “schizoaffective”) 
psychoses. Schizophr Bull 35:482–490. 
Crider  a (1997) Perseveration in schizophrenia. Schizophr Bull 23:63–74. 
Culbreth  a. J, Gold JM, Cools R, Barch DM (2015) Impaired Activation in Cognitive 
Control Regions Predicts Reversal Learning in Schizophrenia. Schizophr Bull:1–10. 
Cunha C, Brambilla R, Thomas KL (2010) A simple role for BDNF in learning and 
memory? Front Mol Neurosci 3:1–14. 
270 
 
Czerniawski J, Ree F, Chia C, Ramamoorthi K, Kumata Y, Otto T a (2011) The 
importance of having Arc: expression of the immediate-early gene Arc is required for 
hippocampus-dependent fear conditioning and blocked by NMDA receptor 
antagonism. J Neurosci 31:11200–11207. 
Dai S, Hall DD, Hell JW (2009) Supramolecular Assemblies and Localized Regulation 
of Voltage- Gated Ion Channels. Physiol Rev 89:411–452. 
Dalton GL, Wu DC, Wang YT, Floresco SB, Phillips AG (2012) NMDA GluN2A and 
GluN2B receptors play separate roles in the induction of LTP and LTD in the 
amygdala and in the acquisition and extinction of conditioned fear. 
Neuropharmacology 62:797–806. 
Dao DT, Mahon PB, Cai X, Kovacsics C, Blackwell RA, Arad M, Shi J, Zandi PP, 
Donnell PO, Potash JB, Gould TD (2010) Mood disorder susceptibility gene 
CACNA1C modifies moodrelated behaviors in mice and interacts with sex to 
influence behavior in mice and diagnosis in humans. 68:801–810. 
Daumas S, Halley H, Francés B, Lassalle J-M (2005) Encoding, consolidation, and 
retrieval of contextual memory: Differential involvement of dorsal CA3 and CA1 
hippocampal subregions. Learn Mem 12:375–382. 
Davidson RJ, Putnam KM, Larson CL (2000) Dysfunction in the neural circuitry of 
emotion regulation--a possible prelude to violence. Science 289:591–594. 
Davis SE, Bauer EP (2012) L-type voltage-gated calcium channels in the basolateral 
amygdala are necessary for fear extinction. J Neurosci 32:13582–13586. 
Degoulet M, Stelly CE, Ahn K-C, Morikawa H (2015) L-type Ca2+ channel blockade 
with antihypertensive medication disrupts VTA synaptic plasticity and drug-
associated contextual memory. Mol Psychiatry 21:1–9. 
271 
 
Delaneau O, Marchini J, Zagury J-F (2012) A linear complexity phasing method for 
thousands of genomes. Nat Methods 9:179–181. 
den Ouden HEM, Daw ND, Fernández G, Elshout JA, Rijpkema M, Hoogman M, 
Franke B, Cools R (2013) Dissociable Effects of Dopamine and Serotonin on 
Reversal Learning. Neuron 80:1090–1100. 
Deogracias R, Yazdani M, Dekkers MPJ, Guy J, Ionescu MCS, Vogt KE, Barde Y -a. 
(2012) Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF 
levels and improves symptoms of a mouse model of Rett syndrome. Proc Natl Acad 
Sci 109:14230–14235. 
Dere E, Pause BM, Pietrowsky R (2010) Emotion and episodic memory in 
neuropsychiatric disorders. Behav Brain Res 215:162–171. 
Desjardins P, Hansen JB, Allen M (2009) Microvolume protein concentration 
determination using the NanoDrop 2000c spectrophotometer. J Vis Exp:3–5. 
Dickinson A (2012) Associative learning and animal cognition. Philos Trans R Soc B 
Biol Sci 367:2733–2742. 
Dietsche B, Backes H, Laneri D, Weikert T, Witt SH, Rietschel M, Sommer J, Kircher 
T, Krug A (2014) The impact of a CACNA1C gene polymorphism on learning and 
hippocampal formation in healthy individuals: a diffusion tensor imaging study. 
Neuroimage 89:256–261. 
Dolmetsch RE, Pajvani U, Fife K, Spotts JM, Greenberg ME (2001) Signaling to the 
nucleus by an L-type calcium channel-calmodulin complex through the MAP kinase 
pathway. Science 294:333–339. 
Dolphin AC (2003) β Subunits of Voltage-Gated Calcium Channels. J Bioenerg 
Biomembr 35:599–620. 
272 
 
Dolphin AC (2012) Calcium channel auxiliary α2δ and β subunits: trafficking and one 
step beyond. Nat Rev Neurosci 13:542–555. 
Dolphin AC (2013) The alpha2delta subunits of voltage-gated calcium channels. 
Biochim Biophys Acta - Biomembr 1828:1541–1549. 
Drevets WC, Price JL, Simpson  Jr. JR, Todd RD, Reich T, Vannier M, Raichle ME 
(1997) Subgenual prefrontal cortex abnormalities in mood disorders. Nature 
386:824–827. 
Duman RS (2004) Neural plasticity: Consequences of stress and actions of 
antidepressant treatment. Dialogues Clin Neurosci 6:157–169. 
Eagle DM, Bari A, Robbins TW (2008) The neuropsychopharmacology of action 
inhibition: Cross-species translation of the stop-signal and go/no-go tasks. 
Psychopharmacology (Berl) 199:439–456. 
Eckart N, Song Q, Yang R, Wang R, Zhu H (2016) Functional Characterization of 
Schizophrenia- Associated Variation in CACNA1C. 
Eichenbaum H (2004) Hippocampus: Cognitive processes and neural 
representations that underlie declarative memory. Neuron 44:109–120. 
Elliott R, McKenna PJ, Robbins TW, Sahakian BJ (1995) Neuropsychological 
evidence for frontostriatal dysfunction in schizophrenia. Psychol Med 25:619–630. 
Erk S, Meyer-Lindenberg A, Schmierer P, Mohnke S, Grimm O, Garbusow M, 
Haddad L, Poehland L, Mühleisen TW, Witt SH, Tost H, Kirsch P, Romanczuk-
Seiferth N, Schott BH, Cichon S, Nöthen MM, Rietschel M, Heinz A, Walter H (2014) 
Hippocampal and frontolimbic function as intermediate phenotype for psychosis: 
evidence from healthy relatives and a common risk variant in CACNA1C. Biol 
Psychiatry 76:466–475. 
273 
 
Ertel EA, Campbell KP, Harpold MM, Hofmann F, Mori Y, Perez-Reyes E, Schwartz 
A, Snutch TP, Tanabe T, Birnbaumer L, Tsien RW, Catterall WA (2000) 
Nomenclature of voltage-gated calcium channels. Neuron 25:533–535. 
Escobar M, Oberling P, Miller RR (2002) Associative deficit accounts of disrupted 
latent inhibition and blocking in schizophrenia. Neurosci Biobehav Rev 26:203–216. 
Everitt BJ, Robbins TW (2005) Neural systems of reinforcement for drug addiction: 
from actions to habits to compulsion. Nat Neurosci 8:1481–1489. 
Falls JG, Pulford DJ, Wylie AA, Jirtle RL (1999) Genomic Imprinting : Implications for 
Human Disease. 154:635–647. 
Fanselow MS, Kim JJ (1994) Acquisition of contextual Pavlovian fear conditioning is 
blocked by application of an NMDA receptor antagonist D,L-2-amino-5-
phosphonovaleric acid to the basolateral amygdala. Behav Neurosci 108:210–212. 
Ferreira MAR et al. (2008) Collaborative genome-wide association analysis supports 
a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40:1056–1058. 
Fields RD, Eshete F, Stevens B, Itoh K (1997) Action potential-dependent regulation 
of gene expression: temporal specificity in ca2+, cAMP-responsive element binding 
proteins, and mitogen-activated protein kinase signaling. J Neurosci 17:7252–7266. 
Fletcher PC, Frith CD (2009) Perceiving is believing: a Bayesian approach to 
explaining the positive symptoms of schizophrenia. Nat Rev Neurosci 10:48–58. 
Flint J, Munafò MR (2007) The endophenotype concept in psychiatric genetics. 
Psychol Med 37:163–180. 
Floresco SB, Zhang Y, Enomoto T (2009) Neural circuits subserving behavioral 
flexibility and their relevance to schizophrenia. Behav Brain Res 204:396–409. 
274 
 
Fone KCF, Porkess MV (2008) Behavioural and neurochemical effects of post-
weaning social isolation in rodents—Relevance to developmental neuropsychiatric 
disorders. Neurosci Biobehav Rev 32:1087–1102. 
Freeze BS, Mcnulty MM, Hanck DA (2006) State-Dependent Verapamil Block of the 
Cloned Human Ca v 3 . 1 T-Type Ca 2+ Channel. Mol Pharmacol 70:718–726. 
Freir DB, Herron CE (2003) Inhibition of L-type voltage dependent calcium channels 
causes impairment of long-term potentiation in the hippocampal CA1 region in vivo. 
Brain Res 967:27–36. 
Frohardt RJ, Guarraci F a, Bouton ME (2000) The effects of neurotoxic hippocampal 
lesions on two effects of context after fear extinction. Behav Neurosci 114:227–240. 
Fromer M et al. (2014) De novo mutations in schizophrenia implicate synaptic 
networks. Nature. 
Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski 
JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW 
(2009) Correlates of cognitive impairment in first episode schizophrenia: The 
EUFEST study. Schizophr Res 115:104–114. 
Gallistel CR, Gibbon J (2000) Time, rate, and conditioning. Psychol Rev 107:289–
344. 
Ganguly K, Schinder AF, Wong ST, Poo M ming (2001) GABA itself promotes the 
developmental switch of neuronal GABAergic responses from excitation to inhibition. 
Cell 105:521–532. 
Gershon ES, Grennan K, Busnello J, Badner J a, Ovsiew F, Memon S, Alliey-
Rodriguez N, Cooper J, Romanos B, Liu C (2013) A rare mutation of CACNA1C in a 
patient with bipolar disorder, and decreased gene expression associated with a 
bipolar-associated common SNP of CACNA1C in brain. Mol Psychiatry:1–5. 
275 
 
Gershon ES, Grennan K, Busnello J, Badner J a, Ovsiew F, Memon S, Alliey-
Rodriguez N, Cooper J, Romanos B, Liu C (2014) A rare mutation of CACNA1C in a 
patient with bipolar disorder, and decreased gene expression associated with a 
bipolar-associated common SNP of CACNA1C in brain. Mol Psychiatry 19:890–894. 
Ghahremani DG, Monterosso J, Jentsch JD, Bilder RM, Poldrack RA (2010) Neural 
components underlying behavioral flexibility in human reversal learning. Cereb 
Cortex 20:1843–1852. 
Ghosh A, Carnahan J, Greenberg M (1994) Requirement for BDNF in activity-
dependent survival of cortical neurons. Science (80- ) 263:1618–1623. 
Gillis J, Burashnikov E, Antzelevitch C, Blaser S, Gross G, Turner L, Babul-Hirji R, 
Chitayat D (2011) Long QT, Syndactyly, Joint Contractures, Stroke andNovel 
CACNA1C Mutation: Expanding the Spectrum ofTimothy Syndrome. Am J Med 
Genet 158(A):182–187. 
Girirajan S, Dennis MY, Baker C, Malig M, Coe BP, Campbell CD, Mark K, Vu TH, 
Alkan C, Cheng Z, Biesecker LG, Bernier R, Eichler EE (2013) Refinement and 
discovery of new hotspots of copy-number variation associated with autism spectrum 
disorder. Am J Hum Genet 92:221–237. 
Goggi J, Pullar IA, Carney SL, Bradford HF (2003) Signalling pathways involved in 
the short-term potentiation of dopamine release by BDNF. Brain Res 968:156–161. 
Goldberg M, Mena I, Miller B (1999) Frontal and temporal lobe dysfunction in autism 
and other related disorders : ADHD and OCD. Alasbimn J. 
Gomez-Ospina N, Tsuruta F, Barreto-Chang O, Hu L, Dolmetsch R (2006) The C 
terminus of the L-type voltage-gated calcium channel Ca(V)1.2 encodes a 
transcription factor. Cell 127:591–606. 
276 
 
Goonasekera SA, Hammer K, Auger-messier M, Bodi I, Chen X, Zhang H, Reiken S, 
Elrod JW, Correll RN, York AJ, Sargent MA, Hofmann F, Moosmang S, Marks AR, 
Houser SR, Bers DM, Molkentin JD (2012) Decreased cardiac L-type Ca 2 + channel 
activity induces hypertrophy and heart failure in mice. J Clin Investig http//www.jci.org 
122. 
Gourley SL, Kedves AT, Olausson P, Taylor JR (2009) A History of Corticosterone 
Exposure Regulates Fear Extinction and Cortical NR2B, GluR2/3, and BDNF. 
Neuropsychopharmacology 34:707–716. 
Grace AA, Floresco SB, Goto Y, Lodge DJ (2007) Regulation of firing of dopaminergic 
neurons and control of goal-directed behaviors. Trends Neurosci. 
Gradin VB, Kumar P, Waiter G, Ahearn T, Stickle C, Milders M, Reid I, Hall J, Steele 
JD (2011) Expected value and prediction error abnormalities in depression and 
schizophrenia. Brain 134:1751–1764. 
Graef I a, Mermelstein PG, Stankunas K, Neilson JR, Deisseroth K, Tsien RW, 
Crabtree GR (1999) L-type calcium channels and GSK-3 regulate the activity of NF-
ATc4 in hippocampal neurons. Nature 401:703–708. 
Graham L, Yoon T, Lee H, Kim J (2009) Strain and sex differences in fear 
conditioning: 22 kHz ultrasonic vocalizations and freezing in rats. Psychol Neurosci 
2:219–225. 
Gray JA et al. (1995a) The role of mesolimbic dopaminergic and retrohippocampal 
afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia. 
Behav Brain Res 71:19–31. 
Gray NS, Pickering AD, Hemsley DR, Dawling S, Gray JA (1992) Abolition of latent 
inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology 
(Berl) 107:425–430. 
277 
 
Gray NS, Pilowsky LS, Gray JA, Kerwin RW (1995b) Latent inhibition in drug naive 
schizophrenics: relationship to duration of illness and dopamine D2 binding using 
SPET. Schizophr Res 17:95–107. 
Graybeal C, Feyder M, Schulman E, Saksida LM, Bussey TJ, Brigman JL, Holmes A 
(2011) Paradoxical reversal learning enhancement by stress or prefrontal cortical 
damage: rescue with BDNF. Nat Neurosci 14:1507–1509. 
Green EK, Grozeva D, Jones I, Jones L, Kirov G, Caesar S, Gordon-Smith K, Fraser 
C, Forty L, Russell E, Hamshere ML, Moskvina V, Nikolov I, Farmer  a, McGuffin P, 
Holmans P a, Owen MJ, O’Donovan MC, Craddock N (2009) The bipolar disorder 
risk allele at CACNA1C also confers risk of recurrent major depression and of 
schizophrenia. Mol Psychiatry:1–7. 
Green MF, Kern RS, Heaton RK (2004) Longitudinal studies of cognition and 
functional outcome in schizophrenia: Implications for MATRICS. Schizophr Res 
72:41–51. 
Guillin O, Diaz J, Carroll P, Griffon N, Schwartz JC, Sokoloff P (2001) BDNF controls 
dopamine D3 receptor expression and triggers behavioural sensitization. Nature 
411:86–89. 
Gurevich E, Bordelon Y, Shapiro R, Arnold S, Gur R, Joyce J (1997) Mesolimbic 
dopamine d3 receptors and use of antipsychotics in patients with schizophrenia: A 
postmortem study. Arch Gen Psychiatry 54:225–232. 
Guzowski JF, McNaughton BL, Barnes CA, Worley PF (1999) Environment-specific 
expression of the immediate-early gene Arc in hippocampal neuronal ensembles. Nat 
Neurosci 2:1120–1124. 
278 
 
Haber S. (2011) Neuroanatomy of Reward: A View from the Ventral Striatum. In: 
Neurobiology of Sensation and Reward (Gottfried JA, ed). Boca Raton (FL): CRC 
Press / Taylor and Francis. 
Hall J, Romaniuk L, McIntosh AM, Steele JD, Johnstone EC, Lawrie SM (2009) 
Associative learning and the genetics of schizophrenia. Trends Neurosci 32:359–
365. 
Hall J, Thomas KL, Everitt BJ (2000) Rapid and selective induction of BDNF 
expression in the hippocampus during contextual learning. Nat Neurosci 3:533–535. 
Hall J, Trent S, Thomas KL, O’Donovan MC, Owen MJ (2015) Genetic risk for 
schizophrenia: Convergence on synaptic pathways involved in plasticity. Biol 
Psychiatry 77:52–58. 
Hamshere ML et al. (2013) Genome-wide significant associations in schizophrenia to 
ITIH3/4, CACNA1C and SDCCAG8, and extensive replication of associations 
reported by the Schizophrenia PGC. Mol Psychiatry 18:708–712. 
Hanslick JL, Lau K, Noguchi KK, Olney JW, Charles F, Mennerick S, Farber NB 
(2009) Dimethyl Sulfoxide (DMSO) Produces Widespread Apoptosis in the 
Developing Central Nervous System. Neurobiol Dis 34:1–10. 
Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and 
neuropathology: on the matter of their convergence. Mol Psychiatry 10:40–68; image 
5. 
He K, An Z, Wang Q, Li T, Li Z, Chen J, Li W, Wang T, Ji J, Feng G, Lin H, Yi Q, Shi 
Y (2014) CACNA1C, schizophrenia and major depressive disorder in the Han 
Chinese population. Br J Psychiatry 204:36–39. 
Heckers S (2001) Neuroimaging Studies of the Hippocampus in Schizophrenia. 
528:520–528. 
279 
 
Hell JW, Westenbroek R, Warner C, Ahlijanian M, Prystay W, Gilbert M, Snutch T, 
Catterall W (1993) Identification and Differential Subcellular Localization of the 
Neuronal Class C and Class D L-Type Calcium Channel alpha1 Subunits. J Cell Biol 
123:949–962. 
Hernandez-Lopez S, Bargas J, Surmeier DJ, Reyes A, Galarraga E (1997) D1 
receptor activation enhances evoked discharge in neostriatal medium spiny neurons 
by modulating an L-type Ca2+ conductance. J Neurosci 17:3334–3342. 
Herry C, Ferraguti F, Singewald N, Letzkus JJ, Ehrlich I, L??thi A (2010) Neuronal 
circuits of fear extinction. Eur J Neurosci 31:599–612. 
Hertzberg L, Katsel P, Roussos P, Haroutunian V, Domany E (2015) Integration of 
gene expression and GWAS results supports involvement of calcium signaling in 
Schizophrenia. Schizophr Res:1–8. 
Herzig S, Lullmann H, Sieg H (1992) Frequency and potential dependency of the 
negatice inotropic action of various dihydropyridine and non-dihydropyridine calcium 
antagonists. Pharmacol Toxicol 71:229–235. 
Heyes S, Pratt WS, Rees E, Dahimene S, Ferron L, Owen MJ, Dolphin AC (2015) 
Genetic disruption of voltage-gated calcium channels in psychiatric and neurological 
disorders. Prog Neurobiol 134:36–54. 
Hirschhorn JN, Daly MJ (2005) Genome-wide association studies for common 
diseases and complex traits. Nat Rev Genet 6:95–108. 
Hockerman GH, Peterson BZ, Johnson BD, Catterall W a (1997) Molecular 
determinants of drug binding and action on L-type calcium channels. Annu Rev 
Pharmacol Toxicol 37:361–396. 
Holland PC, Bouton ME (1999) Hippocampus and context in classical conditioning. 
Curr Opin Neurobiol 9:195–202. 
280 
 
Holt D, Lebron-Milad K, Milad MR, Rauch SL, Pitman RK, Orr SP, Cassidy BS, Walsh 
JP, Goff DC (2009) Extinction memory is impaired in schizophrenia. Biol Psychiatry 
65:455–463. 
Holt DJ, Coombs G, Zeidan M a, Goff DC, Milad MR (2012) Failure of neural 
responses to safety cues in schizophrenia. Arch Gen Psychiatry 69:893–903. 
Hoppa MB, Lana B, Margas W, Dolphin AC, Ryan T (2012) alpha2delta expression 
sets presynaptic calcium channel abundance and release probability. Nature 
486:122–125. 
Hori H, Yamamoto N, Fujii T, Teraishi T, Sasayama D, Matsuo J, Kawamoto Y, 
Kinoshita Y, Ota M, Hattori K, Tatsumi M, Arima K, Kunugi H (2012) Effects of the 
CACNA1C risk allele on neurocognition in patients with schizophrenia and healthy 
individuals. Sci Rep 2:1–6. 
Howe MW, Dombeck DA (2016) Rapid signalling in distinct dopaminergic axons 
during locomotion and reward. Nature 535:505–510. 
Howie BN, Donnelly P, Marchini J (2009) A flexible and accurate genotype imputation 
method for the next generation of genome-wide association studies. PLoS Genet 5. 
Hudmon A, Schulman H, Kim J, Maltez JM, Tsien RW, Pitt GS (2005) CaMKII tethers 
to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ 
signals for facilitation. J Cell Biol 171:537–547. 
Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM 
(1991) BDNF is a neurotrophic factor of dopaminergic neurons of the substantia 
nigra. Nature 350:230–232. 
Iannaccone PM, Jacob HJ (2009) Rats! Dis Model Mech 2:206–210. 
281 
 
Igaz LM, Vianna MRM, Medina JH, Izquierdo I (2002) Two time periods of 
hippocampal mRNA synthesis are required for memory consolidation of fear-
motivated learning. J Neurosci 22:6781–6789. 
Imbrici P, Camerino DC, Tricarico D (2013) Major channels involved in 
neuropsychiatric disorders and therapeutic perspectives. Front Genet 4:76. 
Impey S, Mark M, Villacres EC, Poser S, Chavkin C, Storm DR (1996) Induction of 
CRE-mediated gene expression by stimuli that generate long-lasting ltp in area ca1 
of the hippocampus. Neuron 16:973–982. 
International Schizophrenia Consortium, Purcell SM, Wray NR, Stone JL, Visscher 
PM, O’Donovan MC, Sullivan PF, Sklar P (2009) Common polygenic variation 
contributes to risk of schizophrenia and bipolar disorder. Nature 460:748–752. 
Isokawa M (2012) Cellular signal mechanisms of reward-related plasticity in the 
hippocampus. Neural Plast 2012:945373. 
Izquierdo A, Jentsch JD (2012) Reversal learning as a measure of impulsive and 
compulsive behavior in addictions. Psychopharmacology (Berl) 219:607–620. 
Izquierdo A, Murray EA (2007) Selective Bilateral Amygdala Lesions in Rhesus 
Monkeys Fail to Disrupt Object Reversal Learning. J Neurosci 27:1054–1062. 
Izquierdo A, Wiedholz LM, Millstein RA, Yang RJ, Bussey TJ, Saksida LM, Holmes 
A (2006) Genetic and dopaminergic modulation of reversal learning in a touchscreen-
based operant procedure for mice. Behav Brain Res 171:181–188. 
Jensen J, Smith AJ, Willeit M, Crawley AP, Mikulis DJ, Vitcu I, Kapur S (2007) 
Separate brain regions code for salience vs. valence during reward prediction in 
humans. Hum Brain Mapp 28:294–302. 
282 
 
Jensen J, Willeit M, Zipursky RB, Savina I, Smith AJ, Menon M, Crawley AP, Kapur 
S (2008) The formation of abnormal associations in schizophrenia: neural and 
behavioral evidence. Neuropsychopharmacology 33:473–479. 
Jeon D, Kim S, Chetana M, Jo D, Ruley HE, Lin S-Y, Rabah D, Kinet J-P, Shin H-S 
(2010) Observational fear learning involves affective pain system and Cav1.2 Ca2+ 
channels in ACC. Nat Neurosci 13:482–488. 
Ji Y, Lu Y, Yang F, Shen W, Tang TT-T, Feng L, Duan S, Lu B (2010) Acute and 
gradual increases in BDNF concentration elicit distinct signaling and functions in 
neurons. Nat Neurosci 13:302–309. 
Jogia J, Ruberto G, Lelli-Chiesa G, Vassos E, Maierú M, Tatarelli R, Girardi P, Collier 
D, Frangou S (2011) The impact of the CACNA1C gene polymorphism on frontolimbic 
function in bipolar disorder. Mol Psychiatry 16:1070–1071. 
Jones SH, Gray JA, Hemsley DR (1992) Loss of the Kamin blocking effect in acute 
but not chronic schizophrenics. Biol Psychiatry 32:739–755. 
Kabir ZD, Lee AS, Rajadhyaksha AM (2016) L-type Ca(2+) channels in mood, 
cognition and addiction: Integrating human and rodent studies with a focus on 
behavioural endophenotypes. J Physiol 0:1–15. 
Kafitz KW, Rose CR, Thoenen H, Konnerth A (1999) Neurotrophin-evoked rapid 
excitation through TrkB receptors. Nature 401:918–921. 
Kanamori T, Kanai MI, Dairyo Y, Yasunaga K, Morikawa RK, Emoto K (2013) 
Compartmentalized Calcium Transients Trigger Dendrite Pruning in Drosophila 
Sensory Neurons. Science (80- ) 340:1475–1478. 
Kempermann G, Song H, Gage FH (2015) Neurogenesis in the Adult Hippocampus. 
Keramati M, Dezfouli A, Piray P (2011) Speed/accuracy trade-off between the 
habitual and the goal-directed processes. PLoS Comput Biol 7. 
283 
 
Kiernan MJ, Westbrook RF (1993) Effects of exposure to a to-be-shocked 
environment upon the rat’s freezing response: Evidence for facilitation, latent 
inhibition, and perceptual learning. Q J Exp Psychol Sect B 46:271–288. 
Kim J, Rison R, Fanselow MS (1993) Effects of Amygdala, Hippocampus and 
Periaqueductal Gray lesions on Short- and Long-Term Contextual Fear. :1093–1098. 
Kirov G, Rujescu D, Ingason A, Collier DA, O’Donovan MC, Owen MJ (2009) 
Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 35:851–854. 
Kirtley A, Thomas KL (2010) The exclusive induction of extinction is gated by BDNF. 
Learn Mem 17:612–619. 
Klugbauer N, Dai S, Specht V, Lacinová L, Marais E, Bohn G, Hofmann F (2000) A 
family of gamma-like calcium channel subunits. FEBS Lett 470:189–197. 
Klugbauer N, Lacinová L, Marais E, Hobom M, Hofmann F (1999) Molecular diversity 
of the calcium channel alpha2delta subunit. J Neurosci 19:684–691. 
Kolomeets NS, Uranova NA (1999) Synaptic contacts in schizophrenia: study with 
immunocytochemical identification of dopaminergic neurons. Neurosci Behav Physiol 
29:217–221. 
Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J (2001) 
α1D (Cav1.3) Subunits Can Form L-type Ca2+ Channels Activating at Negative 
Voltages. J Biol Chem 276:22100–22106. 
Kramer A a., Ingraham NE, Sharpe EJ, Mynlieff M (2012) Levels of CaV1.2 L-Type 
Ca2+ Channels Peak in the First Two Weeks in Rat Hippocampus Whereas CaV1.3 
Channels Steadily Increase through Development. J Signal Transduct 2012:1–11. 
Kuniyasu  a, Oka K, Ide-Yamada T, Hatanaka Y, Abe T, Nakayama H, Kanaoka Y 
(1992) Structural characterization of the dihydropyridine receptor-linked calcium 
channel from porcine heart. J Biochem 112:235–242. 
284 
 
Kuzmin A, Zvartau E, Gessa GL, Martellotta MC, Fratta W (1992) Calcium 
antagonists isradipine and nimodipine suppress cocaine and morphine intravenous 
self-administration in drug-naive mice. Pharmacol Biochem Behav 41:497–500. 
Lanahan A, Worley P (1998) Immediate-Early Genes and Synaptic Function. 
Neurobiol Learn Mem 70:37–43. 
Lancaster TM, Heerey E a, Mantripragada K, Linden DEJ (2014) CACNA1C risk 
variant affects reward responsiveness in healthy individuals. Transl Psychiatry 
4:e461. 
Lancaster TM, Ihssen N, Brindley LM, Tansey KE, Mantripragada K, O’Donovan MC, 
Owen MJ, Linden DEJ (2015) Associations between polygenic risk for schizophrenia 
and brain function during probabilistic learning in healthy individuals. Hum Brain 
Mapp 0. 
Lanciego JL, Luquin N, Obeso JA (2012) Functional neuroanatomy of the basal 
ganglia. Cold Spring Harb Perspect Med 2:1–20. 
Langwieser N, Christel CJ, Kleppisch T, Hofmann F, Wotjak CT, Moosmang S (2010) 
Homeostatic switch in hebbian plasticity and fear learning after sustained loss of 
Cav1.2 calcium channels. J Neurosci 30:8367–8375. 
Lashgari R, Motamedi F, Zahedi Asl S, Shahidi S, Komaki A (2006) Behavioral and 
electrophysiological studies of chronic oral administration of L-type calcium channel 
blocker verapamil on learning and memory in rats. Behav Brain Res 171:324–328. 
Laviolette SR, Grace AA (2006) The roles of cannabinoid and dopamine receptor 
systems in neural emotional learning circuits: Implications for schizophrenia and 
addiction. Cell Mol Life Sci 63:1597–1613. 
Leal G, Afonso PM, Salazar IL, Duarte CB (2014) Regulation of hippocampal synaptic 
plasticity by BDNF. Brain Res:1–20. 
285 
 
LeDoux J (2003) The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 
23:727–738. 
Lee  a S, Ra S, Rajadhyaksha AM, Britt JK, De Jesus-Cortes H, Gonzales KL, Lee  
a, Moosmang S, Hofmann F, Pieper  a a, Rajadhyaksha AM (2012) Forebrain 
elimination of cacna1c mediates anxiety-like behavior in mice. Mol Psychiatry 
17:1054–1055. 
Lee AS, De Jesus-Cortes H, Kabir ZD, Knobbe W, Orr M, Burgdorf C, Huntington P, 
McDaniel L, Britt JK, Hoffmann F, Brat DJ, Rajadhyaksha AM, Pieper AA (2016) The 
neuropsychiatric disease-associated gene cacna1c mediates survival of young 
hippocampal neurons. eNeuro 3:ENEURO.0006-16.2016. 
Lee B, Groman S, London ED, Jentsch JD (2007) Dopamine D2/D3 Receptors Play 
a Specific Role in the Reversal of a Learned Visual Discrimination in Monkeys. 
Neuropsychopharmacology 32:2125–2134. 
Lee J, Duan W, Mattson MP (2002) Evidence that brain-derived neurotrophic factor 
is required for basal neurogenesis and mediates, in part, the enhancement of 
neurogenesis by dietary restriction in the hippocampus of adult mice. J Neurochem 
82:1367–1375. 
Lee JLC, Everitt BJ, Thomas KL (2004) Independent cellular processes for 
hippocampal memory consolidation and reconsolidation. Science 304:839–843. 
Lee SH et al. (2013) Genetic relationship between five psychiatric disorders 
estimated from genome-wide SNPs. Nat Genet 45:984–994. 
Leeson VC, Robbins TW, Matheson E, Hutton SB, Ron MA, Barnes TRE, Joyce EM 
(2009) Discrimination Learning, Reversal, and Set-Shifting in First-Episode 
Schizophrenia: Stability Over Six Years and Specific Associations with Medication 
Type and Disorganization Syndrome. Biol Psychiatry 66:586–593. 
286 
 
Leitch B, Szostek A, Lin R, Shevtsova O (2009) Subcellular distribution of L-type 
calcium channel subtypes in rat hippocampal neurons. Neuroscience 164:641–657. 
Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L, Cornblatt BA 
(2006) Generalized and Specific Neurocognitive Deficits in Prodromal Schizophrenia. 
Biol Psychiatry 59:863–871. 
Licata SC, Freeman AY, Pierce-Bancroft AF, Pierce RC (2000) Repeated stimulation 
of L-type calcium channels in the rat ventral tegmental area mimics the initiation of 
behavioral sensitization to cocaine. Psychopharmacology (Berl) 152:110–118. 
Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM 
(2009) Common genetic determinants of schizophrenia and bipolar disorder in 
Swedish families: a population-based study. Lancet 373:234–239. 
Lipscombe D (2004) L-Type Calcium Channels: The Low Down. J Neurophysiol 
92:2633–2641. 
Lissek S, Powers AS, McClure EB, Phelps EA, Woldehawariat G, Grillon C, Pine DS 
(2005) Classical fear conditioning in the anxiety disorders: A meta-analysis. Behav 
Res Ther 43:1391–1424. 
Liu IYC, Lyons WE, Mamounas LA, Thompson RF (2004) Brain-Derived Neurotrophic 
Factor Plays a Critical Role in Contextual Fear Conditioning. Animals 24:7958–7963. 
Lonergan ME, Gafford GM, Jarome TJ, Helmstetter FJ (2010) Time-dependent 
expression of arc and Zif268 after acquisition of fear conditioning. Neural Plast 
2010:8–11. 
Lu Y, Christian K, Lu B (2008) BDNF: A key regulator for protein synthesis-dependent 
LTP and long-term memory? Neurobiol Learn Mem 89:312–323. 
Lubin FD, Roth TL, Sweatt JD (2008) Epigenetic regulation of BDNF gene 
transcription in the consolidation of fear memory. J Neurosci 28:10576–10586. 
287 
 
Lubow RE (1973) Latent inhibition. Psychol Bull 79:398–407. 
Lubow RE, Weiner I, Schlossberg A, Barauch I (1987) Latent inhibition and 
schizophrenia. Bull Psychon Soc 25:464–467. 
Lupien SJ, McEwen BS, Gunnar MR, Heim C (2009) Effects of stress throughout the 
lifespan on the brain, behaviour and cognition. Nat Rev Neurosci 10:434–445. 
Mamiya N, Fukushima H, Suzuki A, Matsuyama Z, Homma S, Frankland PW, Kida S 
(2009) Brain region-specific gene expression activation required for reconsolidation 
and extinction of contextual fear memory. J Neurosci 29:402–413. 
Manning EE, Halberstadt AL, van den Buuse M (2015) BDNF-Deficient Mice Show 
Reduced Psychosis-Related Behaviors Following Chronic Methamphetamine. Int J 
Neuropsychopharmacol:1–5. 
Mar AC, Horner AE, Bussey TJ (2014) Europe PMC Funders Group The touchscreen 
operant platform for assessing executive function in rats and mice. 8:1985–2005. 
Marschallinger J, Sah A, Schmuckermair C, Unger M, Rotheneichner P, Kharitonova 
M, Waclawiczek A, Gerner P, Jaksch-Bogensperger H, Berger S, Striessnig J, 
Singewald N, Couillard-Despres S, Aigner L (2015) The L-type calcium channel 
Cav1.3 is required for proper hippocampal neurogenesis and cognitive functions. Cell 
Calcium 58:606–616. 
Matus-Amat P, Higgins E a, Barrientos RM, Rudy JW (2004) The role of the dorsal 
hippocampus in the acquisition and retrieval of context memory representations. J 
Neurosci 24:2431–2439. 
McKenzie M, Henders AK, Caracella A, Wray NR, Powell JE (2014) Overlap of 
expression quantitative trait loci (eQTL) in human brain and blood. BMC Med 
Genomics 7:31. 
288 
 
McKinney BC, Murphy GG (2006) The L-Type voltage-gated calcium channel Cav1.3 
mediates consolidation, but not extinction, of contextually conditioned fear in mice. 
Learn Mem 13:584–589. 
Mckinney BC, Sze W, White JA, Murphy GG (2008) L-type voltage-gated calcium 
channels in conditioned fear : A genetic and pharmacological analysis. :326–334. 
McKirdy J, Sussmann JED, Hall J, Lawrie SM, Johnstone EC, McIntosh  a M (2009) 
Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. 
Psychol Med 39:1289–1293. 
McLaren IPL, Mackintosh NJ (2000) An elemental model of associative learning: I. 
Latent inhibition and perceptual learning. Anim Learn {&} Behav 28:211–246. 
McLean SL, Idris NF, Woolley ML, Neill JC (2009) D1-like receptor activation 
improves PCP-induced cognitive deficits in animal models: Implications for 
mechanisms of improved cognitive function in schizophrenia. Eur 
Neuropsychopharmacol 19:440–450. 
Mehta MA, Swainson R, Ogilvie AD, Sahakian B, Robbins TW (2001) Improved short-
term spatial memory but impaired reversal learning following the dopamine D2 
agonist bromocriptine in human volunteers. Psychopharmacology (Berl) 159:10–20. 
Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine 
on cognitive function in schizophrenia. Schizophr Bull 25:233–255. 
Millan MJ et al. (2012) Cognitive dysfunction in psychiatric disorders : characteristics, 
causes and the quest for improved therapy. 11. 
Mirenowicz J, Schultz W (1996) Preferential activation of midbrain dopamine neurons 
by appetitive rather than aversive stimuli. Nature 379:449–451. 
289 
 
Missler M, Zhang W, Rohlmann A, Kattenstroth G, Hammer RE, Gottmann K, Südhof 
TC (2003) Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. 
Nature 423:939–948. 
Mizuno K, Dempster E, Mill J, Giese KP (2012) Long-lasting regulation of 
hippocampal Bdnf gene transcription after contextual fear conditioning. Genes, Brain 
Behav 11:651–659. 
Moosmang S, Haider N, Klugbauer N, Adelsberger H, Langwieser N, Müller J, Stiess 
M, Marais E, Schulla V, Lacinova L, Goebbels S, Nave K-A, Storm DR, Hofmann F, 
Kleppisch T (2005) Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-
independent synaptic plasticity and spatial memory. J Neurosci 25:9883–9892. 
Morton RA, Norlin MS, Vollmer CC, Valenzuela CF (2013) Characterization of L-type 
voltage-gated Ca2+ channel expression and function in developing CA3 pyramidal 
neurons. Neuroscience 238:59–70. 
Moskvina V, Craddock N, Holmans P, Nikolov I, Pahwa JS, Green E, Owen MJ, 
O’Donovan MC (2009) Gene-wide analyses of genome-wide association data sets: 
evidence for multiple common risk alleles for schizophrenia and bipolar disorder and 
for overlap in genetic risk. Mol Psychiatry 14:252–260. 
Murphy TH, Worley PF, Baraban JM (1991) L-type voltage-sensitive calcium 
channels mediate synaptic activation of immediate early genes. Neuron 7:625–635. 
Murray GK, Cheng F, Clark L, Barnett JH, Blackwell AD, Fletcher PC, Robbins TW, 
Bullmore ET, Jones PB (2008a) Reinforcement and reversal learning in first-episode 
psychosis. Schizophr Bull 34:848–855. 
Murray GK, Corlett PR, Clark L, Pessiglione M, Blackwell AD, Honey G, Jones PB, 
Bullmore ET, Robbins TW, Fletcher PC (2008b) Substantia nigra/ventral tegmental 
reward prediction error disruption in psychosis. Mol Psychiatry 13:239, 267–276. 
290 
 
Muth JN, Varadi G, Schwartz  a (2001) Use of transgenic mice to study voltage-
dependent Ca2+ channels. Trends Pharmacol Sci 22:526–532. 
Myers KM, Davis M (2002) Behavioral and neural analysis of extinction. Neuron 
36:567–584. 
Nader K (2003) Memory traces unbound. Trends Neurosci 26:65–72. 
Nader K, Schafe GE, Le Doux JE (2000) Fear memories require protein synthesis in 
the amygdala for reconsolidation after retrieval. Nature 406:722–726. 
Narita M, Aoki K, Takagi M, Yajima Y, Suzuki T (2003) Implication of brain-derived 
neurotrophic factor in the release of dopamine and dopamine-related behaviors 
induced by methamphetamine. Neuroscience 119:767–775. 
Nicolae DL, Gamazon E, Zhang W, Duan S, Eileen Dolan M, Cox NJ (2010) Trait-
associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from 
GWAS. PLoS Genet 6. 
Nicoll RA, Tomita S, Bredt DS (2006) Auxiliary Subunits Assist AMPA-Type 
Glutamate Receptors. Science (80- ) 311:1253 LP-1256. 
Nieratschker V, Brückmann C, Plewnia C (2015) CACNA1C risk variant affects facial 
emotion recognition in healthy individuals. Sci Rep 5:17349. 
Nithianantharajah J, Komiyama NH, McKechanie A, Johnstone M, Blackwood DH, St 
Clair D, Emes RD, van de Lagemaat LN, Saksida LM, Bussey TJ, Grant SGN (2013) 
Synaptic scaffold evolution generated components of vertebrate cognitive 
complexity. Nat Neurosci 16:16–24. 
Nordström A-L, Farde L, Wiesel F-A, Forslund K, Pauli S, Halldin C, Uppfeldt G 
(1993) Central D2-dopamine receptor occupancy in relation to antipsychotic drug 
effects: A double-blind PET study of schizophrenic patients. Biol Psychiatry 33:227–
235. 
291 
 
Nyegaard M, Demontis D, Foldager L, Hedemand  a, Flint TJ, Sørensen KM, 
Andersen PS, Nordentoft M, Werge T, Pedersen CB, Hougaard DM, Mortensen PB, 
Mors O, Børglum  a D (2010) CACNA1C (rs1006737) is associated with 
schizophrenia. Mol Psychiatry 15:119–121. 
Østergaard SD, Bertelsen A, Nielsen J, Mors O, Petrides G (2013) The association 
between psychotic mania, psychotic depression and mixed affective episodes among 
14,529 patients with bipolar disorder. J Affect Disord 147:44–50. 
Otto T, Eichenbaum H, Wiener SI, Wible CG (1991) Learning-related Patterns of CAl 
Spike Trains Parallel Stimulation Parameters Optimal for Inducing Hippocampal 
Long- term Potentiation. Hippocampus 1:181–192. 
Pabo CO, Peisach E, Grant RA (2001) DESIGN AND SELECTION OF NOVEL 
CYS2HIS2 ZINC FINGER PROTEINS. Annu Rev Biochem 70:313–340. 
Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung W-H, 
Hempstead BL, Lu B (2004) Cleavage of proBDNF by tPA/Plasmin Is Essential for 
Long-Term Hippocampal Plasticity. Science (80- ) 306:487–491. 
Park H, Poo MM (2013) Neurotrophin regulation of neural circuit development and 
function. Nat Rev Neurosci 14:7–23. 
Pattabiraman PP, Tropea D, Chiaruttini C, Tongiorgi E, Cattaneo A, Domenici L 
(2005) Neuronal activity regulates the developmental expression and subcellular 
localization of cortical BDNF mRNA isoforms in vivo. Mol Cell Neurosci 28:556–570. 
Paulus FM, Bedenbender J, Krach S, Pyka M, Krug A, Sommer J, Mette M, Nöthen 
MM, Witt SH, Rietschel M, Kircher T, Jansen A (2013) Association of rs1006737 in 
CACNA1C with alterations in prefrontal activation and fronto-hippocampal 
connectivity. Hum Brain Mapp 0:1–11. 
Pavlov IP, Anrep G V (2012) Conditioned Reflexes. Dover Publications. 
292 
 
Peralta V, Cuesta MJ (2011) Eugen bleuler and the schizophrenias: 100 Years after. 
Schizophr Bull 37:1118–1120. 
Perez-Reyes E (2003) Molecular physiology of low-voltage-activated t-type calcium 
channels. Physiol Rev 83:117–161. 
Peterson BZ, DeMaria CD, Yue DT (1999) Calmodulin is the Ca 2+  sensor for Ca 2+ 
-dependent inactivation of L-type calcium channels. Neuron 22:549–558. 
Phillips ML, Ladouceur CD, Drevets WC (2008) A neural model of voluntary and 
automatic emotion regulation: implications for understanding the pathophysiology 
and neurodevelopment of bipolar disorder. Mol Psychiatry 13:829, 833–857. 
Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and 
hippocampus to cued and contextual fear conditioning. BehavNeurosci 106:274–285. 
Pocklington AJ, Rees E, Walters JTR, Han J, Kavanagh DH, Chambert K, Holmans 
P, Moran JL, McCarroll S a., Kirov G, Donovan MCO, Owen MJ (2015) Novel 
Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in 
Schizophrenia. Neuron 86:1203–1214. 
Porcelli S, Lee S-J, Han C, Patkar A a., Serretti A, Pae C-U (2015) CACNA1C gene 
and schizophrenia. Psychiatr Genet 25:163–167. 
Pragnell M, De Waard M, Mori Y, Tanabe T, Snutch TP, Campbell KP (1994) Calcium 
channel beta-subunit binds to a conserved motif in the I-II cytoplasmic linker of the 
alpha 1-subunit. Nature 368:67–70. 
Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of 
drugs on anxiety-like behaviors: A review. Eur J Pharmacol 463:3–33. 
Pryce CR, Feldon J (2003) Long-term neurobehavioural impact of the postnatal 
environment in rats: manipulations, effects and mediating mechanisms. Neurosci 
Biobehav Rev 27:57–71. 
293 
 
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, Maller J, 
Sklar P, de Bakker PIW, Daly MJ, Sham PC (2007) PLINK: A tool set for whole-
genome association and population-based linkage analyses. Am J Hum Genet 
81:559–575. 
Purcell SM et al. (2014a) A polygenic burden of rare disruptive mutations in 
schizophrenia. Nature. 
Purcell SM et al. (2014b) A polygenic burden of rare disruptive mutations in 
schizophrenia. Nature 506:185–190. 
Quartermain D, deSoria VG, Kwan  a (2001) Calcium channel antagonists enhance 
retention of passive avoidance and maze learning in mice. Neurobiol Learn Mem 
75:77–90. 
Quinn EM, Hill M, Anney R, Gill M, Corvin AP, Morris DW (2010) Evidence for cis-
acting regulation of ANK3 and CACNA1C gene expression. Bipolar Disord 12:440–
445. 
Quirk GJ (2002) Memory for Extinction of Conditioned Fear Is Long-lasting and 
Persists Following Spontaneous Recovery. Learn Mem 9:402–407. 
Quirk GJ, Mueller D (2008) Neural mechanisms of extinction learning and retrieval. 
Neuropsychopharmacology 33:56–72. 
Ragozzino ME (2007) The contribution of the medial prefrontal cortex, orbitofrontal 
cortex, and dorsomedial striatum to behavioral flexibility. In: Annals of the New York 
Academy of Sciences. 
Ramnania N, Elliotta R, Athwala B., Passinghama R. (2004) Prediction error for free 
monetary reward in the human prefrontal cortex. Neuroimage 23:777–786. 
Ramos A (2008) Animal models of anxiety: do I need multiple tests? Trends 
Pharmacol Sci 29:493–498. 
294 
 
Randall A, Tsien RW (1995) Pharmacological dissection of multiple types of Ca2+ 
channel currents in rat cerebellar granule neurons. J Neurosci 15:2995–3012. 
Rangel A, Camerer C, Montague PR (2008) A framework for studying the 
neurobiology of value-based decision making. Nat Rev Neurosci 9:545–556. 
Rascle C, Mazas O, Vaiva G, Tournant M, Raybois O, Goudemand M, Thomas P 
(2001) Clinical features of latent inhibition in schizophrenia. Schizophr Res 51:149–
161. 
Rattiner LM, Davis M, Ressler KJ (2004) Differential regulation of brain-derived 
neurotrophic factor transcripts during the consolidation of fear learning. Learn Mem 
11:727–731. 
Reading PJ, Dunnett SB, Robbins TW (1991) Dissociable roles of the ventral, medial 
and lateral striatum on the acquisition and performance of a complex visual stimulus-
response habit. Behav Brain Res 45:147–161. 
Reddy LF, Waltz JA, Green MF, Wynn JK, Horan WP (2016) Probabilistic Reversal 
Learning in Schizophrenia: Stability of Deficits and Potential Causal Mechanisms. 
Schizophr Bull 42:sbv226-. 
Redgrave P, Rodriguez M, Smith Y, Rodriguez-Oroz MC, Lehericy S, Bergman H, 
Agid Y, DeLong MR, Obeso JA (2010) Goal-directed and habitual control in the basal 
ganglia: implications for Parkinson’s disease. Nat Rev Neurosci 11:760–772. 
Reich DE, Cargill M, Bolk S, Ireland J, Sabeti PC, Richter DJ, Lavery T, Kouyoumjian 
R, Farhadian SF, Ward R, Lander ES (2001) Linkage disequilibrium in the human 
genome. Nature 411:199–204. 
Rescorla R a (1988) Pavlovian conditioning: It’s not what you think it is. Am Psychol 
43:151–160. 
295 
 
Richards AL, Jones L, Moskvina V, Kirov G, Gejman P V, Levinson DF, Sanders AR, 
Molecular Genetics of Schizophrenia C, International Schizophrenia C, Purcell S, 
Visscher PM, Craddock N, Owen MJ, Holmans P, O’Donovan MC (2012) 
Schizophrenia susceptibility alleles are enriched for alleles that affect gene 
expression in adult human brain. Mol Psychiatry 17:193–201. 
Ripke S et al. (2013) Genome-wide association analysis identifies 13 new risk loci for 
schizophrenia. Nat Genet 45:1150–1159. 
Ripke S et al. (2014) Biological insights from 108 schizophrenia-associated genetic 
loci. Nature 511:421–427. 
Rolstad S, Sellgren Majkowitz C, Joas E, Ekman CJ, Pålsson E, Landén M (2016) 
Polymorphisms of BDNF and CACNA1C are not associated with cognitive functioning 
in bipolar disorder or healthy controls. Cogn Neuropsychiatry 6805:1–8. 
Rosati B, Yan Q, Lee MS, Liou S-R, Ingalls B, Foell J, Kamp TJ, McKinnon D (2011) 
Robust L-type calcium current expression following heterozygous knockout of the 
Cav1.2 gene in adult mouse heart. J Physiol 589:3275–3288. 
Rousseaud A, Del??pine C, Nectoux J, Billuart P, Bienvenu T (2015) Differential 
Expression and Regulation of Brain-Derived Neurotrophic Factor (BDNF) mRNA 
Isoforms in Brain Cells from Mecp2308/y Mouse Model. J Mol Neurosci:758–767. 
Roussos P et al. (2014) A Role for Noncoding Variation in Schizophrenia. Cell Rep. 
Roussos P, Giakoumaki SG, Georgakopoulos A, Robakis NK, Bitsios P (2011) The 
CACNA1C and ANK3 risk alleles impact on affective personality traits and startle 
reactivity but not on cognition or gating in healthy males. Bipolar Disord 13:250–259. 
Rubeis S De, He X, Goldberg AP, Poultney CS, Samocha K (2014) Synaptic, 
transcriptional, and chromatin genes disrupted in autism A. Nature 515:209–215. 
296 
 
Rubin DC, Berntsen D, Bohni MK (2008) A memory-based model of posttraumatic 
stress disorder: Evaluating basic assumptions underlying the PTSD diagnosis. 
Psychol Rev 115:985–1011. 
Rudebeck PH, Murray EA (2008) Amygdala and Orbitofrontal Cortex Lesions 
Differentially Influence Choices during Object Reversal Learning. J Neurosci 
28:8338–8343. 
Rujescu D et al. (2009) Disruption of the neurexin 1 gene is associated with 
schizophrenia. Hum Mol Genet 18:988–996. 
Rupp A, Keith SJ (1993) The costs of schizophrenia. Assessing the burden. Psychiatr 
Clin North Am 38:51–59. 
Rushe TM, Woodruff PW, Murray RM, Morris RG (1999) Episodic memory and 
learning in patients with chronic schizophrenia. Schizophr Res 35:85–96. 
Sakata K, Martinowich K, Woo NH, Schloesser RJ, Jimenez D V, Ji Y, Shen L, Lu B 
(2013) Role of activity-dependent BDNF expression in hippocampal-prefrontal 
cortical regulation of behavioral perseverance. Proc Natl Acad Sci U S A 110:15103–
15108. 
Sakata K, Woo NH, Martinowich K, Greene JS, Schloesser RJ, Shen L, Lu B (2009) 
Critical role of promoter IV-driven BDNF transcription in GABAergic transmission and 
synaptic plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A 106:5942–5947. 
Salgado JV, Hetem LA, Vidal M, Graeff FG, Danion JM, Sandner G (2000) Reduction 
of latent inhibition by D-amphetamine in a conditioned suppression paradigm in 
humans. Behav Brain Res 117:61–67. 
Sandin M, Jasmin S, Levere TE (1990) Aging and cognition: facilitation of recent 
memory in aged nonhuman primates by nimodipine. Neurobiol Aging 11:573–575. 
297 
 
Saxe MD, Battaglia F, Wang J-W, Malleret G, David DJ, Monckton JE, Garcia ADR, 
Sofroniew M V, Kandel ER, Santarelli L, Hen R, Drew MR (2006) Ablation of 
hippocampal neurogenesis impairs contextual fear conditioning and synaptic 
plasticity in the dentate gyrus. Proc Natl Acad Sci U S A 103:17501–17506. 
Schlagenhauf F, Huys QJM, Deserno L, Rapp MA, Beck A, Heinze HJ, Dolan R, 
Heinz A (2014) Striatal dysfunction during reversal learning in unmedicated 
schizophrenia patients. Neuroimage 89:171–180. 
Schlick B, Flucher BE, Obermair GJ (2012) Voltage-Activated Calcium Channel 
Expression Profiles in Mouse Brain and Cultured Hippocampal Neurons. 
Neuroscience 167:786–798. 
Schmunk G, Gargus JJ (2013) Channelopathy pathogenesis in autism spectrum 
disorders. Front Genet 4:1–20. 
Schoenfeld TJ, Cameron HA (2015) Adult neurogenesis and mental illness. 
Neuropsychopharmacology 40:113–128. 
Schultz W (2000) Multiple reward signals in the brain. Nat Rev Neurosci 1:199–207. 
Schultz W (2006) Behavioral theories and the neurophysiology of reward. Annu Rev 
Psychol 57:87–115. 
Schultz W, Dayan P, Montague PR (1997) A Neural Substrate of Prediction and 
Reward. Science (80- ) 275:1593–1599. 
Schwabe L, Wolf OT (2009) Stress Prompts Habit Behavior in Humans. J Neurosci 
29:7191–7198. 
Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kühbandner S, Striessnig 
J, Klugbauer N, Feil R, Hofmann F (2000) Functional embryonic cardiomyocytes after 
disruption of the L-type α1C (Cav1.2) calcium channel gene in the mouse. J Biol 
Chem 275:39193–39199. 
298 
 
Seoane A, Massey P V, Keen H, Bashir ZI, Brown MW (2009) L-type voltage-
dependent calcium channel antagonists impair perirhinal long-term recognition 
memory and plasticity processes. J Neurosci 29:9534–9544. 
Seroogy KB, Lundgren KH, Tran TM, Guthrie KM, Isackson PJ, Gall CM (1994) 
Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic 
factor and neurotrophin-3 mRNAs. J Comp Neurol 342:321–334. 
Sheng M, Thompson M, Greenberg M (1991) CREB: a Ca(2+)-regulated transcription 
factor phosphorylated by calmodulin-dependent kinases. Science (80- ) 252:1427–
1430. 
Silverstone PH, Birkett L (2000) Diltiazem as augmentation therapy in patients with 
treatment-resistant bipolar disorder: A retrospective study. J Psychiatry Neurosci 
25:276–280. 
Simms BA, Zamponi GW (2014) Neuronal Voltage-Gated Calcium Channels: 
Structure, Function, and Dysfunction. Neuron 82:24–45. 
Simon AE, Cattapan-Ludewig K, Zmilacher S, Arbach D, Gruber K, Dvorsky DN, Roth 
B, Isler E, Zimmer A, Umbricht D (2007) Cognitive functioning in the schizophrenia 
prodrome. Schizophr Bull 33:761–771. 
Sinnegger-Brauns M, Huber I (2009) Expression and 1, 4-dihydropyridine-binding 
properties of brain L-type calcium channel isoforms. Mol Pharmacol 75:407–414. 
Sinnegger-Brauns MJ, Hetzenauer A, Huber IG, Renström E, Wietzorrek G, Berjukov 
S, Cavalli M, Walter D, Koschak A, Waldschütz R, Hering S, Bova S, Rorsman P, 
Pongs O, Singewald N, Striessnig J (2004) Isoform-specific regulation of mood 
behavior and pancreatic β cell and cardiovascular function by L-type Ca2+ channels. 
J Clin Invest 113:1430–1439. 
299 
 
Sklar P et al. (2008) Whole-genome association study of bipolar disorder. Mol 
Psychiatry 13:558–569. 
Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, 
Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao M V (2016) Exercise 
promotes the expression of brain derived neurotrophic factor (BDNF) through the 
action of the ketone body β-hydroxybutyrate. Elife 5:1–21. 
Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JI, Ripke S, 
Santangelo S, Sullivan PF (2013) Identification of risk loci with shared effects on five 
major psychiatric disorders: a genome-wide analysis. Lancet 381:1371–1379. 
Sokoloff P, Guillin O, Diaz J, Carroll P, Griffon N (2002) Brain-derived neurotrophic 
factor controls dopamine D3 receptor expression: Implications for 
neurodevelopmental psychiatric disorders. Neurotox Res 4:671–678. 
Solomon P, Crider A, Winkelman J, Turi A, Kamer R, Kaplan L (1981) Disrupted latent 
inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity: 
relationship to schizophrenic attention disorder. Biol Psychiatry 16:519–537. 
Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, 
Schwartz PJ, Joseph RM, Condouris K, Tager-Flusberg H, Priori SG, Sanguinetti MC, 
Keating MT (2004) CaV1.2 calcium channel dysfunction causes a multisystem 
disorder including arrhythmia and autism. Cell 119:19–31. 
Striessnig J, Koschak A (2008) Exploring the function and pharmacotherapeutic 
potential -of voltage-gated Ca 2+ channels with gene-knockout models. Channels 
2:233–251. 
Striessnig J, Koschak A, Sinnegger-Brauns MJ, Hetzenauer A, Nguyen NK, Busquet 
P, Pelster G, Singewald N (2006) Role of voltage-gated L-type Ca2+ channel 
isoforms for brain function. Biochem Soc Trans 34:903–909. 
300 
 
Striessnig J, Pinggera A, Kaur G, Bock G, Tuluc P (2014) L-type Ca2+ channels in 
heart and brain. Wiley Interdiscip Rev Membr Transp Signal 3:15–38. 
Stuber GD, Klanker M, de Ridder B, Bowers MS, Joosten RN, Feenstra MG, Bonci A 
(2008) Reward-predictive cues enhance excitatory synaptic strength onto midbrain 
dopamine neurons. Science (80- ) 321:1690–1692. 
Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a Complex Trait. Arch 
Gen Psychiatry 60:1187–1192. 
Sun P, Enslen H, Myung PS, Maurer RA (1994) Differential activation of CREB by 
Ca2+/calmodulin-dependent protein kinases type II and type IV involves 
phosphorylation of a site that negatively regulates activity. Genes Dev 8:2527–2539. 
Suzuki A, Mukawa T, Tsukagoshi A, Frankland PW, Kida S (2008) Activation of 
LVGCCs and CB1 receptors required for destabilization of reactivated contextual fear 
memories. Learn Mem 15:426–433. 
Swerdlow NR, Braff DL, Geyer M a (2000) Animal models of deficient sensorimotor 
gating: what we know, what we think we know, and what we hope to know soon. 
Behav Pharmacol 11:185–204. 
Swerdlow NR, Braff DL, Hartston H, Perry W, Geyer MA (1996) Latent inhibition in 
schizophrenia. Schizophr Res 20:91–103. 
Swerdlow NR, Weber M, Qu Y, Light GA, Braff DL (2008) Realistic expectations of 
prepulse inhibition in translational models for schizophrenia research. 
Tabuchi  a, Nakaoka R, Amano K, Yukimine M, Andoh T, Kuraishi Y, Tsuda M (2000) 
Differential activation of brain-derived neurotrophic factor gene promoters I and III by 
Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate 
receptor Ca2+ channels. J Biol Chem 275:17269–17275. 
301 
 
Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, Koizumi 
S, Wakabayashi K, Takahashi H, Someya T, Nawa H (2000) Abnormal expression of 
brain-derived neurotrophic factor and its receptor in the corticolimbic system of 
schizophrenic patients. Mol Psychiatry 5:293–300. 
Tang ZZ, Liang MC, Lu S, Yu D, Yu CY, Yue DT, Soong TW (2004a) Transcript 
scanning reveals novel and extensive splice variations in human L-type voltage-gated 
calcium channel, Cav1.2 ??1 subunit. J Biol Chem. 
Tang ZZ, Liang MC, Lu S, Yu D, Yu CY, Yue DT, Soong TW (2004b) Transcript 
scanning reveals novel and extensive splice variations in human l-type voltage-gated 
calcium channel, Cav1.2 alpha1 subunit. J Biol Chem 279:44335–44343. 
Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME (1998) Ca2+ influx 
regulates BDNF transcription by a CREB family transcription factor-dependent 
mechanism. Neuron 20:709–726. 
Tao X, West AE, Chen WG, Corfas G, Greenberg ME (2002) A calcium-responsive 
transcription factor, CaRF, that regulates neuronal activity-dependent expression of 
BDNF. Neuron 33:383–395. 
Terrillion CE (2015) CACNA1C Modulation of Mood Disorder Pathophysiology in the 
Mesolimbic Dopamine System. Unpubl thesis. 
Terry WS (1979) Habituation and dishabituation of rats’ exploration of a novel 
environment. Anim Learn Behav 7:525–536. 
Thiagarajan TC, Lindskog M, Tsien RW (2005) Adaptation to synaptic inactivity in 
hippocampal neurons. Neuron 47:725–737. 
Thoma P, Bellebaum C, Koch B, Schwarz M, Daum I (2008) The cerebellum is 
involved in reward-based reversal learning. Cerebellum. 
302 
 
Thomas K, Davis S, Laroche S, Hunt S (1994) Regulation of the expression of NR1 
NMDA glutamate receptor subunits during hippocampal LTP. Neuroreport 6:119–
123. 
Thomas KL, Davis S, Hunt SP, Thomas KL, Davis S, Hunt SP, Laroche S (1996) 
Alterations in the Expression of Specific Glutamate Receptor Subunits Following 
Hippocampal LXP in Vivo. :197–208. 
Tippens A, Pare J, Langwieser N, Moosmang S, Milner T, Smith Y, Lee A (2008) 
Ultrastructural evidence for pre- and postsynaptic localization of Cav1.2 L-type Ca2+ 
channels in the rat hippocampus. J Comp Neurol 506:569–583. 
Trabzuni D, Ryten M, Walker R, Smith C, Imran S, Ramasamy A, Weale ME, Hardy 
J (2011) Quality control parameters on a large dataset of regionally dissected human 
control brains for whole genome expression studies. J Neurochem 119:275–282. 
Treinys R, Jurevicius J (2008) L-type Ca2+ channels in the heart: structure and 
regulation. Medicina (Kaunas) 44:491–499. 
Trent S, Barnes P, Hall J, Thomas KL (2015) Rescue of long-term memory after 
reconsolidation blockade. Nat Commun 6:7897. 
Triggle DJ (2006) L-Type Calcium Channels. Curr Pharm Des 12:443–457. 
Triggle DJ (2007) Calcium channel antagonists: Clinical uses—Past, present and 
future. Biochem Pharmacol 74:1–9. 
Tucci V, Hardy A, Nolan PM (2006) A comparison of physiological and behavioural 
parameters in C57BL/6J mice undergoing food or water restriction regimes. Behav 
Brain Res 173:22–29. 
Vaitl D, Lipp O, Bauer U, Schüler G, Stark R, Zimmermann M, Kirsch P (2002) Latent 
inhibition and schizophrenia: Pavlovian conditioning of autonomic responses. 
Schizophr Res 55:147–158. 
303 
 
Valins S, Ray A (1967) EFFECTS OF COGNITIVE DESENSITIZATION ON 
AVOIDANCE BEHAVIOR. J Pers Soc Psychol 7:345–350. 
W. Wisden BM (1994) In situ Hybridization Protocols For the Brain (Biological 
Techniques). San Diego: Academic Press. 
Waelti P, Dickinson A, Schultz W (2001) Dopamine responses comply with basic 
assumptions of formal learning theory. Nature 412:43–48. 
Walker MP, Brakefield T, Allan Hobson J, Stickgold R (2003) Dissociable stages of 
human memory consolidation and reconsolidation. Nature 425:616–620. 
Waltz J a., Gold JM (2007a) Probabilistic reversal learning impairments in 
schizophrenia: Further evidence of orbitofrontal dysfunction. Schizophr Res 93:296–
303. 
Waltz JA, Gold JM (2007b) Probabilistic reversal learning impairments in 
schizophrenia: Further evidence of orbitofrontal dysfunction. Schizophr Res 93:296–
303. 
Wang S-H, Finnie PSB, Hardt O, Nader K (2012) Dorsal hippocampus is necessary 
for novel learning but sufficient for subsequent similar learning. Hippocampus 
22:2157–2170. 
Warburton CE, Joseph MH, Feldon J, Weiner I, Gray JA (1994) Antagonism of 
amphetamine-induced disruption of latent inhibition in rats by haloperidol and 
ondansetron: Implications for a possible antipsychotic action of ondansetron. 
Psychopharmacology (Berl) 114:657–664. 
Waterhouse EG, Xu B (2009) New insights into the role of brain-derived neurotrophic 
factor in synaptic plasticity. Mol Cell Neurosci 42:81–89. 
304 
 
Weickert CS, Hyde TM, Lipska BK, Herman MM, Weinberger DR, Kleinman JE 
(2003) Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with 
schizophrenia. Mol Psychiatry 8:592–610. 
Weiner I, Lubow RE, Feldon J (1984) Abolition of the expression but not the 
acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology 
(Berl) 83:194–199. 
Weiner I, Lubow RE, Feldon J (1988) Disruption of latent inhibition by acute 
administration of low doses of amphetamine. Pharmacol Biochem Behav 30:871–
878. 
Weisskopf MG, Bauer EP, LeDoux JE (1999) L-type voltage-gated calcium channels 
mediate NMDA-independent associative long-term potentiation at thalamic input 
synapses to the amygdala. J Neurosci 19:10512–10519. 
Welling A, Kwan YW, Bosse E, Flockerzi V, Hofmann F, Kass RS (1993) Subunit-
dependent modulation of recombinant L-type calcium channels. Molecular basis for 
dihydropyridine tissue selectivity. Circ Res 73:974–980. 
Wessa M, Linke J, Witt SH, Nieratschker V, Esslinger C, Kirsch P, Grimm O, 
Hennerici MG, Gass A, King A V., Rietschel M (2010) The CACNA1C risk variant for 
bipolar disorder influences limbic activity. Mol Psychiatry 15:1126–1127. 
West  a E, Chen WG, Dalva MB, Dolmetsch RE, Kornhauser JM, Shaywitz  a J, 
Takasu M a, Tao X, Greenberg ME (2001) Calcium regulation of neuronal gene 
expression. Proc Natl Acad Sci U S A 98:11024–11031. 
Wheeler DG, Barrett CF, Tsien RW (2006) L-type calcium channel ligands block 
nicotine-induced signaling to CREB by inhibiting nicotinic receptors. 
Neuropharmacology 51:27–36. 
305 
 
White J a, McKinney BC, John MC, Powers P a, Kamp TJ, Murphy GG (2008) 
Conditional forebrain deletion of the L-type calcium channel Ca V 1.2 disrupts remote 
spatial memories in mice. Learn Mem 15:1–5. 
Wiegert JS, Bading H (2011) Activity-dependent calcium signaling and ERK-MAP 
kinases in neurons: A link to structural plasticity of the nucleus and gene transcription 
regulation. Cell Calcium 49:296–305. 
Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer M a, Robbins TW (1994) Social 
isolation in the rat produces developmentally specific deficits in prepulse inhibition of 
the acoustic startle response without disrupting latent inhibition. 
Neuropsychopharmacology 10:61–72. 
Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483–494. 
Woo NH, Teng HK, Siao C-J, Chiaruttini C, Pang PT, Milner T a, Hempstead BL, Lu 
B (2005) Activation of p75NTR by proBDNF facilitates hippocampal long-term 
depression. Nat Neurosci 8:1069–1077. 
Würbel H (2001) Ideal homes? Housing effects on rodent brain and behaviour. 
Trends Neurosci 24:207–211. 
Xavier GF, Saito MIP, Stein C (1991) Habituation of exploratory activity to new stimuli, 
to the absence of a previously presented stimulus and to new contexts, in rats. Q J 
Exp Psychol Sect B 43:157–175. 
Xu W, Lipscombe D (2001) Neuronal Ca(V)1.3alpha(1) L-type channels activate at 
relatively hyperpolarized membrane potentials and are incompletely inhibited by 
dihydropyridines. J Neurosci 21:5944–5951. 
Yasuda R, Sabatini BL, Svoboda K (2003) Plasticity of calcium channels in dendritic 
spines. Nat Neurosci 6:948–955. 
306 
 
Yasumoto F, Negishi T, Ishii Y, Kyuwa S, Kuroda Y, Yoshikawa Y (2004) Dopamine 
receptor 2 regulates L-type voltage-gated calcium channel in primary cultured mouse 
midbrain neural network. Cell Mol Neurobiol 24:877–882. 
Ying S, Futter M, Rosenblum K, Webber MJ, Hunt SP, Bliss TVP, Bramham CR 
(2002) Brain-Derived Neurotrophic Factor Induces Long-Term Potentiation in Intact 
Adult Hippocampus : Requirement for ERK Activation Coupled to CREB and 
Upregulation of Arc Synthesis. J Neurosci 22:1532–1540. 
Yoshimizu T, Pan JQ, Mungenast  a E, Madison JM, Su S, Ketterman J, Ongur D, 
McPhie D, Cohen B, Perlis R, Tsai L-H (2014) Functional implications of a psychiatric 
risk variant within CACNA1C in induced human neurons. Mol Psychiatry:1–8. 
Young  a M, Joseph MH, Gray J a (1993) Latent inhibition of conditioned dopamine 
release in rat nucleus accumbens. Neuroscience 54:5–9. 
Young AMJ, Moran PM, Joseph MH (2005) The role of dopamine in conditioning and 
latent inhibition: What, when, where and how? Neurosci Biobehav Rev 29:963–976. 
Zhang Q, Shen Q, Xu Z, Chen M, Cheng L, Zhai J, Gu H, Bao X, Chen X, Wang K, 
Deng X, Ji F, Liu C, Li J, Dong Q, Chen C (2012) The effects of CACNA1C gene 
polymorphism on spatial working memory in both healthy controls and patients with 
schizophrenia or bipolar disorder. Neuropsychopharmacology 37:677–684. 
Zhang Z, Xu Y, Song H, Rodriguez J, Tuteja D, Namkung Y, Shin HS, Chiamvimonvat 
N (2002) Functional roles of Cav1.3 (??1D) calcium channel in sinoatrial nodes: 
Insight gained using gene-targeted null mutant mice. Circ Res 90:981–987. 
Zheng F, Luo Y, Wang H (2009) Regulation of brain-derived neurotrophic factor-
mediated transcription of the immediate early gene Arc by intracellular calcium and 
calmodulin. J Neurosci Res 87:380–392. 
307 
 
Zheng F, Zhou X, Luo Y, Xiao H, Wayman G, Wang H (2011) Regulation of brain-
derived neurotrophic factor exon IV transcription through calcium responsive 
elements in cortical neurons. PLoS One 6:e28441. 
Zheng F, Zhou X, Moon C, Wang H (2012) Regulation of brain-derived neurotrophic 
factor expression in neurons. Int J Physiol Pathophysiol Pharmacol 4:188–200. 
Zuccotti A, Clementi S, Reinbothe T, Torrente A, Vandael DH, Pirone A (2011) 
Structural and functional differences between L-type calcium channels: crucial issues 
for future selective targeting. Trends Pharmacol Sci 32:366–375. 
 
